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Preface 
 
Neuroimaging methodologies continue to develop at a remarkable rate, providing 
ever more sophisticated techniques for investigating brain structure and function. The 
scope of this book is not to provide a comprehensive overview of methods and 
applications but to provide a “snapshot” of current approaches using well established 
and newly emerging techniques. Taken together, these chapters provide a broad sense 
of how the limits of what is achievable with neuroimaging methods are being 
stretched. In cognitive neuroscience research, however, it is increasingly recognised 
that key theoretical debates about brain function are only likely to be resolved with 
reference to converging evidence from a range of methods. All neuroimaging 
techniques have important limitations which should always be acknowledged. For 
example, functional magnetic resonance imaging (fMRI) is a correlational, indirect 
method of measuring brain activation and interpretation of signal should always 
reflect this fact. Spatial resolution and sensitivity is improving with the commercial 
availability of ultra-high field human scanners, but a single voxel (the smallest unit of 
measurement) still corresponds to many thousands of individual neurons. 
Haemodynamic response to input is slow (in the order of seconds) and the 
relationship between this function and neural activity remains incompletely 
understood. Furthermore, choice of image preprocessing parameters can appear 
somewhat arbitrary and an obvious rationale for selection of statistical thresholds, 
correction for multiple corrections, etc. at the analysis stage can likewise be lacking. 
Therefore, to advance our knowledge about the neural bases of cognition, rigorous 
methodological control, well developed theory with testable predictions, and 
inferences drawn on the basis of a range of methods is likely to be required. 
The first chapter (Zago, Lorusso and Priori) provides an informative (and sometimes 
surprising) historical overview of functional neuroimaging techniques, drawing a 
direct line of influence from cerebral thermometry and brain “pulsation” recordings 
through Roy and Sherrington’s late eighteenth century studies linking neural activity 
with energy consumption and blood flow to the development of photon emission 
tomography (PET), computed tomography (CT), and measurement of the blood-
oxygen-level dependent effect with magnetic resonance imaging (MRI). Chapter 2 
(Nierhaus, Margulies, Long and Villringer) provides a brief but excellent introduction 
to the BOLD effect and a more comprehensive consideration of functional connectivity 
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with specific reference to measurement of baseline or so called “resting state” 
networks. Principles and applications of functional near-infrared spectroscopy (fNIRS) 
are presented by León-Carrión and León-Domínguez (Chapter 3).  These authors 
provide a strong case for more widespread application of fNIRS in a range of clinical 
populations and conditions. The size and portability of fNIRS devices provides 
opportunities for enhancing ecological validity of research investigations (in 
comparison to the restrictive conditions of fMRI), an argument also proposed by 
Tsunashima, Yanagisawa and Iwadate (Chapter 4). Tsunashima et al. provide a 
detailed consideration of NIRS signal analysis and offer a direct comparison of NIRS 
and fMRI data associated with systematic variations in cognitive demand. 
Neuroinformatics is concerned with advancing neuroscience through a process of 
sharing and integrating data and techniques across all levels and scales of 
investigation. Schwabe (Chapter 5) argues convincingly for the importance of 
neuroinformatics tools, able to accommodate a range of spatial and temporal scales, 
for the development of detailed computational models of complex cognitive functions. 
Karanasiou (Chapter 6) discusses strengths and limitations associated with 
multimodal data acquisition (including simultaneous fMRI and 
electroencephalography (EEG), fNIRS with EEG, magnetoencephalography (MEG) 
with fNIRS, and fMRI with fNIRS) and also considers the viability and potential for 
integrating optogenetics with fMRI (ofMRI). 
Diffusion tensor imaging is an MRI technique used to characterise white matter, 
specifically the directionality of pathways (or “tracts”). Visualisation of these tracts 
therefore provides the opportunity for examining structural connectivity in vivo. 
Lanyon (Chapter 7) presents an excellent overview of this technique, including 
consideration of its application for clinical diagnostic purposes. Transcranial magnetic 
stimulation (TMS) offers a number of important potential advantages over the classical 
neuropsychological (lesion-behaviour) approach to understanding neural basis of 
cognition. Through the creation of a “virtual lesion” in normal participants, the 
potential issues of cortical reorganisation, additional pathological substrates, distal 
pressure effects, psychiatric factors etc. in patient populations are avoided. 
Additionally, there is a great advantage in being able to study the same participants in 
control (i.e., pre-“lesion”) and experimental (post-“lesion”) conditions. Clinically, 
repetitive transcranial magnetic stimulation (rTMS) has proved successful (although 
not in all cases) in the treatment of a range of neurological or psychiatric conditions 
through the excitation or inhibition of target areas. However, among a number of 
methodological and interpretative challenges, perhaps the most critical is placement 
precision of the TMS coil. Andoh and Martinot (Chapter 8) present a validated and 
freely available triangulation-based MRI-guided manual method for ensuring accurate 
coil placement. 
Mishra et al. (Chapter 9) describe in vivo neuronal tract tracing in the rat brain using 
biocytin-based tracers which clearly indicated their suitability for visualising cortical 
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connectivity under MRI. Their research provides compelling evidence for the 
suitability of newly synthesized imaging probes for detecting and quantifying 
distributed tracer uptake across the cortex. Puri and Treasaden (Chapter 10) describe 
limitations of using conventional 31-phosphorus neurospectroscopy for quantifying 
membrane phospholipid metabolism (estimated indirectly by the ratio of 
phosphomonoesters to phosphodiesters). Rather than focusing on signals associated 
with narrow resonances, the authors argue that the broad component in the 31-
phosphorous neurospectroscopy signal offers a more direct measure of brain cell 
membrane motion-restricted phospholipids. 
Modern cranial ultrasound provides a number of advantages over neuroimaging 
methods such as MRI and CT, particularly with respect to costs and clinical 
practicalities of assessing intracranial pathology in gravely ill infants. Fickenscher, 
Bailey, Saettele, Dahl, and Lowe (Chapter 11) present a highly detailed overview of the 
approach which benefits greatly from the beautifully presented figures outlining 
normal and abnormal structure.   
Level of recovery in survivors of ischemic stroke is highly variable and contingent 
upon success and speed with which blood flow can be restored to the affected area. 
Recovery can be gradual (months or even years), consistent with cerebral plasticity, 
i.e., the capacity for the structure and function of unaffected brain regions (e.g., the 
homologous contralesional site) to adapt to the behavioural or motor consequences of 
the stroke. Lindenberg and Seitz (Chapter 12) describe methodological issues 
associated with using DTI to assess post-stroke white matter integrity, and discuss 
evidence for structural changes possibly occurring in response to rehabilitative 
therapy. Their review indicates the clinical importance of DTI as a tool for predicting 
whether (and the extent to which) recovery is possible and the potential for 
understanding behavioural response to therapy in the context of underlying structural 
changes in the brain.  
Identification of the extent of penumbral tissue (and differentiation from irreversibly 
infarcted tissue) following stroke is critical for predicting optimal intervention (if any) 
and tissue outcome.  However, while best practice guidelines are typically available, 
there is considerable debate in the literature concerning important factors (including 
time-window for successful outcome, statistical thresholds for differentiating viable 
from unrecoverable areas, etc.). Scalzo, Hu and Liebeskind  (Chapter 13) evaluate 
different flow parameters from perfusion weighted images during the acute stroke 
phase in terms of their predictive power for estimating tissue fate four days post onset. 
Using nonlinear regression models, their results indicate that tissue outcome is best 
predicted by a regional rather than single-voxel based approach. Recovery from stroke 
is also considered in a targeted review by Fabien et al. (Chapter 14). Specifically, these 
authors address possible explanations for why clinical trials of anti-inflammatory 
treatments have failed despite overwhelming evidence for an inflammatory response 
after stroke. They argue for the use of MRI to enable selection of patients most likely to 
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benefit from anti-inflammatory treatment, to identify the therapeutic time-window, 
and to promote the development of interventions targeting specific pathophysiological 
processes. Arboix and Grive (Chapter 15) consider seven sites of intracerebral 
haemorrhage from the perspective of typical clinical spectrum and early outcome. 
With the exception of the familial early onset form, the genetic risk factors of 
Alzheimer’s disease remain poorly understood. Reitz (Chapter 16) discusses the 
potential of imaging genetics for exploring specific candidate genes on brain imaging 
phenotypes. Dementia with Lewy bodies (DLB), like some other forms of progressive 
dementing illness (e.g., semantic dementia), tends to be under-diagnosed. Baglio, Preti 
and Farina (Chapter 17) provide a valuable overview of DLB, with particular focus on 
neuroimaging findings. They convincingly argue for the employment of a range of 
MRI-based methods to improve differential diagnosis of DLB from other forms of 
dementia. In the final chapter, Jimenez-Vazquez provides an overview of endoscopic 
intracranial imaging for diagnosis and treatment of lesions within or adjacent to fluid-
filled cavities. 
I hope that, cumulatively, these chapters convey a broad sense of what can be 
achieved with neuroimaging methods. Rate of technological progress is encouraging 
increasingly sophisticated lines of enquiry in cognitive and clinical neuroscience and 
shows no sign of slowing down in the foreseeable future. 
 
Dr. Peter Bright 
Anglia Ruskin University, 
Cambridge Campus, 
East Road, Cambridge 
United Kingdom 
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1. Introduction 
Modern in vivo functional neuroimaging techniques produce colorful computer images of 
the pattern of metabolic neuronal activity in living humans while engaged in performing 
cognitive and/or emotional tasks, and provide an unprecedented opportunity to examine 
how brain function supports activities in normal and abnormal conditions. The idea of the 
relation between blood flow and brain activity dates back to the second half of the 19th 
century, a time when some scientists made important contributions to this subject. In this 
period, functional brain activity began to be studied in the intact human brain by thermal 
recording from the scalp or by using techniques providing indirect graphical measurements 
of changes in cerebral flow when different mental tasks were performed. This relationship 
began to be quantified by measuring whole brain blood in animals and humans. The 
development of technologies that could measure these changes safely in normal human 
subjects would take another 60 years. Detailed mapping of regional flow changes during 
various mental and motor activities was achieved in 1970s and 1980s using new techniques 
(CT, PET and MRI) with further new valuable information about brain function in normal 
and in pathological conditions. This chapter will focus on a review of the historical 
background of functional brain imaging techniques. 
2. The first evidence: Changes in scalp and cortex temperatures 
Today, we know that brain temperature is a physiological parameter determined 
primarily by neural metabolism, regulated by cerebral blood flow, and affected by various 
environmental factors and drugs (Kiyatin, 2007). This aspect was already conjectured by 
some scientist in the mid-19th century. For example, the French physiologist Claude 
Bernard (1813-1878) in 1872 observed: ‘If we now try to understand the relationship that one 
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can obtain between the intensification of the circulatory function and the functional state of the 
organs, it is easy to see that the increase in blood supply is related to the increased intensity of the 
chemical metamorphoses that take place in tissues, and to the increment in thermogenetic 
phenomena which are the immediate and necessary consequence of those. . . . Each time the spinal 
or a nerve exhibit sensitivity or movement, each time the brain performs intellectual work, a 
corresponding amount of heat is produced’ (Bernard, 1872; Conti, 2002). The famous 
psychologist William James (1842-1910), in 1892, concluded that : ‘. . . brain-activity seems 
accompanied by a local disengagement of heat’ and speculated that cerebral thermometry may 
be valuable for experimental psychology to correlate cognitive and emotional states 
focally to brain regions (James, 1892). 
Starting from this interesting hypothesis, researchers placed thermometers or more sensitive 
thermoelectric piles on the scalp to measure regional changes in temperature. Several 
measurements of brain temperature, in normal and abnormal subjects, engaged in 
performing cognitive, motorial or emotional tasks or after administration of drugs were 
conducted from the second half of the 19th century (see Albers, 1861; Lombard, 1867, 1879; 
Gray, 1878; Maragliano and Seppili, 1879; Bert, 1879; Amidon, 1880; Maragliano, 1880; 
François-Franck, 1880; Sciamanna and Mingazzini, 1882; Bianchi, Montefusco e Bifulco, 
1884; Tanzi, 1888; Mosso, 1894; Berger, 1901). In at least two studies, thermometers were 
placed also in direct contact with the cerebral cortex via skull cracks in patients responding 
to sensory stimuli, doing mental tasks, and undergoing emotional experiences (Mosso, 1894; 
Berger, 1901).  
Among the most famous researchers using the cerebral thermometry approach were Josiah 
Stickney Lombard in the United States (Lombard, 1867, 1879; Marshall and Fink, 2003), 
Pierre Paul Broca in France (Broca, 1879), Angelo Mosso in Italy (Mosso, 1894) and Hans 
Berger in Germany (Berger, 1901).  
In 1866, Lombard, first commenced a series of experiments, with thermoelectric apparatus, 
to determine the amount of blood circulating in the brain and the exterior temperature of the 
human head, in the quiescent mental condition, and in states of intellectual and emotional 
activity. He demonstrated that the exercise of the higher intellectual faculties, as well as the 
different emotions, caused a rise of temperature in the head perceptible through the 
medium of delicate apparatus. Lombard reviewed the results on cerebral temperature in his 
1879 monograph on Experimental Researches on the Regional Temperature of the Head under 
Conditions of Rest, Intellectual Activity and Emotion’. He observed: ‘. . . there is good reason to 
suppose that a slight change of temperature at the surface of the brain can show itself in a degree 
readily perceptible by means of delicate apparatus, at the exterior surface of the head; and we shall see, 
in the experiments now to be given, that the changes of temperature observed in the integument 
during increased mental activity are usually of a degree which may be fairly accounted for by the 
direct propagation outward, through the intervening tissues, of slight thermal changes at the cerebral 
surface’ (Lombard, 1879). 
Mosso, in his book La temperatura del cervello. Studi termometrici [The temperature of the 
brain. Thermometric studies] set out a very large number of sophisticated experiments on 
cerebral thermometry. The temperature was ascertained by means of a delicate thermometer 
which gave to the naked eye a reading of 0.01 degrees. Mosso made observations directly on 
the cerebral human cortex. For example, he examined Delfina Parodi, a girl of twelve years 
who had a wound on the right side of the skull (see Fig. 1).  
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Fig. 1. (A) Delfina Parodi (B) Tracing obtained during sleep showed an increase in brain 
temperature when a dog began to bark in the next garden (A and D) and when the girl was 
called by name, Delfina (F), R=rectum, C=brain. Source: Mosso (1894). 
A 
B 
 
Neuroimaging – Methods 
 
4 
Neither mental nor motor exertions had any influence upon the brain temperature, but 
emotions such as fear of the administration of chloroform caused a rise of temperature of 
0.01 degrees. Berger (1901) stated that his principal aim was to find: ‘. . . and equivalence 
between the chemical and thermic energy of the brain and psychic ‘energy’. Broca tried to 
demonstrate the effect of different mental tasks, especially language, on the localized 
temperature of the scalp of normal subjects, and also studied the diagnostic value of the 
thermogenic exploration of the scalp to discover focal lesion of the brain (Broca, 1877). 
Studies of brain localisation were also carried out by other researchers (Gray, 1878; 
Maragliano, 1880; Putnamm Iacobi, 1880; Bianchi, Montefusco and Bifulco, 1884). 
3. Brain volume produced through mental activity: The Mosso methods  
Though cerebral thermometry was abandoned owing to methodological difficulties and 
contradictory results, it provided the basic rationale for later studies on the relationship 
between function and blood circulation in overlying brain tissue.   
A researcher who championed the idea of studying changes in brain blood flow was the 
Italian physiologist Angelo Mosso (1848-1910) who, at about the same time when he 
conducted his research on regional temperatures in the head and brain, began to investigate 
brain blood flow during certain emotional and cognitive tasks (Zago, Ferrucci, Marceglia 
and Priori, 2009). In his textbook on blood circulation in the human brain, printed in 
Germany in 1881, Mosso observed: ‘Of all the body’s organs, the brain is that in which the most 
frequent and most radical changes in the state of the blood vessels occur. Physiology has not yet 
determined which of these changes are produced reflexively by the action of a central motion vessel 
and which arise from purely local actions as an effect of the chemical transformations which occur in a 
given brain region. That there are, however, local changes due to local chemical action is undeniable’ 
(Mosso, 1881). The concepts expressed by Mosso engender the idea that when brain areas 
are active, changes in the amount of blood flowing in circumscribed brain regions, and 
specific biochemical processes, in the same areas, increase to ensure adequate energetic 
support to the active neurons. This mechanism, is actually termed functional hyperaemia 
(Iadecola, 2004). 
In his investigations on human cerebral circulation Mosso proposed some new and valuable 
non-invasive procedures for detecting the functional correlates of various physiological and 
psychological states. The first method involves the development of a bed scales in which the 
body was placed in perfect balance and where it was possible to measure small tilts of a few 
millimeters of its longitudinal axis determined by the passage of blood from the legs to the 
head and vice versa (see Fig. 2). 
With this apparatus Mosso verifies that the breath and sleep rhythms, the effect of 
pharmacological substance, and the response to particular mental states, determined 
minimal oscillations of the balance corresponding to changes in the distribution of blood 
(Mosso, 1882,1883). He observed that: ‘. . . the spontaneous movements of the blood vessels and 
the undulations corresponding to psychic acts are equally visible by means of the balance’ (Mosso, 
1882). Further research on bodily changes during mental activity appears to have been 
attempted with the Mosso apparatus, although with conflicting results (e.g. Weber, 1910; 
Lowe, 1935).  
The second method used by Mosso consisted of recording the pulsations of the human 
cortex in individuals through the open skull, during mental tasks, by means of a system of 
pistons. For some time, the study of cerebral circulation within the cranial cavity presented 
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Fig. 2. Mosso’s balance apparatus. Source: Mosso (1882). 
difficulties due to relative inaccessibility of the brain in vivo. Mosso was inspired in his 
studies by some animals works carried out during the late 18th and early 19th centuries, 
which were designed to record pulsations of the brain during respiratory changes and 
modifications in cerebral blood circulation. In particular, he mentioned the work of the 
Italian physiologist Antonio Ravina, who invented a direct observation through a glass 
window for recording the change in volume of the cranial content of animal resulting from 
variations in the amount of blood present within the intracranial vessel (Ravina, 1811). 
Another researcher to deal with this type of investigation was the Dutch physiologist, 
Franciscus Cornelius Donders (1818-1889) who conceived the cranial window to observe in 
animals the ability of pia mater vessels to change their caliber in response to various kinds of 
stimulation (Donders, 1850). 
The Mosso method consisting of recording simultaneous intracranial pressure changes in 
humans through a traumatic bone injury in the skull, compared to the pressure to the 
forearm or foot, to graphically demonstrate, the peculiar cerebral hemodynamic patterns 
during emotional and cognitive experiences. Hence, his work brought a modern perspective 
to the study of the central nervous system. Fig. 3 reports Mosso’s instruments to analyse 
pressure changes in man. 
The most famous case studied by Mosso was published in 1880. The report, titled, Sulla 
circolazione del sangue nel cervello dell'uomo [On the blood circulation in the human brain] 
presented the case of Michele Bertino, a 37-year-old farmer who had a large fracture to the 
skull (Mosso, 1880). The fractured bone pieces were removed and the cerebral mass was 
exposed through a bone breach measuring about 2 centimeters in diameter in the right 
frontal region. Intelligence, memory, language, motility and sensitivity all remained 
almost unchanged. Changes in brain volume related to cerebral blood flow were recorded 
through a button fixed to the wooden cupola with a sheet of gutta-percha resting  
on Bertino's exposed dura mater and connected to a screw on the recording drum (see 
Figure 4).  
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Fig. 3. Mosso’s devices for recording the blood volumes in arm and brain.  
Source: Patrizi (1896). 
 
 
Fig. 4. Brain pulsation recordings when (A) Bertino was requested to multiply 8×12. Top 
trace is brain pulsation and bottom trace is the forearm pulsation. α: when the question was 
made, (B) a room clock strikes 12 (arrows). Top trace is forearm pulsation and bottom trace 
the brain pulsation; (C) Mosso asked (arrows) Bertino if Ave Maria should have been said. 
Top trace is forearm pulsation and bottom trace the brain pulsation (D) resting state 
condition. Top trace is the forearm pulsation and bottom trace the brain pulsation. Source: 
Mosso (1880). 
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When the brain volume changed, the pulsation of the brain increased, the pressure on the 
button also increased as did pressure on the screw, thus compressing the air inside the 
drum. Changes in air compression were trasmitted to a second recording drum, and then 
written on a rotating cylinder. When Mosso asked Bertino to multiply 8×12, the pulsations 
increased within a few seconds after the request. Similarly, when Mosso asked him if the 
chiming of the local church bell reminded him that he had forgotten his midday prayers, 
Bertino said yes, and his brain pulsated again. Mosso also demonstrated in this patient that 
the fluctuations in the blood supply to the brain were independent of respiratory changes. 
In another passage he also tackled the modern issue of the ‘resting state’ (Gusnard and 
Raichle, 2001; Morcom and Fletcher, 2007). He wrote: ‘Because the brain is an organ that escapes 
our will why can we not arbitrarily bring it to absolute rest? The variations that the movement of 
blood in the brain can undergo during wakefulness refer far more often to variations in the energy 
needed for intellectual work, rather than to a real change in this organ's functions from a state of 
absolute rest to one of full activity’ (Mosso, 1880).  
The work of De Sarlo and Bernardini (1891), who studied the variations of cerebral 
circulation during mental activity in a 50-year-old farmer, admitted for traumatic epilepsy, 
is also illustrative of the application of the Mosso’s method (De Sarlo and Bernardini, 1891). 
At the age by 24, F. Carlo, while working in a petrol well was hit by falling rocks causing 
cranial fracture in the left parietal region. The injury resulted in a more or less triangular 
shaped opening, measuring between 1.5 cm and 2.5 cm approx. on each side. The posterior 
side was aligned with the Rolandic fissure. The inner side, parallel to the sagittal line, 
measured 1.5 cm. The opening was about one centimeter deep. After positioning a specially 
designed copper helmet of 5 cm in diameter over the cranial breach, using glazier’s putty, a 
funnel-shaped part of the helmet was connected above to a Marey’s drum. The cerebral 
pulse was not evident when the head was held straight, and the patient was asked to rest 
the bowed head on a special support (see Fig. 5A). Figure 5B shows the outline in different 
emotional situations. 
Mosso's cerebral pulse method was used by numerous experimenters to study changes in 
the brain blood flow during mental effort, as well as after the administration of drugs (e.g. 
Fleming, 1877; François-Franck, 1877; Burckhardt, 1881; Mays, 1882; Sciamanna, 1882; 
Sciamanna and Mingazzini, 1882; Bergesio and Musso, 1884; Morselli and Bordoni-
Uffreduzzi, 1884; Musso and Bergesio, 1885; Petrazzani, 1888; Binet and Sollier, 1895; Patrizi, 
1896, 1897; Berger, 1901).  
Mosso’s method was hindered by the technical limitations of his time that precluded him 
from correlating specific regional changes in brain activity to cognitive and emotional 
processes. Although present imaging techniques do not use the same principle as Mosso’s, 
his idea of monitoring the cerebral blood flow nonetheless anticipated the main concepts of 
modern brain imaging tools such as SPECT, PET and fMRI, and could in this sense be 
considered a precursor to modern functional neuroimaging (Raichle, 2008; Zago, Ferrucci, 
Marceglia and Priori, 2009).  
After only 50 years, a new work on a human being was performed by the American 
neurosurgeon John Farquhar Fulton (1899-1960), a resident of Cushing in Boston and 
attendant at the Oxford University with Sherrington, who reported the clinical study of the 
patient Walter K.. The patient had a gradually decreasing visual disorder caused by a 
vascular malformation of the occipital lobe. Surgery removal was unsuccessful leaving a 
bony defect above the primary visual cortex. Walter K. complained that he perceived a noise 
(i.e. bruit) at the back of his head during visual activity. See Fig. 6. 
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Fig. 5. (A) F. Carlo, the patient studied by De Sarlo and Bernardini (1891). The cranial 
fracture in the left parietal region is visible. (B). Brain pulsation recordings when: (1) F. Carlo 
was threatened with a penalty (2) He was promised a prize (3) At the beginning of the trace 
the subject looked for a focal point on the floor. At half way he found it (attention effort) (4) 
He was given different images of the Holy Virgin and kissed one of them (5) A nurse 
entered the room talking excitedly about something terrible that had happened (6) At the 
beginning of the trace he finds himself in pleasant spirits (he spoke about his return home) 
(7) He was shown images of scantily dressed women. He became irritate (8) Continued from 
trace six. Source: De Sarlo and Bernardini (1891). 
A 
B 
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Fig. 6. (A) Walter K, the patient studied by Fulton in 1928. The arrow indicates the point of 
maximum intensity of the bruit. This overlies the region of greatest vascularity of the 
angioma. (B) Typical electrophonograms. (1) after ten minutes rest in a darkened room; (2) 
after two minutes reading small print illuminated by a single 40-watt tungsten bulb at 5 feet; 
(3) three minutes later, after two and half minutes rest in darkened room. It is evident an 
increased size of main deflections in b and the greater number of secondary deflections. 
Source: Fulton (1928). 
This disturbance persisted for several years but he had: ‘. . . never thought much of it’. Fulton 
underlined: ‘It was not difficult to convince ourselves that when the patient suddenly began to use 
his eyes after a prolonged period of rest in a dark room, there was a prompt and noticeable increase in 
A 
B 
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the intensity of his bruit. Activity of his other sense organs, moreover, had no effect upon his bruit’. 
This single case showed that blood flow to the occipital lobe was sensitive to the attention 
paid to objects in the environment. Fulton elicited a history of a cranial bruit audible to the 
patient whenever he engaged in a visual task. Remarkably consistent changes in the 
character of the bruit could be appreciated depending upon the visual activities of the 
patient (Fulton, 1928).  
4. Functional activity, metabolism and blow flow in animal brain 
In their seminal animal experimental observation on the cerebral circulation, Charles Smart 
Roy (1854-1897) and Charles Scott Sherrington (1857-1952), both working in the Cambridge 
Pathological Laboratory in England, mentioned the ‘Mosso method’ as one of the main 
techniques for investigating brain blood flow, however nothing the limitations (Roy and 
Sherrington, 1890).They remarked that studies with the Mosso apparatus had not ‘. . . 
sufficiently recognized the necessity of taking, simultaneously with the curve from the cranial cavity, 
graphic records both of the arterial and venous pressures. The influence of changes in these latter 
where this method is employed, is so great that results obtained without due control of them must, we 
think, be looked upon as likely to mislead' (Roy and Sherrington, 1890).  
In their work, Roy and Sherrington suggested two distinct mechanisms for the control of the 
cerebral circulation, one of them acting through the vasomotor nervous system, and another 
intrinsic one by which the blood supply of various parts of the brain can be varied locally in 
accordance with regional requirements. 
Roy and Sherrington’s experiments were applied chiefly on exposed dogs’ brains but 
controlled by repeating them on cats and rabbits using a trepanation near the middle line of 
the vertex of the cranium. They then registered pressure and blood variation after 
stimulations by inducing currents through parts of the body. Their experimental conclusion 
was that: ‘. . . the chemical products of cerebral metabolism contained in the lymph which bathes the 
walls of the arterioles of the brain can cause variations of the caliber of the cerebral vessels: that in this 
re-action the brain possesses an intrinsic mechanism by which its vascular supply can be varied 
locally in correspondence with local variations of functional activity’. This statement, implying 
that cerebral functional activity, energy metabolism, and blood flow are closely related, and 
presumably most responsible for the concept of ‘tight coupling’ that has played an important 
role in recent years.  
It was observed that experimental data obtained by Roy and Sherrington were inadequate to 
support the interrelation between functional activity, metabolism and blood flow, because 
they hadn’t examined any of the relevant processes, energy metabolism and functional 
activity, but only an indicator of cerebral cortical blood volume rather than cerebral blood 
flow (Sokoloff, 2001). They believed that cerebral blood flow was regulated mainly by 
arterial blood pressure and fine-tuned chemical substances in that they affirmed that ‘the 
blood supply of the brain varies directly with blood pressure in the systemic arteries’ (Roy and 
Sherrington, 1890). 
Later in 1914, Joseph Barcroft (1872-1947), at the University of Cambridge, contended that an 
enhanced functional level in a tissue can be sustained only by increasing the rate at which 
oxygen is consumed. Blood flow was measured without use of extensive surgery or 
profound anaesthetic procedures, and its mechanism was based on the autoregulation of the 
cerebral circulation and the influence of chemical factors. Barcroft supported the association 
between functional activity and energy metabolism and he wrote: ‘There is not instance in 
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which it can be proved that an organ increase its activity, under physiological condition without also 
increasing its demand for oxygen’(Barcroft, 1914).  
In the case of the brain interrelation between functional activity, metabolism and blood flow 
experimental studies on animals by the physiologist Edward Horne Craigie was also of 
note. He demonstrated that the vascular demand in different parts of the brain parts related 
to functional activity, and that increases found in localized areas parts due to a major 
metabolic demand of these regions associated with functional activity (Craigie, 1924). 
5. Subsequent investigations: The diffusible indicators for the determination 
of brain circulation and metabolism in animals and humans 
As pointed out by Raichle (2008), despite this promising study interest in brain circulation 
and metabolism decreased during the first quarter of the 20th century for two main reasons: 
(1) a lack of sufficiently sophisticated tools to pursue this line of research, and (2) criticism 
by some influential researchers who concluded that no relationship existed between brain 
function and brain circulation.  
In particular, the work of Leonard Erskine Hill (1866-1952), physiologist and professor of the 
Royal College of Surgeons in England, was very influential on the research that followed. His 
eminence as physiologist covered the inadequacy of his results and led him to affirm that 
there was no relationship between brain function and cerebral circulation and resolutely 
denied the existence of local metabolic regulation. He proclaimed that: ‘We have been entirely 
unable to confirm the result of Roy and Sherrington obtained with acids and have not found the 
slightest evidence of active dilation of the cerebral vessels . . . In every experimental condition the 
cerebral circulation passively follows the changes in the general arterial and venous pressures . . . The 
brain has no vasomotor mechanism . . .’ (Hill, 1896).  
Progress in the field of cerebral circulation and metabolism was correlated with 
technological development. In the early 20th century, measurement methods were confined 
to indices of brain tissue volume or blood volume and the diameter of retinal or superficial 
cerebral vessels. Following, thermoelectric instruments such as thermostromuhrs, heated or 
cooled thermocouples with other devices were inserted into cerebral vessels or tissue.  
Subsequent investigators determined that cerebral metabolism and blood flow increased 
during the normal activation of the specific region when engaged in brain activity. In 1937, 
Carl Frederik Schmidt (1893-1988) and James P. Hendrix of the University of Pennsylvania School 
of Medicine recorded a localized increase in the blood flow through the visual cortex of a cat 
when a small spot on the animal’s retina was illuminated (Schmidt and Hendrix, 1937). It is 
now clear that there is local change in nerve-cell activity and metabolic rate that gives a rise in 
the increasing blood flow in the active region. This discovery gave a suggestion to study brain 
regional variation in blood flow related to its function. Dumke and Schimdt in 1943 studied, 
for the first time, the circulation of blood to the brain of an anesthetized rhesus monkey, by 
means of a flow meter inserted directly into the cerebral arteries (Dumke and Schmidt, 1943). 
On this basis, studies followed to apply quantitative in measuring cerebral blood flow 
associated with cerebral metabolic rates. The turning point was the mid 1940s, in which the 
American Seymour Kety (1915-2000) and colleagues at the University of Pennsylvania and 
National Institutes of Health, introduced the first technique for measuring whole brain blood 
flow in unanesthetized humans (Raichle, 2010). In 1944, Kety took part in a meeting of the 
Federation of American Societies for Experimental Biology (FASEB), where there was a 
symposium on the cerebral circulation. The main theme of the symposium was 
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measurement methods for cerebral blood flow in unanesthetized men. At that time, there 
were two non quantitative methods of detection of cerebral blood flow in humans: the 
thermoelectric probe placed into the internal jugular to detect changes in flow within the 
vein, and the measurement of cerebral arteriovenous oxygen differences, which varies 
inversely with changes in cerebral blood flow and consumption of oxygen if it remains 
constant. Both techniques were unable to distinguish between blood flow and the constant 
oxygen consumption. The only practicable method for detecting the two parameters: the 
bubble-flow technique of Dumke and Schmidt, required anesthesia in addition to extensive 
surgery and only ever been tried on monkeys (Dumke and Schmidt, 1943). Kety attended 
this symposium and explained his idea on the observation rate at which the brain was 
satured or desatured using an inert gas. The method was based on the venerable ‘Fick 
Principle’ on the conservation of matter (Fick, 1870). According to the principle, cerebral 
blood flow (volume per unit of mass per unit of time) is related to the time course of the 
arterovenous difference and to the final tissue concentration of a diffusible trace. Following 
this, Kety with Schmidt applied the central idea that the amount of an inhaled, highly 
diffusible, inert gas (nitrous oxide) taken up by the brain per unit of time is equal to the 
amount of that gas brought to the brain by the arterial blood minus the amount carried 
away in the cerebral venous blood. The subject inhaled 15 percent nitrous oxide for ten 
minutes, during which time the concentration of the gas was followed by drawing samples 
of arterial and venous blood from the brain. The area between the arterial and the venous 
saturation curves yielded a measure of the average blood flow, which is normally about 50 
milliliters of blood per 100 grams of brain tissue per minute. As pointed out by Kety: ‘A 
method is described applicable to unanesthetized man for the quantitative determination of cerebral 
blood flow by means of arterial and internal jugular blood concentration of an inert gas . . . human 
subjects by this method have thus far been made and suggest the feasibility of applying this method to 
clinical investigations’ .  
The first measurements were obtained in a group of young male volunteers, yelding a mean 
value for blood flow of 54 ml/100 g/min or 750 ml/100 g/min for the whole brain (Kety 
and Schmidt, 1945, 1948). This indirect, minimally invasive technique, applicable to 
normally conscious animals and humans, made a great contribution to estimate the overall 
brain blood flow and metabolic activity of the brain.  
With numerous collaborators, Kety’s methods was applied in neurology, psychiatry, and 
medicine leading to greater knowledge of normal physiology, pathophysiology, and 
pharmacology of the circulation and metabolism of the human brain in healthy and diseased 
conditions, especially regarding the role of glucose in brain metabolism (Kety, 1950). 
In the cat, Kety’s team used a soluble gaseous radioactive tracer, fluorinated methane 
labelled with 131I, and a quantitative application to obtain values for perfusion connected 
with functional activity in 28 cerebral structures (Landau, Freygang, Rowland, Sokoloff and 
Kety, 1955). This method used a unique quantitative autoradiographic technique in which 
the optical densities in autoradiographs of brain sections were quantitatively related to the 
local tissue concentrations of the radioactive tracer. These concentrations were in turn 
determined by the rate of blood flow to the tissue. In summary, the method provided 
pictorial maps of the local rates of blood flow throughout the brain exactly within each of its 
anatomic structures. This technique was called autoradiography because images were 
acquired by laying radioactive brain sections directly onto X-ray film (Kety, 1960; Taber, 
Black and Hurley, 2005). The study included CBF images showing clear changes between a 
baseline (sedated) and stimulated (awake, restrained) state (see Figure 7). 
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Fig. 7. Whole-brain, inert-gas (nitrous oxide) technique for the measurement of blood flow 
and metabolism in humans. Source: Kety and Schmidt (1948). 
Kety and Sokoloff emphasized that the metabolic homeostasis hypothesis of Roy and 
Sherrington does not fully explain the increase in cerebral blood flow accompanying 
increased metabolic activity. Moreover, the association of two events (metabolism and flow) 
does not prove one (metabolism) to be determinant of the other (flow). Other factors on the 
coupling between cerebral metabolism and perfusion can describe the concept of perfusion 
governed by the effects of change in the metabolic rate. Metabolic demands of the cerebral 
tissue is accompanied by focal neural activation and modification of vessels, which may be 
mediated by neurotransmitters or the action of drugs on the cerebral circulation (Freygang 
1958; Sokoloff, 1959, 1961; Lou, 1987).   
These studies were a catalyst for the development of new cerebral blood flow modifications 
to the original Kety-Schmidt nitrous oxide method. Kety’s group continued to refine the 
measurement of CBF introducing new radiotracers; in particular 131I-antipyrine,  
14C-antipyrine, and C-antipyrine, an inert and freely diffusible tracer that had many 
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advantages over previous diffusible indicators (Kety, 1965; Reivich, Jehle, Sokoloff et al., 
1969).  
 
 
Fig. 8. The rationale of inert gas clearance method with a diagram of simple collimator. 
Following its injection into the carotid artery, xenon diffuses in a known ratio between the 
blood and brain tissue. After a sufficiently long injection period the brain tissue and venous 
blood will be in equilibrium. On cessation of the injection the carotid arterial blood, now 
containing virtually no radioactive xenon, will wash out the xenon in the brain tissue and 
the rate at which this takes place will depend on the quantity of blood perfusing the brain. 
Source: Harper, Glass, Steven and Granat (1964). 
Lassen and Munck (1955) modified the classical Kety-Schmidt technique by substituting the 
inhalation of a radioactive inert gas, the 85Kr, in place of nitrous oxide (see also Lassen, Munck 
and Tottey, 1957). In the early 1960s, thanks to the studies with radioactive tracers by Niels 
Alexander Lassen (1926-1997), David Henschen Ingvar (1924-2000) and their Scandinavian 
colleagues, it was becoming possible to measure local blood flow in the cerebral cortex. Lassen 
and Ingvar, injected a radioactive isotopes into the internal carotid artery (85Kr), measuring the 
rate of clearance from the underlying cortex of the beta emissions of the isotope (Lassen and 
Ingvar, 1961; Ingvar and Lassen, 1961, 1962).  
(Lassen and Edt-Rasmussen, 1966). Another report described the measurement of regional 
blood flow evoked by brain activity in the cerebral cortex of man through intact skull 
monitoring the low incidence gamma emissions of 85Kr using scintillation detectors arrayed 
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like a helmet over the head (Lassen, Høedt-Rasmussen, Sørensen, Skinhøj, Cronquist, 
Bodforss and Ingvar, 1963). The use of collimated scintillation detectors allowed blood flow 
measurement in small neural populations of the cortex. Sveinsdottir and Lassen (1973) 
calculated that a regional blood flow was simultaneously measured in about 256 regions of a 
hemisphere. This application signalled the dawn of the modern era in human brain imaging. 
The rationale of inert gas clearance methods with a diagram of simple collimator is 
illustrated in Figure 8 as reported by Harper, Glass, Steven and Granat (1964). 
The method devised by Lassen and Ingvar was suitable for clinical use, following the 
injection of 133Xe, a radioactive tracers originally introduced by the group of University of 
Glasgow headed by Glass and Harper (Glass and Harper, 1963; Harper, Glass, Steven and 
Granat, 1964).  
Some years after, Lassen, Ingvar and Skinhøj, wrote about their application: ‘The radioactive 
gas was dissolved in a sterile saline solution, and a small volume (two to three milliliters, containing 
from three to five millicuries of radioactivity) is injected as a bolus into one of the main arteries to the 
brain. The arrival and subsequent washout of the radioactivity from many brain regions is followed 
for one minute with a gamma-ray camera consisting of a battery of 254 externally placed scintillation 
detectors, each of which is collimated to scan approximately one square centimetre of brain surface. 
Information from the detectors is processed by a small digital computer and is displayed in graphical 
form on a colour-television monitor, with each flow level being assigned a different colour or hue. 
Owing to the attenuation of radiation from structure deeper in the brain, the gamma radiation 
detected comes from the superficial cortex. Thus the radioactive-xenon technique provides a fairly 
specific picture of the activity of the cerebral cortex directly below the detector array’ (Lassen, Ingvar 
and Skinhǿj, 1978).  
The 133Xe tecnique has been extensively and very effectively used as a clinical and research 
tool for several decades (Glass and Harper, 1963; Lassen and Ingvar, 1963; Ingvar, 
Cronqvuist, Ekber, Risberg and Hǿedt-Rasmussen, 1965; Hǿedt-Rasmussen, Sveindottir and 
Ingvar, 1966; Ingvar and Risberg, 1967; Olesen, Paulson and Lassen, 1971; Ingvar and 
Lassen, 1973; Ingvar and Schwartz, 1974; Ingvar and Franzen, 1974; Soh, Larsen, Skinhøj and 
Lassen, 1978; Lassen, 1985). The Figure 10 adapted by Lassen and Ingvar (1972) illustrates 
their apparatus to detect rCBF changes and the results in a normal male adult using 133Xe at 
rest and during a mental task. 
Early techniques such as 133Xe inhalation provided the first blood flow maps of the brain as 
they able to demonstrate directly in normal human change of blood flow within discrete 
parts of the cerebral cortex during mental activation. The first study on induced variation of 
brain blood circulation using this method was reported by Ingvar and Risberg in 1965 at the 
first International Meeting on the Brain Blood Metabolism, held in Lund. This research was 
received with caution because of its potential importance regarding human studies of 
regional change in blood flow using these techniques in normal humans and in conditions 
with neurological disorders.  
6. The origin of new functional imaging techniques: PET, SPECT and fMRI 
The introduction of an in vivo tissue autoradiographic measurement of blood flow in 
laboratory animals by Kety’s group many years later became important for the 
measurement of blood flow in humans when positron emission tomography (PET) provided 
a means of quantifying the spatial distribution of radiotracers in tissue without the need for 
invasive autoradiography (Kety, 1999).  
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Fig. 9. Regional cerebral blood flow estimated from counts of arterially xenon-133 in a 
normal male adult at rest and during a mental task. Areas of large blood flow increase were 
found in temporal and precentral regions of gray matter. Source: Lassen and Ingvar, (1972). 
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PET, based on the decay of radioactive atoms that release positrons, derives its name and its 
fundamental properties from a group of radionuclides (15O, 11C, 18F and 13N). The properties 
of these radionuclides include short half-lives, a unique decay scheme involving the 
emission of positrons and chemical properties whose relevance to studies in biology and 
medicine arises from the fact that these chemical elements are building blocks of most 
biological molecules (Raichle, 2010).  
The concept of emission and transmission tomography was introduced in the late 1950s by 
the American physic David Edmund Kuhl, who has been called the father of emission 
tomography. In the early 1960s, with the collaboration of Roy Edwards, Kuhl designed and 
made a detector which scanned in a series of tangential traverses, rotating about the patient 
on a circular path between scan passes. Their work later led to the design and construction 
of several tomographic instruments (Kuhl and Edwards, 1963). At the University of 
Pennsylvania in Philadelphia, Kuhl headed a group that developed a series of SPECT (single 
photon emission computed tomography) devices, the Mark II in 1964, the Mark III in 1970 
and the Mark IV in 1976. The group also advanced the medical use of tomographic image 
reconstruction based on numerical computation, and made the transaxial section 
tomography of a living body possible. In the mid-1960s, Kuhl and collaborators, who 
improved tomographic image quality, proved their clinical efficacy for image separation 
pathological conditions of the brain and succeeded in the axial transverse tomographic 
imaging of humans. One such important milestone was the introduction of a new 
instrument: X-ray computed tomography (CT), that had enormous impact on the 
development and evolution of various methods of computed tomography, including PET 
(Kuhl, Hale and Eaton, 1966).  
The CT method was invented by a British electronic engineer Godfrey Newbold Hounsfield 
(1919-2004), at the Atkinson Morley Hospital in London, who in 1971 built an instrument that 
combined an X-ray machine and a computer and used certain principles of algebraic 
reconstruction to scan the body (Hounsfield, 1973). Unknown to Hounsfield, the American 
nuclear physicist Allan MacLeod Cormack (1924-1998) had published essentially the same 
idea in 1963 (Cormack, 1963), using a reconstruction technique called the Radon transform. 
Although Cormack's work was not widely circulated, in 1979 he and Hounsfield shared the 
Nobel prize in Medicine and Physiology for the development of CT (www-Nobelprize.org). 
In creating CT, Hounsfield had arrived at a practical solution to the problem of the three-
dimensional transaxial tomographic images of an intact object using data obtained from by 
passing highly focused X-ray beams through the object and recording their attenuation. 
Hounsfield’s invention was fundamental in changing the approach for observing the human 
brain.  
During the mid-1970s, at the Washington University School of Medicine in St. Louis, the 
Armenian-American physic Michel Ter-Pogossian (1925-1996) lead a research team of 
physicists scientist, chemists, and physicians to build the first PET scanner for medical 
application. Previously, Ter-Pogossian performed a quantitative measurement of regional 
brain blood flow and oxygen consumption in humans using a radiotracer technique 
developed by him (Ter-Pogossian et al. 1969, 1970). A fundamental role was played by Ed 
Hoffman and Michael E Phelps which led to the production of the first PET camera, PET III 
(Ter-Pogossian, Phelps and Hoffman, 1975; Phelps, Hoffman, Mullani and Ter-Pogossian, 
1975; Phelps, Hoffman, Mullani, Higgins, Ter-Pogossian, 1976; Hoffman, Phelps, Mullani, 
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Higgins and Ter-Pogossian, 1976). As pointed by Raichle (2010): ‘With PET, we had a tool that 
brought quantitative tissue autoradiography from the laboratory into the clinic. Such things as brain 
blood flow, blood volume, oxygen consumption, and glucose utilization, not to mention tissue pH and 
receptors pharmacology, could now be measured safely in humans’. 
At approximately the same time of the Kulh’s and Ter-Pogossian’s studies, at the Laboratory 
of Cerebral Metabolism at the National Institutes of Health in Bethesda, Sokoloff and colleagues, 
directly disclosed, in the brain of experimental animals (rats and monkeys), cerebral 
utilization of an energy-rich substrate, 2-deoxyglucose tagged with carbon-14 (Sokoloff, 
Reivich, Kennedy, Des Rosiers, Patlak, Pettigrew, Sakurada and Shinohara, 1977). Sokoloff 
and colleagues studied cerebral metabolism on a microscopic scale by injecting a radioactive 
analogue of glucose into the brain demonstrating that the rate at which the substance is 
taken up by nerve cells reflects their functional activity. The brain’s oxygen consumption is 
almost entirely determined by the oxidative metabolism of glucose which in normal 
physiological conditions is the exclusive substrate for the brain’s energy metabolism (Clarke 
and Sokoloff, 1999). 
Aiming to employ the [14 C] deoxyglucose technique clinically, Kuhl’s team conducted joint 
research with Alfred P Wolf of the Brookhaven National Laboratory and with Sokoloff’s group, 
ultimately reaching the conclusion that 18F-2-fluoro-2-deoxy-D-glucose or ‘FDG’ was the 
most appropriate positron emitting tracer for human use (Ido, Wan, Casella, Fowler, Wolf, 
Reivich and Kuhl, 1978; Reivich, Kuhl, Wolf, Greenberg, Phelps, Ido, Casella Fowler, 
Hoffman, Alavi and Sokoloff, 1979; Phelps, Huang, Hoffman, Selin, Sokoloff and Kuhl, 
1979).  
The development of the [14C] deoxyglucose method made it possible to measure the local 
rate of glucose utilization throughout the brain. The method employed a quantitative 
autoradiographic technique like that of the [131I] trifluoroiodomethane method but, 
subsequently, added computerized processing techniques which scanned the 
autoradiographs and redisplayed them in colour with the actual rate of glucose utilization 
encoded in a calibrated colour scale. This was the first use of the deoxyglucose technique for 
the regional measurement of glucose metabolism in laboratory animals and the basis for an 
application for clinical purpose (Sokoloff, Reivich, Kennedy, Des Rosiers, Patlak, Pettigrew, 
Sakurada and Shinohara, 1977). These [131I] trifluoroiodomethane and [14 C] deoxyglucose 
methods were used to measure local cerebral blood flow and glucose utilization in studies in 
animals. Both methods were subsequently were adapted for use in humans by substituting 
positron-emitting tracers and PET in place of autoradiography: [18F] fluorodeoxyglucose in 
place of [14 C] deoxyglucose to measure glucose utilization (Raichle, Phelps, Larson, Grubb, 
Welch and Ter-Pogossian, 1973; Reivich, Kuhl, Wolf, Greenberg, Phelps, Ido, Casella Fowler, 
Hoffman, Alavi and Sokoloff, 1979; Phelps, Huang, Hoffman, Selin, Sokoloff and Kuhl, 1979) 
and 15H20 instead [131I] trifluoroiodomethane to measure blood flow (Herscovitch, Markham  
and Raichle, 1983).   
PET method has had some advantage, such as: the blood flow was measured quickly (<1 
min) by using an easily produced radiopharmaceutical (15H20) with a short half life (123 sec) 
that allowed many repeat measurements in the same subject. However, PET present some 
disadvantages: few spatial resolution than the autoradiography methods, in the mm instead 
of μm range; they contributed very little to define mechanisms that relate blood flow and 
energy metabolism to functional activity in the brain, their application did initiate and 
establish the field of functional brain imaging in humans (Sokoloff, 2008).   
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Raichle and his colleagues, at the Mallinckrodt Institute of Radiology of the Washington 
University of St Louis, used PET technology to measure cerebral blood volume (CBV) in 
normal right-handed human volunteers following inhalation of trace quantities of cyclotron-
produced, 11C-labeled carbon monoxide. The CBV was significantlylarger in the temporal 
left cerebral hemisphere in the tomographic scans during speech, a region which is thought 
to be larger in individuals with left cerebral dominance for speech. As pointed out the 
authors: ‘This observation is the first in vivo demonstration of a structural correlate of a known 
functional difference in the cerebral hemispheres of man’ (Grubb, Raichle, Higgins, Eichling, 
1978).  
In the 1980s, Raichle and colleagues systematically applied PET technique to the normal 
human brain, using oxygen-15 labelled water and to demonstrate regional metabolic 
activation induced by cognitive tasks. The labelled water, which emits positrons as it decays 
with a half-life of approximately two minutes, accumulates in the brain in less than a 
minute, forming an accurate image of blood flow. In a series of original works Raichle and 
colleagues firstly studied the manner in which the normal human brain processes single 
words, from perception to speech (Raichle, 1996) (see. Fig. 10). 
 
 
Fig. 10. Four different hierarchically organized conditions are represented in these mean 
blood flow difference images obtained with PET. All of the changes shown in these images 
represent increases over the control state for each task. Source: Raichle (1996). 
This approach was not embraced by most neuroscientists or cognitive scientists until the 
1980s after increase of technological, procedural and conceptual sophistication at the 
beginning of the 20th century (Raichle, 1987; 1998; 2008).  
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The advent of the nuclear magnetic resonance imaging (MRI) introduced a new and now the 
most convenient and widely used technique for functional brain imaging (fMRI) in both 
animals and humans. It is based on the physical property of atomic nuclei that, when first 
oriented in an magnetic field and then reoriented by radiofrequency pulses, emit during 
their return to their chemical species, concentrations, and environments. The strongest 
signals are those obtained from hydrogen nuclei because they are in water and thus 
prevalent.  
The physical principles associated with MRI were discovered independently by the Swiss-
American Felix Bloch (1905-1983), at Stanford University, and the American Edward Mills 
Purcell (1912-1997), at Harvard University.  In December 1945, at the American Physical 
Society, they met and discussed their research. Both recognized that the theoretical basis of 
their respective projects was the same, although they had been using slightly different 
techniques to achieve experimental results. So they decided to split up the field: Bloch 
would use the effect in the study of liquids; Purcell would examine crystals. The Stanford 
group gathered its first positive results in January 1946 (Bloch, Hansen and Packard, 1946; 
Purcell, Torrey and Pound, 1946). In 1952, Bloch and Purcell were awarded the Nobel Prize 
for Physics for the ‘development of new methods for nuclear magnetic precision 
measurements and discoveries in connection therewith' (Nobelprize.org). Many years of 
research followed, in which the technique was used for basic research in chemistry. During 
this time it was known as nuclear magnetic resonance (NMR).  
In 1973, the American-chemist Paul C Lauterbur (1929-2007) came up with a strategy in 
which the NMR signals could be used to create cross-sectional images in much the same 
manner as a CT (Lauterbur, 1973). In 2003, he was awarded with the Nobel Prize in 
Medicine along with the British physicist Peter Mansfield for their research on NMR. 
Mansfield  is credited with showing how the radio signals from MRI can be mathematically 
analyzed, making interpretation of the signals into a useful image a possibility. He is also 
credited with discovering how fast imaging was possible by developing the MRI protocol 
called echo-planar imaging. Echo-planar imaging allows T2* weighted images to be 
collected many times faster than previously possible. It has also made functional magnetic 
resonance imaging (fMRI) feasible (Mansfield and Baines 1976). This method had an 
immediate use because the technique was free of ionizing radiation, but also for the quality 
of images of the human body with detailed information, when compared to CT it proved 
more sensitive to soft tissue. An opening for MRI in the area of functional brain imaging 
emerged when it was discovered that during changes in neuronal activity there are local 
changes in the amount of oxygen in the tissue (Fox and Raichle, 1986). By combining the 
above observation with another much earlier one by Linus Pauling (1901-1994) and Charles 
D Coryell (1912-1971) it was shown that change in the amount of oxygen carried by the 
hemoglobin alters the degree to which hemoglobin disturbs a magnetic field (Pauling and 
Coryell 1936).  
It was Michael Faraday (1791-1867) who first studied the magnetic properties of 
hemoglobin. In 1845, he noted (to his surprise that hemoglobin contains iron) that dried 
blood was not magnetic, noting ‘Must try fluid blood' (Faraday, 1933). Many years later 
Pauling and Coryell found that the magnetic susceptibility of oxygenated and deoxygenated 
hemoglobin differed significantly. In 1982, Keith Thulborn and collaborators found the 
difference in magnetic susceptibility of oxy and deoxyhemoglobin for the measurement of 
brain oxygen consumption with MRI (Thulborn, Waterton, Matthews and Radda, 1982). 
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They demonstrated clearly the feasibility of measuring the state of oxygenation of blood in 
vivo with MRI. This step was important for the further study of Sieji Ogawa and colleagues 
for the so-called Blood-Oxygen-Level Dependent (BOLD) effect. The physical effect is based 
on the difference between reduced hemoglobin in venous blood, paramagnetic, and 
oxyhemoglobin prevalent in the arterial blood is diamagnetic and has no such effect. During 
the oxygen consumption from the blood by the tissue, the venous system draining the tissue 
within the field of view, contains more oxyhemoglobin and less in deoxthemoglobin. This 
leads to a small increase in the MRI signal, i.e.: the BOLD effect. Owaga labeled his finding 
‘BOLD contrast’ and noted that BOLD contrast adds an additional feature to MRI and 
complements other techniques that are attempt to provide PET-like measurements related to 
regional neural activity (Ogawa, Lee, Kay and Tank, 1990). The potential for BOLD fMRI 
was seen in three groups in 1992 (Ogawa, Tank, Menon et al 1992, Kwong, Belliveau, 
Chesler et al., 1992, Bandettini, Wong, Hinks et al, 1992), in especially from the group at the 
Massachuttes General Hospital led by Ken Kwong. Although MRI also offers additional 
approaches to the measurement of brain function, it is BOLD imaging that has dominated 
the research agenda to date.  
fMRI is the new non-invasive imaging tool for its remarkable high quality and it is 
considered by Raichle a tool for the ‘masses’ (Raichle, 2010). fMRI could be viewed as a 
logical extension of PET although fMRI can acquire images every few seconds and secondly 
is the neuronal responses occurring in the brain are ‘filtered’ by a hemodynamic response, 
which is responsible for the fMRI signals that can give the most powerful strategies for 
neurocognitive studies. According to Raichle, the future in functional brain imaging 
research has two developmental routes. The first is the research on individual differences 
improving the functional imaging in the clinical area. The combination of anatomical and 
functional imaging with genetic information opens new areas of research on the human 
brain in healthy and pathological conditions  (Raichle, 2010). The second is an attempt to 
integrate work from functional brain imaging with neurophysiology in relation to various 
kinds of intrinsic rhythmic activity of the brain (Buzsaki, 2006). 
However, the success of human brain imaging was not only the involvement of 
physiologists, who provided information on basic mechanism of neuronal activity, but also 
of different figures such as neurologists, neuropsychologists, psychiatrists who had the 
strategies and influence to provide an important tool in the understanding of ‘how the mind 
works’ in normal and pathological conditions. 
The scope of brain function imaging in future is to study the brain without requiring the 
subject to remain in a scanner approaching the organization of intrinsic activity of the 
neuronal cells in  normal functional activity not only to addresses a specific feature of its 
activity. Another important step is to achieve rapidly changing electrical events instead of 
changes in slow activity of the brain’s intrinsic work after an ‘environmental stimuli ‘. A 
possible anticipatory signal that could prevent negative behavior neural activity of latent 
brain diseases.  
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of Functional Connectivity 
Till Nierhaus, Daniel Margulies, Xiangyu Long and Arno Villringer 
Max-Planck-Institute for Human Cognitive and Brain Sciences, Leipzig 
Germany 
1. Introduction 
The advantage of modern brain imaging techniques is the ability to non-invasively 
investigate human brain function during mental work. Therefore, most functional 
neuroimaging studies have investigated brain activity evoked by certain types of 
stimulation or tasks. Related brain function is then localized by contrasting task-states, or 
often, with a baseline-state acquired during rest. However, in wakeful human subjects this 
resting condition cannot be associated with neutral brain activity, in part, because there is 
always a relatively high level of neuronal background activity. Thus, the question arises 
whether spontaneous fluctuations of resting brain activity can be dismissed as stochastic 
noise, or whether they contain functionally relevant information. 
In the past decade, numerous studies have investigated brain activity during the resting 
state. Background activity has been shown to fluctuate spontaneously, i.e. unrelated to any 
obvious task, and that these fluctuations are not random. Rather, this spontaneous activity is 
characterized by several distinct pattern of correlated brain activity, so called: “resting state 
networks”. Network activity, usually derived from temporal correlation of neuronal activity 
measured in different brain regions (“functional connectivity”), describes the functional 
relationship between brain regions. Functional connectivity networks have been identified 
by different methods, such as positron emission tomography (PET), optical imaging, 
magneto- and electroencephalography (M/EEG), whereas by far most studies made use of 
functional magnetic resonance imaging (fMRI) data. Traditionally, functional connectivity 
measures rely on correlation analyses, however in recent years the analytic tools for 
describing the functional organization of the brain has increased dramatically. 
This chapter will provide insight into different ways to assess functional connectivity from 
resting-state fMRI data and describe applications of functional connectivity analyses to 
specific scientific questions. We will start with a description of the BOLD-effect, the 
underlying neurophysiological parameter in resting-state fMRI, followed by a résumé of the 
use of BOLD in functional neuroimaging, stating its history from simple "baseline-task-
contrasts" to the nowadays widely-used concept of functional connectivity. In the following 
sub-chapters, we will briefly describe analytic categories as applied to resting-state fMRI 
data, including “seed-based functional connectivity”, “independent component analysis 
(ICA)”, “clustering”, “multivariate pattern analysis (MVPA)”, “graph theory” and 
“centrality”. Finally, we will discuss two specific applications of functional connectivity 
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analyses: (1) investigation of anatomy, and (2) investigation of dynamics using simultaneous 
EEG-fMRI measurements. 
2. History of BOLD in functional neuroimaging, and the beginnings of 
functional connectivity in both task-states and rest 
fMRI is the most widely used imaging technique in modern cognitive neuroscience. It 
allows for non-invasive (albeit indirect) studying of neuronal processes in the brain with 
excellent spatial resolution. While the first functional MRI experiment was performed with 
an exogenous contrast agent (Belliveau et al., 1991), fortunately another method was 
developed using magnetic properties of blood itself, so that such a contrast agent was no 
longer required for functional imaging (Bandettini et al., 1992; Frahm et al., 1992; Kwong et 
al., 1992; Ogawa et al., 1992). The fMRI signal depends on the vascular response to 
functional brain activation and is typically implemented by imaging of the blood 
oxygenation-level dependent (BOLD) contrast. 
2.1 The BOLD-effect 
The use of the BOLD effect for imaging brain activation relies on the fact that changes in 
neuronal activity are associated with changes in energy consumption and cerebral blood 
flow (Roy & Sherrington, 1890; Villringer & Dirnagl, 1995)1. Since changes in oxygen 
consumption and blood flow are associated with changes in haemoglobin oxygenation, the 
latter can also be used as an indirect measure of neuronal activity, assuming that activated 
neuronal circuits have an increased metabolic demand. 
The magnetic susceptibility of blood depends on the magnetic properties of haemoglobin, 
the molecule carrying the oxygen necessary for aerobic cellular metabolism. During brain 
activation, blood focally changes its oxygenation level, which depends on the proportion of 
oxygenated haemoglobin ([oxy-Hb]) and deoxygenated haemoglobin ([deoxy-Hb]). [oxy-
Hb] is a diamagnetic molecule, whereas [deoxy-Hb] is paramagnetic. The presence of 
[deoxy-Hb] causes local field inhomogeneities, which are responsible for a dephasing of the 
local transversal magnetization2, leading to a reduction in the transverse relaxation time T2. 
                                                 
1 Although fMRI is widely used in scientific and clinical approaches, the complex mechanism describing 
the coupling of neuronal activity and metabolic demand ("neurovascular coupling") is not yet fully 
understood. Not only the role of the different mediators dealing with neurovascular coupling is under 
debate, also the formation of the vascular response obtained with fMRI is unclear (Buxton et al. 1998; 
Steinbrink et al. 2006; Villringer & Dirnagl 1995). 
2 In medicine, the MR signal is usually based on the magnetic dipole moment of hydrogen nuclei 
(protons) in water, by far the most abundant nuclei in the human body. In a static magnetic field B0, 
these magnetic dipole moments generate a magnetisation vector ML longitudinal oriented to B0. 
Applying an adequate radio frequency pulse induces an additional magnetic field B1, that flips M into 
the plane perpendicular to B0. According to classical mechanics, this transversal magnetisation vector 
MT starts rotating about the direction of B0, inducing a voltage in a receiver coil proportional to the 
proton density. In the absence of B1, however, the excited magnetic spins will return to equilibrium. 
This relaxation is characterised by (1) a re-growth of ML with the time constant T1, and (2) by a decay of 
MT with the time constant T2. The values of T1 and T2 depend on tissue composition, structure and 
surroundings. The setting of a long echo time TE, that is the time between excitation and read-out, 
produces T2-weighted images, because only tissue with a long T2 decay constant will contribute to the 
signal intensity. 
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As a diamagnetic molecule, [oxy-Hb] does not produce the same dephasing. Thus, changes 
in [deoxy-Hb] can be observed as the BOLD contrast in T2-weighted MR-images, serving as 
an indirect measure of neuronal activity. Since neuronal activation is accompanied by a focal 
increase in oxygenated blood, overshooting the actual metabolic demand, activated brain 
areas are characterised by positive BOLD responses in fMRI measurements. 
2.2 From 'baseline' to 'resting' to 'intrinsic' dynamics 
For functional investigations of the human brain, typically, a task or a stimulus is 
administered to a subject in a block or event-related experimental design and the resulting 
changes in neuronal activity are detected by contrasting a “task-state” and a “control- or 
baseline-state”. The term "baseline-state" thereby cannot be associated with "zero brain 
activity", since even during so called “rest conditions”, there is always some neuronal 
activity (spikes, synaptic activity) associated with a relatively high level of (baseline) 
cerebral blood flow and oxygen consumption (Clarke & Sokoloff, 1999; Sokoloff et al., 1955 
for a review Raichle, 2010). Such task-state contrasts are by far the most used data analysis 
approach in fMRI assuming more or less constant baseline activity to be independent from 
task- or stimulation-evoked activity. 
Given that baseline activity is not zero, the question arises whether spontaneous fluctuations 
of resting brain activity are stochastic (“noise”) and thus can be simply attenuated by 
averaging procedures. Furthermore, it is of relevance whether fluctuations of the baseline 
influence the shape and amplitude of task-evoked activity during the stimulation period. In 
recent years, the issue of “physiological noise” and brain activity during resting states has 
become accessible for investigation. Numerous studies have been published examining 
spontaneous fluctuations of baseline activity (i.e. unrelated to any obvious task) in the low-
frequency range <0.1 Hz (Biswal et al., 1995; Fox et al., 2005). These fluctuations contain 
important function-related information and it has been shown that “resting states” are 
characterized by several distinct patterns of correlated intrinsic brain activity, so called 
“resting state networks”, describing intrinsic functional connectivity (Gusnard & Raichle, 
2001). Resting state activity has been identified by different methods, such as fMRI, PET, 
Optical Imaging, EEG, and MEG, and in several instances simultaneous combinations of 
methods such as EEG/fMRI have been particularly useful. In addition, numerous studies 
have addressed the influence of ongoing activity on behavioural responses and the 
relationship between ongoing activity and evoked activity (Becker et al., 2011; Scheeringa et 
al., 2011; for a review Nierhaus et al., 2009; Sadaghiani et al., 2010).  
2.2.1 Task-state contrasts (evoked brain activity) 
Despite the fact that vascular responses are only indirectly related to changes in brain 
activity and that they develop with time constants of several seconds to the underlying 
neuronal activity, vascular methods, in particular fMRI, have become the most widely used 
method for the assessment of evoked brain activity. Stimuli or tasks are organized either in 
an event-related design, a block design, or a mixture of those two. Data analysis typically 
employs a general linear model of evoked brain activity (Friston et al., 1995). By contrasting 
the “activated state” with the “control state”, changes in brain activity due to task or 
stimulation are visualized. Figure 1 shows a typical fMRI response for a somatosensory 
stimulation paradigm, where subjects received 4-Hz electrical stimulation of the left middle 
finger at amplitude twice of the sensory perception threshold. 
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Alternating stimulation blocks with resting periods allowed for contrasting two activation 
states, revealing a positive BOLD signal change in the contralateral primary 
somatosensory cortex, whereas the secondary somatosensory cortices are bilaterally 
activated (Fig.1A). The time course of the activated region shows a high correlation with 
the stimulation, and the peak of the hemodynamic response occurs with a delay of several 
seconds. This approach of contrasting rest- and task-state assumes fluctuations of baseline 
activity to appear merely stochastic and independent from evoked activity, thus vanishing 
in the averaging process.  
 
 
Fig. 1. Evoked brain activity. BOLD fMRI response on 4 Hz electrical stimulation of the left 
middle finger (adapted from Taskin et al., 2006). Stimulation was applied in blocks of 20 s 
alternating with periods of rest of the same duration. (A) The activation map generated by 
contrasting stimulation- with resting-periods (statistical T-maps, n=6, p<0.05 corrected for 
multiple comparisons). (B) BOLD dynamics as average time course over 30 blocks (red, 
mean+ S.E.M.) of the labelled region in A and stimulation paradigm (blue). 
2.2.2 Resting state (ongoing brain activity) 
The apparent “noise” in the BOLD signal was quite early assessed to have neuronal 
components, however, only in recent years has its investigation become a wide-spread 
research endeavour. Bharat Biswal and colleagues at the Medical College of Wisconsin 
demonstrated in 1995 that low frequency fluctuations of baseline (resting state) fMRI contain 
information about background neuronal activity (Biswal et al., 1995), which was 
subsequently elaborated by other groups (Fox et al., 2005; Greicius et al., 2003). Such 
correlations in the patterns of spontaneous activity specifically within the low-frequency 
band (<0.1 Hz) have given rise to the study of “resting state networks”, an example of which 
is depicted in Figure 2.  
The approach of measuring BOLD signal independent of any task makes the method 
independent of any differences of performance between sessions and/or subjects. Therefore, 
resting-state fMRI can be easily employed in patients with potentially limited ability for 
participation in task paradigms. Indeed it has been successfully applied in many clinical 
populations e.g., with Alzheimer disease (Greicius et al., 2004; Sorg et al., 2007), 
schizophrenia (Calhoun et al., 2009), stroke (van Meer et al., 2010), and different age-groups 
(Madden et al., 2010). 
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Fig. 2. Figure from Smith et al. (2009) depicting similarity between ‘resting-state network’ 
(left) and task-coactivation derived networks (right). 
Many questions remain open regarding the mechanisms underlying the coherence of these 
spatially-distributed, low-frequency fluctuations. However, the rapid employment of these 
techniques by the imaging community over the past decade is due, in part, to both the ease 
of data acquisition and the similarity of results to previous finding using task-induced 
approaches. Since the methods for analysing resting-state activity are not limited to data 
acquired during 'rest', the term 'functional connectivity' has gained popularity, describing 
functional interplay of spatially distinct brain regions. 
3. A brief overview of analytic methods to assess functional connectivity 
Different post-processing techniques can be used for identifying spatial patterns of coherent 
BOLD activity in fMRI data, allowing for interpretation regarding functional connectivity3 
between spatially distributed brain areas. Since the following subchapters will explain only 
very briefly the idea and theoretical presuppositions of each analytic tool, for a more 
detailed description, we refer to a recent review by our group (Margulies et al., 2010). 
3.1 Seed-based functional connectivity 
This technique makes use of correlation from an a priori region-of-interest (ROI) or "seed 
region". In its simplest form, an averaged ROI time series is correlated with the time series of 
                                                 
3 Functional Connectivity is often described in contrast to Effective Connectivity. While the former 
describes different brain regions which are functionally connected, the latter addresses the direction of 
these neuronal interactions. Causality models, such as Dynamic Causal Modelling, Structural Equation 
Modelling or Granger Causality are used to estimate effective connectivity from neuroimaging data. 
Assuming that better prediction is an indication of influence, the common idea is to determine whether 
activity in one brain region can be predicted by the dynamics in other brain regions.  
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all the other voxels in the brain, or with the average time series of several distributed ROIs. 
The resulting matrix of correlation coefficients then can be interpreted as the functional 
connectivity of the selected seed region, where a high correlation coefficient indicates strong 
functional connectivity to the respective area. From such correlation maps, a number of 
different functional networks have been derived, e.g. a motor network, a visual network, the 
default-mode network and others. Seed-based functional connectivity analysis was initially 
applied to resting-state data by Biswal et al. (1995), showing motor cortex functional 
connectivity being similar to motor task activity patterns. Mapping the default-mode 
network - which is implicitly linked to the brains resting state - was much later achieved 
(Greicius et al., 2003). 
Correlation of time series implies quantifying the relation of two signals in the time-domain 
(such as 'covariance' or 'cross-correlation'). Of course, different mathematical methods can 
be used to quantify the relationship between the seed region time series and the time series 
of other voxels or ROIs. While 'coherence' operates equivalently in the frequency-domain 
(Sun et al., 2004), another approach would be to explore the 'phase-spectrum delay' between 
regions (Sun et al., 2005). Thus, the choice of the proper mathematical method, and the 
selection, size and shape of the a priori defined seed region are critical variables for assessing 
functional connectivity with the seed-based method (Van Dijk et al., 2010). 
3.2 Independent Component Analysis (ICA) 
One of the features of resting-state analysis is that there is no stimulation paradigm for 
researchers to be dependent on. Therefore, many data-driven solutions have been employed 
for identification of low-frequency resting state patterns (Beckmann et al., 2005; Fox & 
Raichle, 2007). The most widely used approach is Independent Component Analysis (ICA). 
By using blind source separation techniques4, ICA methods decompose the entire BOLD 
data set into statistically independent components (Hyvärinen & Oja, 2000) without any 
hypothesis paradigms, i.e. prior seed definition is not required any more. Researchers found 
that several separated spatial components could accurately represent specific functional 
networks during resting state. Many neuroimaging studies have demonstrated that ICA is a 
productive tool for investigating resting-state fMRI data. Some widely studied functional 
networks e.g., the default mode network and motor network, show consistency across 
subjects (Damoiseaux et al., 2006; Zuo et al., 2010). ICA has also been successfully applied to 
demonstrate significant differences in connectivity patterns between patients and healthy 
controls (Calhoun et al., 2009; Greicius et al., 2004; Sorg et al., 2007). In addition to 
identifying functionally relevant networks, ICA also enables automatic separation of 
artificial and physiological noise sources from fMRI data (De Martino et al., 2007; Tohka et 
al., 2008). 
Still, two controversial issues should be considered: specifying the number of components 
and selecting those that are functionally meaningful. The number of independent 
                                                 
4 Blind source separation techniques underlie the assumption that the measured signal is a linear 
mixture of independent signals from a number of spatially distributed sources. Decomposition 
algorithms separate multi-channel data into a set of such independent spatial or temporal components. 
Temporal decomposition is widely used in EEG research, generating sources, each given by a time 
course of its activity and a weighting-vector, describing its contribution to the signal recorded in each 
sensor. As fMRI data usually consists of more spatial than temporal data points, spatial decomposition 
is more widely applied. 
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components appropriate to resting-state data is an issue of ongoing debate, and several data 
driven approaches for optimising the selection of this number have been developed 
(Beckmann & Smith, 2004; Li et al., 2007). However, it is worthwhile to consider that due to the 
multiple scales of functional organisation in the brain, determining the number of functionally 
relevant components is also a product of the spatial scale of interest. Thus, even with data 
driven approaches like ICA, certain assumptions about brain organization are still required. 
Selecting components that are of functional relevance is another challenging issue with ICA. 
While automatic rejection of artefact components can be implemented rather easily (through 
assessing the frequency spectrum or high spatial scattering), the most commonly used method 
for identifying functionally relevant components, such as the default-mode network, remains 
visual inspection by an expert—though several automated network selection approaches have 
also been proposed (Greicius et al., 2004; De Martino et al., 2007). 
3.3 Multivariate Pattern Analysis (MVPA) 
In recent years the use of pattern-classification algorithms has gained increasing importance 
in fMRI data analysis (for reviews Haynes & Rees, 2006; Norman et al., 2006). In general, 
these algorithms use specific features of objects to identify classes to which they belong. In 
fMRI data, spatially distributed brain activation or connectivity patterns are used as features 
to classify different brain or cognitive states. Applying this technique requires in the 
beginning a training of the classification algorithm with the features and the prespecified 
classes. Thereby a subset of the data (training-set) must be used to attune the classifier on 
the relationship between features and classes, before the rest of the data (testing-set) can be 
used to verify the classifiers capability for new/unknown data. 
Feature selection and the choice of a proper classifier are critical issues to achieve good results. 
While mathematical methods allow for a data driven, automated selection of discriminative 
features, a manual selection method can be beneficial for designing application specific 
features. For pattern classification, usually supervised5 machine learning algorithms, such as 
support vector machines (SVM), neural networks, or linear discriminant analysis (LDA), are 
used. Knowledge about the relationship between features and classes (i.e. a linear or non-
linear relation is assumed) should be taken into account for classifier selection. 
Revealing disease-related differences in resting-state functional connectivity, MVPA has 
been successfully used for disease-state prediction, discriminating patients and healthy 
controls (Craddock et al., 2009; Shen et al., 2010; Zhu et al., 2008). 
3.4 Clustering 
Similar to MVPA, clustering is a family of mathematical techniques that can be applied to 
fMRI data to search for characteristic patterns. However, clustering algorithms tend to find 
patterns without specific knowledge about classes. This means that data is partitioned 
(classified) into subsets (clusters) in an unsupervised manner, such that observations 
assigned to the same cluster are similar. Different clustering algorithms6 have been applied 
                                                 
5 Unsupervised algorithms, such as clustering, tend to find pattern without prior knowledge about the 
desired classes, inevitably increasing uncertainty of the whole procedure. 
6 Different clustering approaches are e.g. 'hierarchical clustering', 'partitional clustering', 'spectral 
clustering' or 'non-metric clustering', and the development and improvement of clustering methods is 
an intense research field (Margulies et al., 2010). 
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to fMRI data in several studies deriving clusters of voxels or regions that represent known 
functional or anatomical subdivisions in the brain (Bellec et al., 2010; van den Heuvel et al., 
2008; Salvador et al., 2005). Another approach is division of the data into functional units by 
clustering voxels that have similar pattern of functional connectivity (Cohen et al., 2008). 
Although a model-free approach (in this sense similar to ICA) which finds specific pattern 
without prior assumptions (as e.g. seed selection in model based approaches), clustering still 
involves human judgement. Usually, the user has to define a number of clusters in which 
the data should be partitioned, and the clustering results need comparison with known 
functional networks. 
3.5 Graph theory 
Characterising aspects of network structure is a common mathematical problem in which 
graphs represent mathematical structures describing pairwise relations between objects in 
a certain network. A graph consists of a collection of vertices or nodes, and a collection of 
edges connecting pairs of vertices. A path in a graph is a sequence of vertices which are 
connected by edges, and the distance between two vertices is the shortest path connecting 
them. The degree of a vertex is the number of terminating edges. Vertices with very high 
degrees are termed hubs. Translated to fMRI data, a voxel or ROI constitute a vertex and 
their connections are represented by edges. Thus, the theoretical framework of graph 
theory can be used to analyse brain networks obtained from imaging data (for a review 
see Bullmore & Sporns, 2009). Given a functional connectivity map, a graph 
representation can be derived either by assigning an edge if the correlation between two 
vertices exceeds a certain threshold, or the correlation coefficients themselves can be used 
to weight each edge. 
Numerous tools can be used for characterising such network organisation, which can be 
conceptually divided into 'local' measures (characterising vertices individually) and 'global' 
measures (characterising the whole graph). The latter is e.g. realised by the degree 
distribution P(k), that represents the probability that a randomly chosen vertex has the 
degree k (Achard et al., 2006; Eguíluz et al., 2005; Nakamura et al., 2009). It also offers 
information about the number of hubs in a graph - obviously regions of special interest for 
connectivity analyses (Buckner et al., 2009). The ability to separate a network into clusters 
with high internal connectivity is described by modularity, whereas the degree of integration 
of a graph can be described by the average path length. Combining these measures brings up 
the fundamental approach of the brain being characterised as a small-world network, 
supporting both modular processing of information by high clustering and distributed 
information processing via short wiring distances (Bassett & Bullmore, 2006).  
3.6 Centrality 
One of the graph-based approaches is the centrality measure. The centrality of a node within 
a network is an estimation of the relative importance of that node within a network. 
Eigenvector centrality mapping (ECM) was recently implemented to estimate the centrality 
of human brain regions with fMRI data (Lohmann et al., 2010). In their study, the linear 
correlation was proposed to generate a network of every voxel within the entire brain. Then 
centrality of each voxel was estimated within its own brain network. They found that some 
brain regions, e.g. precuneus, cerebellum, showed higher centrality than other brain regions 
during resting state scan. In addition, by comparing centrality between a hungry and sated 
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condition, the results showed that the precuneus has higher centrality in a hungry state than 
in a sated state. 
The ECM analysis is a data-driven method and therefore it is an appropriate tool for data 
analysis of “resting-state” studies. There are only few studies on centrality of brain regions 
but if validity is confirmed, centrality measures will probably be of wide interest for many 
studies on the human brain in experimental and clinical settings. 
4. Applications of functional connectivity analyses to specific scientific 
questions 
As we have just described, functional connectivity provides a means of investigating 
underlying organization of functional systems in the brain. While each of these 
methodologies allows for the description of specific aspects of network structure, 
interaction, and organization, the research question we are now stuck with is how to 
meaningfully apply such techniques. We will here describe two main avenues of research, 
broadly categorized by anatomical and dynamical lines of investigation. More specifically, 
anatomical questions will relate to spatial aspects of brain organization, how regions 
connect to one another, and how those patterns differ between mental states, or between 
patients and healthy control populations. Dynamical aspects address the interactions in time 
between brain regions, and can likewise be evaluated for the aforementioned categorical 
differences. We consider the anatomical/dynamical distinction valuable because each set of 
research questions brackets a different set of analytic tools. For instance, in evaluating 
neuroanatomy, the relation between two regions can be quantified using a variety of 
correlation-based metrics, however, the aim of such analyses lies predominantly in the 
resulting spatial maps.  
4.1.1 Investigation of anatomy 
Brain mapping is mostly based on anatomical structures, e.g., Brodmann areas. Numerous 
schemas have been proposed over the past century for describing subdivisions in various 
areas of the cortex and subcortical regions. Among them, cytoarchitectonics, the mapping of 
the cellular structure within the cortical layers, has maintained popularity as a method for 
describing cortical areas within the functional neuroimaging literature. However, 
cytoarchitectonic mapping has the disadvantage of only being discernable using histological 
techniques, making it difficult to subsequently conduct functional imaging studies on the 
same research subjects. Function-based brain mapping is strongly demanded because of the 
value of precisely localizing functional areas in the brain. Intrinsic functional connectivity 
approaches, a synonym of resting-state functional connectivity, however, take advantage of 
a primary characteristic of the brain: namely, its connectivity. Connectivity has previously 
been applied extensively in the macaque monkey using axonal labelling tract-tracing 
techniques. The success of this approach in the macaque suggests that a non-invasive 
approach in humans also holds great promise. 
In humans, resting-state functional connectivity has been successfully used to map divisions 
with complex structures such as the anterior cingulate (Margulies et al., 2007), precuneus 
(Margulies et al., 2009), striatum (Di Martino et al., 2008), lateral parietal lobule (Cohen et al., 
2008; Mars et al., 2011; Nelson et al., 2010), motor cortex (Cauda et al., 2010; van den Heuvel 
& Hulshoff Pol, 2010), to name a few examples. In addition, functional connectivity has been 
demonstrated to map closely to anatomical connectivity methods, such as diffusion tensor 
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imaging (DTI) tractography (Greicius et al., 2009; Skudlarski et al., 2008) and tract tracing 
studies in the macaque monkey (Margulies et al., 2009; Mars et al., 2011; Vincent et al., 2007).  
Therefore, several studies have begun to use functional networks to find functional areas 
within some anatomical brain regions. For instance, precuneus has been found to show 
similar sub-regions distribution in human and monkey (Margulies et al., 2009). In addition, 
supplementary motor area has been demonstrated to be organized into two functional 
anterior-posterior structures based on their respective functional networks (Kim et al., 2010), 
and a lateral-medial structure has been found in anterior bank of central gyrus (Long et al., 
2010). These findings strongly suggest that functional network is a useful approach to 
delineating functionally unique brain regions. Underlying the strength of this approach is 
the hypothesis that differential functional connectivity is associated with differentiable 
functional roles. 
4.1.2 Methods for investigating neuroanatomy 
As previously described, the seed-based correlation approach creates a spatial map for an 
individual seed. These spatial maps can then be used as features to distinguish seed regions 
from one another. This can be done through both visual inspection, direct contrasts of the 
respective functional connectivity maps, and also through computationally based clustering 
techniques (e.g., Cohen et al., 2008; Kelly et al., 2010)  
As the seed-based functional connectivity approach aims to describe the connectivity of a 
single region-of-interest, regions can also be delineated as whole networks (or ‘functional 
systems’). The ICA approach previously described aims to pull out whole networks 
simultaneously using a multivariate approach. The primary advantage of this approach is 
that it can describe independent systems without a priori hypotheses about the spatial 
location of such systems. Notable early examples of this approach aimed to characterize the 
number of unique “resting-state networks” throughout the brain (Beckmann et al., 2005; 
Damoiseaux et al., 2006; De Luca et al., 2006; Smith et al., 2009). Discriminating the 
appropriate number of networks is still a challenge to the community, as the number of 
networks derived using ICA requires a priori assumptions. However, this data-driven 
approach also offers the advantage of not requiring prior assumptions about the location of 
networks. 
4.2.1 Investigation of dynamics: simultaneous EEG-fMRI 
Although fMRI is widely used in clinical and scientific approaches, many fundamental 
questions are still unknown; most notably, the precise relationship to the underlying 
neuronal activity. Despite significant progress in understanding this relationship (Lauritzen 
& Gold, 2003; Logothetis et al., 2001; Shibasaki, 2008), based on BOLD signal alone, the 
underlying neuronal activity cannot be recovered unambiguously (“Inverse Problem of 
fMRI”). This is not only due to the poor temporal resolution of the vascular response but 
also due to the fact that different types of neuronal (and non-neuronal) events such as 
excitatory/inhibitory postsynaptic potentials (EPSP/IPSP), action potentials, glia-activity, 
etc., are being translated into only a one-dimensional variable of “more or less" BOLD 
signal. Additional sources of information are frequently needed for further clarification of 
the underlying processes in the respective brain areas. Particularly, the combination of fMRI 
with electrophysiological methods such as EEG may be useful for this purpose. 
Simultaneous EEG-fMRI approaches allow for investigation of the link between changes in 
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EEG patterns and changes in the vascular signal. For functional connectivity studies, 
investigating intrinsic brain activity at rest, the EEG signal then can be used as independent 
variable, classifying brain states in the absence of any stimulation or task paradigm. 
Of special interest for the investigation of intrinsic brain activity is spectral analysis of the 
ongoing EEG. Many perceptual and cognitive processes emerge from recurrent network 
interactions, which are induced by, but not necessarily phased-locked to external events. 
Analysis of event-related potentials (ERP)7 excludes these non-phase-locked signal 
components from investigation. Different background rhythms in a large range of frequency 
bands have been described, not only recorded during 'rest', but also with relation to various 
cognitive states, mental activity, and showing specific temporal pattern following external 
events (for a review see Nierhaus et al., 2009). Since different sensory networks were found 
to exhibit distinct background rhythms8, resting rhythmic activity denotes a network 
specific attribute, describing network activity from a different angle. Thus, investigating the 
relationship of spectral EEG phenomena and functional connectivity maps derived from 
fMRI data is an obvious and promising challenge. 
4.2.2 Associating EEG rhythms and resting-state networks 
Simultaneous EEG-fMRI measurements have been applied to investigate the relationship of 
electrophysiological background rhythms and BOLD signal fluctuations (for reviews see 
Laufs 2008; Ritter & Villringer 2006). Most of these studies show an inverse correlation of the 
background rhythm strength with the spontaneous BOLD signal fluctuations in the cortical 
sensory area generating the respective rhythm. However, positive correlations between 
subcortical, i.e., thalamic BOLD signals and occipital EEG alpha power have also been 
reported. Investigation of stimulus driven responses revealed a close coupling between 
gamma-band (40-100 Hz) activity and BOLD signal of sensory cortical regions, 
demonstrated using intracranial recordings in human (Lachaux et al., 2007; Mukamel et al., 
2005) and in animals (Logothetis et al., 2001; Niessing et al., 2005). Since gamma-band 
activity is associated with sensory information processing, further investigation with 
simultaneous EEG-fMRI should allow for a better understanding of resting-state network 
behaviour during mental work. First attempts of such investigations were recently 
performed using direct intracerebral recordings in the default-mode network (Jerbi et al., 
2010). Execution of attention-demanding tasks were shown to suppress gamma power 
accompanied by BOLD deactivation. 
The default-mode network (DMN) has also been investigated in several EEG-fMRI studies. 
Using the power of spontaneous EEG oscillations, a positive correlation of the beta frequency 
band with the DMN was shown (Laufs et al., 2003). The DMN activity has also been found 
to be negatively correlated to frontal theta power derived using ICA on the EEG data in a 
                                                 
7 Repeated measures of external events with subsequent averaging enables investigation of the isolated 
neural response phase-locked to the event.  
8 Most prominent is the occipital alpha rhythm with a frequency between 8-12 Hz. Since occipital alpha 
is strongest in the absence of visual input, it is referred to as the "idle rhythm" of the visual system. Such 
inverse relationship of rhythm strength and sensory input is also found for pericentral rhythms, with 
peak frequencies around 12 Hz (mu) and 20 Hz (beta), which are known to desynchronise following 
motor activation or somatosensory stimulation. Oscillations with a frequency of 3-8 Hz are termed theta, 
which are most prominent in hippocampus and frontal cortex and are associated with the neural basis 
of learning and memory. Delta oscillations (1-3 Hz) are a characteristic feature of deeper sleep stages. 
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resting state experiment (Scheeringa et al., 2008) and, in a second study, even at the single 
trial level increases of frontal theta power induced by a working memory task were 
correlated to decreased DMN activity (Scheeringa et al., 2009). 
Mantini et al. used ICA to identify resting-state networks in fMRI data and then correlated 
the time courses of these networks with the power of five specific EEG frequency bands 
(delta, theta, alpha, beta, gamma), averaged across the entire scalp (Mantini et al., 2007). Four of 
six networks, including a dorsal attention network and a somatomotor network, showed 
exclusively negative correlations with EEG frequency band power. Again, the DMN showed 
a positive correlation with beta activity, and here additionally with alpha power. Also 
gamma power was found to be positively correlated with one network, well in line with the 
previous described invasive findings. Improved results could be expected from EEG source 
separation with direct correlation of source and network activity. 
A common way to integrate EEG data into fMRI analyses is to take EEG frequency band 
power as a regressor in a general linear model, thus, investigating how well fMRI data is 
explained by certain features of the EEG. Vice versa it would be interesting if the EEG data 
can be explained by fMRI activity pattern. To address this question, MVPA might be a 
helpful technique: brain activation or connectivity pattern could be used as features to train 
a classifier, which capability then would be verified using EEG data. 
Also "centrality mapping" could be a promising approach for analysing simultaneous 
acquired EEG-fMRI data. Therefor, the average time course of regions indicated by high 
centrality must be correlated with the time course of frequency band power of EEG source 
activity. The results would show whether regions of high "hubness" are also involved in 
EEG rhythm generation. 
5. Conclusion  
In the past decades the view on background fluctuations in brain activity, which were 
previously assumed to reflect (stochastic) “physiological noise”, has changed dramatically: 
Spontaneous fluctuations have been identified to contain important information reflecting 
brain function. Specifically, it has been shown that the brain ‘at rest' is characterised by 
several distinct pattern of correlated brain activity – resting state networks – and that 
changes in network activity can be associated with cognitive states, mental activity and 
pathophysiological conditions. 
Numerous techniques can be applied to fMRI data for investigating functional connectivity, 
each with different weaknesses and strengths, depending on the experimental design and 
the kind of research question/hypothesis. Although described very briefly, we endeavoured 
to provide insight into each of the various options for investigating functional brain 
organisation with fMRI data. Further, two main research fields were broadly categorized by 
anatomical and dynamical lines of investigation, covering meaningful applications of the 
aforementioned analysis techniques. 
The use of functional connectivity to investigate spatial aspects of brain organization is 
based on the assumption that brain areas with different functional roles exhibit differential 
functional connectivity pattern. Parcellating brain regions by their functional network 
patterns allows for a more precise localisation of brain function and there is no doubt that a 
well-investigated function-based human mapping will be created in future studies. 
Investigating dynamical changes using EEG and fMRI indicate that EEG background 
rhythms and fMRI-based resting state measures are closely related, revealing network 
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specific attributes from different angles. Furthermore, simultaneous EEG/fMRI provides 
insights into the spatio-temporal organization of intrinsic signal fluctuations, whether 
measured at rest or during stimulation or task. Thereby, the interplay of these rhythmic 
fluctuations measured with different modalities at rest can be analysed in a straightforward 
manner. However, tasks involving perception and cognition are accompanied by fast 
changes in EEG signals, and it is still a major challenge for cognitive neuroscience to link 
these transient EEG features to measures of functional connectivity. A proper combination 
of the aforementioned analytic tools will help to further understand this link with task-
based approaches, and will enable future investigation of the interaction between ongoing 
dynamical changes and transient activations evoked by task or stimulation. 
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1. Introduction 
fNIRS is a device designed to detect changes in the concentration of oxygenated  (oxyHb) 
and deoxygenated (deoxyHb) haemoglobin molecules in the blood, a method commonly 
used to assess cerebral activity. Over the last decade, functional near-infrared spectroscopy 
(fNIRS) has widely extended its applications due to its capacity to quantify oxygenation in 
blood and organic tissue in a continuous and non invasive manner (Chance & Leigh, 1977; 
Villringer & Chance, 1997). This technique is an effective, albeit ‘indirect’, optical 
neuroimaging method that monitors hemodynamic response to brain activation, on the 
basis that neural activation and vascular response are tightly coupled, so termed 
‘neurovascular coupling’. Different studies show that neural activity and hemodynamic 
response maintain a lineal relationship (Arthurs & Boniface, 2003; Logothetis et al., 2001), 
suggesting that these changes in hemodynamic response could provide a good marker for 
assessing neural activity. In neuroscience, functional near-infrared spectroscopy (fNIRS) is 
used to measure cerebral functions through different chromophore mobilization 
(oxygenated haemoglobin, deoxygenated haemoglobin and cytochrome c-oxidase) and their 
timing with concrete events. Due to methodological and theoretical problems associated 
with cytochrome c-oxidase functioning (Cyt-Ox) (see section 3.2.), current neuroscience 
studies on cerebral functions only assesses and analyzes oxyHb and deoxyHb mobilizations. 
These chromophore mobilizations are directly related to the cerebral blood flow (CBF) 
associated with an event and the physiological reactions provoked by the brain’s functional 
state (fNIRS measures these reaction in the cerebral cortex). The assessment of these task-
related mobilizations performed in light of a base line established by the researcher 
him/herself. The difference in oxyHb and deoxyHb concentrations at baseline and at task 
performance determines the location in the cortex of an increase or decrease in CBF. An 
increase in CBF is associated with cerebral activity, making the temporal and spatial 
correlation between CBF and task a determinant of cerebral function. This capacity to study 
cerebral functions, both spatial and temporal, is what gives name to the technique described 
in this chapter: functional near-infrared spectroscopy (fNIRS). 
fNIRS has become a valuable neuroimaging technique, novel in its easy application and 
characterized by its small size, portability, and reliability. Although relatively new to the 
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field of health care, fNIRS use is growing rapidly in clinical settings and research, 
particularly in work involving higher level cognitive control. fNIRS measures of 
hemodynamic response have been used in numerous studies to assess cerebral 
functioning during resting state (Lu et al., 2010) and tasks on motor skills (Leff et al., 2011; 
Obrig et al., 1996a), vision (Gratton et al., 1995; Herrmann et al., 2008), hearing (Zaramella 
et al., 2001), speech (Cannestra et al., 2003) social skills (Ruocco et al., 2010 ), learning 
(León-Carrión et al., 2010), emotion (León-Carrión, 2006, 2007a, 2007b), and executive 
functions (Chance et al., 1993; León-Carrion et al., 2008; Nakahachi et al., 2010). fNIRS is a 
proven medical device for monitoring hemodynamic activity through the intact brain 
cortex in normal adult subjects, a powerful and original functional neuroimaging 
technique which charts cerebral functioning in a non-invasive and relatively low-cost 
manner. The application of fNIRS in cerebral functioning studies has been validated by 
other neuroimaging techniques, showing that the NIR signal maintains a strong 
correlation with PET measures of changes in regional cerebral blood flow (rCBF), and the 
fMRI Blood Oxygen Level Dependent (BOLD) signal (Hock et al., 1997; Huppert et al., 
2006; Kleinschmidt et al., 1996; MacIntosh et al., 2003; Toronov, 2001, 2003; Villringer and 
Chance,  1997). Yet compared to traditional neuroimaging technology, fNIRS is non-
invasive, safe, portable and inexpensive (Gratton, et al. 1995; Strangman, 2002; Totaro et 
al., 1998; Villringer & Chance, 1997; Wolf, et al., 2002; Zabel & Chute, 2002). Given these 
characteristics, fNIRS makes it possible for research to be done more ecologically, in 
clinical and social settings, without the restrictions of more traditional scanners. 
Furthermore, fNIRS technology is ideal for studies in which subjects may have a more 
difficult time with traditional neuroimaging techniques, namely children, patients with 
dementia, etc. The flexibility of fNIRS also makes it ideal for studies involving patients 
who are in movement (Milla et al., 2001), patients who are bed-ridden (von Pannwitz et al, 
1998), and new-borns (Goff et al., 2010). 
In this paper, we review the literature to determine the principles of fNIRS, which could 
help create experimental designs and data analysis techniques objectively and effectively. 
We also provide a description of articles carried out by our research team on the use of 
fNIRS as a paradigm in the study of cognitive functions and in clinical applications. 
Specifically, we consider fNIRS use in studies on learning processes and affective 
dimensions in dorsolateral prefrontal cortex (DLPFC), and their influence on evoked 
hemodynamic changes.  
2. The principles of fNIRS 
Spectroscopy is based on the study of light signals. Many fields of science use this technique 
to study the composition of objects, both organic and inorganic. In 1949, Hill and Keynes 
(1949) reported that  nervous system cell activity was associated with changes in the optical 
properties of light. NIRS has thus far the unique feature of being able to measure 
intravascular (oxyHb and deoxyHb) (Jöbsis, 1977) and intracellular (cytochrome c-oxidase) 
(Heekeren et al., 1999) events simultaneously. 
In the study of cerebral functioning, a ray of light is used near the visible spectrum of 
light (NIR). More specifically, a light source known as a light-emitting diode (LED), emits 
a ray of quasi-infrared light at the scalp, half the wave absorbed by the chromophores 
(oxyHb, deoxyHb and cytochrome c-oxidase) found in the nervous tissue. A photo 
detector captures the light wave resulting from the interaction with the chromophores, 
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following a banana-shaped path back to the surface of the skin (see Fig 1.) (Gratton et al, 
1994). The characteristics of this light wave have changed in respect to the original 
emitted by the LED due to the absorption and dispersion capacity of the nervous tissue 
and chromophores. 
 
 
 
 
Fig. 1. Light from the light source is guided to the head by an optode. A photo-detector will 
collect the light which leaves the head at a distance of some centimetres. The photons follow 
a banana-shaped path from light source to detector. 
The absorption spectra of light absorbing molecules (chromophores) are used to interpret 
the attenuated light levels as changes in chromophore concentration. The low absorption 
capacity of biological tissue (composed mostly of water) is one reason why light waves 
pierce different extracerebral tissue with hardly any absorption of NIR rays. In contrast, 
chromophores have characteristic optical properties which absorb rays close to the light. The 
transparency of the biological tissue, along with the absorption capacity of the diverse 
chromophores, makes it possible for optic methods to be used to measure hemodynamic 
responses (Chance, et al. 1998; Villringer and Chance, 1997). The optimal light spectrum for 
studying cognitive functions ranges between 700-900nm, which could be considered the 
biological “optical window”, framed by chromophore mobilization (Jöbsis, 1977) (see Fig 2). 
This optical window lends itself to non-invasive, low-risk methods for studying cerebral 
processes. 
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Fig. 2. Absorption spectrum in NIR window: different absorption spectra of oxyHb and 
deoxyHb at 700-900 (optical window) allow spectroscopy methods to assess their respective 
concentrations. Beyond 900 nm, the majority of the photons are absorbed by the water, 
making measurements difficult. 
One of the limitations of the fNIRS is its scarce depth measurement capacity. This depth is 
determined mostly by two factors: wavelength and interopmode distance (IOD). 
Wavelength is one of the variables which determine a light’s penetration capacity. In 
confocal microscopy at 488/514 nm, a penetration into cerebral tissue of approximately 
0.25mm can be achieved (Dirnagl et al., 1991). When using dual photon technology with an 
excitation of 830 nm (Kleinfeld et al., 1998), penetration depth can surpass 0.6 mm below the 
brain surface. Nevertheless, penetration depth is limited by the optic window, given that a 
wavelength greater than 900nm penetrates tissue poorly due to the spectrum’s high water 
absorption capacity at those depths (See Fig 2). The other parameter determining light 
penetration into nervous tissue is the distance between light source and detector. In general 
terms, the greater the source-detector distance, the deeper the penetration. However, a 
greater distance can also lead to a lower intensity of light captured by the detector. The ideal 
distance between source and detector depends on the capillary depth and demographic 
variables of the subjects being studied. Dark skin and very dark hair can absorb most 
wavelengths, hence a shorter distance between light source and detector would be 
recommended, which increases the intensity of the wavelength. 
The main interaction between light and tissue is absorption, although the latter coexists 
with another phenomenon capable of modifying the optic characteristics of a light wave. 
This phenomenon, known as dispersion, illustrates photon loss which is not due to 
chromophore absorption (the loss depending on the size of the photo detector and the 
system’s geometry). A photon’s trajectory could vary when crossing nervous tissue with 
chromophores. A few photons will reach the photo detector without undergoing any 
dispersion or absorption effects (ballistic photon), some will be absorbed by 
chromophores (absorption), others--scattered out of the sampling volume--will not reach 
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the photo detector (scatter), and the remainder will make it, but by travelling a path 
longer than the geometrical distance between light source and detector (scatter) (See Fig 
3). Dispersion alters the attenuated light wave captured by the photo detector and hence 
the reflected chromophore absorption capacity. If we interpret this light wave solely on 
the basis of chromophores absorption, we would lose analytic access to the biological 
processes which underlie cerebral functions.  
 
 
Fig. 3. Possible trajectory of a photon passing through biological tissue. 
To offset dispersion and obtain a wider analytical scope of a light wave’s optical 
characteristics, we applied the modified Beer-Lambert Law (Table 1). This version differs 
from the original in its conception of the effect of dispersion. In a typical trans-cranial study 
of the human brain, the mean path length of light is six times as long as the distance 
between sender and receiver (Duncan et al., 1995). In the modified Beer-Lambert Law, a new 
term (B) is added to represent the longest path length of light. A second modification to this 
equation is also necessary, given that not all photons reach the photo detector due to the 
dispersion effect. A second term is added (G) which measures photon loss due to dispersion. 
The process of modification of this law is as follows:  
 
Original/Modified Beer-Lambert Law Equation 
Original Beer-Lambert Law A= ε x c x d 
Modified Beer-Lambert Law A= ε x c x d x B + G 
Assuming constant B and C gives ∆A= ε x ∆c x d x B 
Table 1. Variations of the original Beer-Lambert Law due to the dispersion effect.   
A: absorbance, light attenuation (no units, since A = log10 P0 / P ); ε is the molar absorption 
with units of L mol-1 cm-1;c: concentration of the compound in solution, expressed in mol-1; 
d: path length of the sample; G: photon loss due to dispersion; B: longer path length due to 
dispersion effect.  
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3. Technical approaches for functional near-infrared spectroscopy and 
neuroimaging 
Neuroscience interprets the optical characteristics of wavelengths reflected by different 
endogenous chromophores in nervous tissue, to discern the locations of cerebral functions at 
a specific moment. The functional state of the chromophores will determine how much 
spectrum light is absorbed, thereby revealing the functional state of the cortex. For example, 
the absorption spectrum for haemoglobin depends on whether or not it is oxygenated 
(venous vs. Arterial blood) (see Fig 2). Another important chromophore is cytochrome c-
oxidase (Cyt-Ox), the terminal enzyme of oxidative phosphorylation whose absorption 
spectrum depends on its redox-state. Many other agents with absorption capacity are found 
in cerebral tissue, including melanin or water, although the spectral light of near-infrared 
rays practically nullifies their absorption capacity. 
Apart from the changes in concentration of molecules with absorption capacity, dispersion 
causes changes in light’s optical characteristics. The changes provoked by dispersion have 
been described as a result of changes in neural basal state. It is believed that rapid 
dispersion changes are temporally linked to changes in membrane potential (Stepnoski et 
al., 1991), whereas slow changes in dispersion probably reflect changes in cellular volume. 
The following section provides a description of the different parameters and elements used 
to analyze wavelengths and interpret study results.  
3.1 OxyHb and DeoxyHb 
To create cerebral activity, neurons require nutrients in order to generate energy and 
produce action potentials. Glucose, like oxygen and other substances, are sent to 
metabolically active neurons by means of blood perfusion via capillaries, which produces an 
increase in rCBF and in regional cerebral blood oxygenation (rCBO). Hence, changes in 
rCBF or rCBO can be used to map brain activity with high spatial resolution (“functional 
neuroimaging”).  
During functional activation, oxygen metabolism (cerebral metabolic rate of oxygen, 
CMRO2) increases substantially (Ances et al., 2001a; Dunn et al., 2005; Gjeddeet al., 2002) 
This increased oxygen consumption during neuronal activity results in a decrease in tissue 
oxygenation which is counteracted by the increase in O2 supply when CBF and cerebral 
blood volume (CVB) increase (Ances et al., 2001b; Enager et al., 2009; Offenhauser et al., 
2005; Thompson et al., 2003), thanks to a mechanism known as neurovascular coupling. If 
the stimulus is lasting, glucose and oxygen consumption must be kept constant by 
increasing capillary density, which in turn increases total cerebral blood volume (Clarke & 
Sokoloff, 1994; Gross et al., 1987; Klein et al., 1986). However, when the stimulus is short-
lived, the aforementioned hemodynamic and metabolic changes are not produced in the 
same manner. 
CBF and oxygen metabolism is produced not only to counteract the effects of tissue 
oxygenation, but also to oxygenate haemoglobin. When haemoglobin transports oxygen, it 
is called oxyhaemoglobin (oxyHb). When it releases oxygen via an increase in oxygen 
metabolism, it transforms into deoxyhaemoglobin (deoxyHb). A cerebral region, therefore, 
could be considered active when its rCBF increases, producing a decrease in deoxyHb and 
an increase in oxyHb (Lindauer et al., 2001; Obrig et al., 1996b), which in experimentation is 
generally associated with a specific event. 
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The increased oxygen transported to the brain area typically exceeds the local CMRO2 
utilization, causing an overabundance of cerebral blood oxygenation in active areas (Fox et 
al., 1988; Frostig et al., 1990; Lin et al., 2008; Lindauer et al., 2001; Mayhew et al., 2001). When 
there is an increase in CBF, tissue hyperoxygenation takes place (See Fig 4). Different optic 
studies using fNIRS and fMRI have reported that when neural activity commences, 
hyperoxygenation (due to an increase in CBF--increased oxyHb) is preceded by low 
oxygenation (increase in deoxyHb). This vascular response is difficult to measure and very 
controversial (Buxton, 2001; Frostig et al., 1990; Malonek & Grinvald, 1996; Obrig & 
Villringer, 2003). 
 
 
Fig. 4. Diagram of metabolic and hemodynamic changes during brain activity. 
Scientific debate ensues as to which molecule possesses the highest discriminatory capacity 
for measuring neural activity. Currently, this is attributed to the deoxyHb molecule, the 
gold standard neuroscience neuroimaging technique. The deoxyHb molecule for cortical 
activity analysis has a high correlation with the BOLD response in fMRI (R=0.98; P<10-20), 
compared to that of the oxyHb molecule (R=0.71) or the HbTOTAL (R=0.53) (Huppert et al., 
2006). These same results were obtained by other researchers (MacIntosh et al., 2003; 
Toronov 2001, 2003). In addition, concentrations of deoxyHb are reported to have more 
discriminatory power in humans than oxyHb (Herrmann et al., 2008).  
In current research, our team is studying deoxyHb mobilization in different levels of 
consciousness during general anaesthesia. This mobilization has been correlated using 
Bispectral Index System (BIS) technology, the gold standard for controlling depth of 
anaesthesia. Preliminary results show a strong correlation between an increase in deoxyHb 
and a decrease in BIS as the patient reaches the lowest levels of consciousness. These results 
highlight the discriminatory power of the deoxyHb molecule in measuring deactivation in 
different brain areas.  
As we mentioned earlier, oxyHb and deoxyHb possess characteristic optical properties in 
the near-infrared light range as well as wide-ranging sensibility to different wavelengths 
(See Figure 2), making it possible to use optics methods to quantify changes in chromophore 
concentration during neurovascular coupling (Chance et al., 1993; Chance et al., 1998; 
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Gratton et al., 1995; Hoshi et al., 1993; Villringer et al., 1993; Villringer & Chance 1997). To 
calculate the different levels of oxyHb, deoxyHb, and HbTOTAL concentration, the modified 
Beer-Lambert Law is used. The attenuation of light intensity after absorption and scattering 
by biological tissue is expressed as:  
I = GI0e−(αHBCHB+αHBO2CHBO2 )L 
where G is a factor that accounts for the measurement geometry and is assumed constant 
when concentration changes. Io is input light intensity; αHB and αHBO2 represent molar 
extinction coefficients; CHB and CHBO2 indicate concentrations of deoxyHb and oxyHb 
chromophores, respectively; and L represents the photon path, a function of absorption and 
scattering coefficients μa and μb (Izzetoglu et al., 2007). 
By measuring optical density (OD) changes at two wavelengths, the relative change of oxy- 
and deoxy-haemoglobin versus time can be obtained. If the intensity measurement at the 
initial time (baseline) is Ib, and at another time is I, the OD change due to variation in CHB 
and CHBO2 during that period is: 
∆OD = log (Ib/I) = αHB∆CHB + αHBO2∆CHBO2. 
Measurements performed at two different wavelengths allow the calculation of ∆CHB and 
∆CHBO2. Oxygenation and blood volume (HbTOTAL) can then be deduced (Izzetoglu et al., 
2007): 
1. Oxygenation = ∆CHBO2− ∆CHB 
2. Blood Volume (HbTOTAL) = ∆CHBO2 + ∆CHB 
When baseline is taken, it is important to take into account that the subject is medicated or 
anxious, variables which could have a quantitative effect on CBF. Since NIRS measures 
changes in oxyHb and deoxyHb concentrations in the arterial and venous intracerebral 
compartments, comparisons of different measurements depend on the assumption that the 
proportion of arterial and venous compartments remains constant. For this reason, factors 
that alter venous volume should be considered. Changes in head position, likely to occur in 
the clinical use of NIRS, might influence venous pressure and alter the proportion of arterial 
and venous compartments in the cerebral vasculature. In addition, body position might 
modify the tone of the resistive vessels to maintain a constant cerebral blood flow. 
According to Toraro et al (1998), cerebrovascular reactivity measurements may be 
performed without taking into account changes of head position.  
Other variables to take into account when interpreting oxyHb and deoxyHb results are 
those which affect CBF: 
1. In hypercapnia, when baseline perfusion was increased by up to 100% (stronger 
hypercapnia), the deoxyHb response almost disappeared (Jones et al., 2005). 
2. During hyperoxia, the deoxyHb outwash was significantly reduced under normobaric 
conditions (Lindauer et al., 2003) or even abolished under hyperbaric conditions of 3 or 
4 ATA (Lindauer et al., 2010), while neuronal activity and CBF responses remained 
unaltered. 
3. OxyHb and deoxyHb effects remained lineal when the stimulus lasted between 6-24 
seconds. However, during shorter stimulation periods, strong nonlinear effects came 
into play (Wobst et al., 2001). 
4. Although hypothermia reduced baseline CBF by almost 50%, neurovascular coupling 
was preserved. Reduction of functional changes in CBF, deoxyHb and CMRO2 followed 
reductions in neuronal activity during hypothermia (Royl et al., 2008) 
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5. A recent study reported that the amplitude of the functional deoxyHb decrease in rat 
somatosensory cortex was reduced when ICP was elevated to 7 mmHg. At an ICP of 14 
mmHg, the deoxyHb response was close to 0 and even reversed at an ICP of 28 mmHg 
(Füchtemeier et al., 2010). 
6. Changes in oxyHb, deoxyHb and HbTOTA correlated significantly with changes in blood 
velocity (Totaro et al., 1998). 
7. NIRS parameters, induced by CO, reflect variations in resistive vessels, and could thus 
be considered an index of cerebrovascular reactivity (Totaro et al., 1998). 
3.2 Cytochrome-c oxidase 
Cytochrome-c oxidase (Cyt-Ox), an enzyme found in the mitochondria, is responsible for 
more than 90% of cellular oxygen consumption. In isolated mitochondria, Cyt-Ox redox 
states showed transient oxidation during increased cellular activity (Chance & Williams, 
1956), indicating that Cyt-Ox redox state could provide a good approximation for assessing 
transitory changes in cellular metabolism during neuronal activity (Wong Riley, 1989). Cyt-
Ox has a characteristic light absorption pattern in the visible (Keilin, 1925) and near-infrared 
parts of the electromagnetic spectrum (band centred around 830 nm) (Wharton and 
Tzagoloff, 1964), and it is in principle feasible to measure changes in the Cyt-Ox redox state 
in vivo (Cooper et al., 1994; Ferrari et al., 1990; Jöbsis, 1977).  
Cytochrome-c oxidase theoretically could be a biological marker for cellular metabolic 
demand, with the potential to provide more direct information on neuronal activity than 
haemoglobin (Heekeren et al., 1999; Jöbsis, 1977). The theoretical advantage of using this 
enzyme as a marker for neuronal activity is that it is much more exact than oxyHb and 
deoxy-Hb, given that the demand by neurons for oxygen exceeds the need for their 
activation (Fox et al., 1988). Nevertheless, while Cyt-Ox may be a more precise marker for 
measuring neuronal activity, its use in neuroscience as a parameter has been limited by two 
fundamental issues: 
1. The use of non-invasive NIRS to detect redox changes in Cyt-Ox in response to cerebral 
activation is hampered by methodological spectroscopic issues related to the 
modification of the Beer-Lambert law. However, the separation of the haemoglobin 
signal from the Cyt-Ox signal has been regarded as questionable and mere cross talk 
(Cooper 1994, 1998; Matcher et al., 1995). Methodologically, the calculation of the 
enzyme’s redox change may be erroneous due to the simplified assumptions inherent in 
the modified Beer – Lambert approach.  
2. From a physiological standpoint, there is ongoing debate on as to whether or not the 
redox state of Cyt-Ox changes in response to the functional activation of cerebral cortex. 
Recent studies have attempted to resolve these two questions. New algorithms are being 
developed that can help discern the role of Cyt-Ox and its functions during cerebral activity. 
A recent study reported that the differential stimulation of areas rich and poor in 
cytochrome-c-oxidase content results in optical changes which cannot be solely explained by 
the presently available models of cross talk (Uludağ et al., 2004). One of the most renowned 
studies tackling the physiological question reported that the spectra obtained in a state of 
increased brain activity cannot be explained solely by the well-known changes in oxyHb 
and deoxyHb, but must include Cyt-Ox in the analysis. The inclusion of Cyt-Ox to explain 
spectra changes is also applied to explain how Cyt-Ox transient oxidation increases 
significantly during visual stimulation in 9 out of 10 subjects (Heekeren, 1999).  
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For these reasons, Cyt-Ox is not widely used in research on normal cerebral functions, 
whereas other fields are finding use for its capacity as a direct maker for tissue oxygenation 
to study pathologies related to metabolic dysfunction of the mitochondria (Atamna et al., 
2010; Levy et al., 2007; Pickrell et al., 2009). The mechanisms and control of this enzyme have 
been discussed in various reviews (Cooper, 1990; Brown, 1992). 
3.3 Fast and slow light scattering signals 
Another method used for measuring neuronal activation is known as the event-related 
optical signal, or EROS, which capitalizes on the changes in the optical properties of the cell 
membranes themselves that occur as a function of the ionic fluxes during firing (Gratton et 
al., 1995). It is well established that the optical properties of cell membranes change in the 
depolarized state relative to the resting state (Obrig & Villringer, 2003; Rector et al., 1997; 
Stepnoski et al., 1991). Optical technology can be used to study these changes.   
The ability to measure neuronal membrane depolarization provides us with the opportunity 
to study neuronal activity more directly. There are two approaches to studying neuronal 
depolarization via light wave dispersion, one with fast and the other with slow scattering 
signals. These signals differ both in terms of duration (milliseconds vs. seconds) and 
magnitude and their subsequent physiological processes. Fast light scattering signals occur 
in milliseconds (Hill & Keynes, 1949). In isolated nerves cells, Stepnoski et al. (1991) showed 
that changes in light scattering were associated with membrane potentials. Slow light 
scattering signals, reported in bloodless brain slices, occurred in seconds after the onset of 
stimulation (MacVicar & Hochman, 1991). The origin of slow light scattering is still unclear, 
although the primary candidates are changes in intracellular volume and/or in extracellular 
volume (MacVicar & Hochman, 1991; Holthoff & Witte 1996). 
The study of cerebral functions in humans using EROS signals is hampered by numerous 
limitations. The principal shortcoming is that the fast scattering signal represents the low 
signal-to-noise ratio (SNR) resulting from optical properties in the skin, skull and cerebral-
spinal fluid, which are traversed by the quasi infra-red light wave. Furthermore, basic 
sensory and motor movements such as tactile stimulation and finger tapping require 
between 500–1,000 trials to establish a reliable signal (Franceschini et al., 2004).  
Other difficulties have been encountered in attempts to replicate experiments both on fast 
and slow scattering signals, limiting data collection, for example, on the optic characteristics 
of the fast scattering signal in response to a visual stimulus among normal adult humans 
(Obrig & Villringer, 2003). A final constraint is that these methods, apart from requiring a 
more expensive and cumbersome laser-based light source, have an increased risk of 
inadvertent damage to the eyes in comparison to other systems measuring hemodynamic 
response. In spite of these current limitations, the fast optical signal continues to be an 
important area of investigation because it offers glimpses of the “holy grail” of 
neuroimaging: the direct measurement of neuronal activity with millisecond time resolution 
and superior spatial resolution (Izzetoglu et al., 2004). 
4. Instrumentation 
Functional near-infrared (fNIR) instrumentation is composed of various light-emitting 
diodes (LEDs) and photo detectors which pick up light waves after they have interacted 
with brain tissue. The fNIRS normally used for neuroimaging has numerous channels. Each 
channel represents a cerebral region covered by the light wave and which coincides with the 
separation between the LED and its corresponding photo detector. Due to the dispersion 
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effect, a photo detector, which can detect light coming from cerebral tissue, is placed 2-7 cm 
from the LED. The relative contribution of extracranial tissue decreased as the interoptode 
distance increased, for an interoptode distance greater than 4.5 cm, the extracranial 
contribution was negligible (Smielewski 1995, 1997). The contribution of the scalp might be 
minimized by applying moderate pressure on the optodes (Owen et al., 1996). The ideal 
separation between source and photo detector is 4 cm, given that the fNIR signal becomes 
sensitive to hemodynamic changes within the top 2–3 mm of the cortex and extends laterally 
1 cm to either side, perpendicular to the axis of source-detector spacing. Studies have shown 
that at interoptode distances as short as 2–2.5 cm, gray matter is part of the sample volume 
(Chance et al., 1998). 
Three distinct types of fNIR implementation systems have been developed: time-resolved, 
frequency-domain, and continuous wave spectroscopy, each with its own strengths and 
limitations. (For review, see Minagawa-Kawai et al., 2008; Wolf et al., 2007). Our research team 
used the fNIRS system developed by Drexel University’s Optical Engineering Team. This low-
cost functional neuroimaging system provides a variety of clinical, research, and educational 
applications. Our NIRS system (NIM, Inc., Philadelphia, PA) applies light to tissue at constant 
amplitude and can provide measurements of oxy- and deoxy-Hb relative to baseline 
concentrations (see Bunce et al., 2006). The fNIRS probe is 17.5 cm long and 6.5 cm wide. It 
contains four light sources surrounded by ten detectors, for a total of 16 channels of data 
acquisition, covering an area of 14 X 3.5 cm on the forehead (see Figure 1). A source-detector 
distance of 2.5 cm provides a penetration depth of 1.25 cm. The probe positioning is such that 
the line of sources is set at the line of fronto-polar electrodes [FP1–FP2] (in the International 
10–20 system). This is designed to image cortical areas that correspond to DLPFC (Izzetoglu, 
2005). The DLPFC generally occupies the upper and side regions of the frontal lobes. It is 
comprised of BA 9 and 46. Area 9 occupies the dorsal region of lateral PFC and extends 
medially to the paracingulate of humans. Area 46 is generally located at the anterior end of the 
middle frontal sulcus. The fronto-polar PFC, BA 10, is a region positioned above the Orbito 
Frontal Cortex (OFC), inferior to Area 9, and anterior to Area 46, serving as a junction point 
between the OFC and DLPFC (Krawczyk, 2002). A complete data acquisition cycle lasts 
approximately 330ms, making the temporal resolution approximately 3 Hz. 
5. fNIRS research 
5.1 Prefrontal activity and learning processes 
Understanding the processes which underlie learning has become a central theme in current 
society, whether it is in the scope of education or in the field of neurorehabilitation. The 
proper functioning of learning processes can determine the efficacy of an individual’s 
adaptation in society. By identifying these processes, we can identify learning problems 
early on in childhood and intervene. This is also true in the rehabilitation of patients with 
brain injury, or with memory-related neuropathology, where learning processes can 
determine the path of neurorehabilitation within a therapeutic program.  
During learning, different brain structures begin to function, regardless of content, channel 
or mode of information. PFC participates in memory control (Luria 1973; Blumenfeld & 
Ranganath, 2006), particularly dorsolateral PFC (DLPFC), which plays a relevant role in 
temporal integration by means of functions that are complimentary and temporally 
reciprocal. The capacity to learn and remember highlights the plastic, adaptive ability of the 
neural system to change in response to experience. This capacity to integrate information is 
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widely considered to be a product of working memory (WM) (D’Esposito et al., 1998; Owen, 
1997, 2000). The following two articles provide evidences on how prefrontal cortex is related 
to learning capacity and working memory.  
The first study (León-Carrión et al., 2010) was designed to measure the physiological effects 
of repetition on learning and working memory using an adaptation of Luria’s Memory 
Word-Task (LMWT). The study focused on the physiological effects of repetition on learning 
and working memory. We have used an adaptation of Luria’s Memory Word-Task (LMWT) 
to study functional hemodynamic changes related to learning by verbal repetition. 
Functional near infrared spectroscopy (fNIRS) is used to test the hypotheses that repeated 
verbal presentation of information will produce an increase in DLPFC activation only 
during learning, followed by a decrease in activation once the information has been learned.  
This study assessed the hemodynamic response of DLPFC in 13 healthy subjects while 
performing a Luria task. All subjects successfully completed the task. A significant result 
from our data was that during the learning process, an increase in activation takes place in 
right and left DLPFC, which then decreases or ceases when the learning is complete. Our 
findings show neural repetition suppression (NRS) (see Grill-Spector et al., 2006 for a 
review) in DLPFC after effective verbal learning, an adaptation of hemodynamic activity in 
DLPFC during multiple repetitions. The correlations between memory recall and fNIRS 
activation evidences the neurophysiological substrates related to LWMT (see Tables 1 and 
2). In psychobiological terms, this indicates that NRS must be present in successful verbal 
learning to maximize the effectiveness and accuracy of learning, and also to free up space in 
working memory. This optimization of neural responses stems from a verbal learning 
process that to be effective, requires time and repetition of the material being learned. Thus 
effective learning by repetition produces a reduced demand on WM through decreased 
DLPFC oxygenation as a consequence of a shift from controlled to automatic processing. 
Our results also point out that NRS is necessary not only to complete or close learning, but 
to keep DLPFC free and available for engagement in other tasks upon demand. 
The second study used fNIRS and the N-Back paradigm to assess prefrontal activation. The 
N-Back paradigm and its variations have been used in numerous neuroimaging studies 
investigating the neural bases of working memory processes (Owen et al., 2005). In the 
current study, a modified version of the N-back task is applied (see Fig 5), which includes 
working memory manipulation to explore PFC activation during tasks requiring working 
memory (Baddeley, 1986).  
 
The N-back task is designed to increase the manipulative character of information, 
producing more activation in regions associated with working memory. We hypothesized 
that as task difficulty increased, so would the differentiation in activation among different 
areas of DLPFC. The study included 20 healthy volunteers (14 female, 6 male), all right-
handed and between 22 – 39 years of age (mean age = 26.6; SD = 4.15). fNIRS and oxyHb 
molecule mobilization were also used to measure DLPFC activation. The preliminary results 
showed that like classic verbal N-back tasks, the modified version activated the same 
regions of PFC but with greater intensity. The main result showed that while both N-back 
tasks (modified and classic) activated the same left DLPFC regions, the modified version 
registered greater differential activation. One possible explanation for the differential 
activation could be that the modified N-back had a deeper processing of information, with 
its manipulation involving semantic category and chronological order (days of the week). 
This higher information processing implies greater executive control, and an increase in 
regional cerebral blow flow in areas related to verbal working memory. In our study, areas  
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Fig. 5. Paradigms for unmodified N-back tasks (above) and modified N-back tasks (below). The 
0-back condition for both sets of tasks required a response when the word "Domingo" appeared. 
A fixation point (+) was located between stimuli. In the unmodified 1-back condition, the 
subject had to respond when a stimulus was repeated. In the unmodified 2-back condition, the 
subject had to respond when the present stimulus coincided with the prior stimulus. The 
modified 1-back condition required the subject to respond if the stimulus coincided with day 
after the prior stimulus. The modified 2-back condition requested a response if the present 
stimulus coincided with the day after the stimulus presented two positions back.  
with significant differential activation, associated with verbal manipulation and 
maintenance, corresponded with DLPFC and left frontal operculum (Brodmann Areas 9, 10, 
45 y 46) (See Fig 6). 
Overall, these two studies carried out with fNIRS indicate the importance of DLPFC in 
learning processes. The learning of verbal information, both auditory and verbally, is 
determined by the capacity of working memory to load information temporarily and 
manipulate it. The increased load and manipulation of verbal information result in 
increased physiological activation in related zones. This increased activation translates to an 
increase in CBF in areas related to verbal tasks, mostly in the left hemisphere. 
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Fig. 6. Channels significantly activated during modified N-back task 
5.2 Prefrontal activity and the affective dimension 
The fNIRS is an excellent tool for studying the temporal dimension of hemodynamic 
activity, in terms of both reaction time (measured in ms) and residual activation after 
stimulus cessation. This residual activation could shed light on the characteristics of human 
behaviour. It is generally accepted that brain activation is elicited by direct 
cognitive/affective stimulation and that this activation decreases with stimulus cessation 
(Huettel & McCarthy, 2001). The DLPFC (Brodmann areas 9 and 46) has been selected as 
region of interest (ROI) based on a review of the literature which guarantees that emotional 
stimuli will produce some kind of activation in our ROI. These findings include DLPFC’s 
sensitivity to emotional and motivationally significant aspects of stimuli (Hikosaka & 
Watanabe, 2000; Williams et al., 2001). The following articles display DLPFC activation 
during the viewing of scenes with different emotional content.  
This first paper introduces a new paradigm in the study of emotional processes, 
emphasizing the role of affective dimensions in DLPFC and their influence on the 
neuroimaging of evoked hemodynamic changes (Leon-Carrion et al., 2007a). Two affective 
dimensions have been studied extensively in neuroimaging research on emotional stimuli: 
arousal (exciting or calming) and valence (positive or negative) (Bradley et al., 1992). 
Another question that needs to be studied is whether the value (valence) and intensity 
(arousal) of an emotional stimulus evokes the same type of neural activation. 
By using fNIRS, our intent was to image PFC oxyHb (oxygenated haemoglobin) changes 
and the duration of activation in relation to how subjects rated emotional stimuli (valence 
and arousal). We studied evoked-cerebral blood oxygenation (CBO) changes in DLPFC 
during direct exposure to emotion-eliciting stimuli (‘on’ period) and during the period 
directly following stimulus cessation (‘off’ period). Our hypothesis was that the evoked-
CBO, rather than return to baseline after emotional stimulus cessation, would show either a 
significant increase (overshoot) or a significant decrease (undershoot) in oxyHb.  
This study used visual emotional stimuli (film clips) of moderate length (approx. 20 s) and 
different emotional content to study the duration of DLPFC activation and provoke strong, 
lasting responses that could be easily registered. The content of the scenes ranged from 
mutilation, repulsive acts, and violence to walking along the street, cartoons, and scenes 
with explicit sex. The results showed that by using subjective ratings in analyzing PFC 
activation to account for individual differences in emotional response to salient stimuli, and 
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by incorporating subjective data on emotional arousal, more robust activation occurred 
within DLPFC during the ‘off’ period than the ‘on’ period. In other words, when the 
subjective degree of arousal is high, the representation of the stimulus remains in the 
prefrontal cortex, even when the stimulus is no longer present. The persistence of sources of 
DLPFC activation during the ‘off’ period is closely related to the degree of arousal that the 
subject assigns to the stimulus (Fig 7). 
 
 
Fig. 7. Figure displays relative oxyHb concentrations, interpolated from the DLPFC channels 
of data acquisition in both on and off period for each emotional condition. The brain 
templates on the left and right represent the mean oxygenation during ‘on’ and ‘off’ periods, 
respectively. Valence category: (a) for unpleasant clips; (b) for neutral; and (c) for pleasant. 
Arousal category: (d) for non-arousing; and (e) for arousing. (Leon-Carrion et al., 2007a) 
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The principle finding of this study was that an overshoot related to level of arousal in the 
DLPFC persists even when the arousing stimulus has disappeared. Our data also confirmed 
that valence and arousal have different effects on the course of evoked-CBO response in 
DLPFC. We also found significant post-stimulus overshoot related to arousal ratings. 
Significant differences between ‘on’ and ‘off’ periods of DLPFC activation based on valence 
ratings were not observed. In conclusion, our findings provide the first fNIRS evidence 
directly showing that an increment in subjective arousal leads to activation within DLPFC. 
This paper introduces a new paradigm in the study of emotional processes using functional 
neuroimaging techniques. Since arousing stimuli produce longer periods of brain activation 
than do non-arousing stimuli, neuroimaging studies must consider the duration and 
affective dimensions of the stimulus as well as the duration of the scanning. It will be 
necessary to specify how long a subject is exposed to a stimulus and how much of the 
recorded response is analyzed.  
The second study (Leon-Carrion et al., 2007b) explored DLPFC structures involved in the 
processing of erotic and non-sexual films. DLPFC plays a specific role in working memory 
in order to guide the inhibition or elicitation of sexual action. Different neurosurgery studies 
have demonstrated that frontal cortex is involved in the inhibitory control of human sexual 
behaviour (Freeman, 1973; Terzian & Ore, 1955). Here, we measured stimulus response both 
during direct viewing of the stimulus and for a short time after stimulus cessation, and 
recorded the temporal course of activation in DLPFC. Our hypothesis was that the sexual 
stimulus would produce a DLPFC overshoot during the period of direct perception (“on” 
period) that would continue after stimulus cessation (“off” period), whereas the non-sexual 
stimulus would not produce overshoot during either period. 
Changes in pre-frontal concentrations of oxygenated haemoglobin (oxyHb) were measured 
during the two experimental conditions (“on” and “off” periods). Figure 8 shows a diagram 
of stimuli presentation and the sequence of fNIRS data acquisition. At the end of the 
presentation, participants were asked to rate each scene from 1 to 9 on a 2-dimensional scale. 
The first dimension, valence, corresponded to the subject’s personal evaluation of the degree 
of pleasantness/unpleasantness of each scene, and the second, arousal, referred to how 
exciting or relaxing the subject perceived the scene to be. 
 
 
Fig. 8. Diagram of stimuli presentation and sequence of fNIRS recording. Note that to avoid 
accumulative effect, independent local baselines were recorded. (Leon-Carrion et al., 2007b) 
This is the first study to show that exposure to a sexually explicit scene produces strong 
overshoot in DLPFC, while exposure to a non-sexual scene does not. A significantly rapid 
and ascendant course in DLPFC overshoot was observed during direct viewing (“on” 
period) of the sexual scene, which became even more pronounced directly after viewing 
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(“off” period), whereas a strong undershoot was observed for the non-sexual condition 
during the “off” period. We also found that the hemodynamic response to visual sexual 
stimuli differed between genders, with men registering higher oxyHb levels in DLPFC than 
women. Men seemed to be more interested in arousing visual stimuli as soon as these were 
perceived, and they experienced greater conflict in controlling their response. Men and 
women could differ in the urgency of response to a sexual stimulus, with men experiencing 
a greater degree of urgency than women. Compared to baselines, both genders showed 
significant overshoot in response to the sexual stimulus, but men showed a higher 
activation in absolute values. In men, activation was rapid and quickly increased, right 
from the onset of the stimulus, whereas women generally had a more delayed initial 
activation, which remained more stable than in men. This indicates that women, in 
general, would be more capable than men of controlling their response once aroused, and 
that this control, in both men and women, is a function of DLPFC. We therefore conclude 
that DLPFC plays a critical role in the self-regulation of sexual arousal. This study also 
demonstrates the feasibility of examining brain activation/sexual response relationships 
in an fNIRS environment. 
Summarizing, the fNIRS is proven to be a useful tool for research on cognitive as well as 
emotional processes. Its high temporal resolution facilitates research of cerebral processes in 
their most dynamic and lasting form.  
5.3 Near-Infrared Spectroscopy and its clinical use 
In recent years, the use of near-infrared spectroscopy (NIRS) has steadily increased. It is 
now being applied in clinical settings, primarily in the field of medical monitoring and 
diagnosis (Frangioni, 2008; Kurth et al., 1995; Ward et al., 2006). One significant 
development has been the Infrascanner©, a tool which uses NIRS technology for the early 
diagnosis of cerebral haematomas (Leon-Carrion et al., 2010).  
Traumatic brain injury (TBI) is a leading cause of death and disability and a major public 
health problem in the US, Canada (Leon-Carrion et al., 2005; Zygun et al., 2005) and 
Europe (Bruns & Hauser, 2003; Tagliaferri et al., 2006). Delayed medical attention is the 
strongest independent predictor of mortality in TBI patients. Early detection and surgical 
evacuation of mass-occupying lesions have decreased mortality and improved outcome in 
these patients. This reduction in mortality and morbidity requires rapid identification of 
the patient’s cerebral and cranial status. Any further delay in haematoma evaluation 
severely increases mortality and worsens functional outcome in patients who survive 
(Seeling et al., 1985). NIRS technology could improve existing methods of identification of 
intracranial haematomas in these patients in situ. The Infrascanner test lasts 3 minutes 
and is easy to use in assessment applications as well as data organization and 
transmission. The purpose of this pilot investigation was to evaluate the Infrascanner as a 
handheld medical screening tool for the in situ detection of brain haematomas in patients 
who sustained a head injury. 
The Infrascanner includes two main components: a NIRS-based sensor and a wireless 
personal digital assistant (PDA). The sensor includes a safe Class I NIRS diode laser, 
optically coupled to the patient’s head by means of two disposable light guides in a 
‘hairbrush’ like configuration. This configuration allows the sensor to contact the skin of the 
scalp. The 4.0cm separation between light source and detector allows NIRS absorbance 
measurement (~2cm wide and 2–3cm deep) in tissue volume. The light source uses an 
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808nm wavelength. The detector is covered by a band pass filter to minimize interference 
from background light. Electric circuitry is also included to control laser power and detector 
signal amplifier gain. Signals acquired from the detector are digitized and transmitted by a 
wireless link to the PDA. This link is also used to receive and set the sensor’s hardware 
parameters. The PDA receives the data from the sensor and automatically adjusts its settings 
to ensure good data quality. The data is further processed and the results are displayed on 
the PDA screen (Fig 9). 
 
 
 
 
 
 
Fig. 9. Scanning sequence for brain haematoma. (a) The NIRS Sensor has two components: a 
808nm diode laser and a silicon detector. The NIRS light source emits a light that penetrates 
the brain and is registered by the NIRS detector connected to the scalp through two optical 
fibres. The light intensity determines approximately how much blood volume is present. 
The Infrascanner performs symmetrical readings in the four main brain lobes: frontal, 
temporal, parietal and occipital. Haematoma detection derives from the difference in optical 
density between left and right readings for each brain lobe. (b) The detected signal is 
digitized and transmitted to a Bluetooth wireless personal digital assistant (PDA) that 
displays the results on the screen. (Leon-Carrion et al., 2010). 
The results of this pilot study showed that handheld near-infrared Infrascanner 
demonstrates high sensitivity and specificity in detecting intra- and extra-axial hemorrhagic 
haematomas and, even more importantly, it could detect small haematomas (<25 mL) 
within the first 24 hours following injury. Data showed that the Infrascanner achieves 89.5% 
sensitivity when used on patients with TBI. Its on-site capacity to identify patients that have 
suffered an intracranial haematoma may be considered very high. The Infrascanner also 
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showed excellent specificity (81.2%) or the capacity to detect true negatives, identifying 
patients with TBI that have not suffered an intracranial haematoma. When compared to gold 
standard CT scans, its probability of positive predictive value was 85% and 86.7% for 
negative predictive value. This means that the Infrascanner is very accurate when 
confirming the presence or the absence of a haematoma. 
This study demonstrated that the Infrascanner is a useful tool in the initial examination and 
screening of patients with head injury. It has proven utility as an adjunct to CT scans or as a 
preliminary exam given within 24 hours post-injury, when a CT scan is not available. In 
conclusion, the data shows that the Infrascanner is a sound portable device for detecting 
pre-operative intracranial subdural, epidural and subarachnoid haematomas in intensive 
care fields and emergency care units. It could aid paramedics, emergency room physicians 
and hospital staff, permitting earlier treatment and reducing secondary injury caused by 
present and delayed haematomas. 
6. Conclusion 
fNIRS has been approved by the FDA for clinical purposes and can be used simultaneously 
with other neuroimaging technologies. Studies show that fNIRS is a valid and reliable 
assessment tool for task-associated oxygenated blood, and while it may be early to define all 
the applications of this new technology, we believe it promises to find utility far beyond this 
in clinical practice. There are several types of clinical applications that could benefit from the 
unique attributes of fNIRS neuroimaging technology (Izzetoglu et al., 2004): 
- Populations that may not be able to readily tolerate the confines of an fMRI magnet or 
be able to remain sufficiently still, e.g., schizophrenics, autistic children, neonates. 
- Populations that require the long-term monitoring of cerebral oxygenation, e.g., 
premature and other high-risk infants. 
- Studies that require repeated, low-cost neuroimaging, e.g., treatment studies that image 
the cortex for efficacy. 
- Applications where an fMRI system would be too expensive or cumbersome, e.g., for 
use in a clinical office. 
- Applications that require ecological validity, e.g., working at a computer or in an 
educational setting. 
Furthermore, its current use is widely accepted by the neuroscientific community for 
studying cerebral functions due to its high level of consistency with findings based on 
traditional neuroimaging techniques. Like these, it measures neuronal activity indirectly via 
hemodynamic response. However, fNIRS is the only technique which can measure both 
extracellular and intracellular activation, with the latter still under development. fNIRS 
holds great potential for growth and application in clinical and research settings, offering 
new possibilities in neuroimaging techniques and expanding our knowledge about the 
functional organisation of the brain.  
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1. Introduction 
Near-infrared spectroscopy (NIRS) has gained attention in recent years (Hoshi et al., 2001; 
Tamura, 2003). This non-invasive technique uses near-infrared light to evaluate increases or 
decreases in oxygenated hemoglobin or deoxygenated hemoglobin in tissues below the 
body surface. 
NIRS can detect the hemodynamics of the brain in real time while the subject is moving. 
Brain activity can therefore be measured in various environments. Recent research has used 
NIRS to measure brain activity in a train driver (Kojima et al., 2005, 2006). NIRS has also 
been used to evaluate the mental activity of an individual driving a car in a driving 
simulator (Shimizu et al., 2009). 
Various arguments have focused on interpretation of signals obtained from NIRS, and no 
uniform signal-processing method has yet been established. Averaging and baseline 
correction are conventional signal-processing methods used for the NIRS signal. These 
methods require block design, an experimental technique that involves repeating the same 
stimuli (tasks) and resting multiple times in order to detect brain activation during a task. 
However, brain activation has been noted to gradually decline when a subject repeats the 
same task multiple times (Takahashi et al., 2006). 
Fourier analysis, which is frequently used for signal analysis, transforms information in the 
time domain into the frequency domain through the Fourier transform. However, time 
information is lost in the course of the transform. As the NIRS signal fluctuates, time-
frequency analysis is suitable for the NIRS signal. 
The wavelet transform is an efficient method for time-frequency analysis (Mallat, 1998). This 
approach adapts the window width in time and frequency so that the window width in 
frequency becomes smaller when the window width in time is large, or the window width 
in frequency becomes larger when the window width in time is small. Multi-resolution 
analysis (MRA) (Mallat, 1989) decomposes the signal into different scales of resolution. 
MRA with an orthonormal wavelet base effectively facilitates complete decomposition and 
reconstruction of the signal without losing original information from the signal. 
Oxygenated hemoglobin and deoxygenated hemoglobin as measured in NIRS are relative 
values from the beginning of measurement and vary between subjects and parts of the 
brain. Simple averaging of the NIRS signal thus should not be applied for statistical analysis. 
To solve this problem, we propose the Z-scored NIRS signal. 
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The aim of this chapter is to propose a signal processing method suitable for the NIRS signal 
and applicable for neuroimaging studies. We first describe the principle underlying 
measurement of brain activity with NIRS in Section 2. We then propose discrete wavelet-
based MRA to extract the task-related signal from original NIRS recordings in Section 3. 
In Section 4, we describe simultaneous measurement experiments with NIRS and 
functional magnetic resonance imaging (fMRI) using mental calculation tasks to confirm 
the validity of the proposed signal processing method. To investigate relationships 
between brain blood flow and skin blood flow, measurement is carried out using NIRS 
and the laser Doppler skin blood flow probe. The Z-scored NIRS signal is proposed for 
statistical analysis. 
Two application examples with the proposed method for NIRS signals are shown in 
Section 5. We demonstrate the possibility of using the proposed method for evaluating 
brain activity associated with driving a car in a realistic driving environment. Another 
application is to brain-computer interfaces (BCIs), which are used in actively conducted 
studies. A BCI is a system that controls machines and devices by extracting neural 
information from human brain activity. BCIs are expected to become prominent as 
nursing robotics, such as artificial hands. The proposed method is applied for BCI systems 
that can control a robot arm using NIRS. We measured brain activity during actual 
grasping tasks and imagined grasping tasks using the BCI system to demonstrate the 
validity of the proposed BCI system. 
Finally, some conclusions are given in Section 6. 
2. Near-infrared Spectroscopy (NIRS) 
Using near-infrared rays, NIRS non-invasively measures changes in cerebral blood flow. 
The principle of measurement was developed by Jöbsis (1977), based on the measurement of 
hemoglobin oxygenation in the cerebral blood flow. 
In uniformly distributed tissue, incident light is attenuated by absorption and scattering. 
The following expression, a modified Lambert-Beer law, was therefore used:  
 log( / )out inAbs I I lC S    . (1) 
Here, Iin is the irradiated quantity of light; Iout is the detected quantity of light;   is the 
absorption coefficient; C is the concentration; l  is the averaged path length; and S is the 
scattering term. 
If it is assumed that no scattering changes in brain tissue occur during activation of the 
brain, the change in absorption across the activation can be expressed by the following 
expression: 
 log( / ) ( , )out in oxy deoxyAbs I I l C X X         . (2) 
Furthermore, if the change in concentration ( C ) is assumed to be proportional to the 
changes in oxygenated hemoglobin ( oxyX ) and deoxygenated hemoglobin ( deoxyX ), the 
following relational expression can be obtained: 
 ( ) [ ( ) ( ) ]i oxy i oxy deoxy i deoxyAbs l X X         . (3) 
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The absorption coefficients of oxygenated hemoglobin and deoxygenated hemoglobin at 
each wavelength, ( )oxy i   and ( )deoxy i  , are known. As a result, oxyl X  and deoxyl X  can 
be obtained by performing measurements with near-infrared rays of two different 
wavelengths and solving Equation 3. However, the  quantity obtained here is the product of 
the change in concentration and the averaged path length. In general, this averaged path 
length l  varies greatly from one individual to another, and from one part of the brain to 
another. Caution must therefore be exercised in evaluating the results. 
3. Signal processing methods for NIRS 
3.1 Recording of NIRS signal 
As mental calculation tasks, a low-level task comprising simple one-digit addition (e.g., 3 + 
5) and a high-level task comprising subtraction and division with a decimal fraction (e.g., 
234/(0.61 − 0.35)), were set to obtain NIRS signals. Brain activity in the prefrontal lobe was 
measured using NIRS. The measurement instrument was the OMM-3000 multichannel NIRS 
system (Shimadzu Corporation, Japan) (Kohno, 2006). 
Figure 1 illustrates the arrangement of optical-fiber units and the location of each channel 
(37 matrix, 32 channels). Figure 2 shows the recorded temporal histories of oxygenated 
hemoglobin (red line, indicated as oxy-Hb) and deoxygenated hemoglobin (blue line, 
indicated as deoxy-Hb) in channel 20. 
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Fig. 1. Position of optical fibers and channels for recording NIRS signals  
(mental calculation task: matrix, 32 channels) 
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Fig. 2. Temporal history of NIRS signals in mental calculation (channel 20) 
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3.2 Analysis of NIRS signals 
In NIRS signal analysis, brain activity related to a task must be separated from that which is 
not, since NIRS measures not only signals of brain activity during a task, but also other 
signals, including measurement noise. 
In general, changes in oxygenated hemoglobin and deoxygenated hemoglobin when the 
brain is activated and restored to the original state exhibit the trend illustrated in Figure 3 
(Huettel, 2004). Therefore, if these signals can be extracted from the measured signals, the 
brain has obviously been activated. 
Averaging and baseline correction are conventional signal-processing methods. These 
methods require block design, an experimental technique that involves repeating the same 
stimuli (tasks) and resting multiple times in order to detect brain activation during a task. 
Averaging is the method by which data are averaged for each task. Randomly generated 
noise approaches zero with averaging, and only periodic data are left. Averaging is effective 
when similar reactions are generated repeatedly. However, for cerebral blood flow that 
shows large variations in reactions to the same stimuli, the reliability of averaged signals is 
low, and false signals may be created. Furthermore, even significant signals may become 
undetectable after averaging. 
Baseline correction corrects the start and end points of a block to zero to remove gradual 
trends, based on the assumption that blood flow is restored to its original state during a task 
block. However, because blood flow involves irregular fluctuations, the reference points are 
unstable. Therefore, if the whole block is corrected based on those two points alone, signals 
may be distorted. 
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Fig. 3. Schematic of changes in hemoglobin concentration due to neural activity 
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Figure 4 shows the result of baseline correction applied for NIRS signals (Fig. 2) after 
removing high-frequency noise using a moving average of 25 data. Figure 5 indicates the 
functional brain imaging of the frontal lobe. It should be noted that brain activation 
gradually declines when a subject repeats the same task multiple times. 
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Fig. 4. Results of signal processing with baseline correction and de-noising 
3.3 Decomposition and reconstruction of NIRS signals using wavelet transform 
3.3.1 Wavelet transform 
Fourier analysis, which is frequently used for frequency analysis, transforms information in 
the time domain into information in the frequency domain through the Fourier transform. 
However, time information is lost in the course of the transform. 
A short-time Fourier transform, or windowed Fourier transform, can be used for time-
frequency analysis of signals. However, the detection capacity varies widely, depending on 
the setting of the window. 
In contrast, wavelet transform is an efficient method of time-frequency analysis. This 
approach adapts the window width in time and frequency so that the window width in 
frequency becomes smaller when the window width in time is large, or the window width 
in frequency becomes larger when the window width in time is small. 
Wavelet transform expresses the local shape of the waveform to be analyzed, ( )S t , by 
shifting and dilating the waveform called the mother wavelet, ( )t , and then analyzes the 
waveform. 
A wavelet   is a function of zero average 
 ( ) 0t dt   (4) 
which is dilated with a scale parameter a and translated by b as 
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 ,
1( ) ( )a b
t bt
aa
   . (5) 
The continuous wavelet transform of signal ( )S t  is computed with , ( )a b t  as 
 *,( , ) ( ) ( )a bS a b S t t dt  . (6) 
Here, *  denotes the complex conjugate of  . 
One can construct wavelets   such that the dilated and translated function 
 /2, ( ) 2 (2 )
m m
m n t t n     (7) 
is an orthonormal base. Discrete wavelet transform can be computed by 
 ,( ) ( )m m nD S t t dt  . (8) 
In the continuous wavelet transform, information is duplicated, requiring many 
calculations. Discrete wavelet transform handles a smaller volume of information than 
continuous wavelet transform, but is able to transform signals more efficiently. 
Furthermore, use of an orthonormal base facilitates complete reconstruction of original 
signals without redundancy. The following section describes decomposition and 
reconstruction of signals using MRA. 
3.3.2 Multi-Resolution Analysis (MRA) 
MRA decomposes signals into a tree structure using the discrete wavelet transform. In the 
case of the object time-series signals, ( )S t , it decomposes the signals into an approximated 
component (low-frequency component) and multiple detailed components (high-frequency 
components). 
A signal ( )S t  can be expressed as follows by discrete wavelet transform using an 
orthonormal base ,m n  as 
 
0
0 0, , , ,( ) ( ) ( )
m
m n m n m n m n
n m n
S t A t D t  
  
    . (9) 
Here, , ( )m n t  is the scaling function as defined by the following equation: 
 /2, ( ) 2 (2 )
m m
m n t t n    . (10) 
The coefficient of the approximated component is calculated by 
 , ,( ) ( )m n m nA S t t  . (11) 
The detailed components of the signals on level m can be expressed by 
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 , , ( )m m n m n
n
d D t

  . (12) 
Thus, signal ( )S t  can be expressed as 
 
0
0
( )
m
m m
m
S t a d

   . (13) 
Task-related components can thus be reconstructed from detailed components md . 
In the wavelet transform, the choice of a mother wavelet ,m n  is important. We employed a 
Daubechies wavelet (Daubechies, 1992), which is orthonormal base and is a compactly 
supported wavelet. The vanishing moments of the Daubechies wavelet can be changed by an 
index N. We decided to use a relatively high-order generating index, N = 7. 
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Fig. 5. Decomposition of NIRS signal using a wavelet base (Daubechie 7) 
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Figure 5 presents MRA results for oxygenated hemoglobin in channel 20, where task-related 
changes were marked. Here, the measured signal was decomposed into ten levels. The trend 
of the whole experiment was extracted on the approximated component (a10), in the lowest-
frequency range. 
Here, d1 and d2, the highest frequency ranges, showed a relatively large amplitude. It is 
possible that these ranges represented measurement noise. As the interval for repetition of 
tasks and rests was 64 s, the d8 component was the central component of task-related 
changes. Signals were therefore reconstructed by adding the d7, d8, and d9 components. 
Reconstructed signals are illustrated in Figure 6. Of note, the activation pattern of 
oxygenated hemoglobin and deoxygenated hemoglobin, shown in Figure 3, can be observed 
very clearly. Comparison between Figure 4 (signal processing with baseline correction and 
de-noising) and Figure 6 (wavelet-based method) shows the improved performance of the 
proposed method. Results revealed that oxygenated hemoglobin increased and the brain 
was activated during mental calculation tasks. 
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Fig. 6. Results of brain imaging using reconstructed signals 
4. Measurement of brain functions under mental workload 
4.1 Setting of workload 
To confirm the validity of the signal-processing method explained in the previous section, 
we measured brain functions through simultaneous use of NIRS and fMRI. 
To measure brain activity under workload, we used the workload of mental calculation. 
Mental calculation tasks were set to low, medium, and high levels as follows: 
 Low-level task: Simple one-digit addition (e.g., 3 + 5) 
 Medium-level task: One-digit addition of three numbers (e.g., 6 + 5 + 9) 
 High-level task: Subtraction and division with decimal fraction (e.g., 234/(0.61 − 0.35)) 
The design of the experiment is presented in Figure 7. Each set was composed of 28 s of task 
and 36 s of rest, in that order. By arranging three sets for each level in random order, a total 
of nine sets of experiment were conducted over 592 s. 
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L: Low difficulty task
M: Middle difficulty task
H: High difficulty task
R TaskL Rest
Task
M Rest
Task
H Rest
Task
M Rest
Task
L Rest
Task
H Rest
Task
L Rest
Task
H Rest
Task
M Rest
16 28 36 28 36 28 36 28 36 28 36 28 36 28 36 28 36 28 36 [s]  
Fig. 7. Experimental design 
A 28s task consisted of 14 questions at 2s intervals for the low level, 10 questions at 2.8s 
intervals for the intermediate level, or two questions at 14s intervals for the high level. The 
subject answered the questions displayed on the computer monitor without speaking. 
During the 36s rest time, the subject rested while steadily gazing at a cross mark displayed 
on the computer monitor. 
4.2 NIRS and fMRI signal recording 
Brain activity in the prefrontal lobe was measured using NIRS and fMRI simultaneously. 
NIRS data were collected using the OMM-3000 system (Shimadzu Corporation, Japan) in 
the MRI scanner. 
Data from fMRI (3 mm thickness, 40 slices) were collected using a Siemens Symphony 1.5T 
(T2*-weighted gradient-echo sequence, TR = 4000 ms, TE = 50 ms, FA = 90 degrees, 6464 
pixels, FOV = 192 mm). Whole-brain images were obtained as T1-weighted images (TR = 
2200 ms, TE = 3.93 ms, FA = 15 degrees, TI = 1100 ms, 1 mm3 voxel, FOV = 256 mm). 
Data from fMRI were pre-processed using Statistical Parametric Mapping (SPM99; Welcome 
Department of Imaging Neuroscience, UK) Normalized contrast images were smoothed 
with an isotropic Gaussian kernel (FWHM = 12 mm). Regions of interest (ROIs) were 
defined as clusters of 10 or more voxels in which estimated parameter values differed 
significantly from zero (p<0.01). 
Subjects were nine healthy volunteers (nine men, no women). The arrangement of optical 
fiber units and measurement positions is shown in Figure 1. 
4.3 Signal processing 
Figure 8 presents measurement results through all channels for Subject A during the first 
three tasks. During the mental calculation task at the high level (i.e., the third task), 
oxygenated hemoglobin increased and deoxygenated hemoglobin decreased on both outer 
sides of the frontal lobe. 
Figure 9 presents MRA results for oxygenated hemoglobin in channel 26, where task-related 
changes were marked. The trend of the whole experiment was extracted on the 
approximated component (a10). As the interval of repetition of tasks and rests was 64 s, the 
d8 component was the central component of task-related changes. Signals were thus 
reconstructed by adding the d7, d8, and d9 components. 
Reconstructed signals from channel 26 are illustrated in Figure 10. Results revealed that 
oxygenated hemoglobin increased and the brain was activated during mental calculation 
tasks. Furthermore, such changes became larger as the level of mental calculation task 
increased. 
Figure 11 shows a comparison of functional brain imaging by fMRI and NIRS with the 
proposed method. The rectangle in the fMRI image indicates the region of measurement 
with NIRS. NIRS images agree with those for fMRI at a different workload level. This result 
supports the effectiveness of MRA with the discrete wavelet transform. 
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Fig. 8. Hemoglobin concentration changes in frontal lobe 
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Fig. 9. Decomposition of NIRS signal (channel 26) 
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(b) Reconstructed NIRS signal 
Fig. 10. Comparison of original signal and reconstructed signal (channel 26) 
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Fig. 11. Functional brain imaging by fMRI and NIRS 
4.4 Influence of skin blood flow (SkBF) 
To investigate relationships between brain blood flow and SkBF, we took measurements 
using NIRS and the laser Doppler SkBF probe. The laser Doppler SkBF probe (Advance 
Corporation, Japan) was placed on the right side of the forehead, 5 cm from the nasal root. 
The semiconductor laser Doppler velocimeter used a monochromatic light source at 780 nm. 
Figure 12 shows the comparison of NIRS signal (cerebral blood flow) and SkBF. Oxygenated 
hemoglobin increased and the brain was activated during mental calculation tasks. 
Furthermore, such changes became larger as the level of mental calculation task increased. 
But, SkBF did not increase in relation to task level. 
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Fig. 12. Comparison of NIRS signal (channel 26) and SkBF 
Mean values of oxygenated hemoglobin and SkBF at each task level are shown in Figure 13. 
The mean value of NIRS (Fig. 13(a)) became higher with higher task level. However, the 
mean value of SkBF (Fig. 13(b)) did not change in relation to task level. This result 
confirmed that SkBF did not influence NIRS signals (cerebral blood flow) in the recognition 
task. 
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(a) Result of oxy-Hb mean value                    (b) Result of SkBF mean value 
Fig. 13. Averaged result for oxy-Hb and SkBF at each task level 
4.5 Statistical analysis 
The NIRS signal expresses the quantity of relative changes using the start point as the 
reference. However, comparisons of measurements between subjects or statistical 
processing of measurements of all subjects cannot be implemented using this signal as is. 
Therefore, we propose a method for converting data of oxygenated hemoglobin and 
deoxygenated hemoglobin reconstructed by MRA into Z-scores using the following 
expression, so that the mean value is 0 and standard deviation is 1. 
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 XZ 
  (14) 
Here, X  is the signal of oxygenated hemoglobin or deoxygenated hemoglobin reconstructed 
using MRA;   is the mean value; and   is the standard deviation. 
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(a) Averaged reconstructed fNIRS signal (channel 26) 
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(b) Brain activity imaged by averaged NIRS signals 
Fig. 14. Results of group analysis of NIRS signals for nine subjects 
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Fig. 15. Functional brain imaging by fMRI and NIRS (group analysis for nine subjects) 
Figure 14 shows averaged NIRS signals using Z-score for nine subjects. Of note, the 
difference in workload level is reflected in the gradient of the oxygenated hemoglobin 
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concentration. Figure 15 shows the results of group analysis for nine subjects. The rectangle 
in the fMRI image indicates the region of measurement with NIRS. NIRS images agree with 
results of fMRI regarding different workload levels. This result supports the effectiveness of 
the proposed method. 
4.6 Subjective and objective evaluation of workload 
In this experiment, the workload of each subject was measured using the Japanese version 
of NASA-TLX to evaluate correlations between the workload of mental calculation tasks and 
the objective evaluation using NIRS. The NASA-TLX is composed of six measures: mental 
requirements; physical requirements; temporal demand; work performance; effort; and 
frustration. Before workload evaluation, the subject performed one-to-one comparisons of 
the importance of elements of the workload involved in task performance. 
The weight of each measure was based on the number of times an element was selected as 
more important during 15 one-to-one comparisons. When evaluating the workload of each 
task, the subject placed a mark at the appropriate position on the segment drawn between 
both extremes for each of the six measures. 
A weighted workload (WWL) score was obtained by reading the position of each evaluation 
mark on a scale of 0 to 100 and multiplying by the weight for each measure determined by 
one-to-one comparison, then averaging all the products. Figure 16 (left) presents the WWL 
score of Subject A as determined by NASA-TLX. Workload became higher with higher task 
level. 
Figure 16 (right) shows the results for 9 subjects evaluated using the maximum gradient of 
oxygenated hemoglobin in the task with different workload levels. Multivariate test using 
the Ryan method was used. Significant differences between high- and low-level tasks, or 
between high- and medium-level tasks are apparent (p<0.05). The results exhibited good 
correlation with subjective evaluation using NASA-TLX. This result confirms the feasibility 
of evaluating workload using the signal of cerebral blood flow obtained from NIRS. 
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(a) Workload evaluation by NASA-TLX.    (b) Maximum gradient of NIRS signal during the 
task 
Fig. 16. Subjective and objective evaluation of workload 
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5. Application examples 
5.1 Measurement of brain functions while driving a car 
5.1.1 Background 
Car drivers obtain visual information on the surrounding environment, recognize and judge 
that information suitably and then control their vehicle using the steering wheel, accelerator 
and brake pedal operations. Human brain activity functions to control all of these processes. 
In situations where it is necessary to predict unexpected danger, brain activity of the driver 
is thought to strengthen the cognitive function by spontaneously raising the level of 
attention. In the course of developing driver support systems, having a clear understanding 
of human brain activity is important in such driving situations. 
In recent years, various driving-assistance systems have been developed to improve safety 
by reducing driver workloads. Examples include the adaptive cruise control (ACC) system, 
which maintains a safe distance between the driver’s vehicle and the vehicle ahead, and the 
lane-keeping assistance system, which keeps the car in a lane through steering support. 
However, while driver workload is reduced, the attention of the driver may also be reduced, 
resulting in unexpected accidents. Driver workload thus needs to be examined from the 
perspectives of cognitive engineering and human physiology. It is necessary to clarify 
relationships between driver workload and brain activity, which includes recognition and 
judgment. Driver attention then needs to be evaluated and the relationship between brain 
activity and driving performance clarified. 
A small number of neuroimaging studies have used driving simulators to examine brain 
activity during driving. In these studies (Uchiyama, 2003; Spiers & Maguire, 2007), fMRI has 
been used. However, fMRI has many shortcomings in evaluating driving performance, 
requiring the subject to lie in a narrow cylinder during evaluation and not permitting 
movement of the body, particularly the head. This situation makes the driving task 
unrealistic and unnatural. 
5.1.2 Driving task 
To verify that the reduction in driving workload with ACC could be evaluated from brain 
activity, we conducted an experiment that involved the use of a driving simulator 
simulating following a vehicle (Fig. 17). 
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Fig. 17. Speed pattern of leading car 
The main specifications of the driving simulator were as follows. Dimensions: 2,440 mm (W) 
 2,280 mm (H)  1,850 mm (D), front view: wide-field (138 degrees) screen projection, DLP 
projector with a total pixel count of 780,000 (XGA), rear view: 3 mirror independent LCD 
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display 640480 pixel (VGA), computer graphics: redraw speed, 30-60 frames/s, simulation 
system: 6-axis motion base system using six electric screw cylinders. 
Driving tests were conducted under two conditions: one involved following a vehicle while 
utilizing the ACC; and the other involved following a vehicle while driving without ACC. 
The subject performed practice runs to become somewhat skilful in handling the driving 
simulator and then drove twice under each condition. Brain activity during one condition 
was compared with that during the other condition. 
5.1.3 Measurement method 
Brain activity in the frontal lobe was measured using NIRS. Figure 18 depicts the scene of 
the experiment. The measuring instrument was the OMM-300 near-infrared imaging device 
(Shimadzu Corporation, Japan). Figure 19 illustrates the arrangement of optical-fiber units 
(3  9 matrix, 42 channels). 
Numbers between the light-emitting fiber unit and the light-receiving fiber unit denote the 
measurement channels; measurements were performed through a total of 42 channels. 
Furthermore, driving performance was also recorded on the driving simulator while 
measuring brain activity. Four male subjects in their 20s participated; all were in healthy 
condition and had ordinary driving licenses. 
 
     
Fig. 18. Experiment with driving simulator (driver follows the proceeding vehicle with and 
without ACC) 
 
 
Illuminator
Detectot
channel
1 2 3 4 
9 10 11 12 13
18 19 20 21
26 27 28 29 30
35 36 37 38
5 6 
14 15
22 23
31 32
39 40
8
16
25
33
42
7
24
41
17
34
 
Fig. 19. Position of optical fibers and channels (driving task: 39 matrix, 42 channels) 
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5.1.4 Decomposition and reconstruction of NIRS signals 
NIRS signals include signals that are unrelated to brain activity (e.g., noise of the 
measurement instrument, influences of breathing, and changes in blood pressure). These 
unrelated signals need to be removed to evaluate brain activity in detail. The measured 
NIRS signals were thus decomposed through MRA using discrete wavelet transform, and 
components related to the driving task were reconstructed. Group analysis using Z-score 
was then conducted for all subjects. 
5.1.5 Results 
Figure 20 presents the results of group analysis for four drivers without ACC, while 
Figure 21 presents the results with ACC. Figure 20(a) confirms that oxygenated 
hemoglobin increased when the subject drove without ACC and exhibited a high value in 
the latter half of the task. The brain function imaged in Figure 20(b) confirms that, as 
common brain activity, both outer portions of the frontal lobe became active during the 
driving task. 
Figure 21(a) indicates that oxygenated hemoglobin did not increase while driving with the 
use of ACC. Also, the brain function image in Figure 21(b) reveals that the frontal lobe was 
less active than when the subject drove without ACC. This result may reflect the reduction 
of driving workload by ACC. 
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(a) Averaged reconstructed NIRS signal (channel 26) 
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(b) Functional brain imaging 
 
 
Fig. 20. Results of group analysis for four drivers without ACC system 
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(a) Averaged reconstructed NIRS signal (Channel no. 26) 
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(b) Functional brain imaging 
Fig. 21. Results of group analysis for four drivers with ACC system 
5.2 Brain-Computer Interface (BCI) using NIRS 
5.2.1 Background 
Currently, the concept of BCIs is under intense study. BCIs extract activity from the human 
brain as cranial nerve information and use the information as inputs to control machinery 
and equipment. If this could enable the operation of machinery and equipment directly 
from cranial nerve information without the subject moving the hands and feet, such systems 
could be applied to care-taking robots for physically handicapped individuals. 
BCI systems can be divided into two types. The invasive type reads cranial nerve 
information using electrodes embedded directly into the brain. The non-invasive type reads 
cranial nerve activity from the surface of the head using NIRS or electroencephalography 
(EEG). The invasive type offers high signal accuracy, but imposes heavy burdens on the 
user, such as the need for invasive procedures and the risk of infections after such 
procedures. The non-invasive form thus seems to have wider applicability. 
In a study on the non-invasive type, Matsumura et al. extracted cranial nerve information 
using EEG and controlled a humanoid robot (Matsumura & Nakagawa, 2006). Many other 
studies of BCIs have used EEG. However, EEG may be greatly affected by movement of the 
user’s body, and is vulnerable to electronic noise. In contrast, NIRS imposes fewer 
restrictions on body movement than EEG and is more resistant to electronic noise, so the 
load imposed on the user is less and electronic devices have no influence. The present study 
therefore focused on BCIs using NIRS. 
In an earlier study, Nagaoka et al. developed an NIRS-BCI rehabilitation system (Nagaoka 
et al., 2010). In that study, electric stimuli corresponding to cranial nerve information were 
applied to the biceps brachii muscle of the user by setting a threshold on signals measured 
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from NIRS, in order to cause the elbow joint to move. Signals measured by NIRS are 
unstable, since signals components that are irrelevant to the subject (e.g., noise of 
measurement instruments, heartbeat, and respiration) are included. Moreover, no 
processing method for NIRS signals has yet been established. For these reasons, obtaining a 
highly accurate operation by merely setting a simple threshold on NIRS signals is difficult. 
In this study, we assumed artificial arms for physically handicapped individuals and 
proposed a BCI system that would enable operation of the robot arms using NIRS to 
measure cranial nerve information in a non-invasive manner. Furthermore, we applied new 
signal-processing methods, such as multiresolution analysis with discrete wavelet transform 
and a brain activity-judging method that uses derivatives of NIRS signals, to achieve highly 
accurate on/off operations. 
In imaging tasks where the subject performs imaging in the brain without moving the body, 
signal intensity is weak and the presence of brain activity is difficult to judge. We therefore 
first verified the effectiveness of the system and judging method in grasping tasks, which 
have high signal intensity, and then verified the identification accuracy of the system from 
tests that involve imaged grasping tasks, with consideration of applying the system. 
5.2.2 A robot arm control using a NIRS-BCI system 
Figure 22 depicts a robot arm control system that uses a NIRS-BCI system. This system is 
composed of a cerebral function measurement section, a feature extraction and recognition 
section, and a device control section. In the cerebral function measurement section, the 
oxygenated hemoglobin level of the user is measured using the OMM-3000 multichannel 
NIRS instrument made by Shimadzu Corporation, Japan. In the feature extraction and 
recognition section, the threshold is obtained by analyzing the original signal of oxygenated 
hemoglobin that was measured. When oxygenated hemoglobin after analysis exceeds the 
threshold obtained in the feature extraction and recognition section, the on signal is sent to 
the device control section to enable rotation of the joint of the robot arm (MR-999; Elekit, 
Japan). 
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Fig. 22. Robot arm control using the NIRS-BCI system 
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Experiments were conducted using the robot arm control system depicted in Figure 22. 
Optical fibers were arranged in 44 matrices on the right and left sides to perform 
measurement, with a total of 48 channels. 
Five trials were carried out, with each trial consisting of 10 s of pre-task rest, 30 s of task, and 
10 s of post-task rest. The first two trials were defined as the learning stage, where the 
feature extraction and recognition section learned the fluctuation pattern of the user’s 
oxygenated hemoglobin levels without moving the robot. 
In the third and subsequent trials, the robot arm was rotated according to the learned 
pattern corresponding with oxygenated hemoglobin. Both grasping tasks and imaged 
grasping tasks were performed. The subject was instructed to rest during the rest time. The 
motor area was selected as the measurement site. 
5.2.3 Judgment of brain activity 
Judgment with a simple threshold 
In the judgment method that used a simple threshold, the average oxygenated hemoglobin 
level in the first two trials and the standard deviation were converted to Z-scores, and the 
moving average was obtained. The threshold was set to 20% of the maximum oxygenated 
hemoglobin level during the first two trials; judgment was made in the third and 
subsequent trials, and an "on" state was judged when oxygenated hemoglobin level 
exceeded this threshold. 
Changes in density of oxygenated hemoglobin level and the judgment results for imaged 
grasping tasks and actual grasping tasks are depicted in Figure 23. In Figure 23(a), "on" 
judgments were observed in the first and second trials, but not in the third trial. Next, in 
Figure 23(b), "on" judgments were made in all tasks from the first to third trials, but "on" and 
"off" judgments alternated within a short time, indicating instability. Furthermore, an "on" 
judgment was made during the rest period in the second trial, indicating erroneous 
judgments. 
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                    (a) Actual grasping tasks                                    (b) Imagined grasping tasks 
Fig. 23. Results for on/off decisions using a simple threshold 
Judgment using oxygenated hemoglobin level and its derivative 
NIRS can measure both change in density of oxygenated hemoglobin and that of 
deoxygenated hemoglobin; however, the change in density of oxygenated hemoglobin is 
highly correlated with the change in regional cerebral blood flow (rCBF) (Hoshi, 2001), and 
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an increase in rCBF reflects an increase in neural activity. We therefore focused on the 
oxygenated hemoglobin signal. 
Furthermore, the derivative of oxygenated hemoglobin is highly correlated with the 
workload of the task as shown in Section 4.6, so we judged brain activity using two indices: 
oxygenated hemoglobin; and its derivative. First, NIRS signals include signal components 
that are irrelevant to brain activity (e.g., noise of measurement instruments, influences of 
respiration, and fluctuations of blood pressure). Signals were thus decomposed and 
reconstructed by MRA. 
The original oxygenated hemoglobin signal and reconstructed oxygenated hemoglobin 
signal are depicted in Figure 24(a). In Figure 24(a), oxygenated hemoglobin includes not 
only brain activity, but also the effects of blood pressure, breathing and measurement 
noises. However, in Figure 24(b), the reconstructed oxygenated hemoglobin signal can be 
seen to be smoothed. 
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Fig. 24. Changes in original and reconstructed oxygenated hemoglobin signals 
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Fig. 25. Oxygenated hemoglobin concentration change due to neural activity 
Changes in oxygenated hemoglobin and its derivative when the brain is activated are 
depicted in Figure 25. Oxygenated hemoglobin was defined as Xoxy and its derivative was 
defined as dXoxy/dt. The threshold of oxygenated hemoglobin (denoted as y1) and that of the 
derivative (denoted as y2) were computed by y1 = K1 max(Xoxy) and y2 = K2 max(dXoxy/dt). K1 
and K2 were weight factors that depended on the point where Xoxy reached a maximum. 
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The point where Xoxy reached a maximum was defined as e = (toxy − ttask/2)/(ttask/2). Here, 
ttask was a time at which tasks were performed and toxy was a time from start of the task to 
when Xoxy reached a maximum. In this study, K1 and K2 were set to K1 = 0.8e + 0.2 and K1 = 
−0.8e + 1. If Xoxy reached maximum in the middle of the task, y1 was 20% of the maximum 
value of Xoxy. If Xoxy reached maximum at the end of the task, y2 was 20% of the maximum 
value of dXoxy/dt. The on/off decision (on = 1, off = 0) was made by Y (= 1: Xoxy>y1 or 
dXoxy/dt>y2, = 0: otherwise). 
The judgment result for grasping tasks when the proposed judgment method was applied is 
depicted in Figure 26(a), and that for imaged grasping tasks is depicted in Figure 26(b). 
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(a) Actual grasping tasks   (b) Imagined grasping tasks 
Fig. 26. Result of on/off decision using oxygenated hemoglobin and its derivative 
In contrast to the judgment method where a simple threshold was imposed on oxygenated 
hemoglobin in grasping tasks (Fig. 23(a)), "on" judgments were confirmed during the first 
and all subsequent tasks with the method depicted in Figure 26(a). However, "on" 
judgments were made continually for 5 s after completion of the task in each trial, indicating 
that erroneous judgments may be made. The judgment method thus needs further 
refinement. 
In contrast to the judgment method where a simple threshold was imposed on oxygenated 
hemoglobin in imaged grasping tasks (Fig. 23(b)), more stable judgment was made in Figure 
26(b), and the problem of alternating "on" and "off" judgments within a short time was 
reduced. 
6. Conclusions 
A signal-processing method to extract task-related components with MRA based on discrete 
wavelet transform is proposed for NIRS. Integration of data from multiple subjects using Z-
scores was then developed for statistical group analysis. 
Brain activity of subjects with workloads comprising different levels of mental calculation 
tasks were measured using NIRS and fMRI. NIRS images constructed using the proposed 
method agreed with fMRI images at different workload levels. Those results show that the 
proposed method is effective for evaluating brain activity measured by NIRS. 
Comparison between NIRS signal (cerebral blood flow) and skin blood flow showed that 
skin blood flow does not affect NIRS signal in the recognition task. 
Changes in brain activity in connection with workload were compared with the subjective 
evaluation of workload by NASA-TLX. Good correlation was observed between brain 
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activity detected by NIRS and workload scores obtained from NASA-TLX. This result 
indicates the possibility of evaluating workload from cerebral blood flow signals obtained 
using NIRS. 
Whether the reduction of driving workload by ACC can be evaluated from brain activity 
was evaluated through experiments using a driving simulator. The results revealed that 
while the outer portions of the frontal lobe were active in connection with driving 
performance when the subject drove without ACC, no activity related to driving 
performance was seen with the use of ACC. These results suggest the possibility of 
evaluating driving-assistance systems through the evaluation of driving workload from 
measurement of brain activity using NIRS. 
We developed MRA using discrete wavelet transform as a real-time post-signal processing 
for NIRS-BCI system and applied this approach to control of a robot arm. With a judgment 
method that used a simple threshold, no stable operation could be obtained for grasping 
tasks or imaged grasping tasks. 
We proposed a judgment method that uses two indices (oxygenated hemoglobin and the 
derivative of oxygenated hemoglobin) for judging brain activity, and adjusts the threshold 
of oxygenated hemoglobin and its derivative depending on the point of maximum 
oxygenated hemoglobin during the task. Results indicate that our proposed method enables 
more accurate judgments than use of a simple threshold. We thus confirmed the feasibility 
of our proposed method for a NIRS-BCI system. 
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1. Introduction 
Brain imaging has been a key technology in advancing our understanding of the neuronal 
basis of cognition. However, in order to fully unleash the power of brain imaging it needs to 
be combined with other sources of information such as gene expression, behavioural 
performance, as well as with computational models. 
In so-called “model-based brain imaging” computational models of how the brain processes 
information are employed in order to interpret the data. A prominent example is the use of 
models from reinforcement learning in order to interpret responses in basal ganglia, or frontal 
cortex. However, while such a model-based brain imaging certainly adds a new level of 
explanation beyond the mere description of the evoked neuronal activations, it will always be 
limited by the spatial and temporal resolution of the employed imaging technologies. 
Here, we argue that the application of multi-scale modeling, which bridges the gap between 
the various spatial and temporal scales, is a necessary next step in the analysis of brain 
imaging data. For example, this way it will be possible to simulate the effects of altered 
membrane currents under pharmacological manipulation on brain-wide network dynamics 
and compare simulation results with recorded brain imaging data. 
We emphasize that one important benefit of models is to operationalize as many 
assumptions as possible (Section 2). Then, we summarize the state-of-the-art in 
Neuroinformatics tool support, which is necessary for multi-scale models in model-based 
brain imaging. We also argue that even without complete physical models, which bridge the 
various scales, a data-driven approach using partly phenomenological model can be 
pursued, but this calls for new Neuroinformatics tools (Section 3). We summarize some of 
our recent work in network modeling of the visual system, where we performed systematic 
model comparisons (Section 4), and we close with identifying a challenging test case for 
multi-scale modeling in model-based brain imaging, namely the investigation of the 
neuronal basis of the self (Section 5). 
2. Two dimensions of theory-dependence of observations in neuroscience 
Brain imaging studies are already heavily dependent on various kinds of models. We argue 
that a key advantage of models in brain imaging (and in the interpretation of neuronal data 
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in general) is to make assumptions explicit in order to deal with the fact that all observations 
are theory-dependent. Interestingly, we can distinguish two dimensions of theory-
dependence in brain imaging (Figure 1a): First, the dependence on the physical theories 
upon which the measurement devices like magnetic resonance imaging (MRI) scanners are 
built; second, the dependence on computational theories to derive teleological explanations 
of brain activity. While the former is shared with other scientific disciplines, the latter is a 
more recent advancement. Let us consider these two dimensions of theory-dependence in 
greater detail. 
 
 
 
Fig. 1. Theory-dependence of observations and Bayesian model comparison. a) In brain 
imaging one can identify two dimensions of theory-dependence of observations: an implicit 
dependence on the theories underlying the measurement devices (such as the working of an 
MRT scanner), and a more recent explicit theory-dependence, where computational theories 
are used in order to interpret neuronal activations in a teleological manner with formally 
defined computational theories. b) Graphical model for Bayesian model comparison. 
Models M are parameterized with parameters . Once prior distributions P(|M) and 
forward models P(x|) are defined, different models M (each of which is parameterized 
with a ) can be compared with each other. 
2.1 Theory-dependence of the measurement process 
Since the work of Fleck (Fleck, 1979), Kuhn (Kuhn, 1962), and also Popper (Popper, 1972) in 
the last century we know that all scientific observations are theory-laden, i. e. even the most 
basic “facts” depend on a certain theoretical background. These ideas have been developed 
with physics as the main application domain, because in the last century physics 
experienced many radical changes of its fundamental theories. In brain imaging the theory-
dependence of observations becomes most visible when considering the measurement 
process. For example, it is still not clear how signals from functional magnetic resonance 
imaging (fMRI) should best be interpreted in terms of neuronal and synaptic activations, 
and models are needed to ensure a proper interpretation of the measured brain activation in 
terms of neuronal activity (Almeida and Stetter, 2002). The situation is similar for research in 
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electroencephalography (EEG), where source localization methods aim at solving the 
inverse problem of estimating the sources of electrical activity inside the head based on the 
measured EEG activity outside the head. This kind of theory-dependence is usually implicit, 
but can be made explicit in terms of a model for the measurement process as part of the data 
analysis. 
2.2 Theory-dependence of the interpretation of the data 
Another more recent kind of theory-dependence in neuroscience is not implicit, but explicit 
theory-dependence. Here, the neuronal activity in the nervous system is interpreted in terms 
of a (computational) function for the organism in a teleological manner. Teleological 
explanations in biology have a long history, but what makes their re-appearance in 
neuroscience attractive is that nowadays they are often articulated in at least a semi-formal 
way, but now more often also in an explicit formal manner. A prime example is reward 
learning. Here, algorithms from reinforcement learning are used to provide a basis for the 
semantic interpretation of the neuronal activations (Schultz, 2002). In other words, the 
neuronal circuitry in the brain is considered as a “wetware” on which algorithms are 
running (with all the associated constraints brought about by the slow processing speed and 
sluggishness of nervous systems compared to today’s computers). Here, the empirical 
observations are intentionally theory-dependent, which we think is noteworthy and a new 
tool in the methodological toolbox to investigate complex biological systems. 
2.3 Models make the theory-dependencies explicit 
Both kinds of theory-dependence can be made explicit using models, which then allows for 
systematic comparisons between competing models on the basis of experimental 
observations. The approach of Bayesian model comparison is widely accepted as a 
principled method for comparing different models. Figure 1b shows the graphical model 
(graphical models are marriage of graph and probability theory used artificial intelligence 
and statistics) for Bayesian model comparison. Different models M can be parameterized 
with a parameter vector . Once prior distributions  P |M  are specified, observed data x 
can be used in order to compare different models M1 and M2 using the so-called posterior 
odds    1 2P M | /P M |  , or the posterior distributions over model parameters  for a 
certain model can be inspected. Performing the necessary calculations, such as evaluating or 
estimating the integral    P | ,M P |M d   x , is technically demanding and defining the 
prior distributions  P |M  can be non-trivial. Still, however, this way of model comparison 
can serve as a general framework for model-based brain imaging even with multi-scale 
models, i. e. the particular definition of  P |x  will need to incorporate both kinds of 
theory-dependence (see Section 3.3). 
3. Neuroinformatics support 
Neuroinformatics is an emerging discipline, which provides methods and tool support for 
neuroscience. Prime examples are databases for neuronal data, and tools for modeling and 
simulation. Let us briefly review selected advances in this field in order to identify ways in 
which Neuroinformatics could contribute to model-based brain imaging with multi-scale 
models. 
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3.1 Neuroinformatics support for sharing and analysis of data 
The brain imaging community has always been very progressive in terms of sharing data 
and tools. While new analysis methods could certainly be developed within a single 
method-oriented laboratory, it is the community-wide evaluation of new methods, which 
provides their ultimate test. The free sharing of tools is certainly helpful. 
In the field of fMRI studies, the SPM software (http://www.fil.ion.ucl.ac.uk/spm) is 
probably the most widely used open source software, and comparing models given 
observed data is a well-developed feature of SPM. It is the tool of choice to apply Dynamic 
Causal Models (DCMs) to brain imaging data, i. e. performing Bayesian model comparison 
with Neural Mass Models (NMMs), which are models accounting for averaged population 
activity in a whole cortical area with a greatly simplified local circuit architecture. Other 
software packages for specialized tasks such as, for example, multivariate pattern 
classification exist, but the advantage of a mature platform with a long tradition such as 
SPM is that one can almost consider it as a “software ecosystem” for data analysis as other 
tools and toolboxes can easily be integrated into analysis workflows. 
In the field of EEG studies, the situation is more diverse. This may be due to the fact that 
EEG as a brain-imaging modality has been (and still is) in a “renaissance” phase, i. e. it is 
recognized that new analysis methods can pull out much more information about brain 
states than plain averaging. Prominent tools for EEG analysis are EEGLAB (Delorme and 
Makeig, 2004) and the FieldTrip toolbox (Oostenveld et al., 2011), both of which support 
time-frequency analysis and source localization, namely dipole-based localization and the 
beamformer algorithm, respectively. EEGLAB is the probably best first choice for applying 
Independent Component Analysis (ICA) to EEG data (Onton and Makeig, 2006). Even 
though the application of ICA to EEG is controversial, recent advances suggest that properly 
adapted variants of ICA can yield physiologically plausible results (Hyvärinen et al., 2010). 
SPM can also be applied for EEG analysis, and it supports DCMs for EEG data. Another 
prominent tool for EEG analysis is Cartool (http://brainmapping.unige.ch/cartool), which 
supports a so-called topographic analysis of event-related potentials (Pascual-Marqui et al., 
1995; Murray et al., 2008) as well as distributed source localization. In contrast to the other 
Matlab-based tools, Cartool is an application for the Windows operating systems with a 
graphical user interface and currently no possibility for external scripting, i. e. it cannot be 
part of an automated toolchain. 
In terms of data sharing, it is notable that for more than 10 years the fMRI community has 
the possibility to share the raw data (Editorial, 2000). Initially, this was viewed rather 
skeptically, but it has facilitated the development of new analysis methods (Van Horn and 
Ishai, 2007). Unfortunately, it appears that EEG researchers do not typically take such an 
approach and are still far more protective of “their” data. As of now, this also applies to data 
sharing in neurophysiology. Only some neurophysiology researchers freely share their data 
via web pages. However, progress and standardization can be expected from efforts taken 
by, for example, the International Neuroinformatics Coordination Facility or actions of 
major funding agencies and publishers. 
Taken together, the sharing of tools and data from various imaging modalities (including 
neurophysiology) is an essential prerequisite for applying multi-scale modeling to model-
based brain imaging. Very likely, there will never be a single tool to cover all requirements 
for data analysis. Instead, a “software ecosystem” with loose coupling between components 
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(such as in terms of specifications for data and file formats and ultimately implementations 
using service-oriented architectures) appears as a promising solution. The existing Matlab-
based tools come closest to such an ecosystem. 
3.2 Neuroinformatics support for multi-scale modeling 
In order to evaluate the forward model,  P |x , for multi-scale models one needs to 
account for the observed data in terms of the neuronal activity of synaptically coupled 
neurons. Do we currently have enough knowledge in order to define such models 
mathematically, not to mention their numerical simulation? For example, for fMRI it is 
still not clear if the signal reflects pre- or postsynaptic activity (Logothetis, 2008), or 
excitatory or inhibitory synaptic activity (Lauritzen and Gold, 2003). For EEG forward 
models, the anisotropy of the conductivities may matter (Güllmar et al., 2010), and linking 
local field potentials to the spiking/synaptic activity is also a current research topic 
(Rasch et al., 2009). 
For example, we have recently combined NMMs and anisotropic head-models in order to 
simulate EEG activity (Zimmermann et al., 2011) as an attempt for a multi-scale forward 
model. Here, we argue that even without a complete physical description of how spiking 
activity causes, for example, EEG signals one could still pursue model-based brain imaging 
with multi-scale models, namely by using phenomenological models for those parts of the 
full model, where a physical description is currently not available. The procedure of 
Bayesian model comparison is blind to the physical plausibility or “truth” of a model, 
 P |x , but only compares probabilistic models with each other. Thus, by using data from 
multiple imaging modalities and employing phenomenological models for the boundaries 
between different scales of modeling, one could iteratively improve these models. Of course, 
one needs to accept that parts of such multi-scale models are incomplete. From a pragmatic 
perspective, this shifts the focus from finding a “true” model or physical principle to bridge 
the gap between different scales to the very practical question: How to simulate forward 
models, and how to share models? 
Sharing models in terms of scripts for established simulators like NEURON, GENESIS or 
NEST has been a major step towards facilitating the exchange of models. Recently, these 
efforts have been extended by the development of simulator-independent model 
descriptions like generating models via Python scripts (Davison et al., 2008), renewed 
interest in NeuroML (Goddard et al., 2001), or the recent NineML initiative 
(http://ninml.org). Compared to Systems Biology, however, corresponding efforts in 
Computational Neuroscience are less developed in terms of model exchange (De Schutter, 
2008), because a standard as widely accepted as the Systems Biology Markup Language 
(SBML) is still missing, but it is actively developed within the Neuroinformatics community. 
As of now, web portals like ModelDB (http://senselab.med.yale.edu/modeldb) or, for 
vision science, the Visiome (http:// visiome.neuroinf.jp) are an excellent source of models in 
terms of scripts for simulators. Hopefully, in the near future, such portals will also host 
model descriptions (as compared to simulator scripts), similar to the BioModels database for 
Systems Biology models (http://www.ebi.ac.uk/biomodels). However, we argue that it is 
essentially the multiplicity of different (spatial and temporal) scales of neuronal models, 
which makes similar efforts a challenge for Neuroinformatics. 
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3.3 Is there any Neuroinformatics support for multi-facet modeling? 
In addition the different scales, neuronal systems can also be described at different levels 
of abstractions such as in terms of the neuronal dynamics, but also in terms of the 
computations carried out by the neuronal “wetware”. Marr distinguished between the 
computational problem, the algorithmic solution, and a “wetware” used to execute the 
algorithm (Marr, 1982). This distinction is very close to a typical computer science 
approach, where the algorithms are clearly distinct from the hardware on which they are 
running. Such an apparently clear separation has been questioned recently, because the 
algorithms and the neuronal “wetware” may not be as independent as previously thought 
(Noë, 2005). Computational Neuroscience researchers have produced hypotheses, which 
aim at bridging the gap between mere mechanistic descriptions and computational 
properties by essentially proposing transformations from algorithmic descriptions to 
neuronal circuitry. Is there any Neuroinformatics support for such a multi-facet 
modeling? Can multi-facet modeling be considered within the framework of Bayesian 
model comparison? 
The answer to the first question is simply “no”. As of now, there is no tool support to 
explicitly formulate such multi-facet models, but we have recently started to address this 
problem (Ansorg and Schwabe, 2010) by taking inspiration from software engineering. How 
can such multi-facet models fit into the framework of Bayesian model comparison? One 
simply needs to define a forward model  P |x  for the observed data, but for multi-facet 
models this calls for defining a computational model and a transformation into the 
“wetware”. If proper description languages for such multi-facet models and transformations 
would be available, one could compare different hypothesis about the computations in 
neuronal circuits in a data-driven way. Readily available candidates for such multi-facet 
modeling include hypotheses about the role of dopamine in reward learning (Schultz, 2002), 
or postulates about population codes in sensory systems (Ma et al., 2006). 
4. Selected advances in cortical microcircuit models 
The NMMs employed in DCMs are a major step beyond the mere statistical models 
embodied in, for example, effective connectivity analyses. However, these NMMs often 
assume a simplified cortical architecture. In our modeling of visual cortical networks we 
also employed mean-field firing rate models as in NMMs (as well as more detailed models 
with so-called “spiking neurons”). We could show that single neuron responses in primary 
visual cortex (V1) are best explained when the local cortical microcircuits are assumed to 
operate in a balance between strong recurrent excitation and inhibition (Mariño et al., 2005a; 
Stimberg et al., 2009), and that inter-areal feedback into V1 may play a crucial role in “lateral 
inhibition” (Schwabe et al., 2006a; Ichida et al., 2007; Schwabe et al., 2010). To the best of our 
knowledge, such and other recent advances in cortical microcircuits models have not yet 
been implemented into NMMs used in brain imaging. Here we review some of these 
advances and outline how they could be used in model-based brain imaging with multi-
scale models. 
4.1 The operating regime of local cortical computations 
More than 50 years after the discovery of orientation tuning in V1, there are still 
controversial discussions about the underlying neuronal circuits (Figure 2a). Probably the 
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dominant controversy relates to the question: To what extent is neuronal selectivity in 
sensory systems determined by the afferent feedforward connections vs. intra-cortical 
processing (or even feedback from higher visual areas)? Previous theoretical studies already 
investigated a so-called “balanced regime” of neuronal networks, where excitatory and 
inhibitory inputs are balanced and largely cancel each other out. We have investigated such 
an operating regime in joint experimental-modeling studies. 
 
 
 
 
 
 
 
 
Fig. 2. Orientation tuning models and Bayesian posterior over models. a) Illustrations of 
circuits, which may compute orientation-tuned responses in area V1. b) Bayesian posterior 
for models enumerated in terms of the strength of local recurrent inhibition (x-axis) and 
excitation (y-axis), given the data reported in (Mariño et al., 2005b). (Figure 2b is taken from 
Stimberg et al. (2009), by permission of Oxford University Press) 
A study by Stimberg et al. (2009) employed a Bayesian approach to investigate data reported 
first by Mariño et al. (2005b). Most importantly, a class of models was defined, which 
includes all the different variants shown in Figure 2a, by considering the strength of 
recurrent excitation and inhibition within a network model of an approx. 1mm2 cortical 
patch as parameters  in a forward model  P |x . Then, using this forward model, the 
posterior probabilities over the model parameters were computed, given the experimental 
data (Figure 2b). It turned out that a recurrent regime (Figure 2a, right icon) is the most 
probable regime. The details of this calculation and the simulations are given in Stimberg et 
al. (2009). A few aspects of this study are important to emphasize here: First, the data to be 
explained by the network model was already postprocessed data from multiple 
experimentally recorded neurons, i. e. it was not aimed at accounting for every recorded 
spike. Second, compared to the NMMs used in DCMs the network model referred to a 
smaller scale than accessible by current brain imaging studies (<1mm2). Third, this model 
used parameter values for the model neurons (such as membrane conductances), which are 
at best good guesses informed by other studies, but way beyond a comprehensive 
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characterization in a single preparation. Finally, the class of models was sufficiently 
restricted so that one could investigate the full posterior distribution. 
Hence, this study demonstrates that large-scale network simulations can be used 
successfully in a Bayesian model comparison (of models within a properly defined class). 
Note that while the employed model certainly lacks many potentially biophysically relevant 
details, it is far more realistic than the NMMs used in DCMs. We argue that the most 
relevant way, in which it goes beyond the NMMs, is not the level of biophysical realisms but 
the fact that it operates the model network in a “balanced” regime. In such a regime, 
recently termed “inhibition stabilized network” (Ozeki et al., 2009) as recurrent excitation 
makes the network unstable in the absence of recurrent inhibition, even small external 
inputs can be amplified via local recurrent connections. The dynamic properties of such 
strong local recurrent connections have not yet been considered in DCMs, which address 
inter-areal networks and use greatly simplified local circuit models. 
4.2 Contextual effects and “lateral inhibition” 
In another series of joint experimental-modeling studies we investigated such inter-areal 
networks, but we focused on the detailed microcircuits of the inter-areal connections. This is 
a key question one needs to deal with when interpreting large-scale brain activations in 
terms of network models. Here, the spatial scales of the connections need to be identified 
(see Angelucci et al. (2002) for the corresponding anatomy of feedback within the visual 
system), but network simulations needs to be conducted in order to predict the 
physiological responses. 
 
 
Fig. 3. Surround suppression in network models and data-model comparison. a) Illustration of 
surround suppression: When the surround of a neuron's classical receptive field is also 
stimulated, then the response is reduced. b) Illustration of a recurrent network model of many 
recurrently coupled orientation hypercolumns in area V1. They receive feedforward inputs 
from the lateral geniculate nucleus (LGN), are interconnected via long-range horizontal 
connections within V1 and reciprocally to another retinotopically organized extra-striate visual 
area (here: area MT). c) Summary of surround suppression data from macaque V1 from two 
experimental conditions (stimulus in the classical receptive field at high, y-axis, and low, x-
axis, contrast). The ellipse indicates the 50% confidence region of the measured surround 
suppression in N=63 cells. The lines show predicted surround suppression of the recurrent 
network model from Schwabe et al. (2006) for increasing strength of the inter-areal feedback 
connections to local inhibitory cells for moderate (dashed) and strong intra-areal (solid) lateral 
inhibition. (Figure 3c is taken from Schwabe et al.(2010), with permission from Elsevier). 
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A prominent phenomenon of interest in visual neuroscience is surround suppression. When 
another stimulus in the surround of a classical receptive field of a neuron is shown, then the 
response is suppressed compared to the stimulation of only the classical receptive field. 
Figure 3a illustrates this for visually responsive neurons tuned to orientation. The concept of 
“lateral inhibition” is usually invoked to explain this surround suppression, i. e. recurrent 
connections between different 1mm2 patches implement a competition via mutual 
suppression. In a modeling study we predicted that feedback from extrastriate areas into V1 
(see Figure 3b for an illustration of the model architecture) may play a major role in 
mediating this “lateral inhibition” (Schwabe et al., 2006a), which in this model is an inter-
areal inhibition. Interestingly, we also predicted that stimuli with a large separation from 
the receptive field of the recorded neuron could even facilitate (and not only suppress) the 
responses when the classical receptive field is stimulated at low contrast. Later we 
confirmed this prediction experimentally (Ichida et al., 2007). These studies show that 
stimulus-driven responses and their modulation can depend on the stimulus properties and 
are mediated by inter-areal connections. Most importantly, such studies could inform the 
stimulus design in brain-imaging experiments (Harrison et al., 2007). While the models of 
the 1mm2 patches of cortex (see Section 4.1) are currently at the limit of the spatial resolution 
accessible to fMRI, the spatially more extended models considered in these studies are in 
principle directly applicable as network models in DCMs, but now with cortical areas 
explicitly modeled as spatially extended patches of cortex. 
In our investigation of inter-areal networks we also performed systematic comparisons 
between model predictions and the experimentally recorded single neuron responses, but 
here we did not apply a Bayesian approach (Schwabe et al., 2010), and this can serve to 
highlight an important distinction to be respected for the comparison of network models, 
namely between the definition of a “noise model” and variability due to true heterogeneity 
of the recorded neurons. Let  Input; y f  denote the functional dependence between a 
sensory input into a neuronal network model, parameterized by , and a mean output y 
predicted by, for example, a NMM. Since the experimental observations x are usually much 
more variable than predicted by such a mean output, one could formulate a noise model, 
such as  x y  with  being additive Gaussian noise, for the observations x, which shall 
account for the observed variability in the data. We have experimentally measured the 
strength of surround suppression of neurons with an oriented stimulus in the classical field 
brought about by stimulation at more distant visual field locations (the “far surround”). A 
summary of the measured surround suppression strengths is shown in Figure 3c in terms of 
the error ellipse (50% confidence) around the estimated mean suppression for two 
experimental conditions (high contrast stimulus in the center, y-axis, vs. low contrast 
stimulus, x-axis). Clearly, the measured suppression strengths are variable, but we assumed 
that this variability is due to the fact that we recorded different types of neurons without 
being able to distinguish them based on the extracellular recordings. For example, it is 
conceivable that some neurons were excitatory while others were inhibitory, some neurons 
may operate in a different local network neighborhood than others, etc. In Schwabe et al. 
(2010) we hypothesized that this variability is due to different strengths of the intra-areal vs. 
inter-areal connections (the model parameter ), and we simulated the network model with 
different parameter values. As we increased, for example, the strength of the feedback 
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connections in the model (to local inhibitory neurons in V1) we predict different strengths of 
surround suppression (see lines in Figure 3c). For certain strengths the predicted 
suppression is within the 50% confidence region while for others it is outside. 
This study shows that one can respect the variability in the data in terms of heterogeneity of 
the underlying microcircuits and still use experimental data with NMM-like network 
models in order to learn something about the actual microcircuits: Here, we found that 
within the class of models we considered the models with stronger feedback projections to 
inhibitory neurons in the model V1 produce quantitatively better matches to the measured 
surround suppression than models with less feedback to these inhibitory neurons; see 
Schwabe et al. (2010) for more details. Of course, stochastic models respecting heterogeneity 
in single cell properties and network connections, or models for large-scale simulations 
could be described with model parameters , which capture such heterogeneity and hence 
would be directly useable within a Bayesian model comparison. 
5. The neuronal basis of the self as a test case 
Multi-scale models will soon enter model-based brain imaging studies. The method of 
DCMs can be extended to include cortical circuit models, which take into account, for 
example, the exquisite balance between excitation and inhibition, or the retinotopy and 
spatial scales of intra- and inter-areal connections. This could also lead to a re-evaluation of 
many already published brain imaging studies, where a “neuronal activation” was 
associated with a certain informally described function. One such discipline, which lacks 
more formalized models suitable for model-based brain imaging, is the emerging field of 
“the neuroscience of the self”. In other words, we argue that addressing the fundamental 
question of how the brain organizes self-related computations is a challenging test case for 
model-based brain imaging with multi-scale models, in particular because of the lack of 
computational models and the need for microcircuits models to ensure a proper 
interpretation of the already available imaging data. 
5.1 Computational modeling of self-related processing 
We argue that investigating self-related processing in the brain in order to determine the 
neuronal basis of the first-person perspective, or “selfhood” (Blanke and Metzinger, 2009), is 
a challenging but do-able test case for model-based brain imaging with multi-scale models. 
Of course, one could ask: Why address such problems, given that we still haven’t resolved 
the circuitry underlying orientation tuning in V1? 
What makes investigating the neuronal basis of the self a challenging test case is that we 
are currently lacking proper computational models for that, but brain-imaging studies 
suggest that certain brain regions and networks (including the so-called default mode 
network) may play an important role. It has been shown experimentally that by using 
incongruent multi-sensory stimulations the apparently hard-wired body scheme and 
body image of a subject can be disturbed as evident in the so-called “rubber hand 
illusion” (Botvinick and Cohen, 1998) or an extension of this to the full body 
(Lenggenhager et al., 2007). By applying computational concepts developed for the visual 
and sensory-motor system, we proposed computational models for such self-related 
processing, which do not at all refer to a “self” but only to (multi)sensory signals relevant 
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for self-related tasks. For example, vestibular signals are likely to be of importance 
(Schwabe and Blanke, 2008) as well as proper multi-sensory integration in sensory-motor 
loops (Schwabe and Blanke, 2007; Kannape et al., 2010). We have conceptualized the sense 
of self as a set of learning and inference algorithms for such self-related sensory signals, in 
particular vestibular signals, which are running on a neuronal “wetware”. Thus, from a 
computational perspective, the processing of self-related (multi)sensory signals may be 
very similar to the processing of, say, visual signals in the visual system. Accordingly, 
such computational theories can be tested in a similar manner, but the main challenge is 
to control the sensory stimulation. Ideally one would like to exert fine-grained control 
over the vestibular stimulations, but in fMRI studies this is only possible via caloric or 
galvanic stimulation, which are far from the stimulation encountered in more natural 
scenarios. Thus, in order to investigate the self via brain imaging, one shall investigate the 
brain activity of whole bodies in action. As of now this is only possible with brain-wide 
intracranial recordings as pursued in, for example, the Neurotycho project 
(http://neurotycho.org), because EEG in behaving human subjects is very noisy. In the 
Neurotycho project, the full-body motions of freely behaving monkeys are also recorded. 
Unfortunately, the vestibular system is widely distributed (Lopez and Blanke, 2011). This 
makes large-scale recordings necessary so that animal studies may be the method of 
choice for the foreseeable future. Initiatives such as the Neurotycho project provide 
valuable data, which can also enter a Bayesian model comparison, where the forward 
models may now also account for the full-body motions (recorded via motion-capture 
technology). Of course, simulating such forward models calls for combining models at 
various scales and coupling them with each other via phenomenological models. 
5.2 The function role of the temporoparietal junction 
Model-based brain imaging with multi-scale models can be performed in a truly data-driven 
manner once the model classes are defined. We have argued that it is already applicable 
even in the absence of a complete physical model for relating, for example, spikes to 
measured EEG activity (given that proper Neuroinformatics tool support is available). Then, 
applying such techniques could help to decipher the computational role and network 
connectivity of those brain areas, where we currently have only a rather limited grasp on 
their role for cognition. One such area is the temporoparietal junction (TPJ). Very briefly, the 
TPJ has been implicated in the theory of mind (Young et al., 2010), mental perspective taking 
and out-of-body experiences (Blanke and Mohr, 2005), and as part of an attention-
management network (Corbetta et al., 2008). Having available formal model-descriptions of 
such theories in computational terms (which is not yet possible as we don’t have a proper 
support for multi-facet modeling), and a proposal for how to transform them into neuronal 
activations would allow for systematically comparing such theories using data. The need to 
formally describe such computational theories becomes evident by inspecting the rather 
descriptive nature of many imaging experiments. As of now, the computational theories 
imported from, for example, research in the visual and sensory-motor system seem to be the 
most promising candidates to explain TPJ activations in computational terms, namely as 
part of a (Bayesian) model a subject is using internally in order to infer the state of another 
person’s mind (Kilner et al., 2007), as part of an attention-management network (Corbetta et 
al., 2008), or simply as a vestibular error signals in imagined (but not actually carried out) 
full-body movements in the case of mental perspective taking. In the case of distributed 
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brain activations and in a still rather exploratory phase of investigating self-related brain 
networks, combining multi-facet modeling and (even phenomenological) multi-scale models 
may be most fruitful. 
6. Conclusion and future research 
In summary, we have emphasized that a Bayesian model comparison is the most systematic 
method to compare different models on the basis of measurements. The explicit use of 
models makes the theory-dependence of observations explicit and emphasizes that within a 
Bayesian model comparison we compare only models within a class (or between classes) of 
models as compared to finding a single “true” model. Our work in modeling orientation 
tuning and surround suppression further emphasize this: The employed models are 
certainly more detailed than the NMMs currently employed in brain-imaging, but they are 
also far too simplistic to account for many biophysical details. Still, our comparison of such 
network models within a class of models for a given data set is a valuable example of a 
systematic model comparison. 
We also argued that multi-scale modeling, combined with multi-facet modeling, will be an 
important method for investigating even rather challenging neuroscientific questions such 
as explaining the neural basis of the self in terms of computational and neuronal models. 
This can be done even in the absence of a complete multi-level model for relating spikes to 
macroscopic data from brain imaging, namely by employing phenomenological models. As 
a consequence, we see the development of supporting Neuroinformatics tools to support the 
data-driven comparison of multi-scale and multi-facet models as an important step for 
future research. 
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1. Introduction  
Current and future trends in functional neuroimaging focus on the combination and 
synchronous application of imaging modalities by integrating more than one measures of 
brain function, e.g., hemodynamic and electrophysiological (EEG and fMRI). These multi-
modal approaches aim at achieving sufficient temporal and spatial resolution in order to 
localize neural activity and identify the functional connectivity between different brain 
regions, hypothesizing that the multi-modal information represents the same neural 
networks (Laufs et al., 2008).  
In parallel, besides the impressive recent advancements in neuroimaging research, arguably 
even more outstanding advances have been reported in molecular medicine and genetics 
research. In this context, current and future trends in medical research aim at bridging 
biomolecular information and neural function through studies in anatomic and functional 
biomedical imaging, focusing on methods to discover novel markers influencing specific 
traits in psychiatric and neurological diseases. The new field of imaging genetics uses 
neuroimaging methods to assess the impact of genetic variance on the human brain. Ideally, 
several imaging methods are implemented in combination to achieve an optimal 
characterization of structural and functional parameters. The latter are statistically related to 
the genotype, resulting in a form of a genetic association study. Such procedures acting as a 
mediator between genetic polymorphisms and psychiatric disease risk may shed light on 
the relevant underlying neural processes (Hariri et al. 2006). Although this approach is still 
relatively novel, the emerging literature and initial results hold great promise that it may 
contribute to the understanding of the pathophysiology of complex psychiatric and 
neurological disorders. Importantly, the future trends in neuroimaging envision imaging of 
the chemical functions of the organ cells and even realtime images of the genes and proteins 
at work within cells. These will convey sophisticated fingerprints of disease processes and 
better assessment of the effectiveness of curative procedures. Overall, it is evident that 
profiling of the molecular changes in disease will also expand the scope of body imaging. 
In this scientific and technological milieu, the widely-acknowledged “THz gap” makes this 
region of the electromagnetic spectrum a scientific frontier, with critical questions in 
physics, chemistry, biology, and medicine that need answers. All molecules (biological, 
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organic, inorganic, etc) have vibrational and rotational spectra that lie in the Terahertz 
frequency range with signatures resulting from intra- and inter-molecular interactions. 
Terahertz technology is considered a viable option for medical imaging (Siegel, 2004), since 
many biological and chemical substances exhibit signatures in this spectral region. 
Opportunities for imaging modality development in the Terahertz spectrum range, offers 
the possibility of understanding complex reactions in which the chemical state of the sample 
under study changes as time evolves. Nevertheless, despite recent advances, this part of the 
electromagnetic spectrum, remains unexplored and challenging with respect to medical 
applications (Siegel, 2004; Sherwin et al., 2004). 
The next big challenge in the field of medical imaging and especially neuroimaging is the 
wide application of functional imaging methods in clinical practice, which will add 
significant knowledge towards a more holistic comprehension of the mechanisms of 
neurological and psychiatric diseases. The identification of effective therapeutic strategies, 
which will have a dramatic impact on the lives of millions of people, as neuropsychiatric 
disorders (e.g., mood disorders, stroke, epilepsy) are among the most common diseases, will 
then be the most valuable consequence. 
Taking into consideration the aforementioned, the present chapter will focus on the 
following topics:  
a. short review of state-of-the-art of non-invasive, non-ionizing functional neuroimaging 
techniques,  
b. current and future trends in multimodal neuroimaging comprising concurrent 
measurements during activation of specified brain areas in-vivo via non-invasive and 
non-ionizing methodologies,  
c. current and future trends in neuroimaging genetics with emphasis on the potential 
identification of new brain biomarkers related to brain functionality both in health and 
disease through Terahertz biomolecule imaging (ex-vivo) and the newly developed 
optogenetics method.  
2. State-of-the-art of non-ionizing functional brain imaging techniques 
The main current common methods for functional neuroimaging are functional magnetic 
resonance imaging (fMRI), multichannel electroencephalography (EEG), 
magnetoencephalography (MEG) and near infrared spectroscopic imaging (NIRSI) or 
functional near infrared spectroscopy (fNIRS). fMRI and fNIRS can measure localized 
changes in cerebral blood flow related to neural activity. Two other methods which are not 
actually 3D imaging modalities, but both contain information that, after appropriate post-
processing, may result in three-dimensional brain maps of the recorded data, are EEG and 
MEG.  
Local voltage fluctuations or changes in blood flow and volume, are referred to as 
activations. These activations are monitored and recorded with the various neuroimaging 
techniques when a subject performs a particular task and it is suggested that local brain 
activations may be involved in the underlying neural processes which mediate behavior. For 
instance, in tasks with visual stimulation, extensive activation of the occipital lobe is 
typically observed. This is explained by the fact that this rear part of the brain receives 
signals from the retina and is considered to be associated with visual perception. 
Different methods present different advantages for research fact that resulted in the design 
and development of experimental studies that currently focus on a combined concurrent 
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implementation of the various modalities. Several research groups, for example, have 
reported results of data elicited using synchronous EEG recordings and fMRI during event-
related experimental procedures or fNIR and EEG recordings for instance, aiming at 
achieving sufficient temporal and spatial resolution to clarify the functional connectivity of 
neural processes, provided that the methodology combinations represent the same neural 
networks. Before, presenting the current and future trends of the multimodal configurations 
of the abovementioned techniques, a brief overview of the current state-of-the-art attributes 
of each methodology is given in the following sections. 
2.1 Recent advances in Magnetic Resonance Imaging techniques 
Magnetic Resonance Imaging (MRI) is a well known structural imaging modality that is 
being used in clinical practice to distinguish tumors, inflammatory lesions, and other 
pathologies from the normal brain anatomy while it has also been proven useful for the 
diagnosis of demyelinating disorders. Recently, special advanced techniques of magnetic 
resonance tomography such as diffusion weighted imaging (DWI), functional magnetic 
resonance (fMRI) and spectroscopy gave new insights to the acquired images, providing 
also information about the function and chemical metabolites of the brain. Various MRI 
techniques, also without the use of contrast agents may present venous or arterial 
angiograms.  
More specifically, diffusion-weighted imaging (DWI), diffusion tensor imaging (DTI) and 
tractography methods constitute an original microarchitectural approach based on water 
molecule diffusion nearly set to be introduced into clinical practice (Cotten et. Al, 2009). 
Importantly, the acquisition of diffusion-weighted MRI (DW-MRI) data is multidimensional. 
Multiple three-dimensional volumes with different diffusion-sensitization scanning 
parameters are provided by the modality. Following, implementation of appropriate post-
processing procedures result in the reconstruction of the features of the three-dimensional 
diffusion profile of water molecule in each voxel. Depending on the chosen processing 
technique, different features of the diffusion scatter pattern at voxel level can be estimated. 
In this context, many approaches are being proposed for the processing of a set of DW-MRI 
volumes with diffusion tensor imaging (DTI) being the most popular. Many quantitative 
measures can be calculated from the diffusion tensor (Pierpaoli et al., 1996) that can be used 
for in between-subject comparisons, as well as in within-subject follow-up studies. 
In parallel, tractography is currently the only tool that allows in an entirely non-invasive 
manner and in-vivo the reconstruction of white matter anatomical paths. The simplest 
tractography approaches generate, in a deterministic way, curves that are tangent to the 
vector field of DTI principal eigenvectors (Basser et al., 2000; Mori et al., 1999). More 
advanced methods, consider the uncertainty associated with these vectors to produce 
distributions of curves in a probabilistic framework (Behrens et al., 2003; Parker et al., 2003). 
Latest approaches utilize frameworks that allow incorporation of information from different 
MRI modalities to study brain anatomical connectivity that will also allow observations of 
functional connectivity as well by revealing the way activation of one part of the brain 
affects and is related to other areas (Sotiropoulos et al., 2010).  
Functional magnetic resonance imaging (fMRI) measures the hemodynamic response 
related to neural activity in the brain, in other words the hemodynamic correlates of neural 
activity (Cui et al., 2011). It measures the blood oxygen level-dependent (BOLD) response 
that results from local concentration changes in paramagnetic deoxy-hemoglobin (deoxy-
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Hb) (Ogawa et al., 1990a), first discovered the 90s (Ogawa et al., 1990b; Ogawa et al., 1992; 
Kwong et al., 1992) and is the most common functional magnetic resonance imaging 
technique. Due mainly to the relatively high spatial resolution provided by this technique 
fMRI has rapidly become the gold standard for in vivo imaging of human brain activity, 
(Cui et al., 2011). The main current clinical application of fMRI is presurgical mapping of 
speech and motor brain areas as well as epilepsy foci (Stippich et al., 2007). 
Recently, during rest conditions, functional imaging studies have shown that multiple 
cortical brain regions are functionally linked forming the so called resting-state networks 
(Raichle et al., 2001; Greicius et al., 2003; Raichle and Snyder, 2007) and fMRI is suitable to 
study this functional connectivity of the human brain (Damoiseaux et al., 2006). This finding 
led to the hypothesis that these regions constitute a network supporting a default mode of 
brain function. The suggested high level of functional connectivity within resting-state 
networks implies the existence of direct neuroanatomical connections between the 
respective functionally linked brain regions to facilitate the ongoing interregional neuronal 
communication. White matter tracts are the structural highways of our brain, enabling 
information to travel quickly from one brain region to another (van den Heuvel et al., 2009).  
Both functional and diffusion MR images are acquired with fast imaging protocols. The 
most commonly used fast imaging protocol is echo planar imaging (EPI), which allows the 
acquisition of an image within a time window of a few milliseconds (Mansfield, 1984; 
Turner et al., 1990). It should be noted that EPI images suffer from low signal-to-noise-ratio 
(SNR) a parameter that should be considered when designing experiments. 
2.2 Optical methods 
The part of the electromagnetic spectrum with wavelengths from approximately 650nm to 
950nm, is known as near-infrared (NIR) light and has been described as an “optical 
window” into biological tissue since it is weakly absorbed by tissue. Due to this property, 
light of these wavelengths may be detected after having penetrated tissue at a depth of a few 
centimeters. NIR light eventually interacts with biological tissue and therefore, also, with 
the human brain tissues. Based on the absorption of different wavelengths of light as it 
passes through the head, optical methods, such as near infrared spectroscopy (NIRS), have 
been developed to provide another non-invasive measure of local brain activation 
(Villringer et al., 1995; Strangman et al., 2002). 
Oxyhemoglobin (HbO2) and deoxyhemoglobin (HbR)are the two principal chromophores 
that are absorbed in the NIR wavelength range and thus constitute two biologically relevant 
markers for brain activity (Strangman et al., 2002). In other words, near-infrared 
spectroscopy can provide information on concentrations of oxy-and deoxy-hemoglobin in 
cortical areas of the brain related to the activation of the brain regions in question. 
Significant differences in the absorption spectra at near-infrared wavelengths have been 
observed for other tissue chromophores as well, such as cytochrome oxidase during 
acquisition of simultaneous data from several wavelengths.  
The detection of such hemodynamic markers, as also noted in previous sections, is 
considered as an indirect measure of brain function. Interestingly, it has been suggested that 
diffuse optical techniques may simultaneously provide both indirect and even direct 
measures of neuronal activity monitoring. In this context, supporting data exist to imply 
that diffuse optical methods may detect cell swelling taking place 50–200 milliseconds after 
neuronal firing. Although, the spatial interrelations between such signals and hemodynamic 
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ones remain subject to investigation, they could be feasibly recorded by sufficiently high-
speed and sensitive detectors (Strangman et al., 2002). 
Hence, by measuring the changes in the intensity of diffusely transmitted near-infrared light 
across a brain tissue volume, in non-invasive manner from sensors placed on the human 
skull, it is possible to gain well-localized information about haemoglobin oxygenation, 
cytochrome-c-oxidase redox state, and two types of changes in light scattering reflecting 
either membrane potential (fast signal) or cell swelling (slow signal) during local brain 
activation (Strangman et al., 2002). Advantages of the optical methods include biochemical 
specificity, a temporal resolution in the millisecond range, the potential of measuring 
intracellular and intravascular events simultaneously and the portability of the devices 
enabling bedside examinations (Villringer and Chance, 1997).  
Based on the above mentioned, it becomes reasonably evident that near-infrared (NIR) 
imaging techniques have become an increasingly popular research means to study brain 
activity (Cooper et al., 2009) non-invasively using harmeless non-ionizing radiation (Gibson 
et al 2005, Hillman 2007). To date fNIRS has been successfully applied in several fields 
providing interesting and meaningful brain activation related data (Cui et al., 2011). NIRS 
has been used to investigate and add useful knowledge to the understanding of the 
physiological mechanisms of the BOLD response (Toronov et al., 2003; Hoge et al., 2005; 
Kleinschmidt et al., 1996; Schroeter et al., 2006; Emir et al., 2008; Malonek et al., 1997; 
Huppert et al., 2006, 2007, 2009). After early studies employing single-site near-infrared 
spectroscopy, first near-infrared imaging devices are being applied successfully for low-
resolution functional brain imaging (Strangman et al., 2002; Villringer and Chance, 1997). 
NIRS is a very portable technique (Atsumori et al., 2009) and has been proposed as a useful 
technology for non-invasive brain–computer interfaces (Power et al., 2010; Coyle et al., 2004, 
2007; Sitaram et al., 2007; Utsugi et al., 2008). NIRS has been used to study brain activity in 
both event-related tasks and resting states (Boecker et al., 2007; Herrmann et al., 2005; White 
et al., 2009; Honda et al., 2010; Zhang et al., 2010; Lu et al., 2010). It has been also proposed 
as useful alternate in experimental paradigms which are difficult to perform in the MRI 
scanner, such as face-to-face communication (Suda et al., 2010) or driving (Tomioka et al., 
2009). 
The applications of NIR techniques which improve spatial information by affording two-
dimensional imaging of changes in both oxyhaemoglobin (HbO2) and de-oxyhaemoglobin 
(HHb) during stimuli driven experiments, include optical topography (OT) (Obrig and 
Villringer 2003; Cooper et al., 2009). This methodology has been broadly used to study the 
functional activation of the motor (Franceschini et al 2003, Maki et al 1996) and visual (Zeff 
et al 2007) cortices as well as in experimental procedure investigating language processing 
and development (Pe˜na et al 2003; see Cooper et al., 2009 for more details). 
NIRS instrumentation is a flexible and portable technology and can be made unobtrusive, 
low-cost, low-power, even robust to motion artifacts (e.g., Totaro et al 1998) or technology 
enabling such artifacts to be successfully tackled (Izzetoglu et al., 2005; Izzetoglu et al., 
2010). It is supported by three main categories of systems, each presenting advantages and 
drawbacks: time domain, frequency domain and continuous wave systems (Strangman et 
al., 2002).  
Continuous wave fNIRS systems (CW) apply light to tissue with invariable amplitude and 
measure the attenuation of the amplitude of the incident light (Hoshi, 2003; Izzetoglu et al., 
2004; Obrig & Villringer, 2003; Irani et al., 2007). Although it is evident that CW systems 
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provide less information than time or frequency domain systems, they also have several 
benefits that are important for certain applications: they can be manufactured using light 
emitting diodes (LEDs) and not necessarily using lasers, thus increasing safety with respect 
to their possible negative effects on vision (e.g. possible negative effect on eye retinas); their 
total cost can be significantly lower than time and frequency domain systems, enabling 
deployment of these systems in clinical settings; minimization of dimensions of these 
systems is also feasible proving them practical solutions for use in educational or clinical 
settings (Irani et al., 2007). Laser-based time-resolved or frequency domain systems, on the 
other hand, provide information on both phase and amplitude, and their use is compulsory 
experimental setups where more precise quantification of fNIRS signals is crucial to ensure 
robustness of results taking advantage of the added spatial specificity of time domain 
instruments and the ability to separate absorption and scattering effects (see Hoshi, 2003; 
Izzetoglu et al., 2004; Obrig & Villringer, 2003; Irani et al., 2007 for more discussion of these 
system differences). In general, the selection of the fNIR system architecture is determined 
by the spatial resolution and sensitivity requirements of the brain area activation related 
research question (Strangman et al., 2002). For investigations of cortical activation and 
especially when referenced to an external topographic system (e.g., the international 10/20 
system), diffuse optical methods seem to provide opportunities and capabilities unavailable 
with any other brain functional imaging existing technology (Strangman et al., 2002). 
2.3 EEG and MEG 
Electroencephalography (EEG) and magnetoencephalography (MEG) are well known 
widely practiced brain monitoring techniques on the scalp surface of the electromagnetic 
effects of activation of groups of neurons, but without actually being directly three-
dimensional imaging techniques. Nevertheless, they are briefly presented in this chapter, 
focusing on their main operational principles and on a short overview of the inverse 
problem solution approaches which result in the 3D mapping of EEG and MEG recording, 
mainly due to the following: measuring electromagnetic field distributions allows 
localization of cognitive processing (Haufe et al., 2011); EEG and MEG are used in 
conjunction with functional imaging modalities in most multimodal emerging settings; 
based on the aforementioned and taking also into account that both noninvasive localization 
methodologies can be applied without restriction (as opposed to invasive measurements), it 
is evident that they are highly significant for neuroscience research and medical diagnosis.  
The main advantage of the EEG methodology, besides being entirely harmless, is the high 
temporal resolution opposed though to the relatively low spatial resolution achieved. The 
typically low EEG spatial resolution is due to the presence of a multilayered tissue interface, 
such as the skull, the cerebrospinal fluid and other cortex tissue layers between the electrode 
and the source of brain activation that is being measured (Cooper et al., 2009). Based on the 
aforementioned it is obviously derived that the scalp maps, namely the activation pattern 
distributions, of the corresponding cognitive processes elicited via the EEG/MEG 
measurement analysis, only afford an estimation of the actual underlying sources (Haufe et 
al., 2011). These spatial maps are derived by the inverse problem solution, which because of 
its ill-posedness imposes significant restrictions on the way the inverse solution is derived 
(Darvas et al., 2004). In other words, this inverse problem is ill-defined since any 
measurement can be equally well justified by infinitely different source distributions (Haufe 
et al., 2011). 
Functional Brain Imaging Using Non-Invasive  
Non-Ionizing Methods: Towards Multimodal and Multiscale Imaging 
 
121 
Various approaches have been developed and discussed in order to evaluate inverse 
problem procedures and to assess the statistical significance of the subsequent results (for a 
review on this subject, see Darvas et al., 2004; Haufe et al., 2011). It should be noted though 
that recent developments in this field include the following: (i) independent components 
analysis has been relevantly recently considered as a useful means of separating 
physiological and other noise processes from brain activation, and possibly for also 
revealing distinct dissociated components of neural activation; (ii) time–frequency analysis 
application to single trial data has been proven useful to the identification of underlying 
communication mechanisms between neuronal clusters; (iii) the development of multimodal 
concurrent data acquisition methodologies reveal the potential of combining the high 
temporal resolution of electrophysiological data with the higher spatial resolution of 
hemodynamic effects (e.g. Dale et al., 2000; Darvas et al., 2004). 
Magnetoencephalography measures the other component of electromagnetism, the 
magnetic field outside the head induced by current flow within the brain generated directly 
by neural current generators (Darvas et al., 2004). These primary currents are activated 
during an event-related study and are used in solving the inverse problem since they are 
localized to brain activated areas. Recently, MEG and EEG are mostly considered as 
complementary modalities and MEG based experiments routinely include concurrent 
multichannel EEG recording (Darvas et al., 2004).  
2.4 Focused Microwave Radiometry 
Active imaging is very important in the context of clinical practice and has proven its 
indisputable contribution to medical diagnosis. Nevertheless, constant research efforts are 
pursued in order to minimize radiation exposure during medical imaging (e.g., CT, PET) 
since the number of repetitive scans a person may undergo during a specified period of time 
in order to ensure patient safety is limited. Considering the above, as well as the wide 
variety of potentially harmful agents that coexist in contemporary everyday life, entirely 
passive, non-invasive and painless assessment of brain function in living subjects constitutes 
a wishful perspective and scientific vision.  
Under this rationale, the functional imaging perspective of a novel passive microwave 
imaging device is being investigated during the past 7 years (Karanasiou et al., 2004, 2008; 
Karathanasis et al., 2010; Gouzouasis et al., 2010). Microwave radiometry is an important 
scientific research and application area of microwave sensing because it provides a passive 
sensing technique for detecting naturally emitted electromagnetic radiation. This technique 
has been used in biomedical applications mainly for monitoring the temperature 
distribution in depth inside the human body. The proposed system (Microwave Radiometry 
Imaging System, MiRaIS), is able to provide real-time temperature and/or conductivity 
variation measurements. The functional imaging perspective of this system is based on the 
fact that both local temperature and conductivity variations in the brain have been 
associated with brain activation. 
More specifically, it has been suggested that knowledge of thermal patterns inside the brain 
may provide useful information about brain activity. Under normal, quiet, resting 
conditions intrabrain heat production is balanced by heat dissipation from the brain, while 
under several physiological conditions temperature balance modifications occur and brain 
temperatures either increase above (hyperthermia) or decrease below (hypothermia) their 
average resting-state values. Experiments have reported for instance, increase by 1–2 C 
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during the transition from sleep to wakefulness (Abrams and Hammel, 1964; Delgado and 
Hanai, 1966), in response to various stressful, emotionally arousing, and even simple 
environmental stimuli (Abrams and Hammel, 1964; Delgado and Hanai, 1966; Moser et al., 
1993; Yablonskiy et al., 2000; Kiyatkin 2005; Kiyatkin, 2007). Brain temperature balance may 
also be affected by pharmacological drugs, which influence brain metabolism and 
consequently alter heat dissipation to the external environment (Kiyatkin, 2007). Thus, brain 
temperatures fluctuations that naturally take place may cause significant functional 
consequences given that most physical and chemical processes that determine neuronal 
activity are dependent by temperature (Kiyatkin, 2007). Thus, It has been suggested that 
brain temperature fluctuations reflect neural activation (Kiyatkin et al. 2002). Even empirical 
data obtained with fMRI suggest that increases in regional cerebral blood flow during 
functional stimulation can cause local changes in brain temperature and subsequent local 
changes in oxygen metabolism (Yablonskiy et al. 2000). Nevertheless, brain temperature 
changes in humans remains generally unknown because of lack of actual direct 
experimental studies (Kiyatkin, 2007). 
In addition, another parameter that has been suggested to change during functional 
neuronal activity is the electrical conductivity of the brain. It has been hypothesized that an 
increase of regional cerebral blood volume (rCBV) due to neuronal activity will lead to the 
decrease of cortical impedance (increase of conductivity) because blood has lower 
impedance than the surrounding cortex (Geddes and Baker, 1967). During functional 
activity, there is a predominant impedance decrease as a result of an increase in blood 
volume. During epilepsy and ischemia, it has also been reported that impedance increases 
due to cell swelling because this reduces the size of the conductive extra-cellular space 
(Andrew and MacVicar, 1994). Since brain activation produces changes in regional cerebral 
blood flow (rCBF), it will also produce conductivity changes in the same direction. These 
(increased usually) blood-flow changes are associated to increased rCBV. Also, reproducible 
impedance changes of approximately 0.5% have been measured in humans during visual, or 
motor activity, using 3-D electrical impedance tomography (EIT) (Tidswell et al., 2001). 
As stated above, the MiRaIS system measures temperature and/or conductivity fluctuations 
at low microwave frequencies. Following the aforementioned rationale, if brain activation 
related temperature and/or conductivity variation measurements changes can be measured 
with the proposed method, then it could be used to image brain activity in an entirely 
passive and non-invasive manner that it is completely harmless and can be repeated as often 
as necessary without any risk even for sensitive populations. The operation principal of the 
proposed system is based on the use of an ellipsoidal beamformer providing the necessary 
focusing on the brain areas of interest. Its main advantage is that it operates in an entirely 
passive and non – invasive manner. In order to use a diagnostic and device such as the 
proposed one, it is of great importance to achieve imaging of any arbitrary area inside the 
human head, placed on the ellipsoid’s focal point where maximum peak of radiation is 
achieved. Previous theoretical results have shown the system’s ability to focus on specific 
areas of human head models with varying depths and positions with respect to the 
ellipsoidal focal point (Karanasiou et al., 2004; 2008). Also, in an effort to improve the 
system’s focusing properties several configurations using dielectric matching layers on the 
air – model interface or as filling material inside the ellipsoid chamber were tested both 
theoretically and experimentally showing promising results for the reduction of the 
scattering effects on the interface under consideration (Karathanasis et al., 2010; Gouzouasis 
et al., 2010). Both spatial resolution and detection depth provided by the system have been 
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estimated through detailed theoretical analysis and validation experimental procedures 
using phantoms and animals (e.g. Karanasiou et al., 2004, 2008; Karathanasis et al., 2010; 
Gouzouasis et al., 2010). In the range 1.3–3.5 GHz, imaging of the head model areas placed 
at the ellipsoid’s focus is feasible with a variety of detection depths (ranging from 2 to 4.5 
cm) and spatial resolution (ranging from less than 1 cm to over 3 cm), depending on the 
frequency used. The system’s temperature resolution ranges from 0.5 ◦C to less than 1 ◦C in 
phantom and small animal experiments. 
Importantly, the system has been used in human experiments in order to explore the 
possibility of passively measuring brain activation changes that are possibly attributed to local 
conductivity and/or temperature changes. The results indicate the potential value of using 
focused microwave radiometry to identify brain activations possibly involved or affected in 
operations induced by particular psychophysiological tasks (Karanasiou et al. 2004). 
3. State-of-the-art and beyond of multimodal neuroimaging 
After having reviewed all basic operation principles and attributes of the functional brain 
imaging methodologies, it is concluded that MEG and EEG differ from fMRI and fNIR, not 
only in the physiological processes that are measured but also in the properties of the 
inverse problem solutions that result in the functional images (Darvas et al., 2004). 
Thus, in summary, on one hand MEG and EEG signals directly record neuronal activation at 
the millisecond scale at which they occur whereas fMRI and fNIR measure neuronal 
activation indirectly through hemodynamic changes detection at the order of 1s. In addition, 
it is still under investigation whether these neuronal and hemodynamic changes refer to the 
same brain activated areas. Regarding the solution of the inverse problem of MEG and EEG 
it is illposed affording estimation solutions based on the imposed constraints and 
methodologies used whereas fMRI directly provides images of the activated areas. Finally, 
fNIR is a less expensive and more easily administered than the gold standard fMRI, having 
also better temporal resolution and providing larger content information (both oxygenated 
and deoxygenated haemoglobin data). Nevertheless, it is a not a clinically implemented 
technology yet with inferior spatial resolution and decreased signal-to-noise ratio compared 
to fMRI (Cooper et al., 2011). 
Since each of the non-ionizing non-invasive functional brain imaging techniques has 
different characteristics as described in the preceding section, in order to acquire the most 
valuable complementary data in terms of quality and quantity, benefiting from the 
advantages of the various techniques, combination of two or more techniques is expected 
(Shibasaki, 2008). The so-called multimodal approach may be achieved either by post-
measurement combination and fusion of data or via simultaneous use of hemodynamic and 
electrophysiological techniques in order to reveal the multifactorial interplay of the 
underlying mechanisms during brain activation (Shibasaki, 2008). 
In this chapter only the latter will be presented whereas the first category holds the 
disadvantage of uncontrolled background since it is not possible to guarantee the exact 
same experimental conditions between different measurement sessions (Honda et al., 1998; 
Shibasaki, 2008). 
3.1 Simultaneous fMRI-EEG 
Simultaneous fMRI and EEG is the most widely implemented multimodal human brain 
mapping technique which aims at combining high time and spatial resolution in a signle 
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modality, affording research of functional cortical activity and neurovascular coupling. Due 
to technological progress, technical obstacles are constantly superimposed and concurrent 
fMRI-EEG studies are increasingly and successfully performed in a variety of recent studies 
(e.g. Horwitz and Poeppel, 2002; Sammer et al., 2005; Otte and Halsband, 2006; Stern, 2006; 
Horovitz et al., 2008; Shibasaki, 2008; Ritter and Villringer 2006, Mulert et al 2004; Cooper et 
al., 2009) including cognitive processing, epileptic and seizure activity in children and adults 
(Gotman, 2008; Vulliemoz et al., 2010; Cooper et al., 2011) and neurovascular coupling (e.g. 
Kruggel et al 2000, Goldman et al 2002, Gotman et al 2006; Cooper et al., 2010). 
The main artefacts that occur in simultaneous fMRI and EEG recordings rise from the 
interference of the scanner gradients with the EEG and many artefact elimination methods 
have been developed to manage this drawback (e.g. Ritter et al., 2007). Other artefacts rise 
from human physiological activity such as electrocardiographic artefacts and relevant 
removal methods have also been implemented successfully (Nakamura and Shibasaki, 1987; 
Nakamura et al., 1990; Shibasaki, 2008).  
Currently, simultaneous recording of EEG in the MR scanning room is usually pursued in 
clinical practice for the presurgical evaluation of partial epilepsy patients (Jager et al., 2002; 
Stern, 2006). In research, EEG and fMRI paradigms are increasingly developed to study the 
underlying mechanisms of functional processing in a non-invasive manner combining high 
time resolution neuronal activation measurements with high spatial resolution 
hemodynamic response imaging (Shibasaki, 2008). 
3.2 Simultaneous EEG-fNIR 
The complementary information that is acquired by simultaneously measuring 
electrophysiological and cerebral blood volume changes, besides the combined fMRI-EEG 
settings, it has also recently been exploited by simultaneous EEG and NIR spectroscopy 
(Rovati et al 2007, Roche-Labarbe et al 2007; Cooper et al., 2009). 
fNIR and other optical methods such as diffuse optical imaging presents several advantages 
compared to fMRI which have been exploited in recent studies involving neonatals and 
infants (Cooper et al.,2011, Telkemeyer et al., 2011; Ancora et al., 2009). They are portable, 
compatible with EEG and relatively insensitive to movement artifacts and therefore suitable 
to be used on neonatals and infants. Recently, two studies of concurrent assessment of 
vascular based imaging and electrophysiological responses of neonatal seizure (Cooper et 
al., 2011) and infant language acquisition (Telkemeyer et al., 2011) have been carried out 
with combined EEG and fNIR. Other studies of the simultaneous inegrated use of the two 
methodologies include the measurement of workload states (Hirshfield et al., 2009), mental 
stress (Ishii et al., 2008), during epileptic discharges (Machado et al., 2011), in auditory 
sensory gating (Ehlis et al., 2009). 
3.3 Simultaneous MEG-fNIR 
Besides the combination of EEG with fNIR, recently simultaneous MEG with fNIR 
measurements are being performed to once more investigate the neurovascular coupling of 
activated brain areas. After the first feasibility study using nonselective NIRS and DC-MEG 
recordings (Mackert et al., 2004, Mackert et al., 2008), several studies with simultaneous 
MEG and fNIR measurements have been realized (e.g. Sander et al., 2007; Mackert et al., 
2008; Ou et al., 2009). Recently, during a standard motor task time-resolved multichannel 
NIRS (trNIRS) has been combined with DC-MEG to analyze simultaneously and 
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quantitatively hemodynamic and neuronal changes in activated brain areas (Mackert et al., 
2008). 
In another recent study (Ou et al., 2009), by simultaneous implementation of diffuse optical 
imaging (DOI) and magnetoencephalography (MEG) neurovascular coupling is once more 
investigated. Interestingly, an event-related and not a block design of the experimental 
paradigm has been followed to achieve evaluation of the contribution of single neural 
components to the hemodynamic responses, enabling direct comparison of the elicited 
results with the significant number of neurovascular coupling findings in animals using 
invasive recordings (Ou et al., 2009). 
3.4 Simultaneous fMRI-fNIRs 
Several research efforts of the simultaneous implementation of the fMRI and NIRS 
methodologies have been reported over the last two decades (Kleinschmidt et al., 1996; 
Punwani et al., 1998; Toronov et al., 2001; Mehagnoul-Schipper et al., 2002; Strangman et al., 
2002; MacIntosh et al., 2003; Huppert et al., 2006; Zhang et al., 2006). These studies provide 
convincing evidence regarding the effective correlation and combination of the two 
methodologies towards a more practical implementation (Toyoda et al., 2008). Combined 
fMRI and NIR methods have also been widely used in animal studies (Zhang et al., 2006).  
The main constraint imposed by the integration of the two modalities and actually occurs 
every time during any experimental design in the MR chamber, is the fact that the use of 
only non-magnetic material is allowed. In the case of combined fMRI-EEG measurements, 
research and technological progress have resulted in the construction of MRI-compatible 
EEG devices, many of which currently exist commercially. Similarly, the optical probe must 
be designed and constructed to be fully MRI-compatible without causing any MR image 
distortion. Also, the final setup must afford accurate co-registration of optical and MR 
images in order to achieve an efficient integration of the two imaging techniques (Zhang et 
al., 2006). The high spatial resolution is accomplished through structural MR imaging where 
all optical and functional MR data are co-registered. This procedure also forms the basis of 
the inverse problem solution and the possibility to superimpose all data on the Talairach 
space for group studies (Zhang et al., 2006). 
3.5 Simultaneous recordings using more than two modalities 
As shown in previous sections, current and future trends in functional human brain 
mapping focus research on implementing multimodal approaches in order to acquire the 
largest possible set of measurements of correlates of neural activity in a single experimental 
procedure. It has been shown that there is a strong correlation between mass neuronal 
activity and localized changes in blood flow and volume and this is the reason why 
methodologies that measure electrophysiological responses are combined with techniques 
the measure hemodynamic changes in the multimodal approaches in question. Interestingly, 
each of these modalities through the so-called steady state measurements reveal brain areas 
that are functionally and structurally correlated and thus, provide new insights into brain 
function (Gore et al., 2006). Attempts to integrate more than two modalities are also pursued 
by combing simultaneous fMRI, NIR and ERP measurements (Gore et al., 2006). 
In this context, besides electrophysiological and hemodynamic measurements, feasibility of 
integrating additional measures, such as non-invasive local temperature and conductivity 
measurements could also be investigated. Magnetic Resonance Spectroscopy (MRS) can 
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measure temperature noninvasively (e.g. Corbett et al., 1997). It is a well-established 
technique that uses an MRI scanner to detect certain naturally occurring brain metabolites. 
By interpreting the relative frequencies of a reference metabolite (N-acetyl aspartate; NAA) 
and water, it is possible to estimate tissue temperature with precision of approximately 
+0.5°C (Harris et al., 2008). Microwave Radiometry with the additional advantage of being 
completely passive maybe used for estimating temperature and/or conductivity changes 
non-invasively in the brain. 
Taking all of the above into consideration, research efforts focus on integrating MiRaIs with 
EEG and fNIR (Karanasiou et al., 2009). A customized head cap for simultaneous mounting 
of EEG electrodes and the proposed fNIR system according to the 10-20 system that is also 
MiRaIS-compatible and appropriate post-processing software tools, focusing on fNIR/EEG 
image reconstruction are being developed. Therefore, the resulting multi-modal 
measurements will comprise electrical activity (EEG), blood flow (fNIR), as well as 
temperature and conductivity variations (MiRaIS) in activated cortical areas.  
4. State-of-the-art and beyond of neuroimaging genetics: THz imaging and 
optogenetics 
Besides multimodal functional imaging and the indisputable advances in this field, current 
and future trends in neuroscience research aim at bridging neural function and 
biomolecular information and studying microscopic processes at the molecule level. This 
scope is pursued through studies both in anatomic and functional biomedical imaging, 
integrating the rapidly advancing research fields of medical imaging/neuroimaging and 
molecular medicine/genetics. In this context, research has emphasized new methods for 
discovering novel markers that may have an influence on specific features in psychiatric and 
neurological diseases, expecting to also take advantage of next-generation imaging 
technologies that will potentially afford the monitoring of the chemical processes of the cells 
within the organs and produce real-time images of biomolecules, such as genes and proteins 
functioning within cells.  
In this scientific and technological milieu, the widely acknowledged ‘THz gap’, including 
the complete frequency range from 100 GHz up to 30 THz, makes this region of the 
electromagnetic spectrum a scientific frontier holding great promise not only for identifying 
and classifying biomolecules, but also for understanding the underlying molecular 
dynamics. All molecules (biological, organic, inorganic, etc) have inherent vibrational and 
rotational spectra that lie in the terahertz frequency regime with spectral signatures 
resulting from intra- and inter-molecular interactions. Specific proteins for instance, absorb 
certain characteristic t-ray frequencies leading to a distinct terahertz ‘fingerprint’ for each 
biomolecule; sensors that can detect this absorption may reveal the identity of the protein. 
To this end, THz technology can serve as a viable option for medical imaging envisaging the 
expansion of current knowledge on biomolecular information and its correlation with neural 
function. 
The THz “gap” became the subject of research for the past 8 years approximately and its 
application in biomedicine is considered very promising (Bakopoulos et al., 2009). 
Considerable effort has been invested in the development of applications of the THz 
frequency regime (0.1–5 THz) for the detection and characterization of biological material 
focusing on their interaction with THz radiation (e.g. Siegel, 2004; Woolard et al., 2005) as 
well as for the detection of cancer by developing novel THz imaging systems (Woodward et 
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al., 2005; Wahaia et al., 2010). Nevertheless, THz waves is a state-of-the-art research field 
exhibiting constant technological progress and as such the interaction of biological materials 
with THz radiation is not completely known and still under investigation: the THz response 
of biological samples is considerably affected by the specific radiation properties, the 
experimental configuration as well as the sample preparation and measurement procedures. 
THz technology may add significant knowledge to the understanding of brain function in 
health and disease by providing biochemical profiling of various neurotransmitters in 
various conditions. Recent findings support the abovementioned claims; a novel study on 
the use of terahertz (THz) spectroscopy to distinguish between healthy and diseased snap-
frozen tissue samples obtained from three regions of the human brain has been recently 
reported (Png et al., 2009). The research team based their work on the fact that as protein 
structures have been successfully marked using THz radiation, the group vibrational modes 
of protein plaques could be also probed in the THz frequency range. With this view, they 
used tissue samples with Alzheimer’s disease; the latter were neuropathologically 
diagnosed to comprise abnormal high quantity of protein plaques consistent with the 
disease in question. Results showed that a rough classification between healthy and 
diseased tissue was accomplished based on their THz absorption spectra, which could be 
attributed to pathological changes in the diseased tissue (Png et al., 2009).  
Recently, a few more studies have been reported towards the same research direction 
(Abbas et al., 2009; Treviño-Palacios et al., 2010). A new approach including the 
development of integrated THz circuits for the detection of biochemical events was 
implemented to the detection of nitric oxide synthase (NOS) activity (Abbas et al., 2009). The 
authors designed and fabricated a BioMEMS (Biological MicroElectro-Mechanical System) 
compatible with microfluidic circulation and electromagnetic propagation which they 
successfully used to detect NOS activity ex vivo. Real-time THz spectroscopy was used to 
detect biomolecule processes associated with neurodegenerative phenomena (Abbas et al., 
2009). Another group, classify healthy and cancerous tissue using the non-ionizing water 
absorption to terahertz radiation. This seems to be a somewhat complementary reciprocal 
classification methodology since one of main drawbacks that THz radiation is not being 
currently widely considered for in-vivo body imaging is the large absorption by body water 
content (Treviño-Palacios et al., 2010). 
In parallel, in the broader field of genetic imaging, the use of a novel combination of fMRI with 
a recently developed state-of-the-art technique called optogenetics (Boyden et al., 2005), holds 
great promise to reveal direct evidence that the fMRI signal is a compelling measure of brain 
activity. Moreover, combining functional imaging with a technique that controls 
subpopulations of neurons using light, will result in the enhancement of the basis of 
neuroscience research and lead new ways to understanding the mechanisms and treatment of 
brain injury and disease (Lee et al., 2010). The researchers support that the new functional 
genetic imaging technique, the integrated optogenetics and BOLD-fMRI (ofMRI) will enable 
the observation of the big picture of the causal connectivity of neurons in specific brain regions 
without of course suggesting that absence of a BOLD signal would prove the absence of such 
connectivity. ofMRI aims at further probing and defining the causal generation of BOLD 
signals and most importantly at enabling the causal connectivity mapping of cells which are 
genetically and anatomically- by circuit topology -defined (Lee et al., 2010). Nevertheless, this 
approach being significantly novel and recent is also followed by reservations and some 
doubts; the validity of the technique itself as well as the interpretation of the fMRI data is still 
being questioned and under constant debate (Logothetis 2010).  
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5. Conclusion  
Functional neuroimaging has had a huge impact in cognitive neurosciences and in our 
understanding of the healthy human brain. The next big challenge in this field is the wide 
application of functional imaging methods in a clinical context, which will help us 
understand the mechanisms of neurological and psychiatric diseases and to identify 
effective therapeutic strategies, which will have a dramatic impact in the lives of millions of 
people, as neuropsychiatric disorders (e.g., mood disorders, stroke, epilepsy) are among the 
most common diseases. 
More precise assessment of the underlying biophysics of the measured signals and 
especially of their interrelations will be extremely important for the better understanding of 
the healthy and diseased brain. The proposed unprecedented concurrent assessment of 
multiple biophysical correlates of neural activation (blood flow, volume and oxygenation, 
conductivity and temperature) will allow detailed correlation studies that will further 
elucidate the nature of brain activation measurement and the neurovascular coupling. 
The current decade may be remembered in the future for the progress of neuroscience 
beyond the level of basic and clinical, into a field of innovative and challenging research 
applications. The development of new tools and methodologies and pursuing integrated 
approaches focus on revealing not only the underlying mechanisms of the measured neural 
correlates of local brain activation but also on leading the way to the global mapping of their 
interrelations, connectivity and causal activation. 
Functional brain imaging research in conjunction with the rapidly expanding knowledge in 
genetics, offers not only the promise of dramatic cures and amelioration of mental health, 
but also a profound understanding of the brain’s functionality. 
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Diffusion Tensor Imaging:  
Structural Connectivity Insights,  
Limitations and Future Directions 
Linda J. Lanyon 
University of British Columbia 
Canada 
"The brain is a monstrous, beautiful mess. Its billions of  
nerve cells-called neurons-lie in a tangled web that displays cognitive  
powers far exceeding any of the silicon machines we have built to mimic it"   
William F. Allman 
1. Introduction 
Almost 40 years since the invention of magnetic resonance imaging (MRI)(Lauterbur, 1973) 
and just over 25 years since the first use of diffusion imaging (Le Bihan et al., 1986; 
Merboldt, Hanicke, & Frahm, 1985; Taylor & Bushell, 1985), the pace of advance of these 
fields and rate of publication of findings are still increasing. MRI neuroimaging delivers 
enticing insights into the function of the human brain. Elucidation of the networks in the 
brain that allow information to be processed in a hugely parallel and adaptive manner is 
crucial to the understanding of brain function. Functional MRI (Kwong et al., 1992; Ogawa 
et al., 1992) has shown that the brain is a modularised highly distributed system with 
components specialising in one or more types of information processing (Kanwisher, 2010), 
such as the network of cortical regions involved in the visual processing of faces (C. J. Fox, 
Iaria, & Barton, 2008; Haxby, Hoffman, & Gobbini, 2000; Ishai, Schmidt, & Boesiger, 2005; 
Kanwisher, McDermott, & Chun, 1997; Rossion et al., 2003). Investigation of the large-scale 
interconnectivity of these modules will lead to better understanding of how these functional 
building blocks cooperate to confer human cognition, behaviour, memory and conscious 
thought. Diffusion tensor imaging (DTI) is a non-invasive MRI method used to visualize 
white matter pathways by identifying the location and orientation of large white matter 
bundles, at the millimetre-level of 3D visualization. The remarkable advantage of this 
technique is that it provides the first opportunity to non-invasively investigate this 
structural connectivity in vivo in human beings. 
The aim of this chapter is to provide an accessible outline of DTI methods and their use in 
elucidating large-scale brain connectivity. We will review the field discussing results from 
human DTI in health and disease, using examples to demonstrate the use of DTI in 
providing an indication of the structural integrity of cortical white matter, and correlation of 
individual structure and behavioural performance. We will describe the principles of DTI 
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tractography and show how this is used to investigate and visualize white matter pathways 
in healthy and pathological brains. Finally, we will discuss future developments in the field, 
in particular directions of research that aim to overcome some of the current limitations of 
the technique. We begin with the principles of diffusion-weighted MRI. 
2. Foundations of the field: DW-MRI and the diffusion tensor 
DTI employs diffusion-weighted MRI (DW-MRI) scanning. MRI techniques generally 
observe properties of hydrogen nuclei, which consist of a single proton, and are the most 
dominant atom in the human body due to the abundance of water molecules. DW-MRI 
observes the displacement of these protons due to random Brownian motion (diffusion). 
Specifically, the technique measures the probability density function of proton 
displacements over a fixed time interval. In the presence of a strong magnetic field inside 
the MRI scanner, water protons are excited and begin to precess (spin), in similar fashion to 
a series of gyroscopes, in phase with each other. For functional MRI, a T2-weighted scan 
measures the time taken in different media for this precession to relax, following excitation. 
When molecules are able to move freely, this relaxation tends to take longer, so areas of 
cerebral spinal fluid (CSF) tend to appear brighter than white or grey matter and white 
matter tends to appear darker than grey matter. Similarly, in DW-MRI, differences in the 
homogeneity of the precession of water molecules are used to confer information about 
media type. In these scans a dephasing gradient pulse field is used to dephase the 
precession of molecules. The extent of dephasing varies along the gradient, as shown in 
figure 1. A subsequent rephasing gradient of opposite polarity restores phase to all 
molecules that have not moved. Molecules that have moved in the time between the two 
gradient pulses will not have their phase fully refocused by the rephasing pulse. By 
applying this pair of gradients between MRI excitation and data collection, the image is 
sensitised to the motion of water molecules by diffusion (or flow). The strength of diffusion-
weighting is often expressed as a b value, which is proportional to the product of the square 
of the gradient strength and the time interval between the two pulses. The extent of signal 
decay depends on the diffusion constants of the medium. Signal from CSF decays faster and, 
therefore, produces a darker image than that for the rest of the brain. The signal from white 
matter decays the slowest and, therefore, white matter appears as the darkest regions of the 
image. Simple scalar apparent diffusion constant (ADC) images reflect this overall signal-loss 
and the acute stage of stroke can be detected from these images because swelling restricts 
diffusion and so the affected region appears bright (Moseley et al., 1990). 
In anisotropic media such as brain white matter, a single scalar measurement of diffusion 
(ADC) is insufficient because the measured diffusivity depends on the orientation of the 
tissue. A symmetric diffusion tensor (Basser, Mattiello, & LeBihan, 1994; Crank, 1975) is 
used to characterise diffusion in 3 dimensions. The tensor is usually visualised as an 
elliptical Gaussian. MRI scanners can measure diffusion along any desired angular direction 
by using in combination three independent gradient units that are orthogonal to each other. 
In order to create a diffusion tensor, information must be acquired from gradients applied at 
a minimum of 6 independent angular directions (Basser, et al., 1994), typically more are 
used, in addition to an image acquired without diffusion weighting (known as a b0 image). 
In regions where diffusion of water molecules is unhindered, such as in CSF, molecules are 
able to diffuse equally in all directions producing an isotropic distribution. In this case, the 
diffusion tensor is isotropic, depicted as a sphere. In contrast, in white matter, fiber 
membranes restrict diffusion in the direction perpendicular to the fibers. In fact, water  
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Fig. 1. Illustration of DW-MRI, from Mori and Barker  (1999) figures 5 & 6. First, a 
dephasing gradient pulse is applied (as shown on the left). This causes protons to lose 
their uniform phase (dephase) because each proton starts to precess at different rates 
depending on its position in space. The gradient shown on the left is applied  
(shown here in the x direction), introducing a linear magnetic field inhomogeneity with a 
specified time period, magnitude, and direction. The length of grey arrows indicates the 
strength of the magnetic field that is non-uniform during the application of the gradients. 
The direction along the magnet bore (the strong static magnetic field to which the main 
magnetic field aligns) is defined as z. Following application of the gradient field, 
precession rates vary according to position of the protons within the field, as shown. After 
a time delay, a rephrasing gradient pulse of opposite magnitude polarity is applied  
(see diagram on right) and the system restores uniform phase (rephase). This rephasing is 
complete only when protons did not move by Brownian motion (i.e. diffuse) during the 
time between the application of the first and second gradients. The less complete the 
rephasing, the more signal loss results. (Figures reproduced with permission from John Wiley 
and Sons) 
diffuses 3-7 times more rapidly along the length of axons aligned in white matter tracts than 
in the direction perpendicular to the axons (Le Bihan, 2003; Pierpaoli, Jezzard, Basser, 
Barnett, & Di Chiro, 1996). This results in a tensor that is elongated, anisotropic in shape, 
such that the longest principle axis of the tensor reflects the main direction of diffusion in 
the voxel. While unmyelinated axonal membranes are sufficient to produce anisotropic 
diffusion (Beaulieu & Allen, 1994), the presence of myelin further modulates anisotropy 
(Beaulieu, 2002) and this leads the technique to be suitable to detect a range of diseases that 
affect myelin. Anisotropy is higher in white than grey matter, and in adult brains compared 
to those of newborns. In fact, DTI has been used to quantify the development of major white 
matter pathways in premature infants in whom indices of anisotropy increase with age 
(Berman et al., 2005). The presence and direction of fiber tracts can be inferred from the 
diffusion tensor but, given the size of imaged voxels (typically 1-4mm for DTI) compared to 
the size of an axon (<10m, white matter packing density 1011m-2), many collinear fibers 
must be present to influence overall diffusion anisotropy across the voxel. This is why DTI 
tractography, discussed later, typically describes the path of major white matter fiber 
bundles in the brain. The reader is referred to Basser and Jones (2002), Hagmann et al. (2006) 
and Mori and Barker (1999) for further explanation of DW-MRI. 
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Fig. 2. Directionality-coloured anisotropy map, axial slice view. Voxels with anisotropic 
diffusion in the superior-inferior direction are shown in blue, anterior-posterior in green and 
left-right in red (for example, part of the corpus callosum) 
Various scalar indices can be derived from the diffusion tensor to describe the profile of 
diffusion within an imaged voxel. Mean diffusivity (MD), a scalar invariant to the direction 
of anisotropy, describes the overall mean-squared displacement of molecules. MD has been 
shown to increase in certain disease states, for example in Alzheimer's disease (Agosta et al., 
2011), likely reflecting a loss of white matter integrity. Of the diffusion anisotropy indices, 
the most commonly used is fractional anisotropy (FA), which ranges from 0 for isotropic 
diffusion to 1 for anisotropic diffusion. FA values across the brain are typically plotted in a 
colour-coded manner to form a directionality-coloured FA map, such as the one shown in 
figure 2. It can be seen that tensor information alone somewhat delineates white matter 
structure in the brain because it shows the locations and orientation of areas of high 
anisotropy. However, this information is based on local anisotropy in each imaged voxel. 
Tractography techniques, described later, consolidate this information to form a description 
of the pathways. 
3. Correlating structure & behaviour 
3.1 Individual variation in the healthy population 
DTI can be used as an index of individual structural variation within the human population. 
Differences in DTI indices have been shown to correlate with measures of behavioural 
performance in both health and disease. For example, correlation between FA and 
behavioural performance has been found in cognitive domains such as reading ability 
(Klingberg et al., 2000), visuo-spatial attention (Tuch et al., 2005) and mental rotation 
(Wolbers, Schoell, & Buchel, 2006). We compared FA value in the human hippocampal 
region with healthy individual behavioural performance during a spatial navigation task in 
a virtual environment (Iaria, Lanyon, Fox, Giaschi, & Barton, 2008). The ability to spatially 
orient within an environment varies greatly between individuals (Ohnishi, Matsuda, 
Hirakata, & Ugawa, 2006). In our experiment subjects first had to navigate within a 
computerised virtual environment to form a "cognitive map" (Tolman, 1948), a spatial 
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memory of the environment. Next, they were asked to navigate to a specified landmark as 
quickly as possible using the shortest route. The task, therefore, involved both learning and 
retrieval components. Subjects underwent MRI scanning to obtain a high-resolution 
structural scan and diffusion-weighted scans using 32 gradient directions. Using these 
images we draw a region of interest (ROI) in the region of each subject's hippocampus, as 
shown in figure 3, and obtained the mean FA value within this ROI (using DTI Studio 
software (Hiang & Mori)). The results revealed a statistically significant correlation between 
the FA in the right hippocampus and the time spent by the participants performing both the 
learning and retrieval tasks. Subjects with higher FA values in the area of the right 
hippocampus required less time to form a cognitive map (figure 4a) and were more efficient 
in using the map during navigation in the subsequent retrieval task (figure 4b). No similar 
correlations were found in the left hemisphere. 
 
 
Fig. 3. Region of interest drawn in hippocampal area, from Iaria et al. (2008) figure 2. ROIs in 
the bilateral hippocampal regions are shown overlaid on diffusion images: (a) the color-
coded directionality maps (directions: red=left-right, green=anterior-posterior direction, 
blue=inferior-superior) and (b) monochromatic FA maps. 
 
 
Fig. 4. FA value correlates with spatial navigation performance in healthy individuals, from 
Iaria et al. (2008) figure 3. A negative correlation was found between FA values of the right 
hippocampus and (a) the time spent by the participants to form a cognitive map of the 
environment (the learning task) and (b) the average time they spent to reach the target 
locations (the retrieval task). 
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3.2 Structural variation with age 
Diffusivity properties of cerebral white matter change across the lifespan of healthy 
individuals, likely reflecting developmental and aging-related changes in tract morphology 
(Bennett, Madden, Vaidya, Howard, & Howard, 2010; Davis et al., 2009; Kochunov et al., 
2010; Madden et al., 2009; Madden et al., 2007). Aging causes increases in MD and decreases 
in FA, presumably due to deterioration in the integrity of white matter tracts due to 
demyelination (Abe et al., 2002; Yoon, Shim, Lee, Shon, & Yang, 2008). Recent studies have 
established an anterior-posterior gradient of age-related deterioration amongst healthy  
 
 
Fig. 5. Age-related differences in fractional anisotropy (FA), radial diffusivity (RD) and axial 
diffusivity (AD) for specific tracts, from Davis et al. (2009) figures 2 & 3. 
Top, FA differences are shown along a tract; FA data were smoothed with a 6mm kernel and 
displayed upon mean tracts from a representative subject for the genu, uncinate fasciculi, 
cingulum bundle, inferior longitudinal fasciculi, and splenium. RD and AD differences are 
displayed in graphs corresponding to specific tracts. Metric dimensions: AD, RD: 10−3 
mm2/s; * = P < 0.01; ** = P < 0.005; *** = P < 0.001. YA = younger adults; OA = older adults. 
Below, differences in AD (left) and RD (right) are represented upon the same tracts, 
demonstrating greater age-related effects for RD than AD. Colour scales for RD have been 
reversed such that OA > YA differences are reflected by warmer colors.  
(Figures reproduced with permission from Elsevier) 
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adults, such that indices of diffusivity show anterior regions of cortex are affected more, or 
perhaps sooner, than posterior regions (Bennett, et al., 2010; Davis, et al., 2009; Madden, et 
al., 2007; Yoon, et al., 2008). This anterior-posterior gradient of age impact is the reverse of 
the gradient observed in the childhood development of white and grey matter, where 
anterior regions have a more protracted development course than posterior regions 
(Eluvathingal, Hasan, Kramer, Fletcher, & Ewing-Cobbs, 2007; Giedd et al., 1999; Paus et al., 
1999; Sowell et al., 2004; Sowell, Trauner, Gamst, & Jernigan, 2002). A current trend in DTI 
aging research is to examine radial diffusivity (RD) and axial diffusivity (AD), indices of 
diffusion in the primary and perpendicular directions of the diffusion tensor, which 
contribute to FA. AD describes the principal eigenvector of the diffusion tensor and is 
assumed to indicate the integrity of axons (Glenn et al., 2003) or changes in extra-
axonal/extracellular space (Beaulieu & Allen, 1994). RD describes an average of the 
eigenvectors that are perpendicular to the principal diffusion direction and is assumed to 
reflect changes associated with myelination or glial cell morphology (Song et al., 2003; Song 
et al., 2002; Song et al., 2005). Such techniques provide a unique insight into normal cortical 
changes across the lifespan that can also be correlated with associated behavioural changes. 
 
 
Fig. 6. FA differences across the brain related to aging, from Bennett et al. (2010) figure 1. 
Shown in red are white matter clusters where FA was significantly greater in younger 
compared to older adults, across four axial and four sagittal slices. Axial slices are presented 
in radiological orientation (right = left). RLIC = retrolenticular part of the internal capsule. 
(Figure reproduced with permission from John Wiley and Sons) 
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A recent study (Davis, et al., 2009) used streamline tractography (described later) to 
establish the location of several major white matter pathways in each individual’s brain. 
Reconstructed tracts were then averaged to form a mean position for each pathway in 
each individual, and then combined into two groups: younger (mean age 20 years) and 
older (mean age 69 years) adults. In 10mm segments along each pathway, mean FA, AD 
and RD values were examined. Age-related differences were apparent in all three indices 
but especially the FA and AD. Consistent with the anterior-posterior model of FA changes 
with aging, the greatest age-related changes in FA occurred in anterior segments of 
longitudinal fibers that traversed the frontal lobe (see figure 5). In particular, examination 
of the cingulum bundle and uncinate fasciculus showed that age effects increase gradually 
from the posterior to anterior brain, likely due to myelodegeneration. In all cases age 
differences were greater for radial than axial diffusivity. In contrast, an age-related study 
(Bennett, et al., 2010) that examined FA changes throughout the brain rather than those 
within specified tracts, found that reduced FA values in older adults (as shown in figure 
6) were caused by either an increase in RD only, increases in both RD and AD, or an 
increase in RD with a corresponding decrease in AD, depending on region of the brain. 
Again, the largest changes were observed in frontal regions. The frontal cortex seems to be 
susceptible to early deterioration in dementia also. Changes in AD in tracts projecting  
to the frontal cortex have been associated with cases of amnestic mild cognitive 
impairment, a pre-cursor to Alzheimer’s disease, with changes in diffusivity in all 
directions, and widespread FA decrease, apparent in cases of Alzheimer’s disease 
(Agosta, et al., 2011). 
3.3 DTI in disease  
In addition to comparisons within the healthy population, DTI indices have been used to 
detect structural differences, and provide an index of disease state, in a range of 
neuropsychiatric and neurological diseases, for example multiple sclerosis (Sigal, Shmuel, 
Mark, Gil, & Anat, 2010), Huntington's disease (Rosas et al., 2010), schizophrenia 
(Manoach et al., 2007), obsessive-compulsive disorder (Cannistraro et al., 2007), bipolar 
disorder (Adler et al., 2004; Beyer et al., 2005), Alzheimer’s disease (Hanyu et al., 1997; 
Pievani et al., 2010), amnestic mild cognitive impairment (Agosta, et al., 2011), and in 
presymptomatic groups at risk of developing Alzheimer’s disease (Gold, Powell, 
Andersen, & Smith, 2010). Since anisotropy is modulated by the presence of myelin, 
diffusion indices have been used to demonstrate changes in white matter integrity in 
many diseases that involve myelin degeneration and, recently, as a way to measure 
neuroprotective therapies (R. J. Fox et al., 2011).  
We used FA value to detect white matter deterioration in Niemann-Pick Type C (NPC) 
disease (Scheel, Abegg, Lanyon, Mattman, & Barton, 2010). NPC is a fatal autosomal 
recessive neurodegenerative disorder resulting from mutations in the NPC1 or NPC2 genes 
(Vanier & Millat, 2003) that leads to impaired intracellular lipid trafficking and consequent 
excess lysosomal storage of glycosphingolipids and cholesterol in multiple tissues. In the 
central nervous system, the storage material results in dysfunction and death of Purkinje 
and other select neuronal cells (Karten, Peake, & Vance, 2009). The disorder affects the entire 
brain but some regions are particularly susceptible, with cerebellar degeneration leading to 
gait ataxia (a lack of coordination of muscle movements), dysarthria (motor speech disorder) 
and dysphagia (difficulty swallowing), and cortical degeneration leading to dementia and 
seizures. An early characteristic sign of the disease is vertical supranuclear gaze palsy, 
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meaning that patients find it extremely difficult to make vertical eye movements, while their 
horizontal eye movements are nearer normal. These eye movement deficits are reflected in 
more severe cell loss in the rostral interstitial nucleus of the medial longitudinal fasciculus 
(riMLF), the nucleus linked to the generation of vertical eye movements, compared to the 
paramedian pontine reticular formation (PPRF), the nucleus linked to the generation of 
horizontal eye movements (Solomon, Winkelman, Zee, Gray, & Buttner-Ennever, 2005). 
Standard clinical MR sequences are relatively insensitive to changes in the early stages of 
NPC. However, DTI, which measures the integrity of myelinated axons, is a plausible 
technique to identify early NPC changes, given the impaired lipid storage associated with 
the disease.  
We examined FA values across the brain of a young early-stage NPC patient in 
comparison with a group of healthy control subjects. We found significantly lower FA in 
the patient compared to controls, particularly in white matter regions, as shown in figure 
7. A voxelwise analysis, using a voxel-by-voxel statistical contrast (tract based spatial 
statistics tool of FSL: Smith et al., 2006) revealed some clusters of local FA differences. Of 
particular interest was a region of reduced FA in the dorsal midbrain because of the 
involvement of this region (riMLF) in the generation of vertical eye movements. Another 
prominent cluster was found in the superior cerebellar peduncle, a possible cause of the 
patient's cerebellar ataxia. After one year of treatment, areas of reduced FA persisted but 
there were significantly fewer voxels with lower FA and the cerebellar peduncle cluster 
was reduced in size, which might have been linked with the patient's improved tremor 
and dysarthria, and reports of fewer falls. Also, the midbrain cluster was not apparent 
after treatment, possibly correlating with the patient's slight improvement in making 
vertical eye movements.  
 
 
Fig. 7. Histogram of FA values for white matter regions, from Scheel et al. (2010) figure 2. 
Mean healthy FA value is shown as the black line with vertical errors bars representing the 
range of values. The NPC patient's FA value before treatment is shown (red line), and after  
1 year of treatment with Miglustat (orange line). The patient's white matter has significantly 
lower FA value than that of healthy controls. The mean FA in the patient's white matter 
(0.359) was more than 6 standard deviations from the control’s mean (0.452 ± 0.016). After 
treatment, the FA value improved to 0.377, but was still 5 standard deviations from the 
control’s mean. (Figure reproduced with permission from Elsevier) 
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This example demonstrates the use of FA as an early marker of disease state (before 
abnormalities were evident in standard clinical MRI), revealing local changes that correlate 
with specific clinical signs. FA was also used as an objective structural index to track disease 
progression and assess the effects of treatment. 
4. Visualising tracts 
Assuming that the largest principal axis of the diffusion tensor aligns with the predominant 
fiber orientation in the MRI voxel, a vector field is created that reflects the orientation of 
fibers at all voxels throughout the brain. Tractography is the 3D reconstruction of tract 
trajectories from these vector fields. At the resolution of MRI voxels (typically 1-4mm for 
DTI), reconstructed tracts reflect the orientation of large white matter bundles present in the 
brain. The technique does not permit the tracking of individual axons or dendrites (whose 
typical size is <10m). Hence, tractography models large-scale connectivity within the brain. 
It has provided insights into in vivo white matter morphology in health and disease/lesion. 
Methods of DTI tractography generally seek to propagate a line through the field using a 
deterministic algorithm based on tensor information at each stage of the propagation1. This 
is known as streamline tractography (Mori & Barker, 1999; Mori, Crain, Chacko, & van Zijl, 
1999; Mori & van Zijl, 2002). Simply, the vector field is converted into a continuous number 
field and a line is propagated through this field with a small step size, using the distance-
averaged vector information, as depicted in figure 8. This algorithm is known as fiber 
assignment by continuous tracking (FACT) and was used for the first successful tract 
reconstruction, performed for a fixed rat brain (Mori, et al., 1999; Xue, van Zijl, Crain, 
Solaiyappan, & Mori, 1999). From a starting seed voxel or ROI, tractography commences and 
lines are propagated while the FA value indicates high anisotropy (typically a threshold of 
0.2 is chosen because voxels with lower FA value tend to be in grey matter or CSF). An 
example of fibers tracked from the striate cortex (area V1) is shown in figure 9. 
 
 
 
 
Fig. 8. FACT streamline technique for tractography, from Mori and van Zijl (2002).  
(Figure reproduced with permission from John Wiley and Sons) 
                                                 
1 An alternative approach to propagating a line thorough the tensor vector field is to use energy 
maximisation techniques (Parker, 2000). These techniques use principles of global energy minimisation 
to find the energetically most favourable path by which two points are connected. So far this approach 
has been less extensively adopted than streamline tractography and probabilistic methods. 
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Fig. 9. Streamline tractography using primary visual cortex (area V1) as an ROI. An oval 
seed ROI was drawn over the occipital pole and streamline tractography performed in DTI 
Studio (Hiang & Mori). Reconstructed tracts are shown in 3 dimensions overlaid on a 2 
dimensional axial brain slice. Tracts forming part of the optic radiation and corpus callosum 
are some of the pathways shown. Note each tracked 'fiber' represents a line that has been 
tracked through the tensor vector field so each line represents multiple real axons and 
dendrites. 
Once the tractography encounters a region of low anisotropy it ceases. An issue with this 
approach is that a DTI voxel is a few millimetres in size and more than one bundle of 
oriented tracts might be present, i.e. tracts of different orientations may cross within the 
voxel. If there are two predominant fiber directions within the voxel, the tensor may appear 
'pancake-shaped' (see Mori & van Zijl, 2002, for review) and, with higher numbers of 
directions the overall diffusion may appear isotropic. If the tractography is unable to 
determine the onward fiber direction, due to tensor isotropy, it stops at that voxel. Hence, 
tractography is difficult in regions of complex fiber architecture. Nonetheless, streamline 
tractography results are robust for major pathways and have been shown to have good 
correspondence with known neuroanatomy (Kang, Zhang, Carlson, & Gembris, 2005; Mori 
& van Zijl, 2002). To illustrate the potential and limitations of tractography, we will now 
discuss two studies where this form of deterministic streamline tractography was used to 
investigate pathways for visual perception in healthy humans. 
4.1 Pathways for visual motion perception  
Patients who sustain a loss of the primary visual cortex (striate area V1) are rendered blind 
in the respective part of their visual field. Most of these cortically blind patients have no 
residual visual perception. However, some "blindsight" patients (Weiskrantz, 1998) retain 
residual visual abilities such as the ability to make perceptual discriminations or perform 
associated visuomotor control at better than chance levels, while denying conscious 
awareness of stimuli in their blind visual fields (Blythe, Kennard, & Ruddock, 1987; 
Corbetta, Marzi, Tassinari, & Aglioti, 1990; Perenin & Jeannerod, 1975; Perenin, Ruel, & 
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Hecaen, 1980). Several reports suggest that V1 is necessary for conscious visual perception 
(Celesia, Bushnell, Toleikis, & Brigell, 1991; Cowey & Stoerig, 1997; Merigan, Nealey, & 
Maunsell, 1993). However, some degraded conscious “blindsight” vision may remain, 
particularly if structures like the superior colliculus, LGN and extrastriate cortex are not 
directly affected. Conscious perception of visual motion seems to be particularly likely to be 
spared (Barbur, Watson, Frackowiak, & Zeki, 1993; Blythe, et al., 1987; Giaschi et al., 2003; 
Mestre, Brouchon, Ceccaldi, & Poncet, 1992; Morland et al., 1999; Perenin, 1991; Ptito, 
Lepore, Ptito, & Lassonde, 1991; Riddoch, 1917; Schoenfeld, Heinze, & Woldroff, 2002), and 
motion perception has even been reported in a case where the striate cortex was completely 
congenitally absent (Giaschi, et al., 2003). Many cortical regions exhibit motion sensitivity, 
but key areas are the middle temporal area (MT), medial superior temporal cortex (MST) 
and the fundus of the superior temporal cortex (FST), known collectively in humans as the 
V5/MT complex, or V5/MT+ (Zeki et al., 1991). The main route by which V5/MT+ receives 
visual inputs from the retina is via the lateral geniculate nucleus (LGN) of the thalamus, 
which projects to V1 which, in turn, projects to V5/MT+. If this were the sole pathway by 
which visual motion is perceived, damage to any part of this path should render the person 
blind to visual motion. Human and animal studies suggest that there may be direct 
projections, perhaps from LGN, pulvinar or superior colliculus, to V5/MT+ that bypass V1 
(Cowey & Stoerig, 1991; Rodman, Gross, & Albright, 1989; Stoerig & Cowey, 1997). Such 
pathways might be responsible for the residual visual abilities observed in some cortically 
blind patients. 
We used a combined functional magnetic resonance imaging (fMRI) and streamline 
tractography approach to investigate the presence of sub-cortical connections to V5/MT+ in 
10 healthy human subjects (Lanyon, Giaschi et al., 2009). DTI data were collected using 32 
gradient directions. We first localised V5/MT+ in each subject using fMRI (because the exact 
anatomical location of this area is subject to individual variation (Dumoulin et al., 2000; 
Watson et al., 1993) and then used this region as the seed for tractography. We performed all 
analyses in each subject’s native space, without conversion to a standard brain template, in 
order to retain individual differences in tract morphology. Tracts extending to area V1 were 
eliminated from the analysis. We found individual variation in the results of tractography: 
direct connections between V5/MT+ and sub-cortical locations were found in 4 of our 10 
subjects. All 4 of these subjects had fibers connecting V5/MT+ with the pulvinar, 2 had 
fibers connecting with the superior colliculus and 1 subject had fibers connecting with the 
region of the LGN. An example of fibers tracked to the pulvinar in one subject is given in 
figure 10. Further examples are given in Lanyon, Giaschi et al. (2009). Consistent with 
known feedback connections from V5/MT+ to the pons in monkeys (Boussaoud, Desimone, 
& Ungerleider, 1992; Maunsell & van Essen, 1983), fibers were found extending inferiorly in 
the brain stem through the pons in 3 of the 4 subjects, and a small number proceeded into 
the medulla.  
Since the outputs of tractography are computationally-derived it is important to validate 
findings with other forms of evidence. Our tractography findings are supported by studies 
in monkeys: feedforward thalamic and collicular projections to V5/MT+ have been 
described (Boussaoud, et al., 1992; Cowey & Stoerig, 1991, 1997; Cusick, Scripter, 
Darensbourg, & Weber, 1993; Lin & Kaas, 1980; Rockland, Andresen, Cowie, & Robinson, 
1999; Sincich, Park, Wohlgemuth, & Horton, 2004; Stoerig & Cowey, 1997); MST and FST 
have been shown to be reciprocally connected to the pulvinar, and to project to the pons 
(Boussaoud, et al., 1992); and feedback connections have been found from area MT to the 
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pulvinar, LGN, the superior colliculus and the pons (Maunsell & van Essen, 1983; Wall, 
Symonds, & Kaas, 1982). DTI tractography can only confirm the presence of a hypothesised 
fiber tract, it does not provide information about the direction of axonal projections. Hence, 
the pathways we have identified could represent feedforward connections from thalamus to 
V5/MT+, or feedback from V5/MT+, or both. The evidence from monkeys supports both 
forms of connection. 
 
 
Fig. 10. Streamline tractography using functionally-defined visual cortical area V5/MT+ as 
an ROI, with fibers extending to area V1 eliminated. 
Fibers extend from V5/MT+ to the pulvinar nucleus of the thalamus in the left hemisphere 
(orange line). The panels show output from DTI Studio (Hiang & Mori). Top left: 
reconstructed tracts are shown in 3 dimensions overlaid on a 2 dimensional axial brain slice. 
In the other panels only the fibers present in that slice are shown (top right: axial, bottom 
left: sagittal, bottom right: coronal views). Images are displayed in radiological convention 
(right = left). White regions denote the location of functional activation in V1 and V5/MT+. 
An example of a subject in which tractography did not connect V5/MT+ with subcortex is 
shown in figure 11. This inter-subject variability could be due to the technical limitations of 
DTI tractography in terms of resolving crossing fibers within a voxel, particularly since we 
were tracking through regions of complex fiber structure. However, the diversity in our 
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results could also reflect true inter-subject anatomical variability of pathways, as suggested 
by others (Leh, Johansen-Berg, & Ptito, 2006). Finding a direct pathway between subcortical 
structures and V5/MT+ in less than half our healthy subjects is consistent with the fact that 
only a minority of patients with cortical visual loss retain residual visual abilities (Barton & 
Sharpe, 1997; Kasten, Wuest, & Sabel, 1998; Scharli, Harman, & Hogben, 1999).  
 
 
Fig. 11. Tractography in a subject for whom fibers did not connect V5/MT+ with subcortex. 
4.2 The network for face perception 
Functional MRI studies have identified multiple cortical regions that are involved in face 
perception, a key visuosocial skill (Gobbini & Haxby, 2007; Haxby, et al., 2000; Ishai, et al., 
2005; Rossion, et al., 2003). Current models divide these into a core system, which is 
predominantly involved in the processing of facial stimuli, and an extended system which, 
though not solely involved in face processing, contributes to it (Gobbini & Haxby, 2007; 
Haxby, et al., 2000). The core system consists of the occipital face area (OFA), located on the 
inferior occipital gyrus; the fusiform face area (FFA), located on the lateral fusiform gyrus; 
and a face-selective region in the posterior superior temporal sulcus (pSTS) (Haxby, et al., 
2000; Ishai, et al., 2005; Kanwisher, et al., 1997). These regions consistently show increased 
activity in fMRI studies that contrast activity to faces over other objects, with the right 
hemisphere being dominant for face processing. Damage to component parts of face 
processing cortical network can result in face processing deficits, a condition known as 
prosopagnosia (Barton, 2003; Rossion, et al., 2003). Patients with prosopagnosia are typically 
unable to recognize faces, a major social impediment. Prosopagnosia is a selective visual 
agnosia and the ability to recognize other objects is usually unimpaired. Prosopagnosia can 
take a developmental form, where onset occurs prior to the development of normal face 
recognition abilities (either due to genetic causes or acquired in early childhood), or be 
acquired in later life through cortical damage due to illness or injury. Various cortical lesion 
locations have been associated with the condition (see C. J. Fox et al., 2008, for a review). 
While loss of one or more of the functional components of the core face network is an 
obvious cause in some patients, for example a lesion in the area of the OFA in patient PS 
(Rossion, et al., 2003), other patients have robust fMRI activation in the three cortical areas of 
the core network. It has been suggested that some cases of prosopagnosia could be due to 
damage to the connectivity of the face processing network (C. J. Fox, et al., 2008).  
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In order to better understand interconnectivity of the cortical face-processing network we 
performed DTI tractography in 5 healthy subjects and examined fibers tracked from OFA, 
FFA and pSTS, which were defined by fMRI. For the fMRI face-selective region localiser we 
contrasted activity invoked by presentation of static pictures of neutral and emotionally 
expressive faces with that evoked by presentation of static pictures of non-living objects (see 
C. J. Fox, Iaria, & Barton, 2009, for fMRI methods). A threshold of p<0.05, Bonferonni 
corrected, was used to determine the extent of activation and this became the seed region for 
DTI tractography. DTI data were collected using 32 gradient directions. Structural, 
functional and DTI images were co-registered and streamline tractography was performed 
in Brain Voyager QX (www.brainvoyager.com, Brain Innovation) for each subject. All fMRI 
and DTI analysis were performed in each subject’s own native brain space, without 
conversion to a standard template. Figure 12 shows fibers tracked from the regions of the 
core network in an example subject. Fibers from right OFA and FFA interconnected these 
regions and fibers from these posterior regions travelled anteriorally along the inferior 
longitudinal fasciculus toward the inferior temporal cortex (a region which forms part of the 
extended network, possibly contributing facial memories). We found a lack of fibers 
connecting right OFA, FFA and the right anterior temporal lobe in a prosopagnosic patient 
who had a right amygdalohippocampectomy for epilepsy that resulted in lesion of the 
anterior part of the inferior longitudinal fasciculus (Lanyon, Scheel, Fox, Iaria, & Barton, 
2009). Contrary to current models of the core cortical network for face perception (Haxby, et 
al., 2000), our tractography did not reveal a connection between pSTS and either FFA or 
OFA. However, we cannot rule out the existence of a connection between pSTS and these 
posterior regions because tractographic technical difficulty may have prevented fibers 
traversing this region, since it contains the intersection of several major fiber pathways. 
 
 
Fig. 12. Results of tractography showing fibers extending from core face-selective areas. 
The core network was defined by fMRI and then tractography performed using these areas 
as seed regions. OFA (red) FFA (green) and pSTS (orange) fibers in a healthy subject are 
shown. In the right hemisphere, fibers from OFA and FFA interconnect these two regions 
and extend along the inferior longitudinal fasciculus towards the inferior temporal cortex,  
as shown on the left. The three dimensional view on the right shows that the pSTS is not 
connected with OFA or FFA in our tractographic analysis. OFA = occipital face area; FFA = 
fusiform face area; pSTS = face-selective region in the posterior superior temporal sulcus.  
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4.3 Limitations and alternatives to the tensor model 
The tensor model of diffusion provided the first and currently most popular technique to 
map fiber orientations in the brain. It has proved to be a powerful model that has stimulated 
much research in the field of DW-MRI and adoption of these techniques. This has led to 
many insights into human neuroanatomy with visualisation of major fiber pathways in the 
brain. However, in fitting a Gaussian distribution of diffusion to each voxel, the tensor 
model assumes there is a single predominant orientation of fibers travelling within the 
voxel, and this results in the major limitation of DTI. In voxels containing complex fiber 
architecture, the tensor model cannot describe more than one dominant fiber orientation. 
Current research is attempting to provide models and tractography approaches that better 
account for the distribution of diffusion in voxels that contain crossing fibers. Many 
solutions rely on measuring diffusion over a higher number of angular directions. These 
techniques are referred to as high angular resolution diffusion imaging (HARDI). These high-
resolution methods aim to provide richer information about the direction of fibers in voxels 
that contain numerous fiber orientations.  
4.3.1 Diffusion Spectrum Imaging (DSI) 
DSI Diffusion spectrum imaging (DSI)(Wedeen, Hagmann, Tseng, Reese, & Weisskoff, 2005; 
Wedeen et al., 2008) is a high angular technique that reconstructs a full account of fiber 
orientations by transforming data directly from the DW-MRI measurements. The result is an 
orientation distribution function (ODF). An ODF may be considered a deformed sphere whose 
radius in a given direction is proportional to the sum of values of the diffusion probability 
density function in that direction. The ODF has peaks in the directions in which the 
probability density function has most mass, which DSI assumes are the fiber directions. DSI 
is a superior technique to DTI in that DSI is able to resolve multiple fiber orientations. 
However, DSI is very time intensive during acquisition, because several hundreds of image 
volumes are required (compared to a minimum of 6 in DTI), and this has hindered its 
widespread use because it is often not well tolerated by subjects.  
4.3.2 Multi-compartmental models 
Models of diffusion that account for the multi-compartmental nature of matter within the 
voxel attempt to overcome the limitation of DTI imposed by the fitting of the single 
orientation Gaussian. Such models assume that each voxel comprises a discrete number of 
compartments reflecting particular fiber directions and extra-axonal components (Assaf, 
Freidlin, Rohde, & Basser, 2004; Behrens et al., 2003). Hence, these models are an extension 
of DTI in which the tensor model is simply generalised to account for more than one fiber 
orientation, for example the single Gaussian model is replaced with a mixture of Gaussian 
densities. A problem with this approach is in deciding how many fiber orientations should 
be fitted, since selecting two or more can result in a loss of accuracy in voxels that contain a 
single predominant fiber orientation. A prominent model by Behrens et al. (2003) replaces 
the Gaussian model with a tensor that has only one nonzero eigenvalue and a Gaussian 
distribution in all other directions. Hence, a single fiber direction combined with isotropic 
diffusion in all other directions is modelled. Behrens et al. also take a probabilistic approach 
in which the likelihood of various fiber orientations is considered. This local probability 
distribution is then used to confer global probability estimations when determining whether 
two regions connect. This probabilistic tractography approach uses a sampling technique to 
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draw samples based on the probability estimate of fibre direction at each voxel. Samples are 
generated from each voxel within the seed region and a connectivity distribution results in 
which the probability of a pathway passing through a voxel is reflected in the number of 
samples passing through it. Connections are visualised by applying a threshold to view only 
the most likely pathways from all calculated possible connection paths. Hence, local and 
global probability information is used to determine the likelihood of connections. Whereas 
streamline tractography traces fibers through regions of high anisotropy where uncertainty 
is low, these methods chose to model the uncertainty of fiber direction at each local voxel. 
Hence, it is claimed that this approach offers an advantage over streamline methods when 
tracking through regions of crossing fibers and orientation uncertainty. Typically tracts are 
converted to a standard anatomical template for group analysis and this carries some 
disadvantage in terms of a loss of individual information, given the high level of individual 
variation in morphology of both white and grey matter2.  
4.3.3 Estimators of the Orientation Distribution Function (ODF) 
A new generation of multiple-orientation fiber reconstruction algorithms is emerging. These 
attempt to combine the benefits of DTI (speed of acquisition) with the sophistication of the 
high angular DSI approach in estimating multiple fiber orientations. A distribution of fiber 
orientations within a voxel is assumed, rather than the discrete number assumed in the 
multi-compartmental approaches. Hence, these methods do not suffer from the problem of 
model selection since it is not required to know the number of fiber orientations in advance. 
Data is acquired using the spherical sampling scheme typical of DTI and the ODF is 
approximated by estimating the angular structure of the proton displacement probability 
density function directly from the MRI measurements. Examples of these approaches are  
q-ball imaging (Tuch, Reese, Wiegell, & Wedeen, 2003), spherical deconvolution (Tournier, 
Calamante, Gadian, & Connelly, 2004) and PASMRI (Jansons & Alexander, 2003). These 
algorithms produce results in regions of fiber crossings that are in good agreement with DSI: 
see Alexander (2005) for a review of current approaches. However, these methods are 
currently computationally and acquisition-time heavy, and many still require 
implementation in software with a simple user interface to facilitate widespread adoption. 
4.4 Validation of results  
The outputs of tractography are very compelling and aesthetically interesting but results 
should be interpreted with some caution since tracked fibers are computational constructs 
and not imaged directly from the brain unlike chemically traced fibers, for example. Hence, 
it is normal practise for the results of DTI tractography to be compared with known findings 
from "gold standard" techniques such as chemical tract tracing in animal models and 
histological staining of brain slices. There will not necessarily be an exact correspondence of 
results, however, since DTI provides a level of macroscopic information that is difficult to 
obtain using chemical tracers in individual axons. DTI tractography then provides 
information that forms part of the converging evidence about brain connectivity. For 
                                                 
2 The issue of group analysis applies in general to all methods of tractography if fiber tracking is based 
upon ROIs defined by a group-level fMRI analysis since the location of these functionally-defined 
regions will extend into different regions of white matter in each individual and, hence, result in tracts 
being selected that would not be derived from an individual analysis. 
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example, our tractographic identification of a pathway for visual motion perception is 
consistent not only with other DTI studies using alternative tractography techniques (Leh, 
Chakravarty, & Ptito, 2008) but with the thalamic projections described in many histological 
and tracing studies, discussed above. Overall, tractography has proved to be remarkably 
accurate in reconstructing major fiber pathways in the human brain thought to exist based 
on evidence from post-mortem studies and animal models (Mori, et al., 1999). 
5. Conclusion  
Understanding how neural network connectivity confers human behaviour in health and 
disease is one of the most important challenges facing neuroscientists in the 21st century. 
DTI affords the ability to investigate the structure of large white matter pathways in vivo, 
offering profound insights into living human neural anatomy. In addition to its use in 
neuroscientific research, DTI as a method for detecting and monitoring certain disease states 
seems certain to become established in normal clinical practice. In this chapter we described 
a case of early Niemann-Pick Type C disease in which DTI revealed significant white matter 
structural changes which were not evident on standard clinical MRI structural imaging 
(Scheel, et al., 2010). 
DTI offers an important contribution to the emerging array of scientific methods that aim to 
reveal insights into large-scale connectivity in the brain. Methods of fMRI functional 
connectivity (see Rogers, Morgan, Newton, & Gore, 2007, for a review) confer information 
about connectivity between functionally active regions of the brain by examining temporal 
correlations in the fMRI signals in the active regions. Methods of effective connectivity 
additionally provide information about causal relationships, i.e. the direction of influence of 
one area upon another. Whereas DTI reveals structural connectivity in the brain, functional 
and effective connectivity methods show how these networks change under different 
stimulus or task conditions. Hence, DTI and functional/effective connectivity together can 
provide converging evidence about neural networks, from both a structural and a 
conditional (task- or stimulus-related) perspective. Such insights into structural and 
functional neural connectivity have not previously been possible in vivo. In addition, 
computational neuroscience models based on these empirical findings will provide a 
theoretical grounding for understanding neural network connectivity, as well as provoking 
further empirical investigation to answer questions deriving from these models. 
Foremost amongst the key challenges in the development of DW-MRI methods is the 
development of algorithms capable of elucidating fiber directions in regions of complex 
structural architecture whilst being computationally tractable and remaining feasible in 
terms of acquisition times. The immediate future of DW-MRI research centres on improving 
methods for high angular resolution diffusion imaging so that acquisition and computation 
times are feasible. Techniques that exploit the full orientation distribution function of 
diffusion within each voxel will ultimately lead to better definition of fiber orientation in 
complex matter and, hence, provide more reliable descriptions of neural connectivity. To 
allow widespread adoption of these evolving technologies, it is necessary for the algorithms 
to be implemented in software platforms that can be readily used by medical and other 
researchers. As these new methods become more accessible in terms of acquisition times, 
computational tractability and general usability, DW-MRI will become an increasingly 
important method and even more pervasive in neuroscience research and in medical 
diagnosis and monitoring. DTI is just the beginning of this important field. 
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"The human brain, then, is the most complicated organization of matter that we know" 
Isaac Asimov 
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1. Introduction   
1.1 From lesions to functional neuroimaging 
The first model about the cerebral organization of cognitive functions was based on lesion 
observation. This consisted in inferring association between a particular deficit of the 
language (e.g., word production) and a brain lesion observed post-mortem (Wernicke, 1874; 
Broca, 1861). Brain imaging techniques (e.g., functional Magnetic Resonance Imaging) 
provide complementary but different types of information regarding brain-behavior 
relationships. By providing indirect measures of cerebral activity such as blood flow or 
oxygen consumption, neuroimaging techniques enable one to establish a relationship 
between the activities of different brain areas and the cognitive processes being performed 
(Bestmann et al. 2003; Frith 1997). For instance, the combination of functional magnetic 
resonance imaging (fMRI) with language tasks has shown that language-related areas have 
a more complex role than the ones attributed by lesion studies, e.g. Broca’s area in the left 
inferior frontal gyrus has been involved in speech production as well as in speech 
comprehension, and Wernicke’s area located in the left temporoparietal area has been 
involved in language comprehension as well as phoneme discrimination (Friederici 2002; 
Luke et al. 2002). In addition, brain imaging studies showed that language processing is not 
restricted to Broca’s and Wernicke’s areas as shown by lesion studies, but requires a 
network of different brain areas which may be interconnected (Catani, Jones, and ffytche 
2005; Behrens et al. 2003). However, the measures of brain activity implicate rather than 
demonstrate the critical contribution of a brain area to behavior, which can lead to 
misinterpretations. 
1.2 Basic principles of TMS  
During the last two decades, transcranial magnetic stimulation (TMS) has rapidly become a 
valuable method to investigate the human brain noninvasively (Siebner et al. 2009; Walsh 
and Rushworth 1999). TMS is based on electromagnetic induction: a change in electric 
current generates a magnetic field, which in turn induces a current in a second conductor 
brought into the magnetic field (Figure 1).  
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Fig. 1. an electric current (I) flowing through a coil of wire generates a magnetic field (B), 
which in turns induces electrical current in a secondary conductor. 
The focality of stimulation with TMS depends on many factors such as the coil geometry 
(size and shape), the stimulus intensity or other external parameters such as the electrical 
properties of the cortex under the coil (Amassian et al., 1992; Cohen et al., 1990; Maccabee et 
al., 1993).  The magnetic field induced by the TMS coil can be defined by the Biot-Savart law 
(see equation). The integration is performed with the vector dl along the coil windings Coil 
and 0 is the permeability of free space (see Figure 1). 
0
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The most common coils are the circular coil and the 8-shaped coil (see Figure 2), but recently 
developed coils (e.g. iron-core, Hesed or stereotactic) provide a more efficient and a deeper 
stimulation (Epstein and Davey 2002; Roth, Zangen, and Hallett 2002). 
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Fig. 2. The two most common TMS coils: (left) the circular coil and (right) the 8-shaped coil. 
With a circular TMS coil (see Figure 2, left), the maximum electric field induced in the brain 
lies in an annulus under the coil (Figure 3). The 8-shaped coil is more focal than the circular 
coil (around 2 cm and 10 cm respectively) but in practice the circular coil is sometimes 
preferred over the 8-shaped coil because motor responses can be rapidly evoked without 
need for accurate coil positioning.  
 
 
Fig. 3. Focality of the induced electric field for the circular coil (in blue) and for the 8-shaped 
coil (black). Data from constructor (Magstim Ltd., Wales, UK). 
The focality and the strength of stimulation depend on the coil size and on the distance from 
the coil, both degrading quickly with increasing depth. As an indication, the field at a 
distance of 4 cm may be only about 30% of that at the coil surface as measured by Bohning 
et al. (1997) using fMRI and an MR-compatible TMS coil to map the magnetic field induced 
by the TMS coil in human volunteers. 
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1.3 TMS and interference with function 
By inducing a local electric field, TMS creates a “virtual lesion” that may transiently 
interfere with cognitive processing. This 'perturb and measure' approach provides a direct 
link between anatomy and function and could also infer causality in neural connectivity. 
When TMS is applied over the motor cortex, an immediate motor response is obtained and 
can be measured by motor evoked potentials. Depending on the frequency of stimulation, 
TMS has been reported either to excite or to inhibit cortical motor excitability. Low 
frequency rTMS (<1Hz) on the motor cortex has been shown to result in an inhibition of 
corticomotor excitability (Chen et al. 1997; Muellbacher et al. 2000; Muellbacher et al. 2002), 
whereas high frequency rTMS (>1Hz) has been associated with facilitation of corticomotor 
excitability. TMS-induced effects on cognitive functions can be quantified using indirect 
measures such as changes in behavioral performance during a cognitive task (e.g. response 
time or error rate). For example, Andoh et al. (2006, 2008)) applied rTMS over the left 
temporoparietal area (TMP) of Wernicke and showed a reduced RT during an auditory task 
of word detection compared with rTMS applied over the left inferior frontal gyrus (IFG, 
pars opercularis). The authors attributed their findings to the modulation of the semantic 
processing associated with the left TMP and not with the left IFG. TMS-induced effects can 
also be directly quantified using fMRI or positron emission tomography (PET) to detect the 
changes in cerebral blood flow or metabolism respectively. For instance, in a consecutive 
study, Andoh and Paus (2011) carried out an fMRI scan before and after a series of TMS 
stimulations applied off-line over the left TMP area (i.e. TMS applied outside of the scanner 
bore). The comparison of fMRI data pre- and post-rTMS showed a local decrease of the 
neural activity in the left TMP area, and an increased neural activity in the contralateral 
right TMP. The authors hypothesized a mechanism of interhemispheric compensation for 
preserving behavior after a neural interference (for review Andoh and Martinot 2008)). 
Similar change in activity in language-related network was found by Thiel et al. (2006) 
reporting a CBF decrease in the stimulated left IFG and a CBF increase in the homologous 
(contralateral) right IFG during a verb-generation task. In addition, Ilmoniemi et al. (1997) 
reported comparable results using EEG. The authors showed that stimulation over visual or 
motor cortex elicits EEG responses around the site of stimulation within a few milliseconds 
of TMS, followed by responses from a secondary area of activity in the homotopic region of 
the contralateral hemisphere. These studies show that rTMS effects are not focal and 
confined to the site of stimulation, but spreads via pre-existing neuronal connections in a 
network, therefore making TMS a useful tool to investigate functional connectivity and 
plasticity in the normal brain (Paus et al. 1997; Siebner and Rothwell 2003) as well as in 
clinical population (Hampson and Hoffman 2010). 
1.4 TMS as a clinical treatment 
TMS has been investigated as a treatment tool in many neurological and psychiatric 
diseases, including epilepsy, Parkinson’s disease, schizophrenia, or treatment-resistant 
depression. Because of its ability to modulate neural activity, rTMS has been used to excite 
or to inhibit certain brain functions reported to be “abnormal” in these patients. For 
instance, anatomic and functional dysfunctions in brain areas underlying speech generation 
and perception have been shown in schizophrenic patients prone to auditory hallucinations 
(Copolov et al. 2003; Shergill et al. 2000). Low frequency rTMS has been applied over the 
temporoparietal area of Wernicke; and this was shown to decrease its activity and to reduce 
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auditory hallucinations in those patients (Hoffman et al. 2003). Regarding patients with 
treatment-resistant depression, neuroimaging studies have shown a reduced metabolism in 
the dorsolateral prefrontal cortex (DLPFC) in comparison with normal volunteers (George et 
al. 1995). In order to increase the DLPFC activity, TMS has been applied at high frequency 
(i.e. 10Hz) and results have shown an improvement in some patients. However, results vary 
among patients and across studies (Hoffman et al. 2003; O'Reardon et al. 2007, 2010). 
Different factors can account for this variability, such as the parameters of stimulation 
(frequency, intensity, duration), as well as differences between patients in anatomical and 
functional localization of areas stimulated.  
1.5 Importance of TMS coil placement 
The placement of the TMS coil above the proper site of the cortex is critical and several 
methods have been developed to control the positioning of the TMS coil. For example, some 
clinical studies have targeted the dorsolateral prefrontal cortex (DLPFC), Brodman’s area (BA) 
9 and 46, by positioning the coil 5 cm rostrally in the parasagittal plane from the motor cortex 
(Herwig et al. 2001; Pascual-Leone, Catala, and Pascual-Leone Pascual 1996), see Figure 4A. 
However, the DLPFC location using the “5-cm method” was found to correspond to 
Brodman’s area (BA) 6 (premotor cortex) or BA 8 (frontal eye field) in 15/22 participants and 
only 7/22 were correctly targeted for the stimulation of the DLPFC. As this was the method 
used to locate the left DLPFC in most studies, the high degree of variability in the stimulated 
target must surely affect clinical results (Herwig et al. 2001). Nauczyciel et al. (2010) evaluated 
the different sources of variability of this standard “5-cm method” and showed that 
interindividual anatomical variability and interexpert variability were the two main sources of 
error. In addition, Rusjan et al. (2010) developed a neuronavigational method based on a 
standard template and compared the location of the DLPFC with the “5-cm method” and the 
10-20 EEG electrode system and found that the neuronavigational method and the 10-20 EEG 
electrode are superior to the “5-cm method” in reducing inter-subject variability. 
 
 
Fig. 4. Examples of methods used to localize the target for TMS. A. The DLPFC was targeted 
by moving the coil 5 cm forward from the motor cortex. B. Localization of the 
temporoparietal area of Wernicke using the 10-20 EEG system. C. Frameless stereotaxic 
system uses data from Magnetic Resonance Imaging to provide online monitoring of the 
TMS coil position on the participant’s head (Rogue Research Inc.). 
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Other studies used cranial coordinates in the international 10-20 electrode system (i.e. CP5) 
to localize Wernicke’s area (Sparing et al. 2001), see Figure 4B. However, this standardized 
system does not take into account interindividual anatomo-functional variability of 
language organization, which depends on the side and degree of language lateralization 
(Knecht et al. 2000). To reduce the influence of such anatomo-functional variabilities 
between patients, frameless stereotaxic systems, used in conjunction with functional 
neuroimaging have been developed to target individual areas according to well-defined 
anatomo-functional landmarks (Figure 4C). These frameless stereotaxic systems offer a 
relatively high accuracy of coil positioning over targeted areas (of about 10mm) (Gugino et 
al. 2001; Lancaster et al. 2004). However, such systems are expensive, heavy and difficult to 
use in a clinical setting. A recent study compared the accuracy of neuronavigations systems 
and the 10-20 electrode system while targeting the right intraparietal sulcus (electrode P4) 
and found that 9 and 47 participants, respectively were sufficient to obtain significant 
behavioral results.  
2. Triangulation-based MRI-guided method 
More recently, some new methods have been developed to reliably and inexpensively 
position the TMS coil manually over the participant’s head. Those MRI-guided methods are 
based on MRI data in order to take into account individual specificity in head size and 
shape, as well as in anatomical and functional differences between participants. We will 
describe a triangulation-based MRI-guided method that we have developed and validated 
(Andoh et al. 2009). We have evaluated its accuracy with the target of the motor cortex 
because its stimulation produces a measurable muscle twitch quantifiable with motor 
evoked potentials (MEPs). We also evaluated the reproducibility of the target positioning 
across operators while targeting the motor cortex and a target in the parietal cortex localized 
using fMRI during a mental rotation task. This method was recently used in a PET study 
investigating the influence of prefrontal target region on the efficacy of repetitive TMS in 
depressive patients resistant to treatment. The authors used a TMS target based on 
prefrontal hypometabolic regions defined for each patient using individual PET images 
(Paillere Martinot et al. 2010). In addition, this method was also used in an fMRI study 
investigating the TMS modulation of temporal areas during language processing (Andoh et 
al. 2006) or investigating the role of the frequency of TMS stimulation applied over 
temporoparietal areas (Andoh et al. 2008). 
2.1 Description of the MRI-guided method 
The MRI-guided method is included in Brainvisa software, freely available online 
(http://brainvisa.info/) that contains many image processing tools (segmentation of  
T1-weighted MR images, grey/white classification, meshes of hemisphere surface, etc.). 
Some of these tools were used in this paper to provide realistic and accurate 3D 
representations of the head surface and the brain, which enables easy definition of anatomic 
and functional landmarks in each subject (Riviere et al. 2002). In the following section, we 
will describe the procedure of the MRI-guided method, and then we will present the MRI 
protocol, which provides anatomical and functional MR images acquired during a simple 
motor task in order to individually define the target of the motor cortex onto the subject’s 
head surface. A manual describing the step-by-step procedure is also provided at 
ftp://ftp.cea.fr/pub/dsv/anatomist/documents/TMS/Andoh_TMS-positioning.pdf. 
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2.2 Basis of the triangulation-based MRI-guided method 
The approach of the MRI-guided method is based on the triangulation (or “trilateration”), 
consisting in determining the relative position of a target (T) using the known locations of 
two or more reference points (A, B, C) and the distance between the target and each 
reference point di (i=A, B, C). When measurement error is introduced, if we know that the 
distance from the target T to a reference point i (=A, B or C) lies within a range of distance 
[di + dr], then the third point lies in a circular band between the circles of those two radii. If 
we know a range for another point, we can take the intersection, which will be either one or 
two areas bounded by circular arcs (Figure 5). A third point will narrow it down to a smaller 
area, which therefore limits the variability of the target positioning (Snyman 2005). 
 
 
Fig. 5. Determination of the relative position of a target (T) using the known locations of 
three reference points (A, B, C) and the distance between the target and each reference point 
(dA, dB, dC).  
2.3 Procedure of the MRI-guided method  
Some preprocessing steps need to be carried out on the MR anatomical images before using 
the MRI-guided procedure. First, a “bias analysis” is carried out to correct the standard 
inhomogeneities in MR images using a bias estimation for each subject 
(http://www.brainvisa.info/doc/brainvisa/en/processes/VipBiasCorrection.html). 
Second, the “histogram analysis” leads to estimations of the gray and white matter mean and 
standard deviations. It relies on a scale-space analysis of the histogram, which is robust to 
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modifications of the MR sequence (Mangin, Coulon, and Frouin 2005). Third, the “brain 
segmentation” uses the parameters given by the previous step to segment the brain (Mangin 
et al. 2004). The segmentation of the head surface was carried out and MR images were 
thresholded from the intensity histogram. Then, a morphologic closing was applied to fill 
up cavities and holes on the head reconstruction and the resulting mesh object was 
smoothed using a marching-cube algorithm (Figure 6. A, B).  
 
 
Fig. 6. Segmentation of the brain and head providing 3D reconstruction of A/ the brain and 
B/ head surfaces.  
Once those steps have been processed, the MRI-guided procedure can be carried out 
following three steps:  
1. The first step “target projection” consists in the projection of a cortical target (e.g. 
maximum peak of cortical activation) onto a 3D head mesh (see Figure 7). This step is 
particularly crucial as inaccuracy in head surface reconstruction may induce local 
geometric artefacts, and the target projection onto the head surface may be confounded. 
To obtain a robust projection of the cortical target onto the head surface, we used the 
centre of gravity of the (N=10) closest head mesh nodes (Andoh et al. 2006).  
 
 
Fig. 7. 3D visualization of a functional target on A/ a brain mesh, B/ a brain mesh with the 
transparent head surface, and C/ projection of the functional target onto a 3D head surface. 
2. The next step consists in computing the geodesic distances (i.e. tangent to the head 
surface) between the projected target on the head mesh surface and some landmarks on 
B.
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the subject’s head (nose bridge, tragus of both ears, Figure 8). This was done using an 
algorithm available in Brainvisa software (see manual for more information, 
ftp://ftp.cea.fr/pub/dsv/anatomist/documents/TMS/Andoh_TMS-positioning.pdf). 
Three geodesic distances (in mm) were obtained from the target to the nasion, and from 
the target to the left and right tragi of both ears providing three distances for the 
triangulation. 
 
 
Fig. 8. Positioning of the three head landmarks on the 3D head reconstruction relative to the 
target location (nose bridge, tragi of both ears).   
3. The final step consists in using these three geodesic distances to localize the cortical 
target onto the participant’s head. The point of intersection of the three distances 
provides the target in order to position the TMS coil; and this position was marked 
physically on the cap of each participant (Figure 9). The triangulation was done 
manually, by the same investigator (JA) for all subjects, using three tied threads of 
lengths equal to the three geodesic distances. 
2.4 Accuracy of the method 
To assess the accuracy of the method, we used the cortical target of the hand motor area as 
its stimulation with TMS provides quantitative responses with motor-evoked potentials 
(Boroojerdi et al. 1999).  The cortical target of the hand motor area was defined by the peak 
of task-related activity while participants were pressing left and right buttons inside an MR 
scanner. The difference between right and left thumb motor responses provided the location 
of the left motor cortical area (Figure 10). 
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Fig. 9. Illustration of the three steps composing the MRI-guided method. 1/ projection of the 
cortical target of the motor cortex on a 3D head rendering. 2/ Measure of the geodesic 
distances (tangent to head surface) between the target and some landmarks on the subject’s 
head (e.g. nose bridge and tragus of both ears). 3/ Positioning of the geodesic distances on 
the participant’s head using three tied threads corresponding to the three distances. The 
intersection of the three tied threads provided the target location for TMS coil positioning. 
 
 
Fig. 10. Definition of the cortical target of the left motor cortical area. The target was defined 
by the peak of activation resulting from the contrast between right and left thumb motor 
responses (FWE-corrected; cluster size threshold p<0.001). 
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The accuracy of the method was determined by comparing the coil position over the right 
thumb motor target obtained from the MRI-guided method (fMRI-target) and the coil 
position subsequently obtained, where reproducible thumb motor-evoked potentials (MEPs) 
were elicited from TMS (MEP-target). The 3D coordinates of the two positions (fMRI-target 
and MEP-target) were obtained with an optical tracking system included in Brainsight™ 
Frameless. For each participant, the location of the fMRI- and MEP-targets was determined 
using individual coordinates in native space. Those coordinates were then transformed in 
standard space for group comparisons. 
2.5 Measures of motor-evoked potentials in motor cortex with TMS 
The MEP target (the target position that elicits MEPs in response to magnetic stimulation) 
was defined by the motor threshold criteria (MT), namely the lowest intensity of stimulation 
for evoking at least five MEPs in a total of ten stimulations with amplitude superior to 50 
V. A surface electromyogram EMG (Keypoint Portable, Medtronic) was used to record 
MEP amplitude from the relaxed right abductor pollicis brevis (Pascual-Leone et al. 1993; 
Rossini et al. 1995; Rothwell et al. 1999), see Figure 11. Magnetic stimulation was applied 
with a MagPro Stimulator (http://www.medtronic.com). Stimulus intensity started at 50% 
of the stimulator output and was increased in steps of 1% stimulator output. 
 
 
Fig. 11. Recording of motor evoked potentials (MEPs) in response to TMS using an 
electromyogram (EMG). The MEP target was defined by the lowest intensity of stimulation 
that induces at least five MEP with an amplitude > 50V in a total of ten stimulations. 
 
Neuroimaging – Methods 
 
174 
We compared the coil position over the right thumb motor target obtained from the MRI-
guided method (fMRI-target) with the coil position obtained subsequently, eliciting 
reproducible MEPs with stimulation (MEP-target), see Figure 12. For each subject, the 
coordinates of the coil positions over the fMRI-target (xfMRI, yfMRI, zfMRI) and the MEP-target 
(xMEP, yMEP, zMEP) were recorded using an optical tracking system and compared using the 
mean Euclidean distance (D): 
 D= [(xfMRI – xMEP)2 + (yfMRI- yMEP)2 + (zfMRI- zMEP) 2]1/2 = [Dx2 + Dy2 + Dz2]1/2. 
 
 
 
 
 
 
Fig. 12. Locations of A/ the fMRI-target (xfMRI, yfMRI, zfMRI) and B/ the MEP-target 
(xMEP, yMEP, zMEP) on a 3D head surface. The coordinates of both locations were 
recorded using an optical tracking system and compared using the mean Euclidean 
distance. 
2.6 Reproducibility 
The reproducibility of the target positioning was evaluated between operators by localizing 
the target of the motor cortex (see section above) and another target, located more 
posteriorly in the right parietal cortex. This target was functionally defined using a mental 
rotation task similar to the one used by Cooper and Shepard (1973). The mental rotation task 
consisted in displaying visually presented asymmetrical alphabetic characters (L, G, a), 
which had to be judged either normal or mirror image after rotation at different angular 
orientations. A “resting” condition was added in which subjects were asked to maintain 
their gaze on a small centrally located crosshair. The contrast between the task-related 
activity during the mental rotation task, and the resting condition enabled us to find the 
location of the right parietal cortex in each participant (Figure 13). Two operators used the 
MRI-guided method blindly and independently to position consecutively the targets of the 
motor cortex and the right parietal area over the cap of each subject’s head. The difference 
between the locations determined by the two operators was measured by the mean 
Euclidean distance (see section above). 
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Fig. 13. Definition of a target in the right parietal cortex localized using fMRI during a 
mental rotation task. A/ location of the task-related activity on a 2D transverse view, and B/ 
projection of the target onto a 3D head reconstruction. 
3. Results 
3.1 Accuracy 
The mean Euclidean distance (mean ± SD) between the fMRI and the MEP targets was 
measured for ten participants in their individual spaces and was then transformed in the 
standard space (MNI, Montreal Neurological Institute) for group analysis (Table 1). The 
cortical target derived from fMRI during the motor task allowed for determination of the 
motor threshold in two subjects with an MEP amplitude > 50 V in 6 out of 10 trials. The 
mean Euclidean distance (mean ± SD) between the fMRI and the MEP targets was Dm=10.1 ± 
2.9 mm, ranging from 5.2 to 14.0 mm. The components of this distance in the x, y, and z-axes 
were Dx= 4.0 ± 2.2 mm (range 0.6 - 7.7 mm), Dy= 5.0 ± 2.5 mm (range 1.3 – 8.0 mm) and Dz= 
7.1 ± 3.0 mm (range 2.8 - 11.1 mm).  
 
Subjects 
Euclidean distances  
(MNI space, mm) Dm (mm) Motor threshold (%SO) 
Dx Dy Dz 
S1 7.0 4.9 5.4 10.1 50 
S2 1.8 5.7 3.2 6.7 58 
S3 3.7 5.1 10.0 11.9 58 
S4 4.0 8.1 8.8 12.6 51 
S5 3.9 7.8 9.1 12.6 60 
S6 3.2 1.3 3.9 5.2 65 
S7 7.7 1.8 2.8 8.4 56 
S8 5.4 6.7 11.1 14.0 61 
S9 0.6 6.9 9.3 11.6 56 
S10 3.2 1.8 7.3 8.2 63 
Table 1. Euclidean distances between the fMRI target and the MEP target in the x axis (Dx), y 
axis (Dy), and z axis (Dz). Dm is the mean Euclidean distance for each participant averaged 
across x, y and z axes. The last column is the motor threshold expressed in percentage of 
stimulator output (%SO). 
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3.2 Reproducibility 
The results of the repositioning of the motor cortex target across two different operators 
showed a mean Euclidean distance of 6.7 ± 1.4 mm, ranging from 5.4 to 8.3 mm. In all 
subjects, the MRI-guided method allowed operators to induce a motor response. The results 
of the repositioning over the right parietal target across operators was determined on four 
subjects, and showed a mean Euclidean distance of 6.0 ± 3.2 mm, ranging from 1.4 to 8.7 
mm. 
4. Limitations 
Different sources of variability should be considered in the evaluation of this method. First the 
definition of the tragi of both ears and the nose bridge are anatomic structures on the order of 1 
cm diameter, and is therefore operator-dependent. Second, the coil positioning over the target 
cannot be controlled because once the coil is positioned, we cannot verify the location of the 
centre of coil. In addition, despite our results are interpreted as evidencing distance differences 
between the two methods (fMRI and MEP), it is also possible that results reflect the fact that 
the motor-related response obtained by fMRI and the motor evoked responses induced by 
TMS are not directly comparable (Lotze et al., 2003; Herwig et al., 2002). Indeed, TMS is 
activating all excitable circuits within the volume reached by the induced current, whereas 
fMRI measures increased oxygen supply in capillaries adjacent to neural firing. Since the 
responses probably do not involve the exact same tissue area, it is possible that they do not 
imply the same exact spatial representation in the primary motor cortex. Another limiting 
factor is the assumption that the induced electrical field is the strongest at the center of the 
figure of eight coil, however the depolarized neurons may not be directly beneath the center of 
the coil as has been indicated in other studies (Siebner et al., 2009; George et al., 2003), 
therefore introducing a variability in the concordance of the validation methods.  
More recently, similar methods have been developed, showing the crucial need for 
relatively cheap and straightforward image-guided systems that can be used in the absence 
of neuronavigation. For instance, Rusjan et al. (2010) developed a manual method based on 
a standard template to target the left dorsolateral prefrontal cortex in each participant. They 
reported that the ‘neuronavigational method’ for localizing the DLPFC provided less inter-
subject variability compared with the ‘5-cm method’ or the ‘10-20 method’. In addition, 
Weiduschat et al. (2009) developed a surface distance measurements (SDM) method and 
evaluated its accuracy by comparison with a neuronavigation system. They reported a mean 
Euclidean distance of 8.3 mm between their method and the neuronavigation system while 
targeting Broca’s area. However, similarly to our method, these methods do not provide an 
online guiding of TMS coil positions.  
5. Conclusions 
The MRI-guided method provides a relatively accurate and a low cost solution for TMS coil 
positioning. We found an accuracy of 10 ± 3 mm for positioning the target of the motor cortex, 
which is comparable to the accuracy of neuronavigation systems, for instance 10 ± 8 mm 
(Gugino et al. 2001), 10 ± 3 mm (Lancaster et al. 2004). This accuracy is also consistent with the 
focality of the TMS coil (e.g. 2 - 3 cm2, (Thielscher and Kammer 2004). In comparison to 
neuronavigation systems, the MRI-guided method is relatively inexpensive and does not 
require any additional setup, which makes it particularly useful for therapeutic protocols 
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conducted at more than one medical center. In addition, the present method is user-friendly 
and only needs Brainvisa, a software free available on-line. Moreover, a major advantage of 
this method is its ability to target cortical landmarks anywhere in the whole brain, whereas 
neuronavigation systems are limited by the field of view of the tracking cameras and cannot 
localize targets in the occipital cortex. We also showed that this method is reproducible across 
operators to localize a target in the parietal cortex, with a mean reproducibility of 7 ± 1 mm. 
However, a main limitation of our method is its inability to provide an online monitoring of 
TMS coil shifts and orientations, particularly useful for long period of stimulations.  
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1. Introduction  
One of the most striking characteristic of the brain is its profuse neuronal connectivity. Not 
surprisingly, the function of the nervous system critically depends on the spatiotemporal 
pattern of intercommunication between different regions of the brain. Both macro- and 
microscopic aspects of the wiring diagrams of brain circuits are relevant and need to be 
understood in order to cope with the complexity of the brain function. In this way, for 
instance, the long-range connections that carry the functional specification of cortical 
territories need to be studied together with the detailed microcircuits inside a cortical 
column. Moreover, the temporal dimension of these wiring diagrams must be investigated 
since neuronal networks are dynamic structures exhibiting context-dependent changes in 
synaptic weights (Canals et al., 2009) and numbers (Chklovskii et al., 2004). Investigations 
over the last decades strongly suggest that stimulus or task related neural activity is 
distributed over large parts of the brain, covering different cortical and sub-cortical areas. 
For a detailed understanding of brain function, it is of prime importance to understand the 
organization of the neuronal connections. To chart the anatomical connections between the 
various components of brain networks, the neuronal tract tracing technique has been proved 
to be very useful. Thus, experimental tools that allow the exploration of brain circuits at 
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diverse organizational levels are mandatory for the understanding of brain 
intercommunication and information processing. 
Magnetic Resonance Imaging (MRI) has great potential for mapping brain connectivity 
(Koretsky and Silva, 2004). It is a noninvasive volume imaging technique that can be applied 
longitudinally to the same subject, capturing the temporal dimension of brain connections 
and providing complete descriptions of large-scale three-dimensional (3-D) neuronal 
networks. The main limitation of MRI is its low sensitivity. To compensate for weak signals 
in MRI, efforts have been focused on the development of MR contrast agents. Recently, the 
paramagnetic ion manganese (Mn2+) has been introduced as a MR-contrast agent for 
investigating in vivo neuronal connectivity (Canals et al., 2008; Pautler et al., 1998). 
Following the general mechanism of other classical anterograde tracers, Mn2+ is taken up by 
neurons and transported to the distant synaptic terminals where it accumulates and reveals 
the projection fields (Canals et al., 2008; Leergaard et al., 2003; Murayama et al., 2006; 
Pautler et al., 1998; Saleem et al., 2002; Sloot and Gramsbergen, 1994; Tjalve et al., 1995; Van 
der Linden et al., 2002; Watanabe et al., 2004), thus delineating brain connectivity. In 
contrast to classical tracers, which require processed fixed tissue for data analysis, neuronal 
tracing with Mn2+ as an MR tracer is performed in vivo. 
However, cellular toxicity is an important drawback that challenges the applicability of 
Mn2+-enhanced MRI (MEMRI). It has been shown that Mn2+ can be cytotoxic at 
concentrations used for neural tracing (Canals et al., 2008; Chandra et al., 1981; McMillan, 
1999; Pal et al., 1999). Additional disadvantages of this technique are its high diffusion at the 
injection site, which challenge the specificity of the resulting projections, and its 
incompatibility with other visualization systems (Canals et al., 2008). If Mn2+ toxicity is not 
counteracted, it generates such perturbations in the neuronal circuits under study that 
eliminate the advantage of using Mn2+ as an in vivo neuronal tracer. In addition, at the end 
of an in vivo connectivity experiment using a paramagnetic tracer, it could be very 
informative to analyze the laminar and subcellular distribution of the neuronal connections. 
Such an experiment cannot be performed by using current MEMRI methods. New non-toxic 
paramagnetic tracers with anterograde, but also retrograde capabilities (i.e. when the tracer 
moves from the terminal ends to the soma identifying the origin of a synaptic contact) are 
desirable, particularly for functional studies, for quantitative 3-D analysis of connectivity, or 
for repetitive applications investigating the same pathway dynamically over time. 
Here we report a strategy to produce neuronal tract tracers with paramagnetic properties, 
biochemical stability and biocompatibility. The new tracers are imbued with double 
functionality in a single molecule that allows both in vivo longitudinal brain connectivity 
studies by means of MRI and postmortem subcellular investigation in the same 
experimental animal. Therefore, the macro- and microscopic aspects of a brain circuit can be 
simultaneously investigated.  
As a proof of concept we focused on the well-known neuroanatomical tracer biocytin which 
is taken up by neurons and transported in both antero- and retrograde directions (King et 
al., 1989). Several characteristics make biocytin a good tracer model. It has been used in 
numerous tracing studies, both after intracellular or extracellular application, and much is 
known about its biophysical properties (Horikawa and Armstrong, 1988). Due to its high 
affinity to avidin, it can be visualized by using a host of avidin conjugated markers at the 
light- and electron microscopic level. Extracellular application of biocytin results in very 
well localized injection sites with no uptake by fibers of passage or glial cells. These two last 
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characteristics result in a high specificity of biocytin tracings (Kita and Armstrong, 1991; 
Lapper and Bolam, 1991; Wirsig-Wiechmann, 1994). 
Structurally, biocytin consists of D-Biotin and L-lysine connected via an amide bond which 
is susceptible to cleavage by biotinidase enzyme. Biotinidase is the enzyme mainly 
responsible for recycling of the vitamin biotin by cleaving biocytin and biotinylated 
peptides/proteins (Hymes and Wolf, 1996; Mock et al., 1999; Wilbur et al., 1996). Biotinidase 
plays an important role in brain function (Pispa, 1965; Suchy et al., 1985). A deficiency in the 
biotinidase enzyme has been linked to several neurological disorders (Heller et al., 2002; 
Tsao and Kien, 2002; Zaffanello et al., 2003). For this reason, biocytin has relatively small 
half life in vivo, which forces short post injection survival times and increases the probability 
of only partial reconstruction of neuronal projections. Using the same strategy, we recently 
introduced two new biocytin-based neuroanatomical tracers [aminopropyl-biocytin and serine-
biocytin; Scheme 1] with improved enzymatic stability (Mishra et al., 2009). The in vivo 
results for these two derivatives of biocytin demonstrated that they are biochemically stable 
conjugates, retain full tracing capabilities and more importantly these molecules allow 
longer post-injection survival times due to the improved stability and therefore, provide 
more detailed and complete connectivity information. The commercial biocytin was totally 
degraded 96 h postinjection, however, these improved neuronal tracers still stained 
neuronal cell bodies and fibers at the injection site and remote terminal fields. These 
improved neuronal tracers present an edge over conventional histological procedures, as 
their better stability could reduce the problems related to the endogenous degradation of the 
tracer molecule before the animal is sacrificed. As was suggested in the previous work 
(Mishra et al., 2009), the applicability of these new agents could be further diversified by 
coupling with different reporter moieties and utilized for multimodal tracing. For instance, 
the combination of reported molecules with MR reporters could serve as a tool for magnetic 
resonance imaging and, hence, be used for visualizing brain connectivity in vivo. 
Here in, we have followed up our previous investigations and developed two novel and 
structurally distinct gadolinium (Gd3+) containing biocytin-based multimodal neuronal 
tracers ([Gd.L1] and [Gd.L2]) (Scheme 1). The backbone of these structures were 
functionalized by covalently linking the kinetically stable gadolinium caged organic 
macrocyclic moiety [DOTA and DO3A-serine] as MR reporters to perform in vivo 
longitudinal brain connectivity studies by means of MRI, leaving α-position of lysine moiety 
free for internalization in neurons and biotin moiety free for avidin binding for subsequent 
visualization with postmortem microscopic histological methods.  
The first MR tracer [Gd.L1] was derived from the recently published stable biocytin variant 
aminopropyl-biocytin (Mishra et al., 2009), whereby [Gd.DOTA] was coupled to aminopropyl-
biocytin via an amide bond. The second MR tracer, [Gd.L2] consists of a new precursor 
[Gd.DO3A-serine] which has an orthogonal amine and a carboxylate group on the fourth 
nitrogen of [Gd.DO3A] for the coupling of biotin and lysine, respectively. By replacing 
[Gd.DOTA] with FITC in [Gd.L1] fluorescently labeled aminopropyl-biocytin [Fluo.L1] was 
obtained for fluorescence microscopy studies.  
We present data that demonstrate the validity of the approach by showing cortical 
connectivity in vivo applying T1-weighted MR-imaging. In addition, the corresponding 
subcellular details, fibers and neuronal morphology under light microscopy were 
investigated in the same experimental animals by means of avidin-biotin interactions and 
conventional histological techniques.  
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Scheme 1. Structures of studied biocytin-derived neuroanatomical tracers. 
2. Results and discussion  
2.1 Synthesis of ligands and complexes 
Two structurally different Gd3+ complexing neuroanatomical tracers ([Gd.L1] and [Gd.L2]; 
Scheme 1) were designed and synthesized. These conjugates enclosed the [Gd.DO3A] 
construct as an MR reporter and biotin to be used for microscopic visualization by means of 
histological techniques.  
The first MR tracer [Gd.L1] was derived from stable biocytin variant, propylamine-biocytin 
(Mishra et al., 2009), where [Gd.DOTA] was coupled to aminopropyl-biocytin via amide 
bond. [Gd.L1] was synthesised in seven steps prior to complexation with Gd3+ (Scheme 2). 
Propylamine-biocytin 6 was synthesized in three steps, starting with the reaction of 
acrylonitrile on αN-carbobenzyloxy-L-lysine methyl ester giving cyano compound 4. 
Propinonitrile derivative 5 was obtained after coupling acid D-biotin with the secondary 
amine of 4 by using PyBroP as a coupling reagent and diisopropylethylamine as the base in 
anhydrous CH2Cl2. Subsequent selective reduction of nitrile groups in the presence of Ra-
Ni, H2, 7M NH3/MeOH yielded amine intermediate 6. The macrocycle intermediate 3 (tris-
tert-butyl-DOTA) was obtained in two steps by stepwise alkylation of tris-tert-butyl-DO3A, 
1, with benzylbromoacetate in acetonitrile generating 2, and following deprotection of 
benzyl groups produced the corresponding acid 3 in high yield (Pope et al., 2003). Then, 
tetra-ester 7 was synthesized by coupling of amine 6 and acid 3 [EDC/HOBt/NMM] in 
anhydrous DMF, from which L1 was obtained by successive deprotections (benzylcarbamate 
removal by hydrogenation using Pd-C as the catalyst, methyl group with LiOH and tert-
butyl groups with neat TFA). 
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Scheme 2. Reagents and conditions: (i) benzylbromoacetate, MeCN, K2CO3, 100ºC; (ii)  Pd-C 
(10%), H2, MeOH, 50 psi; (iii) acrylonitrile, TEA, MeOH; (iv) Biotin, PyBroP/DIPEA/CH2Cl2; 
(v) Ra-Ni, H2, 7 M NH3/MeOH, 50 psi; (vi) NMM/EDC/HOBt/DMF; (vii) LiOH, 
THF:MeOH:water (3:2:2); (viii) TFA (neat). 
The second MR tracer, [Gd.L2] consists [Gd.DO3A-serine] which has an orthogonal amine 
and a carboxylate group available on the fourth nitrogen of [Gd.DO3A] for the coupling of 
biotin and lysine, respectively. [Gd.L2] was synthesized in 9 steps prior to complexation 
with Gd3+ (Scheme 3). Bromination on the hydroxyl group of N-carbobenzyloxy-L-serine 
methyl ester yielded 8. The bromination reaction was run for no more than 30 min. This 
avoided the formation of allyl analogues of the product by elimination of bromine. The most 
reasonable route to synthesize ligand 10 was by alkylation of 8 on 1 but the elimination of 
the bromine group under highly basic conditions resulted in starting compound together 
with allyl side product. An alternative route was taken to obtain 10 where monoalkylated 
intermediate 9 was generated by alkylation of excess cyclen with 8 in anhydrous toluene, 
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which was further alkylated by tert-butylbromoacetate yielding 10. Mono-acid 11 was 
obtained by mild hydrolysis of the methyl ester in the presence of LiOH, which was further 
coupled to amine of Boc-Lys-OMe [EDC/HOBt/NMM] in anhydrous DMF to produce 12. 
The benzylcarbamate was hydrogenated over Pd/C to yield the secondary amine 13 which 
was coupled to acid D-biotin [EDC/HOBt/NMM] in anhydrous DMF to give tetra-ester 14. 
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Scheme 3. Reagents and conditions: (i) NBS/PPh3/DMF; (ii) cyclen/toluene; (iii) tert-butyl 
bromoacetate/Na2CO3/MeCN; (iv) LiOH, THF:MeOH:H2O (3:2:2); (v) Boc-Lys-OMe, 
NMM/HOBt/EDC/DMF; (vi) Pd-C (10%), H2, MeOH, 50 psi; (vii) biotin, 
HATU/DIPEA/DMF; (viii) TFA (neat). 
Carboxylic acid derivative L2 was obtained by successive deprotections (first the methyl 
group with LiOH and then tert-butyl groups with neat TFA). 
Ligands, L1 and L2, were purified by RP-HPLC and loaded with Gd3+ using GdCl3.6H2O in 
water at pH 6.5. The final concentration of Gd3+ was determined by inductively-coupled 
plasma optical emission spectrophotometry (ICP-OES). 
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2.2 Proton relaxivity modulation of [Gd.L1] and [Gd.L2] by biotin-avidin interaction 
The extensive applications of biotin-avidin interactions have been found attractive in 
biomolecule detection, medical diagnostics, immunoassays and nanoscience (Bickel et al., 
2001; Cao et al., 2003; Caswell et al., 2003; Rivera et al., 2003; Weizmann et al., 2003). Due to 
the high affinity of biotin to tetrameric avidin, biotinylated compounds can be visualized by 
light microscopy in postmortem tissues using avidin-conjugated markers. To investigate 
and quantify the binding behavior of the two contrast agents (CAs) to avidin which is 
important for the histological detection, we performed MRI experiments at 7T (300 MHz) 
[phosphate buffered saline (PBS), 7.4 pH, 23°C] with increasing concentrations of avidin 
proportional to constant concentrations of CAs (0.25 mM) and measured the proton 
longitudinal relaxivities (r1p).  
The proton longitudinal relaxivities (r1p) of [Gd.L1] and [Gd.L2] at 7T (300 MHz) [phosphate 
buffered saline (PBS), 7.4 pH, 23°C] were found to be 5.52±0.08 mM–1 s–1 and 7.27±0.13 mM–1 
s–1, respectively. As anticipated, [Gd.L1] shows similar relaxivity to [Gd.DOTA] complexes. 
However [Gd.L2] shows higher relaxivity than that reported in the literature for Gd-DO3A 
derivatives in such a physiological solution (Caravan et al., 1999). The observed higher 
relaxivity in solution is explained by the high molecular volume and a significant second-
sphere contribution through amide moieties close to the paramagnetic proximity present in 
the molecule (Aime et al., 1996; Botta, 2000).  
 
Complexes r1p (mM
-1s-1) Change (%) [Gd.Ln] [Gd.Ln]:avidin 
[Gd.L1] 5.52±0.08 6.10±0.11 +11 
[Gd.L2] 7.27±0.13 6.65±0.09 -9 
Table 1. Relaxivity (r1p, mM-1s-1) for [Gd.L1]/[Gd.L2] and [Gd.L1]/[Gd.L2]:avidin complexes 
(23°C, 7T (300 MHz), pH 7.4, PBS, 0.25 mM complex). 
Inevitable, r1p of [Gd.L1] was slightly increased (11%) in contrast to [Gd-L2] (9% decreased) 
upon binding to avidin (Table 1). This is in reference to the Solomon–Bloembergen–Morgan 
theory envisaging that at high magnetic fields, the longitudinal proton relaxivity changes with 
the opposite of molecular rotational correlation time (τR) suggesting that relaxivity change 
should be expected upon binding of the CAs to macromolecules (Livramento et al., 2006). The 
saturation in r1p at a ratio approximately at 2:1 (assuming a 2:1 stoichiometry of interaction) for 
the [Gd-L1]/[Gd-L2]:avidin adduct was obtained which clearly indicating similar steric 
hindrance of both CAs. These results suggest that [Gd.L1] and [Gd.L2] block the adjacent 
binding sites of biotin but evidently fit into two opposite binding pockets of avidin. The 
complexes {[Gd.L1]/[Gd.L2]:avidin} (2:1) binding stoichiometry reveal that [Gd.L1] and 
[Gd.L2] could be visualized by binding with avidin via histological techniques. However, an 
improved visualisation is expected if binding occurred to all pockets of avidin in a 4:1 ratio.  
2.3 In vitro cell culture studies  
It is well known from the literature that biocytin is a low molecular weight compound 
which has excellent uptake and transport capability in neuronal cells. Biocytin could be used 
as antero- as well as retrograde neuronal tract-tracer after intra- and extracellular injection in 
the brain (Kobbert et al., 2000). However, the uptake mechanism of biocytin at higher 
concentrations is not well known. A rapid and sodium/potassium-dependent high affinity 
uptake of biocytin in NB2a neuroblastoma cells was reported by Baur et al. This uptake was 
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very specific and selective to NB2a neuroblastoma cells as compared to C6 astrocytoma cells 
(Baur et al., 2002). Saturation kinetic of biocytin in a low concentration range was reported. 
However, the biocytin concentration in the brain is well below the reported concentration at 
half maximal saturation (Km) of the biocytin uptake under physiological conditions (Baur et 
al., 2002). In contrast, after pressure or iontophoretic injection, local concentrations exceed 
the physiological concentration of biocytin manifold. Thus, the uptake mechanism under 
such conditions is not yet established.  
The Gd-chelated macrocyclic modified biocytin molecules, [Gd.L1] and [Gd.L2], are high 
molecular weight compounds as compared to biocytin alone. We investigated the cellular 
internalization of these compounds and their ability to enhance the MR contrast in vitro. For 
these studies murine N18 neuroblastoma cells were used as cellular model. In order to 
induce more neuronal metabolic and morphologic features in these tumor cells, serum 
deprivation was used to differentiate the cells (Marchisio et al., 1979). During the slow 
stepwise reduction of FBS content in the culture medium to 0.625% the growth rate slowed 
down and cells started to show a neuronal morphology with a network of neurite-like 
cellular processes which were completely absent at 10% FBS. Similar in vitro studies were 
also performed with the FITC containing aminopropyl-biocytin [Fluo.L1]. All cell incubations 
were performed in HBSS/10 mM HEPES buffer for 6 hours. 
2.3.1 In vitro studies of cellular toxicity on N18 murine neuroblastoma cells  
We first tested whether the contrast agents would have an adverse effect on differentiated 
N18 cells. For this purpose cells were incubated with [Gd.L1] or [Gd.L2] for 6 h in HBSS/10 
mM HEPES and the number of cells were determined by fluorescence spectroscopy using 
the DNA dye Bisbenzimid Hoechst 33342. Only [Gd.L2] showed a significant cytotoxic effect 
at 50 µM (Figure 1). Thus, all further experiments were done at concentrations below this 
level (40 and 20 µM for [Gd.L1] and [Gd.L2]). 
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Fig. 1. Evaluation of the acute short term toxicity of [Gd.L1] and [Gd.L2]. Differentiated N18 
neuroblastoma cells were incubated with the indicated concentration of [Gd.L1] or [Gd.L2] 
in HBSS/10 mM HEPES for 6h. Afterwards DNA dye Bisbenzimide Hoechst 33342 was 
added for 30 min in complete cell culture medium to determine the number of cells by the 
fluorescence of the dye/DNA conjugate (Ex 355nm/Em 465 nm). Values represent 
mean±SEM (n=6-12). ***p< 0.001, statistically different compared to control  
(ANOVA, Dunnett´s multiple comparison test). 
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2.3.2 Fluorescence microscopy to detect internalization and subcellular distribution 
Since the intracellular distribution of [Gd.L1] and [Gd.L2] cannot be directly detected by 
MRI, the fluorophore containing analogue to [Gd.L1], [Fluo.L1] was used. Fluorescence 
microscopy of living cells displayed a detectable uptake of the compound into 
morphologically differentiated N18 cells. Figure 2 shows the cellular localization of [Fluo.L1] 
after incubation with 50 µM for 12 h and subsequent washing and quenching of remaining 
extracellular fluorescence by Trypan Blue. [Fluo.L1] (green fluorescence of the covalently 
linked FITC) was internalized very quickly and mainly accumulated in vesicles in the 
perinuclear region (nuclei counterstained in blue) of the cells. Green fluorescence of 
[Fluo.L1] could also be detected in the projections of the cells. These results indicate a 
predominantly endosomal uptake of [Fluo.L1] into morphologically differentiated 
neuroblastoma cells. The optical evidence that [Fluo.L1] was also detected along the 
processes of the cells set grounds for possible application of synthesized compounds as tract 
tracers. 
 
 
Fig. 2. Optical evidence for intracellular localization of [Fluo.L1] in N18 neuroblastoma cells. 
Cells were incubated with 50 µM of [Fluo.L1] for 6 h in HBSS/10 mM HEPES as described in 
materials and methods. Overlay of green (FITC in [Fluo-L1]) and blue fluorescence  
(DNA dye Hoechst 33342) (left) and in addition of the phase contrast image (right). 
2.3.3 MRI studies on N18 murine neuroblastoma cells 
After proving the cellular uptake, the ability of [Gd.L1] and [Gd.L2] to enhance contrast in 
MR images of labeled cells was tested. For this purpose differentiated N18 cells were 
incubated with either 20 or 40 µM of [Gd.L1] or [Gd.L2], respectively. After removal of the 
incubation medium of all samples the labeled cells were extensively washed with buffer. A 
constant number of treated cells were transferred into 0.5 mL Eppendorf tubes and cells 
were allowed to settle down. T1-weighted images were taken and the values of longitudinal 
(T1) relaxation times were measured in an axial slice of cell pellets and supernatant at 3T and 
room temperature. 
Figure 3 shows representative examples of T1-weighted images achieved after incubation 
with 20 or 40 µM of [Gd.L1] or 40 µM of [Gd.L2]. A significant contrast enhancement could 
be observed in the images for both compounds compared to control cells incubated in the 
absence of contrast agent. The determination of apparent cellular relaxation rate R1,cell 
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(=1/T1,cell) in the cell pellet confirmed these results (Figure 4). The significance levels here 
were lower since averages of independent experiments were taken. 
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Fig. 3. Examples of T1-weighted MR images of differentiated N18 neuroblastoma cells and 
analysis of the signal intensities in these images. Cells were incubated with 20 or 40 µM 
[Gd.L1] (A) or 40 µM of [Gd.L1] and [Gd.L2] (B) for 6 h in HBSS/10 mM HEPES. Cells were 
washed, trypsinized and resuspended in fresh culture medium (without CA) at a cell 
density of 1×107 cells/500 µL and transferred into 0.5 mL tubes. Cells were allowed to settle 
prior to MR experiments for imaging and determination of T1 values in an axial slice 
through the cell pellet. Parameters for MRI are given in the experimental part. The bar 
graphs resulted from the pixelwise evaluation of signal intensity in the corresponding 
images. Values represent mean±SD (n=37 (A) and 44 (B)); ***, p>0.001, significantly different 
to control, a, p<0.05 and c, p>0.001, significant difference between 20 µM, 40 µM and 
[Gd.L1], [Gd.L2], respectively (ANOVA, Tukey´s multiple comparison test). 
 
 
control [Gd.L1] [Gd.L2]
0
90
100
110
120
130
R
1,
ce
ll
 [%
 o
f c
on
tr
ol
] **
control 20 40
0
90
100
110
120
130
concentration [µM]
R
1,
ce
ll
 [%
 o
f c
on
tr
ol
]
*
A B
[Gd.L1] 40 µM
 
 
Fig. 4. Cellular relaxation rate R1,cell of differentiated N18 neuroblastoma cells. Values 
represent mean±SEM (n=2-5); **, p>0.01, *, p>0.05 significantly different to control 
(ANOVA, Dunnett´s multiple comparison test). 
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2.4 In vivo uptake and transport: MR and histology studies of [Gd.L1] and [Gd.L2] in 
rat brain 
In the final step, we investigated the tracing abilities of these newly synthesized imaging 
probes, [Gd.L1] and [Gd.L2], by means of MRI and classical histological methods in the same 
experimental animal. We performed a series of pressure and iontophoretic injections into 
the primary motor cortex (M1) of anaesthetized albino rats (Sprague Dawley) and evaluated 
the transport of these compounds at 24 and 48 h post-injection (see methods section for 
technical details). After the local injection of [Gd.L1] in the primary motor cortex of the rat, 
the target area was visualized in T1-weighted MRI as a large increase in signal (due to the 
decrease of the T1 relaxation time; Figure 5A). Statistical analysis comparing baseline images 
(acquired either before or immediately after the injection) with images acquired after 24 and 
48 h revealed a significant increase in T1-weighted signal intensity in various brain regions 
 
 
Fig. 5. In vivo neuronal tract tracing with [Gd.L1]. Neuronal connections of the primary 
motor cortex M1 of the rat were investigated. (A) Coronal T1-weighted images acquired 30 
min after the injection of [Gd.L1] in M1. Note the enhanced signal (asterisk) at the injection 
site. The inset shows a representative scheme of rat brain anatomy at the coordinates of the 
injection (Paxinos and Watson, 2007). (B) Shown are six coronal MR images illustrating the 
distribution of [Gd.L1] signal in the brain after an injection in M1. The presence of signal is 
shown as statistical maps (unpaired t test; p<0.01) comparing the baseline (pre-injection 
scans) and scans acquired 48 h later, superimposed on the anatomical images. The results 
demonstrate local increases in signal due to [Gd.L1] injection and long-range neuronal tract-
tracing after 48 h in the striatum (1-4) and thalamus (5-6). After the last MRI session, the 
animal was euthanized and the histology is shown in Figure 6.  
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far away from the injection site. For instance, statistically significant increases in signal 
intensity were detected in the thalamus and the homologous contralateral M1 cortex (Figure 
5B), areas that are well known to be connected with M1, suggesting that the tracer has 
actually been taken up by neurons in vivo and transported in the axons. This result 
corroborates the neuronal-tracing ability of [Gd.L1] and its suitability for in vivo studies of 
brain connectivity. The MRI results obtained with [Gd.L2], after injection into the M1 cortex, 
showed a comparable pattern of neural connections as in [Gd.L1] (data not shown).  
 
 
Fig. 6. Histological stain of the same brain as shown in Fig. 5, 48 h after an iontophoretic 
injection with [Gd.L1]. Neurons at the injection site (A) have been stained. (B) Slightly 
stained fibres in the striatum bundles. The sections were counterstained with methyl green, 
visualizing cell bodies in the background. Bars: 100 µm. 
Biocytin is a powerful tracer for visualizing connections with histological techniques. In a 
previous paper (Mishra et al., 2009) we have shown that both kinds of modified biocytin, 
aminopropyl and serine biocytin, are well suited for tracing and have, in addition, the 
advantage of being considerably more stable than the biocytin itself. We further investigated 
the post-mortem tissue sections of the same MR experimental animals. However, no stain 
could be seen in the case of [Gd.L2], and in case of [Gd.L1] the stain was restricted to places 
where the concentration is usually strongest, i.e. to the injection site and the striatum 
bundles (Figure 6). This could be explained by an impaired reaction with the avidin 
peroxidase-DAB (3,3′-Diaminobenzidine) cocktail, necessary for histological staining. This 
can be concluded from the fact that our in vitro uptake studies on N18 murine 
neuroblastoma cells clearly revealed that these probes were taken up well by neurons even 
at low concentrations. The lower modulation of proton longitudinal relaxivity upon avidin 
binding of [Gd.L1] and [Gd.L2] (assuming a 2:1 stoichiometry of interaction) suggested that 
the interaction with avidin was strongly impaired. To further rule out the lack of uptake 
and/or transport and support the MRI findings, similar behavior was obtained after in vivo 
injections of [Fluo.L1] into the primary motor cortex (M1) of anaesthetized albino rats and 
Biocytin-Based Contrast Agents for Molecular Imaging:  
An Approach to Developing New In Vivo Neuroanatomical Tracers for MRI 
 
193 
evaluation of the transport of this compound 24 h post-injection. We observed by 
fluorescence microscopy that [Fluo.L1] had been taken up by neurons (Figure 7), but we 
could not detect any stain in the same section using the staining technique depending on the 
biotin-avidin peroxidase-DAB (3,3'-Diaminobenzidine) cocktail.    
It is conceivable that the modifications introduced in the model modified biocytin 
(aminopropyl and serine biocytin) described above, together with the significant increase in 
molecular weight by about a factor of 2.5, sterically hinder the staining with avidin 
peroxidase-DAB cocktail in cells substantially, but retain the uptake and transport 
properties of the resulting contrast agent.  
 
 
Fig. 7. Injection site in the motor cortex of a rat, 24 h after injection with [Fluo.L1]. 
It can be seen that the neurons have taken up the tracer. Under transmission light, no stain 
could be seen, although the same section had undergone an avidin-biotin reaction. Bar 50 µm. 
3. Conclusion  
In summary, we present data on the functionalization of biocytin, a well known neuronal 
tract tracer, and demonstrate the validity of the approach by showing cortical connectivity 
in live rats with the help of MRI. Our study offers a new platform for the development of 
multimodal molecular imaging tools for brain connectivity studies in vivo. 
4. Materials and methods 
4.1 Chemicals 
All solvents and reagents were purchased at analytical grade from commercial suppliers 
(Acros, Aldrich, Fluka, Merck, Strem and VWR) and were used without further purification 
unless otherwise stated. All air- or water-sensitive chemicals were stored under an inert 
atmosphere. Ultra pure de-ionised water (18 MΩ cm-1) was used throughout.  
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4.2 Chromatography 
Flash column chromatography was performed using flash silica gel 60 (70-230 mesh) from 
Merck. Thin layer chromatography (TLC) was performed on aluminum sheet silica gel 
plates with 0.2 mm thick silica gel 60 F254 (E. Merck) using different mobile phases. The 
compounds were visualized by UV irradiation (254 nm) or iodine staining. Reverse phase 
HPLC was performed at room temperature on a Varian PrepStar Instrument, equipped 
with PrepStar SD-1 pump heads. UV absorbance was measured using a ProStar 335 
photodiode array detector at 214 nm. Analytical RP-HPLC was performed in a stainless 
steel Chromsep (length 250 mm, internal diameter 4.6 mm and particle size 8 µm) C18 
column and semi-preparative RP-HPLC was performed on a stainless steel Chromsep 
(length 250 mm, internal diameter 21.2 mm and particle size 5 µm) C18 column (Varian). 
The compounds were purified using one of the following two methods. Method A: 
gradient with the mobile phase starting from 95% solvent A (H2O) and 5% of solvent B 
(MeOH) to 70% B in 10 min, 90% B in 18 min, 90% B isocratic till 24 min and decreased to 
5% B in 28 min. Method B: 95% solvent A (H2O, 0.1% HCOOH) and 5% solvent B 
(acetonitrile, 0.1% HCOOH) to 70% solvent B in 10 min and then to 100% in the next 8 min 
running isocratic for 12 min and then back to 5% solvent B in the next 2 min. The flow rate 
generally used for analytical HPLC was 1 mL/min and for semi-preparative HPLC 15 
mL/min. All the HPLC-grade solvents for HPLC were filtered through a nylon-66 
Millipore filter (0.45 µm) prior to use. 
4.3 Spectroscopy 
1H NMR and 13C NMR spectra were recorded on Bruker DRX250 and DRX400 spectrometers 
at room temperature. The 1H NMR chemical shifts were adjusted to the residual protons of 
the solvent peaks which were referenced to TMS (0.0 ppm), and 13C NMR chemical shifts 
were referenced to CDCl3 (77.0 ppm).  
Electrospray ionization mass spectra (ESI-MS in positive and negative ion mode) were 
performed on an ion trap SL 1100 system (Agilent) and High Resolution (HR) mass spectra 
were measured on Bruker Daltonics Apex II FT-ICR-MS (Bruker).  
Inductively coupled plasma optical emission spectrometry (ICP-OES) for the evaluation of 
the Gd3+ concentration was performed using a Jobin–Yvon Ultima 2 spectrometer. 
4.4 In vitro MR tube measurements 
Longitudinal and transverse relaxation times (T1 and T2) of the [Gd.L1] and [Gd.L2] were 
examined using a vertical 7T (300 MHz)/60-cm diameter bore magnet (Bruker BioSpin). 
Four different concentrations (1 mM, 0.75 mM, 0.5 mM, 0.25 mM) of [Gd.L1] and [Gd.L2] 
were prepared in Phosphate-Buffered-Saline (PBS) in 1.5 mL Eppendorf tubes at 
physiological pH to measure relaxivity. Each tube was filled with 400 µl of the CA solution. 
The y-axis intercept of the linear regression plot of the relaxation rate obtained for these 
tubes with the corresponding concentration of CA gave the diamagnetic relaxation rate 
(1/Td).  
To measure the changes in r1 and r2 upon binding to avidin, MRI experiments were 
performed with increasing concentrations of avidin proportional to a constant concentration 
of [Gd.L1] and [Gd.L2] (0.25 mM) incubated for 1 h at 37°C. The stock solution of avidin (1 
mM) was prepared in PBS at pH 7.4. 
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Axial images were obtained for the set of tubes at 7T and the T1/T2 values were then 
calculated. 
Relaxivity at different concentrations of avidin was then calculated using equation [1]. 
 r1,obs = (1/T1,obs-1/T1,d) / [Gd.Ln]  (1) 
where T1,obs is the measured T1, T1,d is the diamagnetic contribution of the solvent (calculated 
to be 2400 - 2700 ms) and [GdLn] is the concentration in mmol/L of the appropriate Gd(III) 
complex (n = 1-2).  
4.5 Synthesis of ligands and tracers 
(S)-methyl 3,15-dioxo-10-(5-((3aR,4R,6aS)-2-oxo-hexahydro-1H-thieno[3,4-d]imidazol-4-
yl)pentanoyl)-1-phenyl-16-(4,7,10-tris(2-tert-butoxy-2-oxoethyl)-1,4,7,10-
tetraazacyclododecan-1-yl)-2-oxa-4,10,14-triazahexadecane-5-carboxylate (7). A solution of 
compound 6 (0.3 g, 0.52 mmol), NMM (0.12 mL, 1.0 mmol) and HOBt (0.11 g, 0.57 mmol) in 
anhydrous DMF (15 mL) was stirred at 0-5˚C for 15 min and then EDC (0.08 g, 0.57 mmol) 
was added. The reaction mixture was stirred overnight at room temperature. Completion of 
the reaction was verified by ESI-MS, the solution was poured into water (50 mL) and 
extracted with EtOAc (3 x 50 mL). The combined organic layers were dried over anhydrous 
Na2SO4, filtered and the filtrate evaporated under reduced pressure. The residue was 
purified by column chromatography (silica gel, 10% MeOH in CH2Cl2, Rf = 0.15) to give 7 as 
a yellow gum (0.28 g, 48%). 1H NMR (CDCl3, 250 MHz), δ (ppm): 1.10-1.30 (m, 2H); 1.42 (s, 
18H); 1.52 (s, 10H); 1.60-1.95 (m, 12H); 2.03 (br s, 2H); 2.34 (br s, 3H); 2.62-2.99 (m, 6H); 3.32-
3.94 (m, 20H); 3.76 (br s, 6H); 3.94-3.98 (m, 2H); 4.23-4.43 (m, 2H); 4.47-4.63 (m, 1H); 5.12 (s, 
2H); 5.48-5.77 (m, 1H); 7.29-7.43 (m, 5H). ESI-MS (+): calcd C56H93N9O13S: m/z 1133.5 
(M+H)+; found 1133.2 (M+H)+. 
[4,7-Bis-carboxymethyl-10-(2-(3-(N-((S)-5-amino-5-carboxypentyl)-5-((3aR,4R,6aS)-2-oxo-
hexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanamido)propylamino)-2-oxoethyl)-
1,4,7,10-tetraaza-cyclododec-1-yl]-acetic acid (L1). A solution of compound 7 (0.25 g, 0.22 
mmol), 10% Pd-C (0.07 g) and H2 (50 psi) in MeOH (20 mL) was stirred at room temperature 
in Parr-apparatus for 8 h. Completion of the reaction was verified by ESI-MS, the solution 
was filtered through a G-4 sintered funnel, and the filtrate was evaporated under reduced 
pressure. This crude product was further dissolved in TFA (20 mL) and stirred overnight at 
room temperature. TFA was evaporated under reduced pressure. A solution of crude 
product in THF:MeOH:water (3:2:2) (10 mL) was stirred at 0-5˚C for 15 min and then LiOH 
(0.11 g, 4.7 mmol) was added. The reaction mixture was stirred for 2 h at room temperature. 
Completion of the reaction was verified by ESI-MS, the solvent was evaporated under 
reduced pressure and the residue was purified by preparative HPLC (tR = 3.8 min). After 
lyophilization, L1 was obtained as a light yellow sticky solid (0.1 g, 56%). 1H NMR (D2O, 250 
MHz), δ (ppm): 1.20-2.16 (m, 16H); 2.47 (t, J=7.0 Hz, 2H); 2.70-3.90 (br. m, 32H); 4.40-4.53 (m, 
1H); 4.24-4.28 (m, 1H). 13C NMR (D2O, 62.9 MHz), δ (ppm): 24.9; 27.8; 28.2; 30.5; 30.9; 32.8; 
35.0; 39.7; 42.4; 46.2; 47.9; 48.4; 50.7; 50.9; 51.2; 53.2; 53.8; 57.1; 58.1; 58.6; 63.0; 64.8; 164.2; 
165.3; 167.2; 177.1; 178.0; 178.8. ESI-MS (+): calcd C35H61N9O11S: m/z 816.4 (M+H)+; found 
816.3 (M+H)+. 
Methyl 2-(benzyloxycarbonylamino)-3-bromopropanoate (8). N-carbobenzyloxy-L-serine 
methyl ester (2 g, 8 mmol) and PPh3 (4 g, 16 mmol) were added in 50 ml anhydrous DMF. 
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Finally N-bromosuccinimide (2.8 g, 16 mmol) was added in small aliquots to the reaction 
mixture. The mixture was stirred for 30 minutes at 50 °C. Heating bath was removed and 2 
ml of MeOH was added to quench the reaction. 100 ml of ether was added and the reaction 
mixture was extracted with 100 ml water. The organic layer was dried over anhydrous 
Na2SO4, concentrated under vacuum and purified by column chromatography (silica gel, 
30% EtOAc in n-hexane) to give 8 as a yellow gum (2.1 g, 84%).  1H NMR (CDCl3, 400 MHz), 
δ (ppm): 3.40-3.70 (m, 5H); 4.57-4.62 (m, 1H); 4.91 (s, 2H); 5.49-5.58 (m, 1H); 7.07-7.28 (m, 
5H). 13C NMR (CDCl3, 100 MHz), δ (ppm) 33.6; 53.0; 54.2; 67.2; 128.0; 128.2; 128.4; 139.5; 
159.5; 169.2. ESI-MS (+): calcd C12H14BrNO4: m/z 317.1 (M+H)+ and found 317.3 (M+H)+. 
Methyl 2-(benzyloxycarbonylamino)-3-(1,4,7,10-tetraazacyclododecan-1-yl)propanoate (9). 
Compound 8 (0.6 g, 1.9 mmol) in 25 ml of toluene was added dropwise to the solution of 
cyclen (2g, 11.6 mmol) in 100 ml of toluene at room temperature. The reaction mixture was 
refluxed for 18 h. The reaction mixture was cooled, filtered through a G-4 sintered funnel; 
filtrate was evaporated under reduced pressure, dissolved in 200 ml CH2Cl2, extracted from 
the water (4x100 ml). The organic layers were combined, dried over anhydrous Na2SO4 and 
then concentrated under vacuum to obtain the product with cyclen. The residue was 
purified by column chromatography (silica gel, 10% MeOH in CH2Cl2) to give 9 as colorless 
oil (0.34 g, 44%). 1H NMR (CDCl3, 250 MHz), δ (ppm): 2.20-3.02 (m, 18H); 3.69 (s, 3H); 4.36 
(br s, 1H); 5.02 (s, 2H); 5.07-5.25 (m, 4H); 7.25-7.40 (m, 5H). 13C NMR (CDCl3, 62.9 MHz), δ 
(ppm) 43.5; 52.5; 53.2; 53.7; 53.9; 55.0; 59.9; 66.3; 127.7; 128.9; 132.1; 134.2; 161.4; 176.8. ESI-
HRMS (+): calcd C20H33N5O4: m/z 408.2605 (M+H)+; found 408.2607 (M+H)+.  
[4,7-Bis-butoxycarbonylmethyl-10-(2-(benzyloxycarbonylamino)-3-methoxy-3-oxopropyl -
1,4,7,10-tetraaza-cyclododec-1-yl]-acetic acid tert-butyl ester (10). A solution of compound 9 
(4.1 g, 10.1 mmol) and sodium carbonate (6.4 g, 60.0 mmol) was added in 70 ml MeCN (dry) 
and heated at 60 °C for 1 h. The reaction mixture was cooled and tert–butylbromoacetate (5.29 
ml, 27.1 mmol) in MeCN (25 ml) was added dropwise. The mixture was then refluxed for 6 h. 
It was then filtered through a G-4 sintered funnel, washed with MeCN and concentrated 
under vacuum. The obtained residue was taken in CH2Cl2 (100 ml) and extracted with water 
(2x50 ml). The organic layer was dried over anhydrous Na2SO4 and concentrated to yellow oil. 
The residue was purified by column chromatography (silica gel, 5% MeOH in CH2Cl2) to give 
10 as light yellow solid (3.5 g, 72%). 1H NMR (CDCl3, 250 MHz), δ (ppm): 1.32 (s, 9H); 1.39 (s, 
18H); 1.83-2.56 (m, 8H); 2.60-3.50 (m, 16H); 3.66 (s, 3H); 4.47 (br s, 1H); 4.71 (br s, 1H); 5.24 (s, 
2H); 7.16-7.42 (m, 5H). 13C NMR (CDCl3, 62.9 MHz), δ (ppm): 27.8; 28.0; 50.3; 50.5; 51.3; 52.3; 
52.6; 53.3; 55.5; 56.1; 56.5; 66.9; 82.1; 82.4; 127.7; 127.9; 128.3; 135.9; 157.0; 171.8; 172.7; 173.1. ESI-
HRMS (+): calcd C38H63N5O10: m/z 750.4647 (M+H)+; found 751.4641 (M+H)+. 
2-(benzyloxycarbonylamino)-3-(4,7,10-tris(2-tert-butoxy-2-oxoethyl)-1,4,7,10-
tetraazacyclododecan-1-yl)propanoic acid (11). A solution of compound 10 (0.1 g, 0.13 
mmol) was stirred in 7 mL of THF:MeOH:water (3:2:2) at 0-5˚C for 15 min and then LiOH 
(6.5 mg, 0.27 mmol) was added. The reaction mixture was stirred for 2 h at room 
temperature. The progress of the reaction was checked by ESI-MS. After completion, the 
reaction mixture was concentrated under reduced pressure and 11 was obtained as white 
powder (0.76 g, 64%). 1H NMR (CDCl3, 250 MHz), δ (ppm): 1.32 (s, 9H); 1.39 (s, 18H); 1.83-
2.56 (m, 8H); 2.60-3.50 (m, 16H); 4.47 (br s, 1H); 4.71 (br s, 1H); 5.24 (s, 2H); 7.16-7.42 (m, 5H). 
13C NMR (CDCl3, 62.9 MHz), δ (ppm): 27.8; 28.0; 50.3; 50.5; 52.3; 52.6; 53.3; 55.5; 56.1; 56.5; 
66.9; 82.1; 82.4; 127.7; 127.9; 128.3; 135.9; 157.0; 171.8; 172.7; 173.1. ESI-MS (+): calcd 
C37H61N5O10: m/z 736.9 (M+H)+; found 737.1 (M+H)+. 
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[4,7-Bis-butoxycarbonylmethyl-10-(2-(benzyloxycarbonylamino)-3-((R)-5-(tert-
butoxycarbonylamino)-6-methoxy-6-oxohexylamino)-3-oxopropyl-1,4,7,10-tetraaza-
cyclododec-1-yl]-acetic acid tert-butyl ester (12). Compound 11 (0.29 g, 0.4 mmol) was 
dissolved in DMF (5 ml, dry) and NMM (0.1 ml, 0.9 mmol), EDC (0.086 g, 0.44 mmol) and 
(R)-methyl 6-amino-2-(tert-butoxycarbonylamino)hexanoate (0.16 mmol, 0.6 mmol) were 
added under N2 atmosphere. The reaction mixture was stirred at 60°C for 1h. Thereafter, 
HOBt (0.06 g, 0.44 mmol) was added and the heating was continued for 3 h. DMF was 
evaporated under reduced pressure and the obtained residue was dissolved in EtOAc. The 
organic layer was washed with water, dried under anhydrous Na2SO4, and concentrated 
under reduced pressure to obtain crude yellowish residue. This was purified by column 
chromatography (silica gel, 5% MeOH in CH2Cl2) to obtain 12 as yellowish solid (46%, 0.18 
g). 1H NMR (300 MHz, CDCl3), δ (ppm): 1.20 - 1.54 (m, 38 H), 1.54 - 1.88 (m, 5 H), 1.87 - 2.65 
(m, 9 H), 2.64 - 3.12 (m, 8 H), 3.12 - 3.52 (m, 6 H), 3.69 - 3.81 (m, 3 H), 4.15 - 4.32 (m, 1 H), 4.67 
(br. s., 1 H), 4.91 - 5.37 (m, 2 H), 7.19 - 7.44 (m, 5 H). 13C NMR (75 MHz, CDCl3), δ (ppm): 
22.7, 27.8, 27.9, 28.0, 28.2, 28.8, 31.9, 38.8, 49.9, 52.0, 53.3, 53.5, 55.4, 56.3, 56.4, 66.1, 79.4, 81.8, 
81.9, 82.3, 127.3, 127.4, 128.1, 136.8, 155.4, 157.0, 171.8, 172.0, 173.3. ESI-MS (+): calcd  
C49H83N7O13: m/z 978.6 (M+H)+; found 978.5 (M+H)+. 
[4,7-Bis-butoxycarbonylmethyl-10-(2-amino-3-((R)-5-(tert-butoxycarbonylamino)-6-
methoxy-6-oxohexylamino)-3-oxopropyl-1,4,7,10-tetraaza-cyclododec-1-yl]-acetic acid tert-
butyl ester (13). Compound 12 (0.05 g, 0.05 mmol) was dissolved in ethanol (10 ml) and Pd-C 
(0.005 g, 10% w/w) was suspended. The mixture was stirred in a Parr aparatus under H2 
atmosphere (3 atm) for 4 h. The solvent was evaporated under reduced pressure to obtain the 
product 13 as yellowish oil in quantitative yield. 1H NMR (300 MHz, CDCl3), δ (ppm): 1.18 - 
1.36 (m, 5 H), 1.36 - 1.41 (m, 11 H), 1.41 - 1.46 (m, 23 H), 1.49 - 1.58 (m, 2 H), 1.58 - 1.67 (m, 1 H), 
1.69 - 1.85 (m, 1 H), 1.93 - 2.35 (m, 4 H), 2.42 - 2.77 (m, 6 H), 2.76 - 3.02 (m, 6 H), 3.08 - 3.39 (m, 7 
H), 3.40 - 3.53 (m, 1 H), 3.68 (s, 3 H), 4.15 - 4.21 (m, 1 H). 13C NMR (75 MHz, CDCl3), δ (ppm): 
22.7, 27.9, 28.1, 28.3, 28.8, 32.0, 39.3, 49.9, 51.2, 52.2, 53.5, 55.4, 56.8, 57.8, 79.6, 81.6, 81.9, 82.5, 
155.5, 167.67, 167.75, 170.7, 173.4. ESI-MS (+): calcd C41H77N7O11: m/z 844.6 (M+H)+; found 844.5 
(M+H)+.  
[4,7-Bis-carboxymethyl-10-(3-((R)-5-amino-5-carboxypentylamino)-3-oxo-2-(5-((3aS,4S,6aR)-
2-oxo-hexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanamido)propyl)-1,4,7,10-tetraaza-
cyclododec-1-yl]-acetic acid (L2). Compound 13 (0.045 g, 0.053 mmol) was dissolved in 
anhydrous DMF (2 ml) and HATU (0.022 g, 0.058 mmol) and DIPEA (0.019 ml, 0.1 mmol) 
were added under inert atmosphere. The reaction mixture was stirred at room temperature 
for 18 h. The formation of 14 was confirmed by ESI-MS, the solvent was evaporated under 
reduced pressure and the residue was redissolved in ethylacetate and washed with water. 
The collected organic layer was dried with anhydrous Na2SO4 and evaporated under 
reduced pressure till dry. The residue was subjected to global deprotection. Methyl ester 
hydrolysis was carried out by LiOH (0.13 mmol, 0.005 g) in THF:MeOH:H2O (3:3:2) for 2h. 
The solvent was evaporated and the residue dissolved in TFA (10 ml, neat) to hydrolyze 
tert-Bu-ester and deprotect the Boc group. TFA was evaporated under reduced pressure to 
obtain a yellowish residue. The residue was redissolved in water, the pH was increased to 7 
and thereafter purified by RP-HPLC (tR = 4.8) to obtain the product, L2, as a yellow sticky 
solid. 1H NMR (300 MHz, D2O), δ (ppm): 1.33 (br. s., 4 H), 1.42 - 1.60 (m, 5 H), 1.60 - 1.72 (m, 
1 H), 1.74 - 1.92 (m, 2 H), 2.16 - 2.38 (m, 2 H), 2.65 - 2.96 (m, 6 H), 2.98 - 3.36 (m, 13 H), 3.41 - 
3.60 (m, 3 H), 3.62 (s, 1 H), 3.64 - 3.82 (m, 4 H), 3.84 - 4.03 (m, 3 H), 4.25 - 4.33 (m, 1 H), 4.36 
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(dd, J=7.88, 4.58 Hz, 1 H), 4.53 (dd, J=7.63, 5.09 Hz, 1 H). 13C NMR (75 MHz, D2O), δ (ppm): 
20.8, 20.9, 23.9, 24.0, 26.9, 27.2, 27.3, 29.0, 34.0, 38.1, 38.9, 46.8, 48.5, 49.9, 51.5, 52.4, 52.8, 53.2, 
54.58, 54.68, 55.1, 55.8, 59.4, 61.2, 149.9, 164.5, 173.0, 176.8. Compound 14: ESI-MS (+): calcd 
C51H91N9O13S: m/z 1070.6 (M+H)+; found 1070.5 (M+H)+. Compound L2: ESI-MS (-): calcd 
C33H57N9O11S: m/z 786.4 (M-H)-; found 786.4 (M-H)-. 
General Preparation of Gadolinium Complexes of L1 and L2. Gadolinium complexes of L1 
and L2 were prepared from corresponding solutions of the ligands (1 eq) and solutions of 
GdCl3.6H2O (1.1 eq). The reaction mixture was stirred at 60°C for 20 h. The pH was 
periodically checked and adjusted to 6.5 using solutions of NaOH (1 M) and HCl (1 N) as 
needed. After completion, the reaction mixture was cooled and passed through chelex-100 
to trap free Gd3+ ions, and the Gd-loaded complexes were eluted. The absence of free Gd3+ 
was checked with xylenol orange indicator. The fractions were lyophilized to obtain off-
white solids. These complexes were characterized by ESI-MS in positive and negative mode 
and the appropriate isotope pattern distributions for Gd3+ were recorded. 
[Gd.L1]. ESI-MS (+): calcd C35H58155GdN9O11S: m/z 971.3 [M+H]+; found 971.4 [M+H]+, r1p = 
5.52 [mM-1s-1] at 300 MHz. 
[Gd.L2]. ESI-MS (+): calcd C33H54155GdNaN9O11S: m/z 965.2 [M+Na]+; found 965.3 [M+Na]+, 
r1p = 7.27 [mM-1s-1] at 300 MHz. 
4.6 In vitro cell studies of [Gd.L1], [Gd.L2] and [Fluo-L1] 
4.6.1 Cell culture 
N18 mouse neuroblastoma cells (kind gift of Prof. Bernd Hamprecht, University of 
Tübingen, Germany) were cultured as a monolayer at 37°C with 5% CO2 in antibiotic free 
Dulbecco’s Modified Eagle's Medium (DMEM) supplemented with 10% fetal bovine serum 
(FBS) and 4 mM L-glutamine, (all purchased from Biochrom AG). Cells were passaged by 
trypsinization with trypsin/EDTA 0.05/0.02% (w/v) in phosphate-buffered saline (PBS; 
Biochrom AG, Germany) for 5 minutes every second to third day. Prior to experiments the 
serum content was stepwise reduced to 0.625% to induce morphological differentiation.  
4.6.2 Preparation of labeling solutions 
CA were dissolved in water and the concentration was determined by BMS measurement 
for [Gd.L1] and [Gd.L2] or by absorbance of fluorescein for [Fluo.L1]. For each experiment, 
dilutions from these stocks were freshly made in incubation medium and thoroughly mixed 
at indicated concentrations.  
4.6.3 Live cell imaging 
Microscopy was done in single channel Ibidi slides (Ibidi GmbH, Germany) by inoculation 
of N18 cells (3 x 105 cells/ml) cultured in Dulbecco’s Modified Eagle's Medium 
supplemented with 0.625% fetal bovine serum and 4 mM L-glutamine (all purchased from 
Biochrom AG). After reaching 70-80% confluency, cells were incubated with 50 µM of 
[Fluo.L1] for 12 hours. Before washing cells were incubated with nuclear stain Bisbenzimid 
33342 (Hoechst 33342) for 5 min. Afterwards, extracellular fluorescence was quenched by 
the addition of ice-cold Trypan Blue for 3 min (Rennert et al.). After repeated cell washings 
with Hank’s buffered saline solution (HBSS, Biochrom AG, Germany), fluorescence 
microscopy was performed on a Zeiss Axiovert 200M (Carl Zeiss AG, Germany) with a 
Plan-Apochromat 63X objective to observe the cellular localization of [Fluo.L1]. The imaging 
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conditions were kept constant for the observation of different samples. Cellular localization 
and distribution of [Fluo.L1] was determined by irradiating with blue light (470 nm) and 
observing at 525 nm, and nuclear labeling by Hoechst was imaged at 460 nm. Also phase 
contrast images with Differential Interference Contrast (DIC) of the same area were made to 
detect if the cells maintain their normal morphology in the presence of compound. 
4.6.4 MR measurement in cells 
For MR imaging, serum deprived N18 cells (1.25% FBS) were cultured in 175 cm2 tissue 
culture flasks and labeled with 20 or 40 µM of [Gd.L1] or [Gd.L2] in HBSS/10mM HEPES for 
6h. After incubation samples of the treatment solution were collected, if required 
centrifuged, and 500 µl were used for determination of R1 and R2. Cells were repeatedly 
washed with HBSS, trypsinized, centrifuged and re-suspended in 0.5 ml Eppendorf tubes at 
a cell density of 1 x 107/500µl in complete medium. Cells were allowed to settle before MR 
measurements. Tubes with medium only and cells without CA were used as controls. Two 
tubes of treatment solutions, HBSS/10 mM HEPES as well as of cells for each condition were 
used. Experiments were done at least twice. 
MR imaging of the cell pellets at room temperature (~21 ˚C) was performed in a 3 T (123 
MHz) human MR scanner (MAGNETOM Tim Trio, Siemens Healthcare, Germany), using a 
12-channel RF Head coil and slice selective measurements from a slice with a thickness of  
1 mm positioned through the cell pellet. 
T1 was measured using an inversion-recovery sequence, with an adiabatic inversion pulse 
followed by a turbo-spin-echo readout. Between 10 and 15 images were taken, with the time 
between inversion and readout varying from 23 ms to 3000 ms. With a repetition time of  
10 s, 15 echoes were acquired per scan and averaged six times. For T2, a homewritten spin-
echo sequence was used with echo times varying from 18 ms to 1000 ms in about 10 steps 
and a repetition time of 8 s. Diffusion sensitivity was reduced by minimizing the crusher 
gradients surrounding the refocusing pulse. All experiments scanned 2562 voxels in a field-
of-view of 110 mm in both directions resulting in a voxel volume of 0.43 × 0.43 × 1 mm3. 
Data analysis was performed by fitting to relaxation curves with self-written routines under 
MATLAB 7.1 R14 (The Mathworks Inc., United States). The series of T1 relaxation data were 
fitted to the following equation. 
T1 series with varying t = TI: S = S0 (1 - exp(-t / T1) + S(TI = 0) exp(-t / T1). 
Nonlinear least-squares fitting of three parameters S0, S(TI = 0), and T1 was done for manually 
selected regions-of-interest with the Trust-Region Reflective Newton algorithm 
implemented in MATLAB. The quality of the fit was controlled by visual inspection and by 
calculating the mean errors and residuals. 
Evaluation of the signal intensities in the T1-weighted MR images were performed in ImageJ 
(http://rsb.info.nih.gov/ij) by defining a circular region of interest (ROI) inside one tube 
image and measuring the mean signal intensity and standard deviation in the included 
voxels. Further statistical analyses were performed in GraphPad Prism 5.03 (GraphPad 
Software, Inc., USA). 
4.7 In vivo rat experiments 
To test whether [Gd.L1], [Gd.L2] and [Fluo.L1] were transported inside cells and could be 
visualized by MR and histological methods, we performed injections of all three compounds 
into the primary motor cortex of 8 albino rats (Sprague Dawley). Three of them (with 
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[Gd.L1]) were sacrificed after 24 h and the other three (one with [Gd.L1] and two with 
[Gd.L2]) were euthanized after 48 h. The remaining two (with [Fluo.L1]) were euthanized 
after 24 h. 
4.7.1 Injections 
All rats were anaesthetized with 2% isoflurane (Abbott) and placed in a stereotaxic frame 
(Kopf Instruments). After additional use of xylocain for local analgesia in the surgery area, a 
craniotomy was performed and a pulled fused silica capillary (ID 50µm; OD 150 µm; tip 
diameter 20-30 µm) was placed in the primary motor cortex at a depth of 1.2 mm below the 
surface. One compound per animal was then injected using a pressure cell containing the 
compound attached to the other end of the fused silica capillary. 100 nl of 4% tracer solution 
was injected at a flow rate of 3.3 nl/min. After injection, the capillary was left in place for 10 
minutes before retracting it stepwise to avoid backflow of the injected solution. 
In some cases we made iontophoretic injections, using borosilicate pipettes with tip 
diameters of 20-25 µm. In case of the injection shown in Fig. 6, injection time was 35 min (7s 
on, 7 s off) with a current of 4 µA. In case of the injection shown in Fig. 7, injection time was 
70 min (7 s on, 7 s off) with a current of 10 µA.  
At the end of the procedure, the animals received an intraperitoneal injection of analgesics 
and antibiotics [5mg/kg Baytril® (Bayer) and 2.5mg/kg Finadyne® (Essex)]. The animals to 
be left for 48 h received another injection of analgesics and antibiotics after 24 h. 
4.7.2 In vivo MRI experiments 
For the MRI experiments, the animals were anaesthetized with 1.5-2% isoflurane and placed 
in a home-made quadrature coil integrated within a stereotaxic animal holder. The head 
holder was adapted with movable bite and ear bars and positioned fixed on a magnet chair. 
This allowed precise positioning of the animal with respect to the coil and the magnet, 
avoiding movement artifacts. Body temperature, heart rate, CO2 and SpO2 were monitored 
throughout the scanning session. We typically scanned the animals before, immediately 
after and 24-48 h after the injection of CAs. One scan session consisted on 5 to 7 scans of 18 
min each. 
Experiments were carried out in a vertical 7T (300 MHz)/60-cm diameter bore magnet 
(Bruker BioSpin, Ettlingen). The saddle coil, which was designed to generate a 
homogeneous field over the whole rat brain, was used to transmit and receive. The MR 
system was controlled by a Bruker BioSpec console (ParaVision 3, 4 and 5 at different time 
periods) running under Linux operating system. We used a Modified Driven Equilibrium 
Fourier Transform (MDEFT) method with MDEFT-preparation (Lee et al., 1995) to obtain T1-
weighted anatomical images. The scan parameters were: TR = 22.2 ms, TE = 4.8 ms, FA = 
20°, ID = 1000 ms and four segments. The geometric parameters of the 3D scans were: 
matrix 192×136×100, FOV = 48×34×25 mm and voxel size 0.25×0.25×0.25 mm. 
The MRI images were analyzed with custom-developed Matlab functions (v7.5.0, 
MathWorks). An automated realignment procedure of SPM (statistical parametric mapping, 
www.fil.ion.ucl.ac.uk) was applied to co-register all scans. For statistical analysis the image 
intensity was normalized to reference signal intensity in the head muscles. Statistical maps 
were generated by implementing a Student's t-test (unpaired) at each voxel comparing brain 
images before and 24-48h after CAs injection. The significant voxels represent the pattern of 
T1-weighted MRI signal enhancement induced by the neuronal transport of CAs. The 
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arbitrary significance threshold was set to P < 0.01 (uncorrected for multiple comparisons) 
for individual voxels, and a minimum cluster size of 3 contiguous voxels constituting at 
least 3% of total number of voxels for a given region of interest (ROI). The same data were 
also tested for lower or higher p-values. 
4.7.3 Perfusion 
After the last MRI session, the animals received a lethal intraperitoneal injection of the 
barbiturate Pentobarbital sodium (Narcoren from Merial; 2.5 ml/kg body weight). After 
cessation of all reflexes, the chest of the animal was opened and 0.4 ml of Heparin-Sodium 
25000 (ratiopharm) was injected into the heart in order to prevent coagulation. Then a 
cannula was inserted and the animal was perfused with iosotonic saline (using NaCl 0.9 E 
from Fresenius) for about 5 minutes and then with the fixative (commercially available 4% 
paraformaldehyde, phosphate buffered; Roti-Histofix 4% from Carl Roth).  
The brain was removed from the skull and kept in the fixative over night. The next day the 
brain was transferred into 30% sucrose in demineralized water and kept there for at least 4 
days until it had sunk. The brain was then sliced into serial sections with a cryotome at a 
thickness of 70 µm. 
4.7.4 Histological procedure 
The protocol for the biotin-avidin reaction largely followed that by Horikawa and 
Armstrong (Horikawa and Armstrong, 1988) with some modifications suggested by Dr. 
Michaela Schweizer (personal communication). In detail: the sections were collected in 
phosphate buffer (PB, 0.1 M; pH 7.3), rinsed again in PB and then transferred into 1% H2O2 
in PB for 1 h, in order to block endogenous peroxidase activity. After rinsing 3 times in PB, 
the sections were kept for 90 min in Triton X-100 (2% in 0.1 M PB from Carl Roth). They 
were then incubated overnight in avidin-conjugated peroxidase (ABC Elite PK 6100 from 
Linaris, 1% in 0.1 M PB: i.e. adding 10 drops per 50 µl of each of the two solutions to 49 ml of 
buffer. Note that the ABC-mixture must stand for 30 min before use). On the next day, the 
sections were rinsed 2 x 10 min in PB (0.1 M) and then 2 x 10 min in Tris/HCl at pH 7.9 
(using a 0.1 M solution of tris-(hydroxymethyl)-aminomethane and pH adjusted to 7.9 with 
HCl). The sections were then transferred into a solution of diamino benzidine (DAB) and 
H2O2 (DAB tablet were dissolved in demineralized water) for 30 – 45 min. After washing 
three times in Tris/HCl, the sections were transferred into 0.05 M PB and mounted on 
electrostatic slides (Superfrost Plus, Menzel, ThermoScientific), air-dried over night, 
dehydrated in ethanol (70%, 2 x 99%, 1 x 100% ethanol, 2 x terpineole and 2 x xylene), and 
covered in Eukitt or DePeX.  
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1. Introduction 
Until relatively recently, the only way non-invasively to study brain cell membrane 
phospholipids in humans in vivo has been through the quantification of membrane 
phospholipid metabolism by means of ascertaining the levels of phosphomonoesters and 
phosphodiesters from 31-phosphorus neurospectroscopy scans. However, this only gives an 
indirect measure of the cell membrane phospholipid molecules. Ideally, one would want to 
study the brain cell membrane motion-restricted phospholipids directly, but it has 
previously proved almost impossible to obtain high-resolution magnetic resonance spectra 
of membrane phospholipids in living tissues owing to the large chemical-shift anisotropy of 
the 31-phosphorus confined to what is, in terms of nuclear magnetic resonance, the 
relatively rigid structure of the cell membrane, whether this be the external cell membrane 
or the membrane of an intracellular organelle.  
2. 31-Phosphorus neurospectroscopy  
Since structural imaging depends on the measurement of proton-based resonances, proton 
neurospectroscopy is readily achievable, in terms of hardware requirements, from magnetic 
resonance imaging scanners that are used for structural neuroimaging studies in humans. In 
contrast, the excitation of 31-phosphorus-containing relatively free moieties from the human 
brain and the measurement of the corresponding 31-phosphorus signals from relaxation of 
the 31-phosphorus nuclei require the use of a different coil tuned to the resonance frequency 
corresponding to the latter nuclei. The resonance frequency, ω, depends also on the strength 
of the static magnetic field, B0, and is given by the Lamor equation: 
 ω = γB0 (1) 
where γ refers to the gyromagnetic constant (or ratio) and is the ratio of the nuclear 
magnetic moment to the nuclear spin angular momentum. The gyromagnetic constant has a 
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unique value for each nuclide possessing a nuclear magnetic moment, such as 31-
phosphorus. For example, the value of the gyromagnetic constant for 31-phosphorus is 17.23 
MHz T-1 while for the proton (1-hydrogen) it is 42.58 MHz T-1. Hence, at a value of B0 of 
1.5 T, which is common for many magnetic resonance scanners in clinical use at the time of 
writing, whereas the value of the resonance frequency is 63.87 MHz for protons, it is just 
under 26 MHz for 31-phosphorus. A method our group have used to allow us to carry out 
31-phosphorus neurospectroscopy studies without having to move each subject’s head in 
relation to the magnetic resonance scanner, is to employ a birdcage quadrature head coil 
dual-tuned to proton (64 MHz) and 31-phosphorus (26 MHz); the proton tuned coil is 
required to enable T1-weighted structural scans to be obtained, in order to allow subsequent 
spectral localization (Puri et al., 2008b). 
Conventional 31-phosphorus neurospectroscopy allows us readily to discern seven narrow 
resonances from the adult human brain. In decreasing order of chemical shift, these are 
signals from phosphomonoesters, inorganic phosphate, phosphodiesters, phosphocreatine, 
gamma nucleotide triphosphate, alpha nucleotide triphosphate, and beta nucleotide 
triphosphate. The first and third narrow resonances, corresponding to phosphomonoesters 
and phosphodiesters, respectively, are considered further below. 
2.1 Phosphomonoesters and phosphodiesters 
The 31-phosphorus neurospectroscopy narrow resonances corresponding to 
phosphomonoesters and phosphodiesters are important in respect of membrane phospholipid 
metabolism for the following reasons.  
The phosphomonoesters narrow resonance reflects membrane phospholipid anabolism. This 
is because it contains contributions from freely mobile phosphomonoesters, including 
phosphocholine, phosphoethanolamine, and even small contributions from inositol 
phosphate, glycerophosphate, phosphothreonine, and L-phosphoserine, and also 
contributions from less mobile phosphomonoester-containing molecules, such as certain 
phosphorylated proteins, and from certain proteins that are part of the neuronal 
cytoskeleton (Puri, 2006).  
In contrast, the phosphodiesters narrow resonance reflects membrane phospholipid 
catabolism, since it contains contributions from freely mobile phosphodiesters, including 
glycerophosphocholine and glycerophosphoethanolamine. The phosphodiesters narrow 
resonance also contains contributions from less mobile phosphodiester-containing molecules, 
such as molecules involved in membrane structure (both cell membranes and intracellular 
organelle membranes) (Puri, 2006).  
Traditionally, therefore, the ratio of phosphomonoesters to phosphodiesters has been used 
as an index of membrane phospholipid metabolism. We turn next to a consideration of the 
presence of a broad component in the 31-phosphorus neurospectroscopy spectrum, which 
enables brain cell membrane motion-restricted phospholipids to be assessed more directly 
than a consideration of just phosphomonoesters and phosphodiesters. 
2.2 Broad component 
In explaining the advantages of measuring the broad component in the 31-phosphorus 
neurospectroscopy signal, the reader may be struck by what is in retrospect a rather ironic 
fact that for many years this broad component has been treated as somewhat of a nuisance, 
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with attempts being made to eliminate it altogether, as far as possible, from the final spectral 
analysis (Estilaei et al., 2001). For example, in previous neurospectroscopy research studies, 
our group have often used a fully automated approach to minimize the baseline roll in 
chemical shift imaging using a technique that employed knowledge-based data processing 
in the frequency domain, the broad component being regarded as an artefact that appeared 
as a result of the summation of several sinc functions; using prior knowledge, a mirror 
component corresponding to the ‘artefact’ was created and added to the delayed spectrum 
and this method compensated for noise and zero-order phase error when computing the roll 
artefact (Saeed and Menon, 1993).  
The broad resonance which underlies the 31-phosphorus spectrum from the living 
mammalian brain is composed of signal directly from the cell membrane phospholipids 
(Hamilton et al., 2003a). Thus the quantification of this broad resonance from 31-phosphorus 
neurospectroscopy data provides a more direct measure of brain cell membrane motion-
restricted phospholipids than does the evaluation of the ratio of phosphomonoesters, which 
index phospholipid anabolism, to phosphodiesters, which index phospholipid catabolism. 
The convolution difference resolution enhancement method may be used to obtain the 
broad component integral, from spectra obtained using an image-selected in vivo 
spectroscopy sequence (ISIS) (Estilaei et al., 2001, Roth and Kimber, 1982), whereby the 
broad component is the difference between the measured raw signal intensity, S, and SCD 
given by: 
 SCD = S(1 – fe-πLt) (2) 
where f is the convolution-difference factor, representing the fraction of the broad 
component contributing to the acquired signal at a given echo time (TE), and L is an 
exponential filter; the broad component integral may then found by fitting the broad 
spectrum to multiple Gaussian lines, minimizing residuals, and summating over all 
Gaussian-line integrals. Estilaei and colleagues (2001) obtained transverse relaxation time 
(T2)-magnetization decay curves by plotting the broad component area as a function of TE; 
having found that mono-exponential fitting did not adequately represent T2-magnetization 
decay curves, they instead used the following bi-exponential fit: 
 S(t) = Sl e-A + Ss e-B (3) 
where S(t) is the total magnetization at a given time t, Sl and Ss are the respective 
equilibrium magnetizations for the slow and fast decaying components, A is the quotient of 
the echo time and the spin-spin relaxation time for the long T2 component, T2l , and B is the 
quotient of the echo time and the spin-spin relaxation time for the short T2 component, T2s. 
Using the model of Radda’s group in which T2l is much greater than T2s (Kilby et al., 1990), 
Estilaei and colleagues (2001) showed that the uncertainty in the determination of the long 
T2 could be eliminated, and, with TE much less than T2l, it followed that 
 ln S(TE) = ln (Sl + Ss) – Ss TE/( T2s (Sl + Ss)) (4) 
and, with TE much greater than T2s 
 ln S(TE) ≃ ln Sl – TE/T2l  (5) 
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Linear regression was then used to carry out the corresponding fits.  
Our group have tended to quantify the 31-phosphorus signals using prior knowledge in 
the temporal domain using the AMARES (advanced method for accurate, robust, and 
efficient spectral fitting) algorithm (Vanhamme et al., 1997) included in the Java-based 
MRUI (magnetic resonance user interface) software program, which allows time-domain 
analysis to be easily carried out (Naressi et al., 2001). Truncation of a specific early portion 
of the signal removes the broad component present in the 31-phosphorus spectra and 
allows initial analysis of the narrow components listed above using a priori knowledge in 
the AMARES algorithm (Hamilton et al., 2003a, Hamilton et al., 2003b). The broad hump 
can then be analyzed, using the above time-domain analysis, thereby allowing distinct 
separation of the narrow and broad components. The broad component is modelled as a 
Gaussian function and its area can be compared with the total peak area of the seven 
narrow resonances and then multiplied by 100 to give the percentage broad signal (Puri et 
al., 2008b). 
2.3 Chronic alcohol consumption 
It has been shown that ethanol increases the fluidity of spin-labelled membranes from 
normal mice, while membranes from mice that have been subjected to long-term ethanol 
treatment are relatively resistant to this fluidizing effect and have an altered phospholipid 
composition; this suggests that the membranes themselves had adapted to the alcohol, 
which constitutes a novel form of drug tolerance (Chin and Goldstein, 1977). This finding 
from this landmark 1977 study has been replicated using non- nuclear magnetic resonance 
techniques, including electron spin resonance and fluorescence polarization: chronic alcohol 
exposure in humans increases the rigidity of isolated brain membranes.  
The related hypothesis that subjects who are heavy drinkers have stiffer brain cell 
membranes than have control subjects who are light drinkers, as reflected in a smaller 
broad signal component with a shorter T2 of the broad signal from 31-phosphorus 
neurospectroscopy, was tested by Estilaei and colleagues (2001). They carried out 
localized 31-phosphorus neurospectroscopy at the level of the centrum ovale in 13 male 
alcohol-dependent heavy drinkers of average age 44 years (standard deviation 9 years) 
who had an average lifetime alcohol consumption of 239 (standard deviation 218) drinks 
per month, where one drink was taken to be an alcoholic beverage containing 
approximately 13 g ethanol, and who satisfied the Diagnostic and Statistical Manual of 
Mental Disorders, fourth edition (DSM-IV) criteria for lifetime dependence on alcohol 
(American Psychiatric Association, 1992). Seventeen male non-dependent light drinkers 
whose average lifetime alcohol consumption was 19 drinks (standard deviation 17 drinks) 
per month, and whose average age (37; standard deviation 10) years was similar to that of 
the first group, acted as the control group for this study. The broad component integral 
was found to be 13 per cent lower in the heavy drinkers compared with the light drinkers 
(p = 0.000 5), while no significant differences were found for any of the metabolite 
integrals. No significant main effect of a family history of alcohol use, assessed using a 
standard questionnaire, was found, and there was no significant family history-by-group 
interaction effect on the broad component integral. No significant correlations were found 
between, on the one hand, the broad component signal integral or its relaxation times, 
and, on the other hand, age, years of abuse, average monthly drinking or total lifetime 
consumption in either the heavy drinking group, or the control group or a combination of 
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both groups. A positive family history of alcohol abuse did not predict a smaller broad 
component integral or shorter relaxation times (Estilaei et al., 2001). In both the heavy 
drinkers and the control group, the T2 distribution of the broad component consistently 
showed two resolvable components, with the fast relaxing component having the same T2 
in both groups while the slower relaxing component T2 was 0.6 ms shorter in the heavy 
drinkers (Estilaei et al., 2001).  
The authors concluded that 31-phosphorus neurospectroscopy ‘provides a powerful and 
practical approach for measuring in vivo changes of the amount and fluidity of 
[phospholipids] in white matter regions of the human brain. Specifically, the smaller, broad 
component in [heavy drinkers] compared with [light drinkers] suggests altered white matter 
[phospholipids] associated with long-term chronic alcohol abuse…[and] may provide 
valuable information regarding possible biochemical mechanisms that [underlie] chronic 
alcohol-induced structural changes…’ (Estilaei et al., 2001). 
2.4 Hypoxia resulting from chronic obstructive pulmonary disease 
The maintenance of cerebral metabolic homeostasis is required for the maintenance of 
consciousness and normal brain function, and this may be perturbed by a variety of 
insults, including hypoxia (Hamilton et al., 2003a). Taylor-Robinson’s group at 
Hammersmith Hospital in London, U.K., had previously shown that abnormal cerebral 
bioenergetics can be detected readily using 31-phosphorus neurospectroscopy in a study 
of 10 patients with stable, but severe, chronic obstructive pulmonary disease and hypoxia; 
compared with controls, the patients with chronic obstructive pulmonary disease showed 
increased phosphomonoesters and inorganic phosphate signals but reduced 
phosphodiesters signals, thought to be caused by the utilization of anaerobic metabolism 
by the brains of hypoxic patients with this disease (Mathur et al., 1999). Since neonatal, 
animal and in vitro studies show an association between anaerobic glycolysis with a 
protective intracellular alkalosis, the same group attempted to identify such a 
compensatory intracellular alkalosis in eight hypoxic patients with chronic obstructive 
pulmonary disease, compared with eight age-matched control subjects, using 31-
phosphorus neurospectroscopy (Hamilton et al., 2003a). As part of this study, the broad 
component was also quantified in the subjects. 
Taylor-Robinson’s group reported that the mean intracellular pH in patients with chronic 
obstructive pulmonary disease was similar to that in the control subjects, but decreased in 
the patients by a mean of 0.02 following the administration of supplemental oxygen, there 
being no such change in normal control subjects following oxygen administration. Of 
particular interest was their finding that the broad component increased in all the patients 
with chronic obstructive pulmonary disease following oxygen administration (Hamilton et 
al., 2003a). These findings point to altered phospholipid membrane fluidity in the brain 
being associated with the change in intracellular pH following oxygen administration. The 
change in the broad resonance was strongly and negatively correlated with the change in 
intracellular pH, and indeed in vitro studies have shown that membrane fluidity is sensitive 
to pH with, for example, the fusion process between synaptosomes, freshly isolated from rat 
brain cortex, and large unilamellar phosphatidylserine liposomes being shown to be pH 
dependent (an increase in both kinetics and extent occurring when the pH is lowered by 1.9 
from 7.4) (Almeida et al., 1994).  
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Based on the above findings, including the results relating to the broad component from 31-
phosphorus neurospectroscopy, the authors hypothesized that the transition from 
compensatory respiratory failure in patients with hypoxic chronic obstructive pulmonary 
disease to the clinical picture of confusion, disorientation and coma in patients with chronic 
obstructive pulmonary disease and with severe exacerbations may be associated with the 
failure of ion transport mechanisms, perturbation of membrane fluidity and the 
overwhelming of the compensatory intracellular alkalosis in neuronal and glial cells 
(Hamilton et al., 2003a). 
2.5 Schizophrenia 
A number of lines of evidence from biochemical studies have suggested that membrane 
phospholipid metabolism may be impaired in at least a subgroup of patients suffering 
from schizophrenia (Puri et al., 2008a). First, reduced levels of highly unsaturated (or 
polyunsaturated) fatty acids have been reported in erythrocyte membranes (Yao and 
van Kammen, 1994, Yao et al., 1994a, Yao et al., 1994b, Peet et al., 1995) in patients with 
schizophrenia. Second, increased levels of the phospholipase A2 group of enzymes, 
which catalyze the removal of highly unsaturated (or polyunsaturated) fatty acids such 
as arachidonic acid and docosahexaenoic acid from the Sn2 position of membrane 
phospholipid molecules, have been found in both plasma (Gattaz, 1992, Gattaz et al., 
1990, Gattaz et al., 1987, Tavares et al., 2003) and platelets (Gattaz et al., 1995) of 
patients with schizophrenia. Furthermore, the dermatological response to the niacin 
flush test, which indirectly indexes membrane phospholipid metabolism, has been 
found to be impaired in schizophrenia (Ward et al., 1998), including in its quantitative 
measurement form as the volumetric niacin response (Puri et al., 2002). These 
converging lines of evidence are consistent with the membrane phospholipid 
hypothesis of schizophrenia, associated with the late Professor David F. Horrobin, and 
also with Professor Iain Glen and Professor Krishna Vaddadi, which proposes a change 
in brain membrane phospholipids leading in turn to changes in the functioning of 
membrane-associated proteins and of cell signalling systems in schizophrenia 
(Horrobin, 1996, Horrobin, 1998, Horrobin et al., 1994). 
Clearly, the above biochemical studies have not directly measured membrane 
phospholipids from the brains of patients suffering from schizophrenia. Similarly, as 
mentioned earlier, the quantification of the ratio of phosphomonoesters to phosphodiesters, 
gleaned from narrow resonances obtained from 31-phosphorus neurospectroscopy, also 
only provide an indirect measure of the ratio of brain cell membrane phospholipid 
anabolism to phospholipid catabolism. Therefore, there is a clear role for analyzing the 
broad component from 31-phosphorus neurospectroscopy in schizophrenia. Accordingly, 
our group were the first to do so. 
In our initial study, we carried out the first analysis of the broad component resonance 
from the brain in forensic patients severely affected with schizophrenia and a comparison 
group of age- and gender-matched healthy normal control subjects, to assess directly 
whether, as expected under the membrane phospholipid hypothesis of schizophrenia, 
there was a change in cell membrane phospholipids in people suffering from 
schizophrenia who have a forensic history such as having perpetrated an act of serious 
violence while psychotic (Puri et al., 2008b). Fifteen male inpatients in a medium secure 
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unit with a diagnosis of schizophrenia according to DSM-IV (American Psychiatric 
Association, 1992), and 12 male healthy control subjects underwent 31-phosphorus 
neurospectroscopy. Expert psychiatric opinion, accepted in court, was that all the patients 
had violently offended directly as a result of schizophrenia prior to admission to the unit, 
these offences consisting of homicide, attempted murder, or wounding with intent to 
cause grievous bodily harm. There was no history of alcohol dependency in these patients 
or in the control subjects. All the patients were suffering from severe positive symptoms 
of schizophrenia, mostly controlled by antipsychotic medication at the time of scanning. 
The average duration of illness since the index offence was 6.8 (standard error 0.4) years. 
Fourteen of the patients were being treated with typical antipsychotic medication, mainly 
in injectable depot form, while the remaining patient was being treated with clozapine. 
Spectra were obtained using an image-selected in vivo spectroscopy sequence with 64 
signal averages localized on a 70 x 70 x 70 cubic millimetre voxel. Owing to the low 
abundance in the brain, and indeed the rest of the body, of 31-phosphorus compared with 
protons, the maximum size voxel was used to collect signal from the brain and thus 
maximize the signal-to-noise ratio. All spectral analyses were carried out by a single 
observer who was blinded to group allocation until after the spectral and statistical 
analyses were completed. It was found that the mean percentage broad component signal 
for the patients did not differ significantly from that for the control subjects and therefore 
it was not possible to reject the null hypothesis that there is no difference in the 
concentration of brain membrane-bound phospholipids in this group of forensic patients 
with schizophrenia compared with controls. 
The above finding from analysis of the broad component in forensic patients with 
schizophrenia was a surprise to our group. An explanation based on the notion that the 
membrane phospholipid hypothesis applies not only to the outer cell membranes but also to 
the phospholipid membranes of intracellular organelles such as the nucleus and 
mitochondrion does not hold since the broad component resonance signal derives from both 
the outer cell membranes and the phospholipid membranes of these organelles (Puri et al., 
2008b).  
We carried out a review of the evidence relating to the membrane phospholipid 
hypothesis of schizophrenia (Puri et al., 2008b). There is strong evidence favouring this 
hypothesis. As alluded to above, much of this evidence is, as might be expected, primarily 
biochemical in nature. Plasma phospholipids that have been studied in schizophrenia 
have tended to show reduced levels of the n-6 (or omega-6) fatty acids linoleic acid and 
arachidonic acid and raised levels of n-3 (or omega-3) fatty acids (Horrobin et al., 1989). 
Interestingly, in a study of plasma phospholipids in patients with schizophrenia, patients 
with affective and paranoid disorders, and normal controls, from Japan, it was found that 
while the patients with schizophrenia had low linoleic acid levels (and a low ratio of 
linoleic acid to its metabolites), and while phospholipid fatty acid levels were in the 
normal range for the patients with paranoid or affective disorders, those patients with 
schizophrenia who showed reduced platelet sensitivity to the aggregation-inhibiting 
effects of prostaglandin E1 had higher levels of oleic acid and lower levels of 
eicosapentaenoic acid (Kaiya et al., 1991). This possibility of a dichotomous nature to the 
fatty acid changes in plasma in schizophrenia also extends to erythrocyte membrane fatty 
acids.  
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Erythrocyte membrane fatty acid changes in schizophrenia have been found more 
consistently than plasma fatty acid changes (Puri et al., 2008b). They tend to point to 
reduced erythrocyte membrane levels of the long-chain polyunsaturated fatty acids 
arachidonic acid and docosahexaenoic acid, in the context of a biphasic distribution with 
one group of schizophrenia patients having essentially normal fatty acid levels, while the 
other has significantly low levels (Glen et al., 1994). It is of particular interest to note that 
when the schizophrenia patients were divided into those with predominantly negative 
symptoms, such as affective flattening, and predominantly positive syndromes, including 
positive symptoms such as auditory hallucinations and thought disorder, the low 
erythrocyte membrane levels of arachidonic acid and docosahexaenoic acid were largely 
confined to patients with a negative syndrome (Horrobin, 2003).  
Clearly it was the case that the schizophrenia patients in the above broad component 31-
phosphorus neurospectroscopy study would all fit into the category of a positive syndrome, 
given their history of seriously and violently offending while psychotic (Puri et al., 2008b) . 
Therefore, this may provide a possible explanation as to why the results of this study did 
not harmonize with the neurospectroscopy changes expected under the membrane 
phospholipid hypothesis of Horrobin, Glen and Vaddadi. It was therefore decided to carry 
to a further study of the broad component from 31-phosphorus neurospectroscopy scanning 
of patients with schizophrenia, but this time of a sample taken from patients who had not 
seriously or violently offended as a result of their illness and who suffered from 
predominantly negative symptoms. 
For our new 31-phosphorus neurospectroscopy investigation, our group studied 16 
psychiatric outpatients who had a diagnosis of schizophrenia according to DSM-IV 
(American Psychiatric Association, 1992), who had no history of dependency on 
psychoactive substances, and the same number of normal healthy controls, who had no 
previous history of psychiatric or neurological disorders. The two groups were matched 
with respect to age and gender. The patients suffered from mild to moderate negative 
symptoms of schizophrenia and had no history of having committed any violent or other 
offences as a result of their schizophrenic illness. The 31-phosphorus neurospectroscopy 
protocol was as mentioned above for the forensic schizophrenia study, with spectra being 
obtained from an image selected in vivo spectroscopy sequence with 64 signal averages 
localized on a 70 x 70 x 70 cubic millimetre voxel, with the signal-to-noise ratio again being 
improved by using this large voxel size (Puri et al., 2008a).  
The broad component from each subject was quantified by an observer who at the time of 
this analysis was blinded to group status. Just as in our previous study mentioned above, 
analysis of these broad resonances in this new study showed no significant difference in the 
broad component between the group of patients with schizophrenia and the normal control 
group.  
We considered that an explanation of these negative results might lie in the possibility 
that the membrane phospholipid hypothesis of schizophrenia could possibly be construed 
as predicting a change only in phospholipid metabolism in the cell membranes of the 
brain, rather than a change in the membrane-bound phospholipids themselves. To test 
this possibility, a further blinded analysis was carried out of the percentage 
phosphomonoesters (indexing phospholipid anabolism) and phosphodiesters (indexing 
phospholipid catabolism) levels in both groups. The mean (standard error) percentage 
The Use of 31-Phosphorus Magnetic Resonance Spectroscopy to  
Study Brain Cell Membrane Motion-Restricted Phospholipids 
 
213 
phosphomonoesters level for the patients with schizophrenia was 11.4 (0.3) and did not 
differ significantly from that for the normal control subjects of 10.9 (0.5). Similarly, the 
mean (standard error) percentage phosphodiesters level for the schizophrenia patients 
was 44.4 (0.5), which did not differ significantly from that for the normal control subjects 
of 44.6 (0.9) (Puri et al., 2008a). In terms of ratios, the mean ratio of phosphomonoesters to 
phosphodiesters was 0.26 (standard error 0.01) in the case of the patients with 
schizophrenia and 0.25 (standard error 0.01) for the healthy controls (Puri et al., 2008a), 
and again these did not differ significantly. Therefore, on the basis of this second study, it 
was not possible to reject the null hypothesis that there was no difference in phospholipid 
metabolism in the brain in the schizophrenia patients compared with the age- and gender-
matched control subjects. 
Our two sets of ‘negative’ results in schizophrenia do not, of course, negate the value of 
quantifying the broad component gleaned from 31-phosphorus neurospectroscopy studies. 
Rather, they must give us cause to examine again the membrane phospholipid hypothesis of 
schizophrenia. 
3. Conclusion  
The above studies of chronic alcohol dependence, chronic obstructive pulmonary disease, 
forensic inpatients with schizophrenia who have seriously and violently offended while 
psychotic, and of outpatients with schizophrenia who are suffering from predominantly 
mild to moderate negative symptoms of schizophrenia, have demonstrated the feasibility of 
analyzing the broad component from 31-phosphorus neurospectroscopy studies in a wide 
range of patient groups. We have also shown the advantages over analysis of narrow 
resonances corresponding to levels of phosphomonoesters (indexing phospholipid 
anabolism) and phosphodiesters (indexing phospholipid catabolism) of the analysis of this 
broad component in order to quantify the level of motion-restricted membrane 
phospholipids in the brains of the individuals being studied. 
The failure of our broad component analyses to yield results which harmonize with the rich 
biochemical literature that is consistent with the membrane phospholipid hypothesis of 
schizophrenia does insert a possible note of caution, however. It should be noted that, given 
the low signal-to-noise in 31-phosphorus magnetic resonance spectroscopy, the areas of the 
peaks obtained are inherently variable (Puri et al., 2008a). This is particularly true of the 
underlying broad component, which has a coefficient of variation double that of the other 
peaks visible in the spectrum (Hamilton et al., 2003b). One should take into account the 
possibility that this variability may be masking any changes in the broad component, 
leading to a reduction in the ability to monitor membrane phospholipids. 
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1. Introduction 
Recent advances in sonographic technology have made ultrasound an increasingly accurate 
and adequate means to detect cranial morphology and intracranial pathology in infants.   
When modern equipment is combined with thorough imaging technique, ultrasound 
delivers similar results to MRI in terms of sensitivity and ability to direct initial management 
(Daneman et. al, 2006; Epelman et. al., 2010). Furthermore, ultrasound offers certain 
advantages over other imaging modalities such as MRI and CT. Cranial sonography is less 
expensive, spares the patient from radiation, does not require sedation, and its portability 
allows for bedside evaluation in gravely ill infants who cannot be transported to radiology 
for imaging. 
The goal of this chapter is to provide an updated approach to modern cranial ultrasound in 
order to improve diagnostic accuracy and increase recognition of normal anatomical 
structures, anatomical variants, pathologic processes, and imaging pitfalls that may simulate 
disease. The discussion will begin with an overview of the approach and interpretation of 
gray-scale imaging. The chapter will continue with a review of Doppler imaging, the use of 
additional fontanels, and linear imaging. The chapter will conclude by reviewing pitfalls 
and normal variants which may simulate pathology. 
2. Ultrasound techniques and interpretation 
2.1 Gray-scale 
The cranial ultrasound examination is performed with a linear-array transducer. Six-eight 
coronal plane images are taken through the anterior fontanel, beginning in the frontal lobes 
anterior to the frontal horns and progressing posteriorly to the occipital lobes past the trigones 
of the lateral ventricles. (Figure 1) The first coronal image acquired at the level of the frontal 
lobes allows the observer to examine the frontal lobes, orbital cones, and the hyperechoic falx 
cerebri located within the interhemispheric fissure (Slovis et. al., 1981). The second coronal 
image is taken through the frontal horns of the lateral ventricles, which allows multiple 
structures to be imaged at once. The frontal horns and cavum septum pellucidum appear as 
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anechoic, CSF-filled spaces. The corpus callosum is a linear, hypoechoic structure crossing the 
hemispheres that is contained within echogenic superior and inferior borders. Finally, the 
globus pallidus, putamen, caudate nucleus, and thalamus of each side can be visualized in 
their respective locations with their characteristic gray matter appearance  (Seigel, 2002). The 
third image is obtained at the level of the foramen of Monro and further illustrates many of the 
structures mentioned above. The third ventricle can be visualized as an anechoic structure 
beneath the septum pellucidum. Brainstem structures such as the pons and medulla can also 
be seen  (Seigel, 2002). Moving posteriorly, the fourth image is taken at the level of the cerebral 
peduncles and shows hyperechoic choroid plexus along the floor of the lateral ventricles and 
the roof of the third ventricle. The tentorium cerebelli and fourth ventricle are also 
demonstrated (Seigel, 2002). The quadrigeminal plate cistern serves as a marker for the fifth 
image, which enables the viewer to see both  temporal horns of the lateral ventricles as well as 
cerebellar structures including the hemispheres and vermis. Below the vermis, the cisterna 
magna is visible. Occasionally, the mammillary bodies can be discerned on this image (Seigel, 
2002). The sixth image is taken through the lateral ventral trigones and shows their innate 
hyperechoic choroid plexus (Seigel, 2002). The perventricular white matter halo is also seen 
and should be less echogenic than the choroid plexus (Grant et. al., 1981; Seigel, 2002). The 
final image is obtained through the cerebral convexities and displays the interhemispheric 
fissure and occipital lobes  (Seigel, 2002). 
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Fig. 1. (a-g). Coronal images of a normal neonatal brain. C (caudate) t (thalamus) f (Foramen 
of Monro) m (midbrain) 3 (third ventricle) Q (quadrigeminal plate cistern) CB (cerebellar 
hemispheres) 
Next, the transducer is turned 90 degrees on the anterior fontanel, and five more images 
are acquired in the sagittal and parasagittal planes. (Figure 2) The first image is a midline 
sagittal view which includes the corpus callosum and cerebellar vermis. Additional 
parasagittal views are obtained laterally on either side, allowing for the inspection of the 
lateral horns and choroid plexus (Epelman et. al., 2010; Seigel 2002; Rumack et. al. 2005). 
The first midline sagittal image displays a number of important structures. The C-shaped 
corpus callosum appears as a hypoechoic structure bound by echogenic superior and 
inferior borders (Seigel, 2002). The cingulate gyrus is seen above the corpus callosum, 
while the septum cavum pellucidum is seen below. The third and fourth ventricles along 
with the cisterna magna appear anechoic at their respective positions (Seigel, 2002). The 
white matter containing pons and cerebellar vermis are also seen (Grant et. al., 1981 
Seigel, 2002). Additional views are obtained in the parasagittal plane by cutting through 
the lateral ventricles. The intraventricular echogenic choroid plexus is well evaluated in 
this plane. The temporal lobe and caudothalamic groove, which separates the caudate 
nucleus from the thalamus, are also visualized. Progressing laterally, parasagittal images 
are obtained through the temporal horns of the lateral ventricles further demonstrating 
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the hyperechoic choroid plexus (Seigel, 2002). A final view can be made on either side 
through the lateral thalamus.  
 
  
A.                                                                  B. 
   
C.                                                              D. 
Fig. 2. (a-d). Sagittal images of a normal neonatal brain. 3 (third ventricle) mi  
(mass intermedia) p (belly of the pons) 4 (fourth ventricle) cv (cerebellar vermis)  
c (caudate nucleus) t (thalamus) 
Interpretation of cranial gray-scale imaging relies not only on neuro-anatomical knowledge 
but also on recognition of the normal echogenic patterns of cranial structures. The following 
concepts are important to keep in mind when examining cranial sonographic images. Gray 
matter is normally hypoechoic while white matter is hyperechoic. Therefore, an anomaly is 
indicated when the appearance of the two is switched (North & Lowe, 2009). Secondly, 
though the normal brain is always symmetric, symmetry is not always normal. A prime 
example is seen in bilaterally symmetric hyperechoic thalami which may signal thalamic 
edema, ischemia, or infarct (Huang & Castillo, 2008; North & Lowe, 2009). Thirdly, it is 
important to visualize the pia mater, cortical gray matter, and white matter to detect focal 
hemorrhages and infarcts (Grant et. al. 1981). From superficial to deep, a hyperechoic, 
hypoechoic, hyperechoic pattern should be seen in these layers, respectively (Figure 3) 
(Slovis & Kuhns, 1981). Finally, periventricular white matter should look homogenous with 
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an echogenicity less than or equal to the neighboring choroid plexus (North & Lowe, 2009; 
Seigel, 2002). A change from this appearance including asymmetry, heterogeneity, or 
hyperechogenicity greater than that of adjacent choroid could be indicative of 
periventricular leukomalacia (Figure 4). 
 
 
Fig. 3. High resolution linear image of the cerebral cortex. Note the hyperechoic pia matter, 
hypoechoic gray matter, and hyperechoic white matter. This image displays normal gray-
white matter differentiation in a term neonate. 
2.2 Doppler imaging 
The next step in pediatric cranial sonography is Doppler screening of the vasculature (North 
& Lowe, 2009). First, the Circle of Willis is investigated with color Doppler imaging using 
either the anterior or temporal fontanels. Spectral tracings of the internal cerebral arteries 
are obtained and used to calculate the peak systolic velocity (PSV), end diastolic velocity 
(EDV), and resistive index (RI). Color Doppler images are then performed in the sagittal 
plane to evaluate the sagittal sinus and vein of Galen. Power Doppler imaging can be 
utilized to detect signs of ischemia which may present as areas of hyper- or hypovascularity 
(Epelman et. al., 2010).  
Doppler imaging, whether color, spectral, or power, can be achieved in either the anterior or 
temporal fontanels according to ease or  vessels to be examined (Figure 5a &b) (Lowe & 
Bulas, 2005). While either fontanel enables the inspection of the circle of Willis, use of the 
anterior fontanel better displays the internal cerebral arteries (Figure 5c) (Rumack et. al. 
2005; Seigel, 2002). Color Doppler imaging is used to screen the vasculature for patency and 
resistance to flow. Arteries are usually evaluated in the coronal plane, while venous 
structures are best imaged in sagittal. Indices, including the resistive index (RI), systolic, and 
diastolic velocities, typically of the middle or internal cerebral arteries are obtained from 
spectral tracings. The RI is calculated from the peak systolic velocity and end diastolic 
velocity by the following formula: 
RI= (PSV-EDV)/PSV 
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A.                                                                  B. 
 
C. 
Fig. 4. (a) Normal  echogenicity in the periventricular white matter is symmetric and 
homogenous. It is less echogenic than the neighboring choroid. (b and c) Periventricular 
leukomalacia is asymmetric, heterogeneous, and more echogenic than the adjacent choroid 
plexus. 
The RI may be impacted by flow velocity, blood volume, congenital cardiac anomalies, and 
peripheral vascular resistance (Bulas & Vezina, 1999; Soetaert et. al., 2009). The RI tends to 
decline with age as diastolic flow increases with the progression from fetal to newborn 
circulation. Premature infants exhibit a normal RI of .62-.92 that typically drops to .43-.58 by 
the time the child is older than 2 years (Allison et. al., 2000; Lowe & Bulas, 2005). Therefore, 
a value ranging from .6-.9 is used to estimate a normal RI in premature and full-term 
infants. Lower values may indicate acute hypoxia or ischemia, which may trigger increased 
diastolic flow through cerebral vasodilation. Higher values may suggest cerebral swelling 
where intracranial pressures rise higher than systemic pressures leading to decreased 
diastolic flow (North & Lowe, 2009). 
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A.                                                               B. 
 
C. 
Fig. 5. (a) Axial and (b) coronal Doppler images and spectral waveforms of the normal Circle 
of Willis. Axial images were obtained through the temporal fontanel. Coronal images were 
obtained through the anterior fontanel. (c) Coronal Doppler images and spectral waveforms 
of a normal ICA obtained through the anterior fontanel. 
As mentioned above, the RI is not always reliable. This is especially true in children with 
extra cardiac shunts or congenital cardiac malformations with left to right intracardiac 
shunt, particularly a patent ductus arteriosis (Lipman et. al., 1982). In addition, vessel 
velocity fluctuations are common leading to the need to acquire multiple measurements. 
2.3 Additional fontanels and linear imaging 
A state of the art approach to head sonography requires utilization of additional fontanels 
and high-resolution linear imaging. The mastoid fontanels enable inspection of the 
cerebellar hemispheres and aid in detection of posterior fossa hemorrhages and congenital 
anomalies (Figure 6) (Di Salvo, 2001). Mastoid fontanels are also used to evaluate the size 
and appearance of the fourth ventricle and cisterna magna. Due to improved posterior fossa 
hemorrhage discovery, these views are now part of the standard of care for hindbrain 
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imaging (Seigel, 2002). The transverse sinuses can  be examined through posterior fontanels 
or foramen magnum. Color Doppler can aid in evaluating vascular flow and patency 
(Brennan et. al., 2005; Epelman et. al, 2010; Lowe & Bulas, 2005, Sudakoff et. al., 1993).  
Linear imaging should be used to assess the subarachnoid space and superficial cortex via 
the anterior fontanel (Figure 7) (Epelman et. al., 2010). Supplementary fontanels may be 
explored to gain accessory views. 
 
 
Fig. 6. Normal posterior fossa image obtained using the mastoid fontanel.  
cb (cerebellar hemispheres) m (midbrain) 
 
 
Fig. 7. High resolution linear image demonstrating prominent extra axial CSF spaces. 
Doppler interrogation demonstrates a vessel crossing the space, confirming subarachnoid 
fluid rather than subdural. 
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3. Pitfalls and normal variants 
3.1 Immature sulcation in premature infants 
The infant brain becomes increasingly sulcated during development. Cerebral cortices in 
neonates born prior to the 24th week gestational age contain only Sylvian fissures in an 
otherwise smooth cerebral cortex making lissencephaly in this age group an avoidable 
diagnosis (Figure 8). At 24 weeks gestational age, the parietooccipital fissure is seen. This is 
followed by the appearance of the cingulate sulci at 28 weeks gestational age with additional 
branching occurring into full term (North & Lowe, 2009; Rumack et. al., 2005). 
 
 
Fig. 8. Coronal image of a 24 week gestation preterm infant. Note the lack of cerebral sulci. 
Only the Sylvian Fissures are clearly visible. 
3.2 Persistent fetal fluid-filled spaces 
Healthy infants commonly exhibit persistent fetal fluid-filled spaces. Typical findings 
consist of cavum septum pellucidum (CSP), cavum vergae, and cavum veli interpositi. 
Usually, these spaces start to close around the 6th month of gestational age, and most (85%) 
are completely closed by 3-6 months of chronological age, although some may remain 
present into adulthood (Epelman, 2006; Faruggia & Babcock, 1981; Needleman et. al., 2007; 
Osborn, 1991). The CSP is a midline fluid-filled space located anteriorly and between the 
frontal horns of the lateral ventricles (Figure 9). It is formed from failed septal laminae 
fusion (Epelman, 2006). If the space extends posterior to the fornices, it is termed cavum 
vergae. (Bronshtein & Weiner, 1992; Epelman et. al., 2006). A cavum veli interpositi is 
located even further posteriorly as a separate fluid-filled space found in the pineal region. 
Due to the location of the cavum veli interpositi. It must be distinguished from other 
commonly occurring manifestations in this region, specifically, congenital pineal cysts and 
vein of Galen malformations (Chen et. al., 1998; Epelman et. al., 2006). 
3.3 Mega cisterna magna 
A mega cisterna magna is defined as a cisterna magna that measures greater than 8mm in 
either sagittal or axial planes. It is present in approximately 1% of infant brains and is a 
benign finding of no clinical significance. It is, therefore, key not to mistake a mega cisterna 
magna for other malformations that can occur in the posterior fossa (Bernard et. al., 2001; 
Epelman et.al., 2006; Nelson et. al., 2004). Unlike arachnoid cysts, a mega cisterna magna 
will not exhibit mass effect on adjacent structures. It can also be differentiated from Dandy-
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Walker malformations by visualization of the cerebellar vermis (Epelman et.al., 2006; Nelson 
et. al., 2004). 
 
 
Fig. 9. Coronal image of a term neonate demonstrating a midline fluid-filled space between 
the frontal horns of the lateral ventricles consistent with a cavum septum pellucidum (csp). 
3.4 Asymmetric ventricular size 
20-40% of infants may exhibit asymmetrical ventricular size (Middleton et. al., 2009; Seigel, 
2002; Winchester et. al., 1986). This can appear as a discrepancy between the frontal and 
occipital horn size termed colpocephaly or as variations in sizes of the left and right 
ventricles. The former may co-occur with agenesis of the corpus callosum or Chiari II 
malformations. (Achiron et. al., 1997; Horbar et. al., 1983; Seigel, 2002). The latter is a 
common finding in which the less dependent ventricle is the largest. The left ventricle is 
most commonly the bigger of the two with sizes varying depending on patient position 
(Enriquez et. al., 2003; Koeda et. al., 1988; Seigel, 2002). 
3.5 Choroid plexus variants 
The choroid plexus is located at the roof of the third ventricle and travels through the 
foramen of Monro into the lateral ventricles (North & Lowe, 2009; Seigel, 2002). It does 
not extend into the frontal or occipital horns, so hyperechoic material in these areas 
should suggest pathology. Choroid appearing substance anterior to the caudothalamic 
groove is likely a germinal matrix hemorrhage, while interventricular hemorrhage may be 
indicated by hyperechoic material in the dependent  portions of the occipital horns (Grant 
et. al., 1983; Seigel, 2002). Choroid plexus morphology, however, is variable and should 
not be confused with hemorrhage. This is especially true in the glomus of the lateral 
ventricles and ventricular atria where lobular and bulbous choroid is commonly seen 
(Figure 10). The occipital horns may also display bulbous and drumstick-shaped choroid 
variations, particularly in conjunction with Chiari II malformations (Di Salvo, 2001; Seigel, 
2002).  
In addition, choroid cysts are commonly identified (Figure 11). When seen in isolation and 
measuring less than 1cm, they are considered a benign finding (DeRoo et. al., 1988; Epelman 
et. al., 2006; Ostlere et. al., 1990; van Baalen & Versmold, 2004). When choroid cysts are 
found to be multiple, bilateral, or greater than 1 cm in size, this may suggest a chromosomal 
abnormality (Gupta et. al., 1995; Seigel, 2002). 
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A.                                                                      B. 
Fig. 10. Sagittal images of the (a) right and (b) left lateral ventricles demonstrating 
asymmetry in the choroid plexus (arrows) with the right being larger and more lobulated 
than the left. Both are normal. 
 
  
A.                                                                      B. 
Fig. 11. Coronal (a) and Sagittal (b) images demonstrate and anechoic, cystic structure 
(arrows) arising from the anterior choroid consistent with a choroid plexus cyst. 
3.6 Periventricular cystic lesions 
Connatal cysts, subependymal cysts, germinolytic cysts, and white matter cysts can all 
appear in the periventricular area (Epelman et. al., 2006; North & Lowe, 2009). Connatal 
cysts are always found in  immediate proximity with the frontal horns where they are found 
in multiples and exhibit a string of pearls appearance (Figure 12). They are a normal variant 
believed to be caused by deficient coaptation of the ventricles (Chang et. al., 2006; Enriquez 
et. al., 2003; Epelman et. al, 2006; Pal et. al., 2001; Rosenfeld et. al., 1997). These cysts are 
often discovered shortly after birth and usually undergo spontaneous regression (Chang et. 
al., 2006; Rosenfeld et. al., 1997). Subependymal cysts and germinolytic cysts both occur at 
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the caudothalamic groove. Subependymal cysts are the sequlae of germinal matrix 
hemorrhages and geminolytic cysts are commonly seen in metabolic disorders. Despite the 
differing pathophysiology, the imaging characteristics are identical and the two cysts cannot 
be distinguished from one another. (Epelman et. al., 2006; Herini et. al., 2003). Lastly, 
hypoxia and ischemic injury in preterm infants can lead to white matter cysts located near 
the lateral ventricles in cases of cystic periventricular leukomalacia (Figure 13) (Epelman et. 
al., 2006; North & Lowe, 2009). 
 
 
Fig. 12. Cystic lesions in the bilateral frontal periventricular white matter (arrows) consistent 
with connatal cysts. Connatal cysts are considered to be a normal variant. 
 
   
A. B. 
Fig. 13. (a) Coronal and (b) Sagittal images demonstrating multiple cystic lesions in the 
posterior periventricular white matter consistent with cystic periventricular leukomalacia. 
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3.7 Periventricular halos 
Periventricular halos are hyperechoic white matter pseudolesions found adjacent to 
ventricles (Figure 14). They are discovered more often in preterm than term infants and are 
caused by anisotropic effect. These artifacts tend to disappear on tangential imaging and 
should have less echogenicity than  neighboring choroid plexus (Enriquez et. al., 2003; 
Seigel, 2002). Linear imaging may serve a complimentary role in evaluation, helping 
distinguish between normal and abnormal processes. Pathological findings such as 
periventricular hemorrhage, leukmalacia, or other abnormalities, are seen in two planes 
(DiPietro et. al., 1986; Schafer et. al., 2009). 
 
 
 
Fig. 14. Coronal image in a premature infant (note the lack of sulci) demonstrating 
hyperechoic psedudolesions in the periventricular white matter consistent with normal 
“periventricular halo”. This should not be confused with the more echogenic, less 
homogeneous findings of periventricular luekomalacia. 
3.8 Lenticulostriate vasculopathy 
Lenticulostriate vasculopathy appears as linear, branching or punctate increased 
echogenicity within the thalami (Figure 15). It can be unilateral or bilateral (Cabanas et. 
al., 1994; Coley et. al., 2000; Makhoul et. al., 2003). It is associated with congenital 
infections (TORCH infections), metabolic syndromes (peroxisomal biogenesis disorders), 
severe congenital heart disease, and chromosomal anomalies (Patau’s syndrome) which 
are all believed to cause lenticulostriate artery wall thickening (Cabanas et. al. 1994; 
Leijser et. al., 2007; Makhoul et. al., 2003; Te Pas et. al., 2005; Teele et. al., 1988). 
Sometimes, however, no specific cause can be ascertained making lenticulostriate 
vasculopathy a non-specific finding on sonography(Cabanas et. al., 1994; Coley et. al., 
2000; Makhoul et. al., 2003). 
 
Neuroimaging – Methods 
 
230 
 
Fig. 15. Sagittal image of the right lateral ventricle and thalamus demonstrating echogenic 
linear and branching vessels in the thalamus consistent with lenticulostriate vasculopthy. 
4. Conclusion 
Technical advances in ultrasound examination have made this a highly sensitive means to 
detect and guide treatment for pediatric cranial pathologies. When performing a head 
ultrasound, it is important to use modern modalities to full advantage. Doppler and linear 
sonography as well as the use of additional fontanels play a key role in the evaluation of the 
pediatric brain. Further knowledge of normal anatomy, normal variants, and imaging 
pitfalls increases diagnostic accuracy and helps to limit misdiagnoses. 
5. References 
Achiron R, Yagel S, Rotstein Z, Inbar O, Mashiach S, Lipitz S. Cerebral lateral ventricular 
 asymmetry: is this a normal ultrasonographic finding in the fetal brain? Obstet 
 Gynecol 1997; 89:233–237 
Allison JW, Faddis LA, Kinder DL, Roberson PK, Glasier CM, Seibert JJ. Intracranial 
 resistive index (RI) values in normal term infants during the first day of life. Pediatr 
 Radiol 2000; 30:618–620 
Bernard JP, Moscoso G, Renier D, Ville Y. Cystic malformations of the posterior fossa. Prenat 
 Diagn 2001; 21:1064-1069 
Brennan KC, Lowe LH, Yeaney GA. Pediatric central nervous system posttransplant 
 lymphoproliferative disorder. AJNR 2005; 26:1695–1697 
Bronshtein M, Weiner Z. Prenatal diagnosis of dilated cava septi pellucidi et vergae: 
 associated anomalies, differential diagnosis, and pregnancy outcome. Obstet 
 Gynecol 1992; 80:838–842 
Bulas DI, Vezina GL. Preterm anoxic injury: radiologic evaluation. Radiol Clin North Am 
 1999; 37:1147–1161 
Cabanas F, Pellicer A, Morales C, Garcia-Alix A, Stiris TA, Quero J. New pattern of 
 hyperechogenicity in thalamus and basal ganglia studied by color Doppler flow 
 imaging. Pediatr Neurol 1994; 10:109–116 
 
Pediatric Cranial Ultrasound: Techniques, Variants and Pitfalls 
 
231 
Chang CL, Chiu NC, Ho CS, Li ST. Frontal horn cysts in normal neonates. Brain Dev 2006; 
 28: 426–430 
Chen CY, Chen FH, Lee CC, Lee KW, Hsiao HS. Sonographic characteristics of the cavum 
 velum interpositum. AJNR 1998; 19:1631–1635 
Coley BD, Rusin JA, Boue DR. Importance of hypoxic/ischemic conditions in the 
 development of cerebral lenticulostriate vasculopathy. PediatrRadiol 2000; 30:846–
 855 
Daneman A, Epelman M, Blaser S, Jarrin JR. Imaging of the brain in full-term neonates: does 
 sonography still play a role? Pediatr Radiol 2006; 36:636–646 
DeRoo TR, Harris RD, Sargent SK, Denholm TA, Crow HC. Fetal choroid plexus cysts: 
 prevalence, clinical significance, and sonographic appearance. AJR 1988; 151:1179–
 1181 
DiPietro MA, Brody BA, Teele RL. Peritrigonal echogenic “blush” on cranial sonography: 
 pathologic correlates. AJR 1986; 146:1067–1072 
Di Salvo DN. A new view of the neonatal brain: clinical utility of supplemental neurologic 
 US imaging windows. RadioGraphics 2001; 21:943–955 
Enriquez G, Correa F, Lucaya J, Piqueras J, Aso C, Ortega A. Potential pitfalls in cranial 
 sonography. Pediatr Radiol 2003; 33:110–117 
Epelman M. The whirlpool sign. Radiology 2006; 240:910–911 
Epelman M, Daneman A, Blaser SI, et al. Differential diagnosis of intracranial cystic lesions 
 at head US: correlation with CT and MR imaging. RadioGraphics 2006; 26:173–196 
Epelman M, Daneman A, Kellenberger CJ, et al. Neonatal encephalopathy: a prospective 
 comparison of head US and MRI. Pediatr Radiol 2010; 40:1640–1650 
Farruggia S, Babcock DS. The cavum septi pellucidi: its appearance and incidence with 
 cranial ultrasonography in infancy. Radiology 1981; 139: 147–150 
Grant EG, Schellinger D, Borts FT, et al. Realtime sonography of the neonatal and infant 
 head. AJR 1981; 136:265–270 
Grant EG, Schellinger D, Richardson JD, Coffey ML, Smirniotopoulous JG. Echogenic 
 periventricular halo: normal sonographic finding or neonatal cerebral hemorrhage. 
 AJR 1983; 140:793–796  
Gupta JK, Cave M, Lilford RJ, et al. Clinical significance of fetal choroid plexus cysts. Lancet 
 1995; 346:724–729 
Herini E, Tsuneishi S, Takada S, Sunarini, Nakamura H. Clinical features of infants with 
 subependymal germinolysis and choroid plexus cysts. Pediatr Int 2003; 45:692–696 
Horbar JD, Leahy KA, Lucey JF. Ultrasound identification of lateral ventricular asymmetry 
 in the human neonate. J Clin Ultrasound 1983; 11:67–69 
Huang BY, Castillo M. Hypoxic-ischemic brain injury: imaging findings from birth to 
 adulthood. RadioGraphics 2008; 28:417–439; quiz, 617 
Koeda T, Ando Y, Takashima S, Takeshita K, Maeda K. Changes in the lateral ventricle with 
 the head position: ultrasonographic observation. Neuroradiology 1988; 30:315–318 
Leijser LM, de Vries LS, Rutherford MA, et al. Cranial ultrasound in metabolic disorders 
 presenting in the neonatal period: characteristic features and comparison with MR 
 imaging. AJNR 2007; 28:1223–1231 
Lipman B, Serwer GA, Brazy JE. Abnormal cerebral hemodynamics in preterm infants with 
 patent ductus arteriosus. Pediatrics 1982; 69:778–781 
 
Neuroimaging – Methods 
 
232 
Lowe LH, Bulas DI. Transcranial Doppler imaging in children: sickle cell screening and 
 beyond. Pediatr Radiol 2005; 35:54–65 
Makhoul IR, Eisenstein I, Sujov P, et al. Neonatal lenticulostriate vasculopathy: further 
 characterisation. Arch Dis Child Fetal Neonatal Ed 2003; 88:F410–F414 
Middleton WD, Kurtz AB, Hertzbert BS. Ultrasound: the requisites. St. Louis, MO: Mosby-
 Year Book, 2009:377 
Needelman H, Schroeder B, Sweeney M, Schmidt J, Bodensteiner JB, Schaefer GB. Postterm 
 closure of the cavum septi pellucidi and developmental outcome in premature 
 infants. J Child Neurol 2007; 22:314–316 
Nelson MD Jr, Maher K, Gilles FH. A different approach to cysts of the posterior fossa. 
 Pediatr Radiol 2004; 34:720–732 
North K, Lowe L. Modern head ultrasound: normal anatomy, variants, and pitfalls that may 
 simulate disease. Ultrasound Clin 2009; 4:497–512 
Osborn A. Handbook of neuroradiology. St. Louis, MO: Mosby-Year Book, 1991 
Ostlere SJ, Irving HC, Lilford RJ. Fetal choroid plexus cysts: a report of 100 cases. Radiology 
 1990; 175:753–755 
Pal BR, Preston PR, Morgan ME, Rushton DI, Durbin GM. Frontal horn thin walled cysts in 
 preterm neonates are benign. Arch Dis Child Fetal Neonatal Ed 2001; 85:F187–F193 
Rosenfeld DL, Schonfeld SM, Underberg-Davis S. Coarctation of the lateral ventricles: an 
 alternative explanation for subependymal pseudocysts. Pediatr Radiol 1997; 27:895–
 897 
Rumack C, Wilson S, Charboneau J. Diagnostic ultrasound. St. Louis, MO: Mosby, 2005 
Schafer RJ, Lacadie C, Vohr B, et al. Alterations in functional connectivity for language in 
 prematurelyborn adolescents. Brain 2009; 132:661–670  
Seigel M, ed. Pediatric sonography, 3rd ed. Philadelphia, PA: Lippincott Williams & Wilkins, 
 2002 
Slovis TL, Kuhns LR. Real-time sonography of the brain through the anterior fontanel. AJR 
 1981; 136:277–286 
Soetaert AM, Lowe LH, Formen C. Pediatric cranial Doppler sonography in children: non-
 sickle cell applications. Curr Probl Diagn Radiol 2009; 38:218–227 
Sudakoff GS, Montazemi M, Rifkin MD. The foramen magnum: the underutilized acoustic 
 window to the posterior fossa. J Ultrasound Med 1993; 12:205–210 
Te Pas AB, van Wezel-Meijler G, Bokenkamp-Gramann R, Walther FJ. Preoperative cranial 
 ultrasound findings in infants with major congenital heart disease. Acta Paediatr 
 2005; 94:1597–1603 
Teele RL, Hernanz-Schulman M, Sotrel A. Echogenic vasculature in the basal ganglia of 
 neonates:a sonographic sign of vasculopathy. Radiology 1988; 169:423–427 
van Baalen A, Versmold H. Choroid plexus cyst: comparison of new ultrasound technique 
 with old histological finding. Arch Dis Child 2004; 89:426 
Winchester P, Brill PW, Cooper R, Krauss AN, Peterson HD. Prevalence of “compressed” 
 and asymmetric lateral ventricles in healthy full-term neonates: sonographic study. 
 AJR 1986; 146 
12 
Impact of White Matter Damage After Stroke 
Robert Lindenberg1,2 and Rüdiger J. Seitz3,4  
1Department of Neurology, Beth Israel Deaconess Medical Center and  
Harvard Medical School, Boston, Massachusetts,  
2Department of Neurology, Charité – Universitaetsmedizin Berlin, Berlin, 
3Department of Neurology, University Hospital Düsseldorf and Biomedical  
Research Centre, Heinrich-Heine-University Düsseldorf  
4Florey Neuroscience Institutes, Melbourne, Victoria, 
1USA 
2,3Germany 
4Australia 
1. Introduction 
Ischemic stroke is one of the leading causes of persistent disability in Western countries 
(Bejot et al., 2007). It results from cessation of blood supply due to an occlusion of a cerebral 
artery. Many patients benefit from thrombolysis with the approved drug recombinant tissue 
plasminogen activator (rtPA). Nevertheless, the clinical effect of intravenously administered 
rtPA is variable (Hallevi et al., 2009; Wahlgren et al., 2008) which is of particular importance 
for middle cerebral artery (MCA) stroke: It has been demonstrated that early artery 
recanalisation yields unevenly distributed, circumscribed infarct lesions within the MCA 
territory with a great potential for functional recovery; in contrast, failed recanalisation 
results in large infarcts with a limited potential for functional recovery (Figure 1). 
Accordingly, an important factor contributing to recovery from stroke is the early 
restoration of cerebral blood flow. Spontaneous recovery is known to continue for the 
subsequent weeks to months (Cramer, 2008). Furthermore, recovery can be facilitated by 
dedicated rehabilitative training with greater effects in greater dosing of training (Kwakkel, 
2006) even years after the stroke (Stinear et al., 2007). 
Animal studies (Dancause et al., 2005) as well as imaging and electrophysiological studies in 
humans (Butefisch et al., 2006) have suggested that recovery is brought about by cerebral 
plasticity. Cerebral plasticity pertains to functional changes such as synaptic efficiency as 
well as structural changes such as synaptic sprouting (Dancause et al., 2005; Nudo et al., 
1996). Even in the adult brain, a loss of hand motor function due to small cortical lesions 
within the sensorimotor cortex can be completely restored (Binkofski and Seitz, 2004). 
However, there are limits to plasticity. For example, severe damage to major pathways such 
as the pyramidal tract (PT) can be compensated for to some extent, but full functional 
recovery is often not possible (Lang and Schieber, 2004).  
To date, neuroimaging studies of brain infarcts have mostly examined grey matter 
alterations. Recent advances in diffusion tensor imaging (DTI) and lesion-symptom 
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mapping techniques provided novel ways to investigate the white matter in the context of 
recovery from stroke (Johansen-Berg et al., 2010). The crucial role of the white matter for 
functional outcome can be illustrated by the observation that small cortical infarcts, e.g. in 
the precentral gyrus, typically allow for profound recovery from stroke, whereas infarcts of 
similar volume in the peri-ventricular white matter or the internal capsule may induce a 
severe and persistent hemiparesis (Kretschmann, 1988; Wenzelburger et al., 2005). Focusing 
on DTI and lesion mapping, we will discuss recent studies that established white matter 
damage as an important factor for functional outcome in the acute stroke phase. 
Furthermore, alterations of fibre tracts will be presented as a critical determinant of 
functional recovery due to cerebral plasticity in the subacute and chronic phases after stroke. 
 
 
Fig. 1. Neurological deficit as assessed with the NIHSS in 108 MCA stroke patients. 
Successful thrombolysis with early MCA recanalization resulted in a significant neurological 
improvement (*: p<0.0001). Adapted from (Seitz et al., 2009). 
2. Lesion mapping in the acute phase after stroke 
Different modalities of magnetic resonance imaging (MRI) are widely used to visualise brain 
lesions. In acute stroke, perfusion-weighted imaging (PWI) and diffusion-weighted imaging 
(DWI) can identify the area of acute ischemia. After reperfusion, PWI deficits can be 
resolved (Davis et al., 2008; Seitz et al., 2005), and also DWI alterations are partly reversible 
(Kranz and Eastwood, 2009). By use of lesion mapping it has been found that the 
hemispheric white matter is preferentially affected in patients with major MCA stroke as 
compared to patients with lesion regression (Stoeckel et al., 2007). Similarly, patients with a 
lacking response to rtPA and no recanalization of the MCA, showed larger brain lesions 
with greater hemispheric white matter damage than those with successful thrombolysis 
(Seitz et al., 2009). The large infarct lesions in patients non-responsive to thrombolysis 
occurred adjacent to the insular cortex and basal ganglia in the internal capsule and 
periventricular white matter and were predicted by the maximal perfusion deficit in the 
acute phase of stroke. These infarcts corresponded to the type II.2 MCA infarcts as described 
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recently (Seitz and Donnan, 2010). Note the close topographic correspondence of the mean 
area of the most severe perfusion deficit, the DWI abnormalities, and the lesion overlap in 
the periventricular white matter found in the patients with severe MCA stroke (Figure 2). 
Since the structural alterations project onto the corona radiate, the corresponding damage of 
well-defined fibre bundles—such as corticospinal motor tracts—can be assessed specifically 
by electrophysiology and MRI techniques such as DTI in order to correlate imaging 
measures with parameters of functional outcome. 
 
 
Fig. 2. Lesion pattern in severe MCA stroke. a) Area of the maximal PWI deficit in severely 
as compared to slightly affected patients. b) Area of common DWI-changes before acute 
stroke therapy (n=64). c) Overlap of the residual infarct lesions in hemispheric white matter 
(n=13). Adapted from (Seitz et al., 2009; Stoeckel et al., 2007).  
3. Diffusion tensor imaging: Methodological considerations 
DTI allows for inferences of the microstructural status of regions of interest in the white 
matter or reconstructed tracts (Beaulieu, 2009). DTI is a DWI technique that uses the 
measurement of Brownian motion of water molecules in different directions to reconstruct  
three-dimensional images of diffusivity (Jones, 2008). Whereas molecules can diffuse 
relatively freely in water, structural boundaries such as cell membranes or myelin sheaths 
cause restrictions and yield anisotropic diffusion (Beaulieu, 2002). The degree of diffusion 
anisotropy can then be used to characterise neural tissue and reveal potential pathological 
processes (Beaulieu, 2002; Jones, 2008). As an example, Figure 3 shows images of fibre 
distributions according to the main directions of diffusivity in each voxel of the image. Here, 
the colour-coding allows for the detection of diffusion abnormalities. Main diffusion 
directions of single voxels also provide the basis for deterministic tractography, which 
reconstructs trajectories through a combination of adjacent voxels with similar main 
directions. Probabilistic tractography, in contrast, propagates numerous pathways through 
the tensor field so that each voxel can be coded with a number that reflects its likelihood of 
being connected with a given seed region from which the tracking is started (see (Jones, 
2008) for a review). 
With both the deterministic and probabilistic approaches, major fibre bundles can be 
reliably reconstructed (Mori and Zhang, 2006; Wakana et al., 2004). Furthermore, 
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tractography not only allows for the visualisation of tract alterations after lesions, but can be 
used to quantify those alterations (Johansen-Berg and Behrens, 2006). Furthermore, 
fractional anisotropy (FA) has been used to describe microstructural abnormalities of white 
matter. FA indicates the coherence of aligned fibres and is calculated from directional 
diffusivities (axial and radial). Based on animal experiments, axial diffusivity is thought to 
primarily reflect axonal integrity whereas radial diffusivity has been suggested to relate to 
myelin degradation (Acosta-Cabronero et al., 2009; Naismith et al., 2009; Sidaros et al., 2008; 
Song et al., 2003; Sun et al., 2008). However, the model of a specific relationship of directional 
diffusivities with discrete pathological processes such as axonal damage or demyelination is 
controversial, especially in regions of complex fibre architecture (Wheeler-Kingshott and 
Cercignani, 2009). Interpretations of these parameters with respect to “fibre integrity” 
should therefore be made with caution.  
 
 
Fig. 3. DTI image of a patient with persistent hemiplegia in a striatocapsular infarct. Arrows 
point to severe diffusion alteration of corticospinal fibres descending in the posterior limb of 
the internal capsule and the cerebral pedunculus. The colour bar indicates the spatial 
orientation of fibres; blue: predominantly inferior—superior orientation, green: 
predominantly anterior—posterior orientation, red: predominantly left—right orientation. 
4. Assessing the impact of white matter damage on motor function using DTI 
Although the concept of disconnection syndromes is well established and helps explaining 
functional deficits after lesions (Geschwind, 1965a; Geschwind, 1965b), the involvement of 
the white matter in stroke has not received much attention until recently (e.g., (Catani and 
ffytche, 2005). White matter damage has been found to be particularly prominent in large 
cerebral infarcts with hemispatial neglect, apraxia and severe hemiparesis (Karnath et al., 
2009; Pazzaglia et al., 2008; Seitz et al., 2009; Stoeckel et al., 2007). However, it is not merely 
the size of the infarct but preferentially its location that determines the functional outcome 
after stroke (Binkofski et al., 1996; Chen et al., 2000; Zhu et al., 2010). 
The importance of corticospinal fibres for recovery of motor function after stroke has been 
demonstrated with different imaging modalities as well as electrophysiological measures 
(Binkofski et al., 1996; Fries et al., 1991; Schaechter et al., 2008; Stinear et al., 2007). Based on 
animal studies, it has been suggested that so-called alternate motor fibres (aMF) can 
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compensate for motor impairment after severe damage to the PT (Lang and Schieber, 2004). 
In monkeys and cats, the cortico-reticulo-spinal and cortico-rubro-spinal tracts may mediate 
motor functions in case of PT lesions (Canedo, 1997), whereas these tracts have been 
described as functionally redundant in healthy animals (Kennedy, 1990). In more detail, it 
has been observed that damage to the PT and the rubro-spinal tract of monkeys yielded 
therapy-refractory impairment of the contralateral upper extremity, but monkeys with 
lesions to the PT that spared the rubro-spinal tract were able to recover considerably 
(Lawrence & Kuypers, 1968a; Lawrence & Kuypers, 1968b). Furthermore, changes in the 
synaptic organization of rubro-spinal neurons in response to PT lesions have been reported 
in monkeys (Belhaj-Saïf & Cheney, 2000). 
The first neuroimaging study that translated these findings into motor recovery after human 
stroke combined structural MRI and electrophysiology to demonstrate that, despite severe 
degeneration of the PT, motor evoked potentials (MEP) could still be elicited from the 
ipsilesional motor cortex in patients who had recovered from stroke (Fries et al., 1991). 
Similarly, patients with hemiparesis due to focal PT lesions were still able to execute 
individuated finger movements contralateral to the lesion, but with reduced selectivity 
(Lang and Schieber, 2004). These studies in humans illustrate the role of aMF after stroke 
similar to that observed in non-human primates. 
Using diffusivity parameters and tractography, researchers can examine fibre degeneration 
at different stages of motor recovery after stroke (Kang et al., 2000; Lindberg et al., 2007; 
Thomalla et al., 2004; Werring et al., 2000). In the chronic stage, structural damage to the PT 
could be related to measures of functional impairment (Schaechter et al., 2009; Stinear et al., 
2007). Besides the PT, DTI has been applied to reconstruct aMF using deterministic fibre 
tracking algorithms and, thereby, to explore their role for motor recovery after stroke 
(Lindenberg et al., 2010). Consistent with previous animal and human studies mentioned 
above, the differential affection of PT and aMF yielded a three-tier classification system 
suggesting that (1) when both PT and aMF could be reconstructed, patients showed only 
mild impairment, (2) when damage occurred to the PT but aMF remained relatively 
preserved, patients were only moderately impaired, and (3) when pronounced damage to 
both the PT and aMF was visible, patients was most severely impaired (Figure 4). In 
addition, DTI-based tractography allows to topographically relate lesions to corticospinal 
fibres and provides insights into their somatotopic organisation (Konishi et al., 2005; 
Kunimatsu et al., 2003; Lee et al., 2005; Nelles et al., 2008; Newton et al., 2006; Yamada et al., 
2004). Furthermore, the calculation of the overlap between lesion and tracts can explain 
some of the variance in motor outcome after stroke (Zhu et al., 2010). 
5. Predicting functional potential for motor recovery using DTI 
One of the most important clinical questions after stroke is a patient’s potential for recovery 
from stroke-induced deficits. Small cortical infarcts in the precentral gyrus typically allow 
for a profound recovery from hemiparesis. In contrast, infarcts of similar volume in the peri-
ventricular hemispheric white matter or the posterior limb of the internal capsule may 
induce a severe persistent hemiparesis (Kretschmann, 1988). Electrophysiological studies 
suggest that the functional integrity of ipsilesional motor circuits as well as inter-
hemispheric interactions play a major role in motor recovery from hemiparesis after stroke 
(Perez and Cohen, 2009). Although transcranial magnetic stimulation (TMS) has been shown 
to strongly correlate with motor impairment in the acute and subacute phase after stroke, its 
 
Neuroimaging – Methods 
 
238 
predictive value appears unclear in the chronic stage (Talelli et al., 2006). However, a 
combination of TMS and DTI-derived parameters of corticospinal tracts proved to be useful 
in estimating a patient’s potential for recovery when undergoing motor rehabilitation even 
years after the stroke (Stinear et al., 2007). Similarly, DTI in the acute stroke phase helped 
predicting outcome at three months (Jang et al., 2008). 
 
 
Fig. 4. The course of the pyramidal tract (PT) and alternate motor fibres (aMF) from the 
white matter underlying the precentral gyrus to the brainstem in a healthy subject.  
In order to define predictors of therapeutic response to novel rehabilitation techniques such 
as non-invasive brain stimulation, it may be useful to examine transcallosal motor fibres as 
well. Using transcranial direct current stimulation (tDCS) or repetitive TMS, it has been 
demonstrated that both the up-regulation of intact portions of the ipsilesional and down-
regulation of contralesional motor cortices facilitates motor recovery after stroke (Schlaug et 
al., 2008). Together with evidence from electrophysiological investigations (Perez and 
Cohen, 2009) and functional MRI (Carter et al., 2009; Grefkes et al., 2008), there is ample 
evidence for the importance of inter-hemispheric interactions in functional recovery from a 
stroke. To complement these findings, a study in healthy subjects revealed an association of 
function and microstructure of transcallosal motor connections (Wahl et al., 2007). In chronic 
stroke patients, DTI-derived measures of transcallosal motor fibres as well as ipsilesional 
corticospinal tracts (PT and aMF) could be used to explain the therapeutic response to 
rehabilitation: the more the diffusivity profiles resembled those observed in healthy subjects, 
the greater a patient’s potential for functional recovery (Lindenberg et al., 2011). Thus, 
diffusivity profiles of motor tracts, particularly, in combination with electrophysiological 
 
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measures can serve as predictors of a patient’s potential for spontaneous recovery as well as 
in response to different types of neurorehabilitation techniques. 
6. Impact of white matter damage for functional deficits beyond hemiparesis 
Brain infarcts with white matter involvement lead to disconnection of areas in perilesional 
tissue, but also remote locations. This has been shown using positron emission tomography 
of cerebral blood flow and metabolism as well as with MRI (Feeney and Baron, 1986). Lesion 
analysis by use of statistical parametric mapping revealed that cortical infarcts result in 
remote changes in the ipsilesional thalamus, while striatocapsular infarcts induce changes in 
the contralesional cerebellum (Seitz et al., 1994). Consequently, functional changes occur in 
regions spatially distant from the area of infarction, an event which has been termed 
diaschisis. In the chronic phase after stroke, scar formation and fibre degeneration have been 
shown to result in brain atrophy (Kraemer et al., 2004). Many patients retain functional 
impairments which can be documented by dedicated investigations including 
neuropsychology, electrophysiology and DTI. A clinical example is ataxic hemiplegia 
resulting from infarct lesions around the internal capsule with cortico-cerebellar 
disconnection (Classen et al., 1995). Similarly, callosal infarcts can induce a lasting 
decoupling of both hands (Seitz et al., 2004). Infarcts in the frontal parasagittal white matter 
can produce a deficit of visual face processing probably due to disruption of fronto-
occipitotemporal projections (Schafer et al., 2007). Lesion studies in neglect have 
demonstrated subcortical white matter involvement in the peri-insular area and the internal 
capsule (Karnath et al., 2004). In Gerstmann’s syndrome it has been shown recently that the 
different parietal cortical subareas which process finger naming, colour naming, right-left 
orientation, and calculation can all be impaired by a single subcortical white matter lesion 
affecting the point of convergence of their subcortical projections (Rusconi et al. 2009). These 
data are of considerable interest given the impact of white matter abnormalities for 
cognitive decline and the development of dementia after stroke (Dufouil et al., 2009). Taken 
together, many clinically well-established syndromes are likely to result from cortico-
cortical and cortico-subcortical disconnections. 
7. Fibre tract changes in white matter and cerebral plasticity  
As observed in lesion experiments, intensive rehabilitation allowed animals with damage of 
corticospinal tracts to recover considerably (Maier et al., 2008). In these animals, collateral 
fibres increased their innervation density and extended toward the ventral and dorsal horn 
in response to forced limb use. In contrast, animals that were impeded in their usage of the 
affected limbs remained impaired and did not show such plastic changes. This highlights 
the importance of examining white matter structures to determine the extent of potential 
recovery. In monkeys it has been found that damage of white matter adjacent to lesions in 
the visual cortex determined the extent of remote and transneural degeneration in the dorsal 
geniculate and retina (Cowey et al., 1999). Preliminary results in humans undergoing 
intonation-based speech therapy for chronic aphasia suggest plastic changes in the 
contralesional arcuate fasciculus associated with improvement in speech production 
(Schlaug et al., 2009). In healthy subjects, it has already been demonstrated that DTI allows 
for the detection of white matter changes in response to training, as indicated by an increase 
in FA after training (Scholz et al., 2009). Taken together, homologous contralesional regions 
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or partially preserved perilesional areas and their associated fibre tracts seem to exhibit 
plastic reorganisation upon dedicated training. However, more work in experimental 
animals is needed to come to a better understanding which microstructural and 
physicochemical changes underlie the signal changes assessed with DTI in men. In the 
future, DTI may serve as a surrogate marker of cerebral plasticity and help evaluating a 
patient’s response to rehabilitation. 
8. Conclusions 
White matter changes after stroke are important determinants for presentation and severity 
of the neurological deficits as well as for prospects of recovery or secondary cognitive 
decline. Notably, DTI appears to be a valuable tool for predicting the individual patient’s 
perspective for recovery in order to tailor an optimized rehabilitation regime.  
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1. Introduction
Stroke is a leading cause of death and a major cause of long term disabilities worldwide.
According to the World Health Organization (WHO), a total of 15 million people suffer
from a stroke each year comprising 5 million with a fatal outcome and another 5 million
with permanent disabilities. While prevention research identiﬁes factors and speciﬁc drugs
that may lower the risk of a future stroke, the treatment of ischemic stroke patients aims at
maximizing the recovery of brain tissue at risk. It is typically done by arterial recanalization
of the vessel where the clot is located. Identiﬁcation of salvageable brain tissue is essential
during the clinical decision-making process. As a general rule for the decision to intervene,
the expected beneﬁts of the intervention should outweigh its potential risks and costs. To
identify viable brain tissue, time is considered as a determining factor in the treatment of
stroke patients. A perfect illustration of this timing issue is the thrombolytic therapy which
uses speciﬁc drugs to break-up or dissolve the blood clot. As shown in a recent study (Hacke
et al, 2008), thrombolysis applied with recombinant tissue plasminogen activator (rt-PA) is
effective for acute ischemic stroke patients when administered intra-venously within a speciﬁc
time window (3 hours, or 4 hours 30 min for patients meeting additional criteria). However,
this time frame is arbitrary andmight be too restrictive for some patients (Schaefer et al., 2007).
For example, some patients could have beneﬁted from this therapy but, instead, have been
unnecessarily excluded. Beyond this ongoing debate about the length of the time window,
there is a recognized need for accurate strategies to quantify the extent of viable tissue for
victims of ischemic strokes and therefore to be able to identify the patients who could beneﬁt
from such a therapy.
Estimating the dynamic of infarct growth in ischemic stroke is extremely complex and its
mechanisms are still poorly understood. Various factors such as quality of collateral perfusion,
energy delivery, and age of the patient are known to have a signiﬁcant impact on the
outcome. However, their interactions over time is not clearly established and has not been
quantiﬁed. The most commonly used techniques currently available to predict tissue outcome
are based on imaging. It is widely accepted that the combination of diffusion (DWI) and
perfusion-weighted (PWI) magnetic resonance imaging (MRI) provide useful information
to identify the tissue at risk at an early stage. Several groups (Chen et al., 2008; Fisher
& Ginsberg, 2004; Kidwell et al., 2004; Schlaug et al., 1999) have studied the mismatch
between DWI and PWI to determine the penumbral tissue. However, DWI-PWI mismatch
approaches have limitations: increased diffusion signals may be reversible (although a recent
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study (Chemmanam et al., 2010) has concluded that it does not seem to be a common
phenomenon), and the determination of the threshold of critical perfusion by PWI has been
controversial (Heiss & Sobesky, 2005). DWI-PWI technique is based on the static thresholding
of images and additional analysis is necessary to predict the ﬁnal infarct size.
More recently, considerable attention has been given to the development of automatic,
quantitative predictive models that can estimate the likely evolution of the endangered tissue.
These approaches that have been proposed in the literature differ on the types of images,
and the prediction techniques they employ. Initially, automatic prediction models have been
trained on a voxel-by-voxel basis by integrating multimodal perfusion information from cases
with known follow-up tissue fate. WU et al (Wu et al., 2001; 2007) proposed in one of their
studies a framework based on a generalized linear model (GLM) and evaluated 14 ischemic
stroke patients. Results showed that combining parameters computed from DWI and PWI
offers higher speciﬁcity and sensitivity than models trained on DWI, or PWI alone. ROSE et
al (Rose et al., 2001) used Gaussian models trained on multiple parameters (DWI, CBF, CBV,
mean transit time (MTT)) to predict tissue outcome on 19 ischemic stroke patients. Other
studies based on logistic regression (Yoo et al., 2010), on ISODATA clustering (Shen et al.,
2005) applied to ADC andCBF have also led to similar conclusions; the combination of various
parameters improves the prediction accuracy. In addition to the DWI-PWI mismatch, several
studies (Olivot, Mlynash, Zaharchuk, Straka, Bammer, Schwartz, Lansberg, Moseley &Albers,
2009; Olivot, Mlynash, Thijs, Purushotham, Kemp, Lansberg, Wechsler, Gold, Bammer, Marks
& Albers, 2009) have demonstrated that time-to-maximum (Tmax) of the residue function
is a reliable parameter to detect penumbra in acute stroke because it implicitly captures a
complex combination of delay and dispersion. It has been shown to predict actual CBF
more accurately than mean transit time (MTT) (Olivot, Mlynash, Zaharchuk, Straka, Bammer,
Schwartz, Lansberg, Moseley & Albers, 2009).
The regional information contained in the surrounding voxels of the location to be predicted
has been shown in recent works to improve the accuracy of the predictive model in
comparison with a single-voxel-based method. Although some regional information may
implicitly be included by single-voxel-based methods via the convolution of the image
with a smoothing ﬁlter, it is usually not taken into account by the models. Promising
approaches have attempted to take into account the regional distribution explicitly by
exploiting spatial correlation between voxels (Nguyen et al., 2008), using a prior map of
spatial frequency-of-infarct (Shen & Duong, 2008), and Neural Networks (Huang et al.,
2010). All these studies have demonstrated signs of improvement in comparison with
single-voxel-based approaches.
Drawing from these ﬁndings, this chapter introduces a predictive model of tissue fate that
captures the relationship between spatial patterns observed in perfusion images after onset
and tissue outcome. This work presents a comparative analysis of the predictive power of
different ﬂow parameters extracted from Perfusion Weighted Images (PWI) during the acute
phase of the stroke. Speciﬁcally, Cerebral Blood Volume (CBV), Cerebral Blood Flow (CBF),
Mean Transit Time (MTT), Tmax, Time-To-Peak (TTP), and Peak are extracted and evaluated
in this study. The predictive model is formalized as a nonlinear regression problem. It
combines the tissue information available at onset in terms of Fluid Attenuated Inversion
Recovery (FLAIR) images with parameters extracted from PWI to predict the tissue outcome
four days after intervention. FLAIR images are used in this study to identify lesions from
previous strokes and, to a lesser extent, early lesions in the acute phase. They are also used
to assess the survival outcome of the brain tissue four days after intervention. While FLAIR
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is the gold standard in neurology to depict irreversible lesions, PWI parameters represent
ﬂow-related features that may be useful for the prediction of tissue outcome.
The novelty of the proposed work is to study the impact of a regional model on each of
these perfusion maps (CBV, CBF, MTT, Tmax, Peak, TTP). The regional distribution among
neighboring voxels is represented by cuboids (i.e. rectangular volumes) (Fig 1(a)). By varying
the size of these cuboids, we expect to determine what is the optimal size for each map that
leads to the most accurate tissue fate prediction. Such an approach can be seen as a 3D
generalization of subwindows-based stochastic methods (Maree et al., 2005) that have been
successfully used on a wide variety of image classiﬁcation problems.
During learning, the cuboids are sampled at similar locations in FLAIR and one of the
perfusion images, and each pair of cuboids is combined into a single vector and used as
input to the predictive model. The output is the tissue fate, in terms of FLAIR voxel intensity,
measured 4-days after an arterial recanalization intervention. A Kernel Spectral Regression
(SR-KDA) (Cai et al., 2007) model is used to represent the relation that exists between PWI
parameters combined with FLAIR images at onset and the tissue fate.
2. Image-based prediction of tissue outcome
2.1 Patients, and MRI data acquisition
MRI data was collected from patients identiﬁed with symptoms of ischemic stroke and
admitted at the University of California-Los Angeles Medical Center. The use of these data
was approved by the local institutional review board (IRB). Inclusion criteria for this study
included: (1) presenting symptoms suggestive of acute stroke, (2) last known well time within
six hours, (3) MRI (including PWI) of the brain performed before recanalization therapy and
approximately four days later, (4) ﬁnal diagnosis of ischemic stroke. A total of 25 patients
(mean age, 56± 21 years; age range, 27 to 89; 15 women; average NIHSS of 14± 6.3) satisﬁed
the above criteria and underwent MRI using a 1.5 Tesla echo planar MR imaging scanner
(Siemens Medical Systems). The PWI scanning was performed with a timed contrast-bolus
passage technique (0.1 mg/kg contrast administered intravenously at a rate of 5 cm3/s) and
with the following parameters on average: repetition time (TR), 2000 ms; echo time (TE), 60
ms. The FLAIR sequence was acquired with the following parameters: repetition time (TR),
7000 ms; echo time (TE), 105 ms; inversion time (TI), 2000 ms. All the images were resized
using bilinear interpolation to match a resolution of 1× 1× 5 mm per voxel.
The median time from symptom onset to baseline MRI was 4h38 (IQR 1h43, 5h39), and to
followup MRI was 4 days 13h30 (IQR 3 days 15h08, 4 days 22h17). Median time from onset
to intervention was 6h20. The degree of success of the intervention in terms of recanalization
and reperfusion, as well as the quality of collaterals have a signiﬁcant impact on the tissue
fate. These factors are not taken into account in our predictive model because it relies only on
onset images.
2.2 Prediction framework
The prediction framework proposed in this chapter relies on a regressionmodel that is learned
in a supervised fashion from a set of training images with known outcome. Once the model
has been trained, it can be used to predict the tissue fate, in terms of followup FLAIR intensity,
on new cases. The following subsections describe a series of preprocessing steps (Figure 1(b))
prior to the predictive modeling.
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(a) Cuboid (b) Prediction Framework
Fig. 1. (a) Illustration of a cuboid extracted from the brain volume. (b) During prediction, the
skull is ﬁrst stripped from the FLAIR image and the result is normalized. A parameter map
is extracted from PWI images and registered to FLAIR images. Cuboids are sampled at the
same locations from both images and used as input to the regression model to predict the
tissue outcome.
2.2.1 Automatic brain volume segmentation
Before learning, the framework requires FLAIR images acquired immediately after onset and
at followup to be co-registered. The skull and non-brain tissue could interfere with the
registration process and therefore have been stripped.
To perform this brain extraction step, we use the FSL Brain Extraction Tool (BET) (Smith., 2002)
that is integrated into a pipeline software developed by the Laboratory of Neuro Imaging
(LONI) at UCLA (http://www.loni.ucla.edu/). BET estimates an intensity threshold to
discriminate between brain/non-brain voxels. Then, it determines the center of gravity of the
head, deﬁnes a sphere based on the center of gravity of the volume, and ﬁnally deforms it
toward the brain surface.
2.2.2 FLAIR image normalization
Because FLAIR images were acquired with different settings and originated from different
patients, their intensity value was not directly comparable. To allow for inter-patient
comparisons, FLAIR images were normalized with respect to the average intensities within
the contralateral white matter. The normal-appearing white matter was delineated manually
by an experienced researcher for both onset and follow-up brain volumes.
2.2.3 Perfusion imaging features
Imaging features are extracted from PWI images with a software developed at UCLA, the
Stroke Cerebral Analysis (SCAN) package. The tissue contrast agent concentration C(t) is
expressed as a convolution of the arterial input function (AIF) identiﬁed from the contralateral
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middle cerebral artery (MCA) and the residue function R(t) (Calamante et al., 2010)
C(t) = CBF× (AIF(t)⊗ R(t)), (1)
where CBF is the cerebral blood ﬂow. The residue function is obtained by deconvolution, and
the time to its maximum value is used to specify Tmax. Therefore, Tmax is the arrival delay
between the AIF and C(t).
After applying a gamma variate ﬁt on a pixel-by-pixel basis, cerebral blood volume (CBV) is
estimated in each voxel by computing the area under the ﬁtted gadolinium concentration time
curve, measured in the corresponding image pixel at every time point after bolus arrival:
CBV =
Nc
∑
t=0
C(t). (2)
The mean transit time (MTT) is computed as the normalized ﬁrst moment of the ﬁtted curve,
up to the peak of the curve. The time to peak contrast concentration (TTP) is another
perfusion-related parameter that corresponds to the time it takes for signal intensity to reach
its minimum in each pixel. The value of this minimum is used to deﬁne another feature called
Peak.
Finally, CBV and MTT are used to calculate the cerebral blood ﬂow (CBF) through the tissue
voxel, according to the central volume theorem:
CBF =
CBV
MTT
. (3)
2.2.4 Image registration
Registration of FLAIR and PWI images is necessary because the outcome of an extracted
cuboid, measured as a voxel value in the followup image, has to correspond to the same
anatomical location in the different volumes. Co-registration was performed for each patient
independently. Because the intensity of FLAIR images may present large variations between
onset and followup due to changes in the tissue perfusion caused by the stroke, several
attempts to use automatic image registration methods failed to accurately align the volumes.
Instead, our framework utilized ﬁve landmark points placed manually at speciﬁc anatomical
locations (center, plus four main cardinal directions) on the slice of the brain that had the
largest ventricular area. An afﬁne projection was applied to project the followup FLAIR and
acute Tmax on the original FLAIR volume.
2.2.5 Ground truth
During evaluation, we pose the prediction task as a two-class classiﬁcation problem, where the
voxel of the groundtruth is set to 1 if it is infarcted and 0 if it is not. The groundtruth is obtained
by manual outline of infarcts on FLAIR images by an expert in neurology from UCLA
who was asked to precisely delineate infarcts, comparing the infarcted hemisphere with
the contralateral hemisphere. Outlining was performed with the help of the commercially
available medical imaging software 3D DOCTOR developed by ABLE SOFTWARE CORP
(http://www.ablesw.com/). No manual outlining is made on the predicted images.
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2.2.6 Cuboid sampling
For training, we exploit a set of FLAIR images F at onset, their corresponding co-registered
PWI feature map M, and followup FLAIR images F′.
The dataset {X,Y} used to train and to evaluate the predictive model is created by extracting
cuboids of ﬁxed size w× l × d among onset images with their corresponding outcome. Each
cuboid c ∈ Rs is described by its raw voxel values, yielding an input vector of s = w× l × d
numerical attributes. Our method extracts a large number of cuboids at random positions
from training images. In practice, given a sampled location {i, j, k}, we extract a cuboid
cF in the acute FLAIR image at F(i, j, k) and a corresponding cuboid cM in the perfusion
map at M(i, j, k). To improve the generalization power of the predictive model, the cuboids
cM, cF are normalized with respect to the direction θ of the image gradient in the XY plane
using an image rotation, performed with bilinear interpolation. Normalized patches cM′ , cF′
thus become invariant to orientation changes in the XY plane. Orientation normalization
is particularly useful when considering the case where cuboids are located at the same
distance from a circular infarction but at different directions. If no rotational normalization
is performed, all the cuboids have a different appearance and the model has to be trained for
all the directions around the infarct and requires more training examples.
cM′ = imrotate(cM,−θM) θM = tan−1
Lσy,M(x, y, z)
Lσx,M(x, y, z)
(4)
cF′ = imrotate(cF,−θF) θF = tan−1
Lσy,F(x, y, z)
Lσx,F(x, y, z)
(5)
where Lσx,F, L
σ
x,F, L
σ
x,M, L
σ
y,M are the Gaussian derivatives in X and Y directions, computed from
the acute FLAIR image F and perfusion map M,
Lσx,M =
∂
∂x
Gσ ⊗ M Lσy,M =
∂
∂y
Gσ ⊗ M (6)
Lσx,F =
∂
∂x
Gσ ⊗ F Lσy,F =
∂
∂y
Gσ ⊗ F (7)
where Gσ is a 2D isotropic Gaussian ﬁlter with standard deviation σ = 3 in our experiments.
The two cuboids are merged into a single, multi-modal cuboid x = {cF′ , cM′ } that corresponds
to the concatenation of the cuboids extracted at the same location in the different volumes.
Each multi-modal cuboid x is then labeled with the intensity y of the central voxel in the
corresponding follow-up FLAIR image y = F′(i, j, k). The dataset consists of the set of
multi-modal cuboids x ∈ X and their corresponding outputs y ∈ Y that represent the
followup FLAIR intensities.
2.3 Regression-based predictive model
Our predictive model takes the form a regression model y = f (x) that maps the tissue
outcome y ∈ Y, described in terms of the voxel intensity in the followup FLAIR image, as
a function of the multi-modal cuboid x ∈ X extracted at the same location. Deﬁning outputs
y in a continuous space, in contrast with a binary one, allow us to easily change the sensitivity
and speciﬁcity of the framework, by varying the threshold on the predictions. A greyscale (or
color) output image is also more adapted than a binary image to visualize complex patterns.
In the context of pattern recognition, the literature of regression analysis has been particularly
proﬁcient in the last couple of years with the emergence of robust, nonlinear methods. In
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this study, the comparative analysis will be based on a Kernel Spectral Regression (SR-KDA)
analysis (Cai et al., 2007) that we successfully used in our preliminary study (Scalzo et al.,
2010), and other regression-based pattern recognition applications Scalzo et al. (2009; 2010).
2.3.1 Kernel spectral regression
Kernel Spectral Regression (SR-KDA) (Cai et al., 2007) is a recently proposed method to
solve Kernel Discriminant Analysis (KDA) problems efﬁciently. Speciﬁcally, it poses the
discriminant analysis as a regularized regression problem that exploits a graph representation.
SR-KDA utilizes a kernel projection of the data (also called “kernel trick” in the literature).
Input data samples X are projected onto a high-dimensional space via a Gaussian kernel K,
K(i, j) = exp−‖xi − xj‖2/2σ2 (8)
where σ is the user-speciﬁed standard deviation of the kernel.
In addition, from the set of n input data samples X, a n × n symmetric afﬁnity matrix W is
generated with Wij having a positive constant value if xi, xj ∈ X are from the same class (i.e.
yi ∈ Y is equal to yj ∈ Y), and zero otherwise. From matrix K and W, SR-KDA uses the
Gram-Schmidt method to obtain eigenvectors φ,
Wφ = λφ (9)
and estimates the mapping α efﬁciently using a Cholesky decomposition,
αT(K + δI) = φ (10)
where I is the identity matrix, δ > 0 the regularization parameter, and φ are the eigenvectors
of W. When a new multi-modal cuboid, xnew, is extracted from the image of a new patient,
the FLAIR intensity at followup, yˆnew, is computed using
k(i) = exp−‖xi − xnew‖2/2σ2, i = 1 . . . n (11)
yˆnew = αˆT(k+ δI) (12)
where k is the vector resulting from the kernel projection of xnew into the kernel space using
training data X.
2.4 Experimental setup
This section describes how the predictive power in terms of tissue fate of the different
perfusion images will be evaluated on our dataset of ischemic stroke patients. The proposed
experiments are designed to answer the following questions: Do the neighboring voxels
signiﬁcantly improve the prediction of the tissue outcome at a speciﬁc voxel in the different maps?
If so, what is the optimal size of this neighborhood in ischemic strokes? Does it differ depending on
the type of image? Speciﬁcally, these questions will be addressed by evaluating the tissue fate
prediction accuracy of the Kernel Spectral Regression (SR-KDA) (Section 2.3.1) method on
our dataset (Section 2.1). The problem is posed as a classiﬁcation task where the output Y (i.e.
followup FLAIR image) was manually binarized to create the ground truth (Section 2.2.5).
A speciﬁc model will be trained for each of the six types of perfusion parameter; CBV, CBF,
MTT, Tmax, TTP, Peak. The training of a speciﬁc regression model is made from a set of
training samples that, in the ideal case, should be uniformly distributed throughout the data
space. However, this is not the case for most of the stroke patients where the brain volume
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contains a larger number of noninfarcted voxels. A recent study (Jonsdottir et al., 2009) has
shown that an unequal number of infarcted and noninfarcted voxels can negatively impact
the overall performance of the system. Following the methods of the study, we perform a
random sampling on the input cuboids so that an equal number of infarcted and noninfarcted
cuboids are present in the training set. The number of training samples for each slice was set
to a maximum of 85 cuboids of class 0 and 85 cuboids of class 1. In theory, this could create
a large dataset of 170× nbSlice × nbCases training samples. In practice, however, we reduce
the size of the dataset during the extraction process such that the number of extracted cuboids
for a slice is equal to the minimum number of occurrence of either class (0 or 1). For example,
if only 10 voxels are infarcted (class 1) on the followup of one slice, only 10 cuboids will be
extracted for class 1 as well as 10 other cuboids for class 0. This procedure has the advantage
of speeding up the cuboid extraction process and generates less than 10, 000 training samples
equally distributed between the two classes.
2.4.1 Cuboid size
For each PWI parameter map, we evaluate the accuracy of the SR-KDA regression method
to predict tissue fate for different sizes of cuboids. A predictive model is evaluated for each
cuboid size using a leave-one-patient-out crossvalidation so that the data from the patient
evaluated is excluded from the training set at each iteration. In this experiment, cuboids are
symmetric; w, l have the same length (Section 2.2.6). The tested sizes 1 spanned from 1× 1
to 23 × 23. During the leave-one-out crossvalidation, the Area Under the Curve (AUC) is
computed from the ROC curve for each patient. The average AUC and standard deviation
across patients are calculated and constitute our measure of performance. The parameters
of SR-KDA σ, δ were optimized at each iteration of the leave-one-out procedure by running
another leave-one-out cross-validation on the data excluding the patient to be tested.
2.4.2 Global ROC curves
Global ROC curves are also generated for each PWI parameter map. For fair comparison,
the cuboid size of each image was the one that led to the best accuracy in the experiment
presented in the previous paragraph and reported in Figure 2. To generate the global ROC
curve, predictions Yˆi are ﬁrst computed for each speciﬁc patient i during the crossvalidation.
Then, all the prediction vectors {Yˆ1, Yˆ2, . . . , Yˆn} are concatenated into a single vector Yˆtotal ,
and the global ROC curve is computed from the data of all patients Yˆtotal .
2.4.3 McNemar’s signiﬁcance test
Although differences in average AUCs can be used to rank the predictive power of the
different PWI parameter maps and to observe the improvements of the regional model versus
a single-voxel-based approach, differences are not necessarily statistically signiﬁcant. We
propose to use a McNemar’s test (Siegel & Castellan, 1988) to verify if the difference between
between regional and single-voxel-basedmodels are statistically signiﬁcant for each PWImap.
McNemar’s test, which is based on a Fisher-test with one degree of freedom, is a useful tool in
determining if two methods have comparable error rates. Given the null hypothesis that the
two methods A and B have the same error rate, and the following contingence table (Table 1),
1 The low sagittal resolution (≥ 7 mm per voxel) of PWI images did not allow us to test the z-size of the
cuboid which was set to 1 slice.
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McNemar’s test can be written as a Fisher-test,
χ2 =
(|b− c| − 1)2
b+ c
. (13)
Correct (B) Error (B) Total
Correct (A) a b a+b
Error (A) c d c+d
a+c b+d n
Table 1. Classiﬁcation contingence table between two methods (A, B).
McNemar’s test is applied to investigate if the main hypothesis of this paper is supported
by a statistical signiﬁcance test. We verify that the improvement in performance obtained
by the regional cuboids versus a single voxel is signiﬁcant. To do so, the McNemar’s test is
performed between the models obtained using SR-KDA with their optimal cuboid size and
with a single voxel 1× 1. We perform the experiment for each PWI parameter map with the
following optimal cuboids size (identiﬁed in the previous experiment): Tmax, 15× 15; MTT,
15× 15; CBV, 9× 9; CBF, 11× 11; TTP, 13× 13; Peak, 11× 11.
3. Results
3.1 Cuboid size
AUC after a leave-one-patient-out crossvalidation for an increased cuboid size is reported
in Figure 2 for each PWI parameter map. The AUC can be interpreted as the probability of
correct classiﬁcation for a randomly selected pair of positive and negative samples. Usually,
any AUC result above .9 is considered as excellent.
Baseline average accuracy for Tmax parameter reaches 0.83± 0.01 with cuboid size 1× 1 and
increases to 0.90± 0.05 at a size of 15× 15. MTT parameter reaches 0.76± 0.02 and increases to
0.87± 0.06 at a size of 15× 15. CBV parameter reaches 0.67± 0.03 and increases to 0.74± 0.10
at a size of 9× 9. CBF parameter reaches 0.71± 0.02 and increases to 0.81± 0.08 at a size of
11× 11. TTP parameter reaches 0.84± 0.02 and increases to 0.91± 0.04 at a size of 13× 13.
Peak parameter reaches 0.74± 0.02 and increases to 0.82± 0.08 at a size of 11× 11.
These results suggest that Tmax and TTP parameters are the most accurate single maps
to predict the tissue outcome. Interestingly, the optimal size of the cuboids vary across
the different modalities, however all of them outperform their respective single-voxel-based
model. These results demonstrate that a regional approach, which takes into account
neighboring voxels may improve the prediction accuracy regardless of the modality used.
Global ROC curves that illustrate the results in terms of true positive and false positive rates
are depicted in Figure 3. The ROC are produced for each parameter map, comparing the
results between a baseline cuboid size of 1× 1 and the optimal size.
The similarity between the prediction and the actual outcome of the brain tissue for each
parameter can be visualized in Figure 4 on arbitrary slices. The columns respectively
correspond (from left to right, top to bottom) to follow-up FLAIR, prediction from Tmax, TTP,
MTT, the manually outlined ground truth of followup FLAIR, and prediction from CBV, CBF,
and Peak. The prediction are produced from the SR-KDAmodel trained using a leave-one-out
crossvalidation with optimal cuboid size for each modality.
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Fig. 2. Effect of the cuboid size on the average Area Under the Curve (AUC) for SR-KDA
regression models using a leave-one-out crossvalidation strategy.
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Fig. 3. For each parameter, ROC curves (dark line) are generated using the cuboid size that
led to the best average AUC for each method as reported in Fig 2, and compared to
single-voxel-based models (gray line). The difference between the dark and gray lines is
proportional to the improvement obtained by a regional model versus single-voxel-based
model.
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Flair Day 4 Tmax Prediction TTP Prediction MTT Prediction
Groundtruth Day 4 CBV Prediction CBF Prediction Peak Prediction
Flair Day 4 Tmax Prediction TTP Prediction MTT Prediction
Groundtruth Day 4 CBV Prediction CBF Prediction Peak Prediction
Flair Day 4 Tmax Prediction TTP Prediction MTT Prediction
Groundtruth Day 4 CBV Prediction CBF Prediction Peak Prediction
Fig. 4. Prediction results for three patients. FLAIR at followup, and predictions from onset
Tmax, TTP, MTT, perfusion map are illustrated on the ﬁrst row. Predictions are compared to
the ground truth manually outlined in followup FLAIR at day 4 on the second row, followed
by CBV, CBF, and Peak predictions.
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3.2 McNemar’s test
Signiﬁcance results of the McNemar’s test are summarized in Table 2. With a 95% conﬁdence
interval and one degree of freedom, two models are considered signiﬁcantly different if the
value χ2 is above 3.8414. McNemar’s values between a baseline model of size 1× 1 versus
an optimal regional model are 25.56, 116.8, 54.04, 5.81, 23.313.12, for Tmax, MTT, TTP, CBF,
CBV, Peak, respectively. Because they are way over 3.8414, regional models for Tmax, MTT,
CBF, CBV (and CBF to some extent) can be considered to improve the prediction accuracy
signiﬁcantly. However, Peak was just below the threshold and therefore the impact of the
regional model on this feature map cannot be considered signiﬁcant on our dataset.
Test McNemar value
Tmax 15x15 vs Tmax 1x1 25.56
MTT 15x15 vs MTT 1x1 116.8
TTP 13x13 vs TTP 1x1 54.04
CBF 11x11 vs CBF 1x1 5.81
CBV 9x9 vs CBV 1x1 23.31
Peak 11x11 vs Peak 1x1 3.12
Table 2. Results of McNemar’s test to measure the signiﬁcance of using single-voxel-based
versus regional models using the optimal cuboid size for each PWI parameter map.
3.3 Computational performance
The predictive model was implemented in Matlab and executed on a Dell Optiplex 760
desktop computer equipped with an Intel Core2 Duo CPU cadenced at 3.33GHz. The training
of the predictive model, excluding image normalization, volume registration, and ground
truth selection took less than ten minutes for 10 × 10 cuboids, while the prediction on an
entire volume took less than two minutes. Note that the speed depends on the size of the
cuboids, larger cuboids require more memory and computational time.
4. Discussion
The prediction of brain tissue fate in ischemic stroke, and therefore the identiﬁcation of
salvageable tissue, is a challenging problem that holds useful information for the clinician
during the decision making process. Ultimately, automatic tissue fate predictive models could
help us understand the underlying mechanisms of infarct growth. These mechanisms are
complex, as they depend on a wide variety of factors such as: quality of blood perfusion to
the area, quality of colaterals, energy delivery, age and medical history of the patient, etc.
Integrating all these elements within a uniﬁed predictive model is the long-term goal of our
research.
In this chapter, we have proposed a comparative analysis about the predictive power of
PWI parameter maps. A generic framework based on a nonlinear regression method was
introduced to predict the likely outcome of brain tissue in ischemic stroke patients. Although
the models were trained on a rather small dataset (25 patients), our experimental results
have demonstrated that signiﬁcant improvement can be obtained by a regional model in
comparison with a single-voxel-based approach. Several feature maps achieve an average
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AUC of over .8 using optimal cuboid sizes. These good performances may be explained by
the three following reasons:
• Regional: The use of optimized cuboids signiﬁcantly improves a single-voxel-based
approach. A possible explanation of this improvement is that cuboids implicitly represent
the regional distribution of intensity and correlation among voxels and are more robust to
noise.
• Nonlinear: The predictive model is based on Kernel Spectral Regression (SR-KDA) that
has demonstrated excellent performances in a wide variety of applications. For the current
application, a possible explanation for this difference is that the relation between the
cuboids extracted at onset from PWI parameters and the followup FLAIR intensity is not a
linear one, and it is, therefore, better captured by a nonlinear model such as SR-KDA.
• Randomness: Because machine learning techniques are often limited in the number of
training samples they can handle in a reasonable time, efﬁciently exploiting the millions of
cuboids available in the training set is a complex task. To obtain a representative training
set, we randomly sample cuboids across images so that a similar number of cuboids is
sampled for each outcome (infarcted or not). This is similar in spirit to what has been
shown in a previous study (Jonsdottir et al., 2009).
In principle, even after normalization, FLAIR images are not necessarily comparable between
patients. However, in practice, the “leave-one-patient-out” approach excludes all the data
of the patient to be evaluated from the training set, and therefore, solely relies on the
other patients to make predictions. Results obtained in terms of average AUC show that
after normalization, infarcted and non-infarcted tissue can, with a reasonable conﬁdence, be
predicted across patients.
The proposed study is not only useful to identify the optimal size of the regional model for
a given perfusion map, but may also serve as a starting point to help us understand the
limitations of current perfusionmaps and to identify inwhich cases other factorsmay improve
the predictions. While a correct prediction tells us that the relation between different PWI
parameters and the outcome of the tissue can be captured by themodel, a prediction errormay
originate from several technical errors (co-registration of images, normalization, classiﬁer,
data sampling, perfusion map) or come from physiological reasons (quality of collaterals,
degree of success of arterial recanalization intervention). For example, in the case of an arterial
occlusion, the infarct core might not grow after an unsuccessful intervention (failed opening
of the vessel) due to good collateral blood supply to the territory. There is, therefore, a margin
for improvement by taking into account additional physiological parameters (e.g. collateral
ﬂow) and a larger dataset.
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1. Introduction 
Stroke is a major healthcare issue in both industrialized and developing countries (Yach et 
al., 2004): it is the third leading cause of death, after myocardial infarction and cancer, the 
second leading cause of dementia, and the leading cause of permanent disability in Western 
countries (Pendlebury et al., 2009; Rothwell et al., 2011). Ischemic stroke accounts for up to 
85% of total stroke events (Feigin et al., 2003). Cerebral ischemia is caused by blood-clot 
obstruction of a cerebral artery. Occlusion of a brain vessel leads to a critical reduction in 
cerebral perfusion and, within minutes, to ischemic infarction. The resulting lesion 
comprises a central infarct core of irreversibly damaged brain tissue and a surrounding area 
of hypoperfused but still viable brain tissue (the ischemic penumbra), which can potentially 
be salvaged by rapid restoration of the blood flow. Intravenous thrombolysis with tissue 
plasminogen activator (tPA) within 4.5 hours of symptom onset can improve the clinical 
outcome (NINDS, 1995; Hacke et al., 2008). Endovascular strategies (e.g. thrombectomy) can 
enhance reperfusion rates in large artery occlusions, but remain to be validated in 
randomized clinical trials. Although approved by North American and European 
authorities, only a small proportion of patients receive acute revascularization therapies, 
mainly because of late diagnosis and limited access to specialized stroke units.  
Neuroprotective drugs aim at salvaging the ischemic brain by targeting multiple 
pathophysiological processes: prolonging the time window for reperfusion therapies, 
limiting reperfusion injury and the risk of hemorrhage, minimizing the deleterious effects of 
inflammation. Compounds regulating the inflammatory response are being evaluated by the 
pharmaceutical industry (Barone & Parsons, 2000). Indeed, stroke triggers a marked 
inflammatory reaction, involving several types of immune cells, including those of the 
mononuclear phagocyte system. There has been a longstanding controversy about the 
respective role of these cells, whether they are infiltrating blood-borne macrophages or 
resident microglia. On one hand, there is evidence that inflammation can contribute to 
secondary ischemic injury and worsening of neurological status (Iadecola & Alexander, 
2001). On the other hand, inflammation under certain circumstances could promote 
functional recovery, by supporting neurogenesis and plasticity (Ekdahl et al., 2009). 
Therefore, targeted intervention to control specific aspects of post-ischemic neuro-
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inflammation is a promising strategy in human stroke, with a potentially wide therapeutic 
window. A thorough understanding of these processes is required in order to develop safe 
and effective anti-inflammatory therapies for stroke patients.  
Microglial cells are the main brain-resident population of the mononuclear phagocyte 
system. Microglial activation is considered a hallmark of central nervous system (CNS) 
inflammation. Activated microglial cells become immunohistochemically indistinguishable 
from infiltrating myeloid cells (monocytes/macrophages) (Raivich et al., 1999). In particular, 
activated cells of the monocytic lineage, whether resident microglia or blood-borne 
macrophages, overexpress an outer mitochondrial membrane protein formerly known as the 
peripheral benzodiazepine receptor (PBR), now renamed “translocator protein (18kDa)” 
(TSPO 18kDa) (Papadopoulos et al., 2006). Nearly 30 years ago, radiolabeling of the 
prototypic PBR/TSPO ligand PK11195 with carbon-11 enabled in vivo imaging of microglial 
activation using Positron Emission Tomography (PET scan) (Camsonne et al., 1984), and 
paved the road for neuroinflammation imaging. However, [11C]PK11195 has shown 
limitations that until now slowed clinical application of neuroinflammation imaging by PET 
(Venneti et al., 2006). Although the field is still very active, as seen from the plethora of 
radioligands for PBR/TSPO that have been radiolabeled these last few years (Chauveau et 
al., 2008), large-scale clinical PET studies are difficult to set up in the context of emergency 
stroke management. 
In contrast, magnetic resonance imaging (MRI) is being increasingly used in the diagnosis 
and management of acute ischemic stroke patients. Abnormalities observed on diffusion-
weighted imaging (DWI) allow early identification of severely ischemic brain regions that 
typically evolve into infarction (i.e. the ischemic core). Perfusion-weighted imaging (PWI) 
provides information about the hemodynamic status of the cerebral tissue. PWI lesions are 
frequently larger than the corresponding DWI lesions during the first hours of stroke 
evolution. Subsequent infarct enlargement has been described in the region of DWI/PWI 
mismatch, supporting the hypothesis that this area represents the ischemic penumbra. 
Combined DWI and PWI imaging at the acute stage of stroke might thus help to identify 
patients with salvageable tissue, who may benefit from thrombolytic therapy. These MRI 
techniques are increasingly used for the evaluation of neuroprotectants, as PWI/DWI 
mismatch is considered a valuable estimate of penumbra in both animal models (Chauveau 
et al., 2011) and patients (Donnan et al., 2009). Given its pivotal role in the management of 
stroke patients, an additional MRI-based technique to image inflammation is thus 
particularly compelling. MRI has an unparalleled ability to image brain structure and 
function in both humans and small animals.  
This chapter focuses on the MRI techniques that have been developed so far to image 
inflammation in stroke.  
2. In vivo imaging of phagocytic cells using endogenous mechanisms 
Magnetic Resonance Imaging of inflammation was first attempted in stroke models by 
taking advantage of endogenous contrast mechanisms. Schroeter et al. (Schroeter et al., 
2001) thus used high resolution multimodal MRI to investigate inflammatory and glial 
response following focal cerebral ischemia. Images were acquired in rats, with transient 
occlusion of the middle cerebral artery 3, 7 and 14 days after stroke onset, and compared to 
immunostaining of phagocytic cells and astrocytes. This MRI approach, however, failed to 
visually discriminate inflammatory regions from healthy tissue, and highlighted the need to 
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develop new MRI techniques for specific detection of inflammatory cells. Two subsequent 
studies (Justicia et al., 2008; Weber et al., 2005) demonstrated the potential of 3D T2*-
weighted sequences for detecting regions with phagocytic activity, due to cell accumulation 
of endogenous iron, which induces strong susceptibility artifacts. However, both studies 
were performed at late stages of stroke (starting 10 weeks post-injury), in a time-window 
that was less than optimal for therapeutic intervention. 
3. In vivo labeling of phagocytic cells 
Cellular imaging of inflammation using MRI coupled with the injection of iron oxide 
nanoparticles has recently emerged as a promising non-invasive technique for pre-clinical 
and clinical studies of several inflammatory diseases. Two distinct classes of iron oxide 
nanoparticles are currently used in MRI, depending on hydrodynamic particle size: 
superparamagnetic iron oxide (SPIO) particles, with a mean particle diameter of more than 
50 nm, and ultrasmall superparamagnetic iron oxide (USPIO) particles with a smaller 
hydrodynamic diameter (Corot et al., 2006). When injected intravenously, both types of 
nanoparticles are phagocytosed by macrophages, whether within the blood-pool (circulating 
monocytes) or locally at the inflammation site (tissue macrophages/activated microglia). 
Macrophages can thus be labeled and monitored in vivo with exogenous magnetic contrast 
agents. Importantly, this technique can be applied in patients, as several (U)SPIOs are 
already being used in humans.  
3.1 Pre-clinical studies 
To date, few teams have monitored phagocytic cell trafficking after focal cerebral ischemia 
on MRI coupled with (U)SPIO injection. Investigations were mostly conducted in rats, using 
differing protocols (various stroke models, rat strains, contrast agents, magnetic field 
strengths and imaging protocols), which render inter-study comparisons difficult. Of note, 
an early study (Doerfler et al., 2000) showed no impact of USPIO injection on clinical scores 
and lesion size in a model of permanent focal cerebral ischemia in rats; the dose, however, 
was ten times as low as in the following studies, the aim being to use USPIO as a marker of 
perfusion, not inflammation.  
Table 1 synthesizes the studies published so far, using a permanent model of focal cerebral 
ischemia (pMCAO). Administration of iron oxide nanoparticles was performed at different 
times after ischemia. T2/T2*-weighted imaging was used in all studies to detect MR signal 
changes following (U)SPIO injection, typically showing decreasing signal intensity. The 
most relevant protocol in terms of T2/T2* effects involved injection at day 5 post-injury with 
a dose of 300 µmol Fe/kg, and follow-up at day 6, whether with USPIO (Ferumoxtran-10) or 
with SPIO (Ferucarbotran) (Engberink et al., 2008; Kleinschnitz et al., 2003; Saleh et al., 
2004b; Schroeter et al., 2004). This 24-hour interval between injection and imaging is 
necessary in order for the iron oxide particles to wash out from the vascular compartment 
(the half-life of Ferumoxtran 10 in plasma is 5 hours in rat). T2/T2* hypointense signals 
were usually observed at day 6 in the perilesional area (Saleh et al., 2004b; Schroeter et al., 
2004). At later time-points, these hyposignals were detected in the lesion core (Kleinschnitz 
et al., 2003). The hypothesis of passive diffusion of iron oxide nanoparticles through a 
disrupted blood brain barrier (BBB) was rejected, because post-gadolinium and post-
(U)SPIO MR signal changes did not superimpose, suggesting an active mechanism of brain 
entry, via (U)SPIO-laden infiltrating macrophages (Engberink et al., 2008; Kleinschnitz et al., 
2003).  
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Animal model Contrast Agent MRI 
Ref. Species Stroke model Name 
Dose 
(µmol/kg)
Injection
time 
Imaging 
times 
Field 
strength Sequences 
Rat EC Ferumo-xtran-10 100 T0+5h 
D0, D1, 
D2, D4, D7 4.7T T2 map 
(Rausch 
et al., 
2001) 
Rat PT Ferucar-botran 200 
MRI-
24h 
D1-9, D11, 
D12, D14 1.5T 
T2, 3D 
CISS, 
Gd-T1 
(Kleinsch
nitz et al., 
2003) 
Rat PT Ferumo-xtran-10 300 
MRI-
24h D6 7T 3D T2* 
(Schroeter 
et al., 
2004) 
Rat PT Ferumo-xtran-10 300 
MRI-
24h D6 7T T2*, 3D T2* 
(Saleh  
et al., 
2004b) 
Rat PT Ferucar-botran 300 
T0, 
T0+2h, 
T0+24h
D1, D2, 
D5, D7, 
D14 
1.5T T2, 3D CISS 
(Kleinsch
nitz et al., 
2005) 
Rat PT Ferumo-xtran-10 300 
MRI-
24h 
D6, D8, 
D11 4.7T 
T2 map, 
T2, 
Gd-T1 
(Engberink 
et al., 
2008) 
Mouse EC Ferumo-xtran-10 2000 T0+5h,
D0, D1,D2, 
D3 7T 
T2, T1, Gd-
T1 
(Wiart et 
al., 2007) 
Mouse EC Ferumo-xtran-10 2000 T0+5h, D0, D1 7T 
T2, T1, Gd-
T1 
(Desestret 
et al., 
2009) 
Table 1. Literature review of USPIO-enhanced MRI in the permanent middle cerebral artery 
occlusion (pMCAO) model. EC- Electrocoagulation; PT- Photothrombosis; T0 = Occlusion 
time; T0+5h = 5h after occlusion; MRI-24h = 24h before MRI; Gd-T1: T1-weighted MRI with 
gadolinium chelate injection (to assess BBB integrity). 
Despite the number of post-ischemia time points investigated (between D0 and D14), few 
animals were followed longitudinally, because most were usually sacrificed after MRI for 
comparison with immunohistochemistry. Post-mortem analysis typically comprised 
immunostaining of phagocytic cells (ED1) and Prussian Blue (PB) staining to detect iron. 
Spatial co-location between macrophages, iron and MR hypointense signals was well 
documented at the periphery of the lesion in a photothrombosis model at D6 (Saleh et al., 
2004b). Double immunostaining on the same histological slices confirmed internalization of 
iron inside macrophages in this set-up (Kleinschnitz et al., 2003). Co-location was also 
suggested in an electrocoagulation model (Rausch et al., 2001). It should be noted, however, 
that in all cases ED1 immunostaining exceeded iron staining, suggesting that only part of 
the inflammatory response was revealed by (U)SPIO-enhanced MRI.  
We sought to investigate the feasibility of macrophage imaging in mice using MRI. USPIOs 
were injected into mice 5h after pMCAO (Wiart et al., 2007). The timing of injection and 
imaging (from D0 to D3) was early compared to previous studies, because we aimed at 
assessing the early, potentially pathological role of macrophages, anticipating future studies 
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of anti-inflammatory drugs at the acute stage. Hypointense MR signals were detected in the 
perilesional area at 48h and 72h post-injury, in accordance with published data obtained in 
rats with a similar protocol (Rausch et al., 2001). More surprisingly, USPIO-enhanced MRI 
kinetic analysis disclosed a hypointense MR signal in the contralateral hemisphere: this 
hyposignal spread along to the corpus callosum (ipsilateral to contralateral) from D0 to D3. 
Imaging data correlated with histochemical analysis at 48h and 72h post-injury, showing 
macrophage activation remote from the lesion, and macrophage ingestion of USPIO (Figure 
1). Remote inflammatory response to brain injury was previously reported in animal models 
of focal cerebral ischemia using invasive techniques (Dubois et al., 1988; Schroeter et al., 
1999) and in stroke patients using PET-scan (Gerhard et al., 2005; Pappata et al., 2000), but to 
our knowledge the present study provided the first evidence obtained in living animals. 
Whereas the accumulation of (U)SPIOs in cells is well explained by phagocytosis activity of 
macrophages, their route of transport to brain macrophages is not yet well described. Three 
hypotheses have been put forward to explain the MR signal changes observed after (U)SPIO 
injection: (i) intravascular trapping of iron particles (Bendszus et al., 2007; Kleinschnitz et al., 
2005); (ii) (U)SPIO uptake by phagocytes, on the assumption that (U)SPIOs are primarily 
taken up by circulating phagocytes (Kleinschnitz et al., 2003); and (iii) interstitial iron 
particle diffusion into damaged tissue after nonspecific leakage through a disrupted blood–
brain barrier (Engberink et al., 2008). To assess the early brain distribution of iron particles, 
MRI signal changes after intravenous USPIO injection were then compared with the 
histological iron and macrophage distribution from 6h to 24h, using the same experimental 
set-up as before (Desestret et al., 2009). In this electrocoagulation model of stroke, USPIO-
related MR signal changes were indisputably paralleled by phagocyte-associated iron 
deposits detected on histology after 24h post-ischemia, but the pattern of results suggested 
that early USPIO-related MR signal changes were mainly caused by passive diffusion of free 
USPIOs after BBB leakage or by intravascular trapping, rather than by peripheral phagocyte 
infiltration. Indeed, at early time-points after USPIO injection, BBB disruption matches the 
spatiotemporal pattern of MR signal change. These results were in accordance with a 
previous study investigating both early and delayed time-points after SPIO injection in a 
photothrombosis model in rats (Kleinschnitz et al., 2005). Intravascular trapping was found 
to be the main mechanism of particle entry into peripheral areas and lesion core. These 
findings highlight the fact that several mechanisms of (U)SPIO entry into the brain may co-
exist, so that MR data interpretation should take account of the experimental set-up used 
(post-ischemia time-points, model characteristics, and nature of the contrast agent used).  
Table 2 synthesizes the studies published so far, to our knowledge, using a transient model 
of focal cerebral ischemia (tMCAO). Transient ischemia was in all cases performed using the 
suture model, which allows mechanical reperfusion by withdrawing the suture from the 
artery. This model is thought to be more representative of the clinical situation than 
permanent ischemia models. Results of these studies are contradictory and all the more 
difficult to interpret since protocols differed on many points (in particular in terms of the 
type of iron oxide nanoparticles used, and timing of injection). The first study (Rausch et al., 
2002) presented the most unexpected results, with the observation of a transient T1 
hyperintense signal inside the lesion, without corresponding T2 hypointense signal, 
although the study was performed at high field (4.7T). Furthermore, while macrophages 
(ED1) were detected in the lesion from day 1 to day 7, Prussian Blue immunostaining was 
positive only at day 7, i.e. 5 days after the onset of the hyperintense signal. The authors 
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Fig. 1. Correlation of gradient echo (GRE) MR signals with immunohistology (Bregma 0mm 
according to Franklin and Paxinos’s atlas). A- GRE MRI 72h post-pMCAO and i.v. injection 
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of USPIO. Note the hyposignal around the lesion, the contralateral corpus callosum and the 
ipsilateral peri-ventricular area. B- Double staining with Prussian Blue and F4/80 of the 
right (ipsilateral) ventricle. Iron-stained microglia/macrophages are clearly visible along the 
lateral wall, in correlation with the hyposignal observed in GRE images (A). C- Prussian 
Blue staining for iron in the contralateral corpus callosum of the corresponding slice. 
Positive staining was observed around cell nuclei, which suggests cytoplasm uptake (insert). 
D- F4/80 immunostaining for mouse microglia/macrophages in the contralateral corpus 
callosum. Note the F4/80+ brown cells, in spatial agreement with iron+ cells (B) and MRI 
hypointense signal (A). E- F4/80 immunostaining of a non-operated control mouse in the 
left corpus callosum, with no positive staining. F- Double staining with Prussian Blue and 
F4/80: magnification of B. Microglia/macrophages, as identified by their brown color and 
typical ramified shape, were also blue-stained, suggesting USPIO intra-cellularity. From 
(Wiart et al., 2007). 
proposed the following explanations: (i) that USPIOs might be leaked by the infiltrating 
macrophages before being re-ingested by secondarily recruited macrophages, and (ii) that 
Prussian Blue might become sensitive to iron oxide nanoparticles only after degradation of 
their dextran coating, an enzymatic process that could take several days. The second study 
(Kim et al., 2008) presented results more in line with those obtained in the permanent 
model, with an hypointense signal appearing relatively late (day 3-4) after stroke onset. 
Macrophages (ED1) and focal iron deposition were detected in the lesion at these time-
points, in agreement with T2/T2* hypointense areas. However, these results obtained with 
SPIO injection failed to be reproduced with USPIO in a recent study : Farr and colleagues 
did not observed T1,T2, nor T2* signal changes, despite a three-dose assay and extensive 
ED-1-positive macrophage accumulation at the sub-acute stage (Farr et al., 2011). In line 
with this negative results, the single study performed with a mouse model of transient 
ischemia reported no detectable MRI changes in the first 72h following stroke onset (Denes 
et al., 2007). It should be noted, however, that the dose used in that study was particularly 
low (160 µmol/kg) and perhaps not optimal for MRI detection. Besides, this study 
confirmed the predominance of microglial response, demonstrated by a panoply of 
immunohistological markers, at acute and subacute stages, compared to monocytic 
infiltration (Denes et al., 2007).  
Henning and colleagues (Henning et al., 2009) used an original strategy of “in vivo pre-
labeling”. The methodology is based (i) on the fact that iron oxide nanoparticles injected 
intravenously target, amongst other phagocytic cells, those from bone marrow (Denes et al., 
2007; Simon et al., 2005); and (ii) on the hypothesis of resident macrophage turnover from 
bone-marrow progenitor cells (Priller et al., 2001). SPIO injection was performed 7 days 
before tMCAO, in order to pre-label bone marrow-derived macrophages. A T2/T2* 
hypointense signal was observed in the lesion periphery with a peak at D4 post-reperfusion 
in pre-loaded rats, and remained constant until D7 in the perilesional area. Conversely, post-
loaded animals (which received the same SPIO injection 5 minutes after occlusion) showed 
no significant signal changes. Another interesting result of the study concerned the nature of 
the subpopulation of labeled macrophages, which were confined to three distinct locations: 
the perivascular regions, the meninges and the choroid plexus. In these areas, Prussian blue 
co-located with differentiated macrophages staining (ED2 marker) rather than with the non-
specific staining of macrophages (ED1 marker) and activated microglia staining (IBA). In 
line with previous studies, Prussian Blue staining was found in only a small proportion of 
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cells. Although the exact mechanisms of cell labeling by SPIOs and migration of these 
labeled cells into the central nervous system were not elucidated in this study, the proposed 
approach is elegant in the sense that it solves the question of passive diffusion of SPIOs 
(since they are washed out from the plasma before stroke onset). Other independent studies 
are nevertheless mandatory to confirm these results. 
 
Animal 
model Contrast Agent MRI Ref. 
Species Extent (min) Name 
Dose 
(µmol/kg)
Injection 
time 
Imaging 
times 
Field 
strength Sequences 
Rat 30 Ferumo xtran-10 300 T0+5h 
D0, D1, 
D2, D3, 
D4, D7 
4.7T T2, T1 
(Rausch 
et al., 
2002) 
Mouse 30/60 Ferumo xtran-10 160 MRI-2h
D0, D1, 
D2, D3 7T 
T2, 
Gd-T1 
(Denes et 
al., 2007) 
Rat 60 Ferucar botran 200 MRI-24h
D1-6, D8, 
D10, D14 3T 
T2, 3D T2*, 
Gd-T1 
(Kim et 
al., 2008) 
Rat 30 Ferumo xide 286 
T0-
7days 
D1-4, 
D7 7T 
T2 map, 
3D T2* 
(Henning 
et al., 
2009) 
Rat 60 Ferumo xtran-10 
300 / 600 / 
1000 
T0+3days
T0+6days
D3-4, 
D6-7 4.7T 
T2, T2*, 
T1 
(Farr et 
al., 2011) 
Table 2. Literature review of USPIO-enhanced MRI in the transient middle cerebral artery 
occlusion (tMCAO) model. All transient models were performed with the intraluminal 
thread model. T0 = Reperfusion time; T0+5h = 5h after reperfusion; MRI-24h = 24h before 
MRI; Gd-T1: T1-weighted MRI with gadolinium chelate injection (to assess BBB integrity); 
PB- Prussian Blue 
3.2 Clinical studies 
The first clinical study was published in 2004 by Saleh et al. (Saleh et al., 2004a). USPIOs 
(Ferumoxtran-10) were injected in 10 stroke patients at the end of the first week after 
symptom onset (6 to 9 days). MRI was performed at 1.5T before injection, then between 
24h and 36h and again between 48h and 72h post-injection. Parenchymal enhancement 
was observed on T1-weighted imaging in most cases (8 out of 10). However, T2/T2* 
effects were not systematically observed and seemed to be associated with vessels. As in 
experimental studies, there was a mismatch between regions showing BBB disruption (as 
assessed by post-gadolinium T1 enhancement) and regions showing USPIO enhancement. 
The authors suggested that USPIO enhancement was due to the infiltration of 
magnetically-labeled macrophages. We conducted a similar study, in which USPIOs were 
injected at D6 after stroke onset and MRI was performed 72h post-injection 
(Nighoghossian et al., 2007). In the 10 included patients, USPIO response was 
heterogeneous and not related to subacute lesion volume. As in the study by Saleh et al. 
(Saleh et al., 2004a), T1 enhancement was observed in most cases (9 out of 10), while 
T2/T2* effects were not systematically observed (5 patients out of 10) (Figure 2). No 
obvious relationship was observed between regions with BBB disruption and those 
showing USPIO-induced signal changes: for example, 3 patients without BBB disruption 
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showed enhancement following USPIO administration, whereas one patient with severe 
BBB disruption showed no USPIO-induced signal change.  
 
 
Fig. 2. A 55–year-old woman, with a past history of transient confusional state 2 months 
before admission, which was likely related to a right posterior middle cerebral artery (MCA) 
stroke, was admitted for acute left MCA stroke with nonfluent aphasia and severe right 
hemiplegia. From left to right: (1) Day 6 diffusion-weighted imaging (DWI) without 
contrast; (2) Day 9 T2*-weighted imaging; and (3) Day 9 T1-weighted imaging 72 hours after 
USPIO infusion. Right, old posterior superficial MCA ischemic infarction and recent left 
superficial MCA stroke with a large USPIO enhancement (arrow) compared with DWI 
lesion volume. From (Nighoghossian et al., 2007). 
In their second study, Saleh et al. (Saleh et al., 2007) investigated an earlier time window: 
USPIOs were injected 2 to 3 days following symptom onset and MRI was performed at 
different post-injection time points (24h-36h, 48h-72h, 10-11 days). Only 3 of the 9 patients 
included in the analysis showed signal change on post-injection MRI. None of these patients 
showed T1 enhancement following gadolinium chelate administration. As in the previous 
study, signal changes consisted in enhancement on T1-weighted images, with an increase in 
enhancement between the first two post-injection examinations, and a decrease between the 
last two. A subsequent study involving the same earlier time-window (2 days after stroke 
onset with MRI performed 48h after) confirmed these findings (Cho et al., 2007). T1 
enhancement was observed inside the lesion in only 1 of the 5 included patients. In this 
patient, post-gadolinium enhancement was more extensive than post-USPIO enhancement. 
The heterogeneity of USPIO-labeling was thought to reflect inter-individual variability of 
post-ischemic inflammation (Saleh et al., 2007). Accordingly, MRI may be of use in selecting 
patients for targeted anti-inflammatory therapies.   
Interpretation of clinical data is mainly based on experimental studies. Since (U)SPIOs have 
been found in macrophages following ischemic stroke, signal changes observed in patients 
are thought to reflect the phagocytic response. There are, however, several obstacles for 
direct translation from small animals to humans. Firstly, the animal model may not properly 
represent the clinical situation, so that the route of (U)SPIO transport to brain macrophages 
might not be the same. Secondly, there are some differences in the time-windows 
investigated: in the perspective of therapy, it is more attractive to treat in the very first days 
or even hours after symptom onset; experimental and clinical protocols performed during 
 
Neuroimaging – Methods 
 
270 
the early stage failed to produce consistent signal changes. Thirdly, the dose used in humans 
(2.6 mg iron/kg body weight) is far less than in animals. Finally, the interpretation of MR 
signal changes may differ according to the field strength at which they were acquired. 
Animal experiments are usually performed at very high field compared to clinical studies, 
which obviously influences relaxation properties. The latter two elements (high dose/high 
field in pre-clinical studies and small dose/low field in clinical studies) could partly explain 
why T1 effects were mostly observed in clinical studies, whereas T2/T2* effects were always 
observed in experimental studies. Besides, though compartmentalization of USPIO inside 
cells is thought to induce magnetic susceptibility gradients leading to T2* effects, it seems 
that SPIO-labeled macrophages could produce T1 effects at 1.5T (Daldrup-Link et al., 2003). 
This shows the importance of performing quantitative studies in order to characterize the 
effects of compartmentalization and concentration on MR signal, at different field strengths 
for each contrast agent (Brisset et al., 2010a). In the future, the development of MR 
sequences specifically dedicated to detection and quantification of (U)SPIO-labeled 
macrophages, such as positive contrast techniques (Brisset et al., 2010b; Mani et al., 2008), 
may help data interpretation and analysis of longitudinal studies. 
4. Ex vivo labeling of phagocytic cells 
MRI techniques using intravenously injected SPIO/USPIO fail to distinguish between non-
specific diffusion of free particles and magnetically labeled phagocytes. Thus, signal changes 
might be wrongly attributed to inflammatory processes. This limitation could be overcome 
in part by magnetically labeling macrophages before their injection (ex vivo labeling). To 
date, the majority of studies using ex vivo labeling in stroke models addressed cellular 
therapy, using subventricular zone progenitor cells (Athiraman et al., 2009; Cicchetti et al., 
2007; Jiang et al., 2005; Zhang et al., 2003), embryonic neural stem cells (Hoehn et al., 2002; 
Modo et al., 2004) mesenchymal stem cells (Lee et al., 2009; Walczak et al., 2008), spleen-
derived mononuclear cells (Stroh et al., 2006) or adipose-derived stem cells (Rice et al., 2007). 
To our knowledge, only one study was published using ex vivo labeling of macrophages in 
a rat stroke model (Engberink et al., 2008): 4 rats were intravenously injected with 5 million 
SPIO-labeled monocytes after induction of cerebral ischemia by photothrombosis. MRI was 
performed at 4.7T pre- and 24h, 72h and 120h post-injection. Although visual examination of 
T2*-weighted images and Prussian Blue staining were not conclusive, quantitative analysis 
(percentage of hypointense voxels compared to baseline) showed significant differences in 
MR signal changes compared to control animals (non-injected or injected with free USPIOs). 
According to the authors, the differences observed between groups are suggestive of an 
active monocytic infiltration into the lesion. One limitation of this method is that injected 
monocytes may not reflect the actual behavior of endogenous monocytes. 
5. Conclusion 
Despite abundant evidence for an inflammatory response after stroke, anti-inflammatory 
treatments have so far failed in clinical trials (Savitz & Fisher, 2007). In this context, non-
invasive detection of inflammatory cells after brain ischemia could be helpful (i) to select 
patients who may benefit from anti-inflammatory treatment; (ii) to identify the optimal 
therapeutic time window; (iii) to develop therapies targeting specific pathophysiological 
processes. MRI coupled with (U)SPIO, a contrast agent taken up by macrophages ex vivo 
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and in vivo, appears to be a promising tool for this purpose. Current limitations of this 
approach include the difficulty in identifying non-specific signal changes. Additional 
studies on long-term monitoring of (U)SPIO-related signal changes are required. This will 
be of crucial importance for clinical trials aiming to assess immunomodulatory drugs. 
Multiple factors are likely to account for post-treatment modifications of MR signal: 
modulation of inflammation, changes in the iron microenvironment and biotransformation. 
Well-designed pre-clinical studies including dedicated quantitative MR sequences are still 
warranted before application of the technique in larger patient cohorts.  
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1. Introduction 
Approximately 10-20% of strokes are due to intracerebral hemorrhage (ICH) [1]. Hospital 
admissions for ICH have increased by 18% in the past 10 years. ICH is a medical emergency. 
Rapid diagnosis and attentive management of patients with ICH is crucial because 
hematoma expansion and early deterioration is common in the first few hours after ICH 
onset. The clinical spectrum and outcome of a patient with ICH is directly related to the site 
of bleeding. The prognosis and treatment of ICH often depends on the areas affected by the 
hemorrhage [3-5]. Particular locations, such as the cerebral lobes, right putamen and 
cerebellum are relatively accesible to surgical drainage, whereas other areas, such as the 
thalamus and the brainstem are inaccesible [6]. 
It is very difficult to determine whether the presenting neurological symptoms are due to 
cerebral ischemia or ICH based on the clinical characteristics alone. Vomiting, elevated 
systolic blood pressure (SBP) (>220 mmHg), severe headache, coma or decreased level of 
consciousness, and progression of neurological deficit over minutes or hours are suggestive 
of ICH, although none of these features are specific and, therefore, neuroimaging 
examination is mandatory. Neuroimaging data, particularly computed tomography (CT) is 
needed to rule out stroke mimics, to confirm the clinical diagnosis, and to distinguish 
ischemia from ICH [4,5]. 
The influence of the site of bleeding on the clinical spectrum and outcome in patients with 
ICH is still a poorly defined aspect of the disease. Factors associated with outcome in ICH 
have been evaluated in many studies but the findings are of limited utility because they 
have tipically considered broad groups of patients with different etiologies or have 
otherwise employed univariate rather than factorial techniques for the analysis of data. 
Moreover, prognostic variables related to morbidity and mortality are of great importance 
but remain difficult to establish clearly because of methodological problems, including 
sample selection bias, timing of initial assessment, criteria for measuring outcome, and the 
role of other confounding factors. Although community-based studies and prospective 
stroke registries have provided data on the identification of prognostic factors in ICH 
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patients, there is a scarcity of information on the differences across the clinical spectrum and 
outcome of hemorrhagic stroke according to the site of bleeding [5-8]. 
The aim of this chapter is to determine the influence of topography of hemorrhage on the 
clinical spectrum, in-hospital mortality, and early outcome in ICH patients according to data 
collected from a review of the literature and the authors’ experience based on a large 
hospital-based stroke registry (Sagrat Cor Hospital of Barcelona Stroke Registry) in 
Barcelona, Spain. 
In relation to the site of bleeding, seven topographies were analyzed. These included the 
thalamus, internal capsule and basal ganglia, cerebral lobes, cerebellum, brainstem, multiple 
topographic involvement  (when more then one of these areas was affected), and primary 
intraventricular hematoma. Secondary intraventricular blood expansion (evidence of 
intraventricular blood on CT and/or magnetic resonance imaging [MRI] scans) for each 
topography was also assessed. 
In relation to localization of the hemorrhage in the Sagrat Cor Hospital of Barcelona Stroke 
Registry (Table 1), lobar ICH was the most frequent (33.2%) followed by hemorrhages in the 
 
Anatomic localization No. patients (%) 
Lobar 76 (33.2) 
Frontal 8 
Parietal 23 
Temporal 14 
Occipital 13 
Frontoparietal 3 
Temporoparietal 6 
Temporo-occipital 6 
Parieto-occipital 2 
Frontoparietotemporal 1 
Thalamus 31 (13.5) 
Cerebellum 15 (6.6) 
Brainstem 15 (6.6) 
Mesencephalon 2 
Pons 6 
Medulla oblongata 1 
Pons and mesencephalon 6 
Internal capsule 7 (3.0) 
Basal ganglia 24 (10.5) 
Internal capsule and basal ganglia 18 (7.9) 
Multiple topographic involvement 34 (14.8) 
Thalamus, internal capsule/basal ganglia 18 
Lobar, internal capsule/basal ganglia 10 
Lobar, internal capsule/basal ganglia, thalamus 5 
Brainstem, basal ganglia 1 
Primary intraventricular hemorrhage 9 (3.9) 
Table 1. Site of bleeding in 229 patients with hemorrhagic stroke in the Sagrat Cor Hospital 
of Barcelona Stroke Registry 
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thalamus (13.5%), basal ganglia (10.5%), internal capsule and basal ganglia (7.9%), 
cerebellum (6.6%), and brainstem (6.6%). Multiple topographic involvement was found in 
14.8% of the patients and primary intraventricular hemorrhage in 3.9%. In these series of 229 
consecutive cases, the main cause of ICH was hypertension in 124 patients, arteriovenous 
malformations in 11, hematologic disorders in 9, and other causes in 12. In 73 patients, the 
cause of bleeding was not identified [5].  
MRI and CT with angiographic studies (where relevant), MR angiography (MRA), MR 
venography or CT angiography (CTA), are reasonably sensitive at identifying secondary 
causes of hemorrhage, including  arteriovenous malformations, aneurysms, cavernous 
malformations, tumors, moyamoya, vasculitis and dural venous thrombosis. Digital 
subtraction angiography (DSA) may be considered if clinical suspicion is high but 
noninvasive studies do not show a clear cause particularly in young, normotensive and 
surgical candidates. DSA remains the gold standard for the evaluation of vascular anomalies 
and allows endovascular treatment, however the use of non-invasive MRA or CTA may 
help to exclude unnecessary invasive DSA [6]. 
Risk factors and clinical variables associated with different topographic locations are shown 
in Tables 2 and 3. Sensory deficit was significantly associated with thalamic ICH; lacunar 
syndrome and hypertension with internal capsule/basal ganglia ICH; seizures and non-
sudden stroke onset with lobar ICH; ataxia with hemorrhage in the cerebellum; cranial 
nerve palsy with brainstem ICH; and limb weakness, diabetes, and altered consciousness 
with multiple topographic involvement. On the other hand, hypertension and sensory 
deficit were inversely associated with lobar and cerebellar ICH, respectively. 
The in-hospital mortality rate was 30.6% (n = 70). Causes of death included cerebral 
herniation in 44 patients, pneumonia in 8, sepsis in 8, sudden death in 3, myocardial 
infarction in 1, pulmonary thromboembolism in 1, and unknown cause in 5.  
Mortality at 3 months was 34% in a review of 586 patients with ICH from 30 centers. In 
other studies it was 31% at 7 days, 59% at 1 year, 82% at 10 years and more than 90% at 16 
years [5]. 
According to the different sites of bleeding, in-hospital mortality rates were 16.3% in 
internal capsule/basal ganglia ICH, 20% in cerebellar ICH, 25% in lobar ICH, 25.8% in 
thalamic ICH, 40% in brainstem ICH, 44.4% in primary intraventricular hemorrhage, and 
64.7% in multiple topographic involvement. Intraventricular extension of the hemorrhage 
was associated with a significantly higher in-hospital mortality rate in all ICH topographies 
except for lobar hemorrhage (presence of intraventricular hemorrhage vs. absence 41.1 vs. 
0%, in thalamic ICH; 50 vs. 9.8%, in internal capsule/basal ganglia ICH; 66.7 vs. 8.3%, in 
cerebellar ICH; 100 vs. 25%, in brainstem ICH; and 87.5 vs. 44.4%, in multiple topographic 
involvement). Survivors were significantly younger than patients who died (mean age 69.07 
12.75 vs. 73.94 10.32 years), for whom the overall mean survival time was 15 (23) days [5]. 
2. Internal capsule/basal ganglia 
The commonest location of hypertensive ICH is the lateral basal-ganglionic-capsular region 
(classical deep subcortical intracerebral hemorrhages) [9,10]. Patients with small hematomas 
in this topography have a good outcome. Small hematomas of subcortical topography in the 
internal capsule, but also in the basal ganglia and more infrequently in the pons, may cause 
a lacunar syndrome [11]. In a clinical series  hypertension and lacunar syndrome were 
significantly associated with internal capsule/basal ganglia ICH (Table 4). The selection of 
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Variable 
Thalamus 
(n=31) vs 
remaining 
ICH 
Internal 
capsule 
basal 
ganglia 
(n= 49) vs. 
remaining 
ICH
Lobar 
(n=76) vs. 
remaining
ICH 
Cerebellum
(n=15) vs.
remaining
ICH 
Brainstem
(n=15) vs.
remaining
ICH 
Multiple 
sites 
(n=34) vs. 
remaining 
ICH 
Intrave-
ntricular 
(n=9) vs. 
Remaining 
ICH 
Hypertension  77.6 vs.55.5%*
42.1 vs.
69.9†     
Diabetes      35.3 vs. 11.8†  
Heart valve 
disease       
22.2 vs. 
0.5‡ 
Atrial 
dysrhythmia       
44.4 vs. 
9.5* 
Previous 
cerebral 
hemorrhage 
  6.0 vs. 1.3§     
Anticoagulant 
treatment       
22.2 vs. 
0.5§ 
Suddent onset   57.9 vs.73.8§     
Non-sudden 
onset   
38.1 vs.
23.5§     
Dizziness    60.0 vs.5.6‡    
Seizures  4.1 vs. 5.0§ 11.8 vs.1.3§     
Nausea, 
vomiting    
66.7 vs.
20.6†    
Altered 
consciousness      
76.5 vs. 
40.5‡  
Limb weakness    40.0 vs.79.9†  
97.1 vs. 
73.8¶  
Sensory deficit 72.4 vs.46.4*   
6.7 vs.
53.7†  
73.5 vs. 
46.1**  
Ataxia  0 vs. 11.1§  86.7 vs.3.7‡    
Cranial nerve 
palsy   
0 vs. 
13.1††  
66.7 vs.
4.7†   
Lacunar 
syndrome  
18.4 vs. 
4.4‡‡      
Data expressed as percentages; *P < 0.2; †P < 0.01; ‡P < 0.001; §P < 0.3; ¶P < 0.07; **P < 0.08; ††P < 0.05; ‡‡P < 
0.06. 
Table 2. Frequency of vascular risk factors and clinical features according to site of bleeding 
in 229 patients with intracerebral hemorrhage (ICH) in the Sagrat Cor Hospital of Barcelona 
Stroke Registry 
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Bleeding topography β SE (β) Odds ratio (95% CI) 
Thalamus    
Sensory deficit 1.1729 0.4365 3.23 (1.37 to 7.60) 
Internal capsule/basal ganglia    
Lacunar syndrome 1.3373 0.5346 3.81 (1.33 to 10.86) 
Hypertension 0.8065 0.3855 2.24 (1.05 to 4.77) 
Lobar    
Seizures 2.4178 0.8278 11.22 (2.21 to 56.84) 
Non-sudden stroke onset 0.8045 0.3344 2.24 (1.16 to 4.31) 
Hypertension ‒1.0669 0.3091 0.34 (0.19 to 0.63) 
Cerebellum    
Ataxia 5.7560 1.1653 316.09 (32.2 to 3102.63) 
Sensory deficit ‒4.0215 1.5093 0.02 (0.009 to 0.35) 
Brainstem    
Cranial nerve palsy 3.7108 0.6393 40.89 (11.67 to 143.15) 
Sensory deficit ‒4.0215 1.5093 0.02 (0.009 to 0.35) 
Multiple topography    
Limb weakness 2.3628 1.0662 10.62 (1.31 to 85.84) 
Diabetes mellitus 1.5992 0.5099 4.95 (1.82 to 13.44) 
Altered consciousness 1.3950 0.4631 4.03 (1.63 to 10.0) 
Table 3. Predictive value of different risk factors and clinical variables on the site of bleeding 
in the Sagrat Cor Hospital of Barcelona Stroke Registry 
hypertension may be explained because blood supply of the putamen is derived 
predominantly from penetrating branches of the middle cerebral artery, which are the 
arterioles most frequently affected by hypertension [9,12]. This finding is consistent with 
other studies showing that the lateral ganglionic region is the most common topography of 
deep hypertensive ICH, and that a great proportion of hematomas found in the putaminal 
region are hypertensive [3,12] (Figures 1 and 2). 
 
 
Fig. 1. Axial CT shows acute hypertensive putaminal hematoma with early peripheral edema. 
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Hemorrhage in the caudate nucleus accounts for approximately 7% of ICH. The symptoms 
and signs in caudate hemorrhage closely mimic SAH but the CT appearance of blood in the 
caudate and lateral ventricles is distinctive. Larger hemorrhages are more likely to rupture into 
the ventricle and have a much higher mortality than do small putaminal hematomas [4,12]. 
 
 
(a)                                                        (b) 
 
(c) 
Fig. 2. Subacute intraparenchymatous hematoma in the right basal ganglia/external capsule. 
A) Axial T1WI MR showing peripheral hyperintensity and central isointensity related to 
different ICH temporal staging. Signal changes first occur peripherally and progress 
centrally; B) Axial T2WI MR; C) Axial MRA (3D TOF) MIP image shows no vascular 
malformation. 
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Variable Lobar hemorrhage 
Deep subcortical 
hemorrhage 
P 
value 
Demographic data    
Male sex 44 (45.4) 59 (64.1) 0.007 
Age, years, mean (SD) 70.3 (14.3) 71.8 (10.9) 0.414 
Vascular risk factors    
Hypertension 41 (42.3) 64 (69.6) 0.001 
Diabetes mellitus 10 (10.3) 13 (14.1) 0.281 
Ischemic heart disease 6 (6.2) 6 (6.5) 0.579 
Atrial fibrillation 10 (10.3) 11 (12) 0.448 
Valvular heart disease 5 (5.2) 1 (1.1) 0.118 
Congestive heart failure 3 (3.1) 2 (2.2) 0.525 
Previous transient ischemic attack 7 (7.2) 3 (3.3) 0.188 
Previous cerebral infarction 8 (8.2) 9 (9.8) 0.454 
Previous intracerebral hemorrhage 8 (8.2) 1 (1.1) 0.021 
Chronic obstructive pulmonary disease 6 (6.2) 5 (5.4) 0.537 
Chronic renal disease  2 (2.2) 0.236 
Chronic liver disease 8 (8.2) 2 (2.2) 0.060 
Obesity 1 (1) 7 (7.6) 0.027 
Alcohol consumption  (> 80 g/day) 3 (3.1) 6 (6.5) 0.444 
Smoking (> 20 cigarettes/day) 11 (11.3) 8 (8.7) 0.360 
Hyperlipidemia 9 (9.3) 13 (14.1) 0.208 
Anticoagulant treatment 4 (4.1) 2 (2.2) 0.367 
Peripheral vascular disease 2 (2.1) 6 (6.5) 0.123 
Clinical features    
Suden onset (min) 59 (60.8) 65 (70.7) 0.102 
Acute onset (hours) 28 (28.9) 20 (21.7) 0.169 
Headache 45 (46.4) 27 (29.3) 0.012 
Seizures 11 (11.3) 2 (2.2) 0.012 
Nausea, vomiting 18 (18.6) 17 (18.5) 0.569 
Decreased consciousness 44 (45.4) 31 (37.5) 0.068 
Motor deficit 66 (68) 77 (83.7) 0.009 
Sensory deficit 36 (37.1) 55 (59.8) 0.001 
Homonymous hemianopsia 31 (32) 19 (20.7) 0.055 
Aplasia, dysarthria 35 (36.1) 32 (34.8) 0.486 
Ataxia 3 (3.1) 3 (3.3) 0.633 
Absence of neurological deficit at discharge 6 (6.2) 5 (5.4) 0.537 
In-hospital mortality 26 (26.8) 18 (19.6) 0.158 
Respiratory complications 7 (7.2) 10 (10.9) 0.267 
Urinary complications 13 (13.4) 15 (16.3) 0.361 
Infectious complications 15 (15.5) 24 (26.1) 0.052 
Length of hospital stay, median (IQR) 17 (18) 20 (16) 0.383 
Table 4. Comparison between 97 patients with lobar hemorrhage and 92 patients with deep 
subcortical bleeding 
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3. Thalamic hemorrhage 
Thalamic hematomas (Figures 3 and 4) is a subgroup of hemorrhagic stroke that accounted 
for 1.4% of all cases of stroke and 13% of intracerebral hemorrhages, a percentage in the 
range between 6%  and 25.6% in the series of other authors [3,7,13]. 
 
 
Fig. 3. Axial CT reveals an acute anterior left thalamic hematoma. 
 
 
Fig. 4. Axial CT shows a large thalamic hematoma with intraventricular rupture. 
Sensory deficit was significantly associated with thalamic ICH [4,5]. It has been shown that 
74.2% of patients with hemorrhage in the thalamus showed sensory deficit, which coincide 
in part with early observations emphasizing that the predominance of sensory deficit over 
motor is one cardinal feature of thalamic ICH [4]. Sometimes the contralateral limbs are 
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ataxic or have choreic movements. The commonest oculomotor abnormalities include 
paralysis of upward gaze, often with one or both eyes resting downward, and 
hyperconvergence of one or both eyes. These ocular abnormalities are due to direct 
extension of the hematoma to the diencephalic-mesencephalic junction or to compression of 
the quadrigeminal plate region.  
The topography of thalamic lesion [14] was anterior in 6% of cases (behavioral abnormalities 
predominate), posteromedial in 24% (abnormalities of consciousness, papillary function and 
vertical gaze predominate), posterolateral in 48% (sensorimotor signs predominate), dorsal 
in 2% (slights sensorimotor signs usually transients and aphasia and behavioral are 
common) and affected all thalamic vascular territories in 20%. Intraventricular involvement 
was present in 42.6% of patients. 
Thalamic hemorrhage is a severe clinical condition with in-hospital mortality rate of 19%, 
and symptom-free at discharge from the hospital documented in only 2.1% [15]. The 
mortality rate of thalamic hemorrhage ranges between 17% and 52% in the experience of 
different authors [14,16]. On the other hand, the mortality rate of thalamic hemorrhage is 
generally lower than that of brainstem hemorrhages or cerebral hemorrhages of multiple 
topographies, which show a very high in-hospital mortality rate usually greater than 40% 
[5]. The mortality rate in patients with thalamic hemorrhage, however, is higher than that of 
patient with capsular stroke [5,17]. Altered consciousness, intraventricular hemorrhage and 
age have been shown to be independent predictors of in-hospital mortality in patients with 
thalamic hematoma [15,17]. In summary, approximately one of each 10 patients with acute 
intracerebral hemorrhage had a thalamic hematoma. Patients with thalamic hemorrhage 
show a differential clinical profile than patients with internal capsule-basal ganglia ICH. 
Altered consciousness, intraventricular involvement and advanced age have been found to 
be independent predictors of in-hospital mortality. 
4. Lobar hemorrhage 
The frequency of lobar hemorrhage varies between 24% to 49% in the different clinical series 
reported in the literature [1,5,18]. In our experience, lobar bleeding was the most common 
ICH (33% of cases) [18]. The symptoms and signs in lobar hemorrhages are similar to 
cerebral infarctions. Seizures, non-sudden stroke onset, and hypertension were independent 
clinical factors related to the site of bleeding. Seizures occurred more frequently in lobar 
ICH than in the remaining ICH. Other studies have shown that seizures are more frequent 
in hemorrhagic than in ischemic stroke as well as more frequent in lobar than in deep 
hematomas mainly in the parietal and temporal lobes [19,20]. On the other hand, it has been 
generally considered that bleeding in ICH lasts only a few minutes. However, recent data 
show that substantial early hemorrhage growth in patients with ICH is common [21]. 
Explanation of the gradual onset of symptoms found in 38% of our patients with lobar ICH, 
suggests that the period of hematoma enlargement can extend for a number of hours from 
onset as a result of active bleeding, a phenomenon that is frequently but not always 
associated with clinical deterioration [4]. Lobar ICH was less commonly associated with 
hypertension than any of the remaining topographies. For this reason, non-hypertensive 
mechanisms of ICH including cerebral amyloid angiopathy (Figure 5), vascular 
malformations, sympathomimetic drugs, and bleeding disorders all have a tendency to 
cause predominantly subcortical lobar ICH with a lower frequency of deep hemispheric and 
brainstem hemorrhages [6,19]. 
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(a)                                                 (b)                                            (c) 
Fig. 5. Lobar hemorrhage related to cerebral amyloid angiopathy. A) Axial T1WI MR shows 
subacute lobar hematoma in the left frontal lobe; in  B) and C) axial T2*GRE MR, apart from 
the subacute lobar hematoma, superficial hemosiderosis, scattered microbleeds and a 
chronic right frontal cortical hematoma are shown. 
In the comparative analysis between lobar hemorrhages and deep subcortical hemorrhages 
(Table 4), lobar hemorrhages were more common in women, in patients with previous ICH 
as well in those presenting with headache and seizures. In contrast, deep subcortical 
hemorrhages occurred more frequently in obese patients and were associated with motor 
and sensory deficits. 
Lobar ICH is a severe disease, with in-hospital mortality (26.8%) and absence of 
neurological deficit at the time of hospital discharge being observed occasionally (6.2%). 
Lobar ICH may be considered a more benign condition as compared with brainstem 
hemorrhages or mutiple topographic location [5,10] in which in-hospital mortality may be as 
high as 40%, but is more severe than capsular hemorrhages, which may even present as a 
lacunar syndrome, mainly pure motor hemiparesis or sensorimotor syndrome [11]. 
The lower frequency of hypertension in lobar ICH (42.3% vs. 69.6% in subcortical ICH) is a 
relevant clinical aspect that coincides with datas reported in the literature [6], because high 
blood pressure has the lowest frequency as compared with other topographies of bleeding. 
However, other causes different from hypertension, such as arteriovenous malformations 
(8.5%), blood dyscrasias (5.5%) or anticoagulant iatrogenia (3%) are more common in lobar 
ICH. Because of the higher incidence of vascular malformations and other bleeding lesions 
in patients with lobar hematomas angiography is often indicated [6]. For patients presenting 
with lobar clots > 30 mL and with 1 cm of the surface, evacuation of supratentorial ICH by 
standard craniotomy might be considered [6]. 
In our experience of the Sagrat Cor of Barcelona Stroke Registry, chronic obstructive 
pulmonary disease (COPD), altered consciousness, previous cerebral infarction, chronic 
liver disease, female sex, seizures and headache were clinical variables independently 
associated with in-hospital mortality in the logistic regression analyses. 
5. Cerebellar hemorrhage 
This subgroup of hemorrhagic stroke account for 0.73% of total stroke and 6.9% of ICH, a 
percentage similar to 5‒10% reported in the literature [4,9].  
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Establishing the diagnosis of cerebellar hemorrhage is important because of the potentially 
serious outcome if not treated and the contrasting good prognosis after surgical treatment. 
Cerebellar hemorrhage usually originates in the region of the dentate nucleus, arising from 
distal branches of the superior cerebellar artery and the posterior inferior cerebellar artery 
(Figure 6). Characteristic presenting symptoms of cerebellar ICH include headache, vertigo, 
vomiting, and inability to stand and walk. Ataxia is an independent clinical factor associated 
with cerebellar ICH. In our experience, ataxia was found in 87% of patients and this finding 
agrees with the high frequency of cerebellar signs including gait ataxia, truncal ataxia, and 
ipsilateral limb ataxia reported by others [4,9]. 
 
 
(a)                                                     (b) 
Fig. 6. Right cerebellar hematoma in the region of the dentate nucleus. A) Axial CT shows 
acute hematoma with halo of surrounding edema; B) axial T1WI MR discloses the same 
hematoma in early subacute stage. Mass effect partially effaces the 4th ventricle. 
Cerebellar hemorrhages are severe, with a high in-hospital mortality (21.4%) and functional 
deficit at hospital discharge in practically all patients. The in-hospital mortality of 21.4% 
observed in our patients [5] is lower than 39‒47% observed in other studies [22-24] and 
similar to death rates (13% and 25%) reported by other authors [25,26]. 
Patients with larger cerebellar hematomas ussually develop brainstem compression [25,28]. 
If the hematoma affects the caudal cerebellum, the medulla is the portion of the brainstem 
compressed and for this reason vasomotor disturbances and respiratory arrest may develop. 
Ocassionally, patients with cerebellar hemorrhage present with symptoms and signs of 
hydrocephalus. In deteriorating patients with accesible lesions, surgery should not be 
delayed. Patients with cerebellar hemorrhage who are deteriorating neurologically or who 
have brainstem compression and/or hydrocephalus from ventricular obstruction should 
undergo surgical removal of the hemorrhage as soon as possible [6].  
6. Pontine and brainstem hematomas 
Hematomas affecting the pons and the brainstem are one of the topographies associated 
with a more severe clinical outcome [4]. Primary brainstem hemorrhages are located most 
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often in the pons. Midbrain and medullary hemorrhages are rare. Pontine hematomas 
(Figure 7) constitute a subgroup of hemorrhagic stroke that accounts for 0.36% of the total 
number of strokes and 3.4% of ICH, which is similar to 3‒6% reported in most studies 
[4,8,9]. 
 
 
Fig. 7. Axial CT demonstrates a large pontine hemorrhage. 
Early cranial nerve dysfunction was the independent clinical factor associated with 
brainstem ICH. Cranial nerve palsy found in 66.7% of our patients may be explained by 
involvement of the brainstem tegmentum by the hematoma either primarily or indirectly 
causing nuclear palsies and conjugate gaze abnormalities [4]. 
Pontine hematomas are severe, with a high mortality rate (50%). A small percentage of 
patients are symptom-free at the time of hospital discharge (7.1%) [5]. The 50% in-hospital 
mortality rate observed in our study [5] is lower than 55‒60% reported by others [29,30] but 
higher than 31‒47.5% of other series [31,32]. 
It should be noted that a pure motor hemiparesis, clinically indistinguishable from a lacunar 
infarction is an infrequent presenting form of pontine hematoma [11,33]. In this cases, there 
are two unilateral pontine hematomas localized in the basis pontis or at the union of basis 
pontis and tegmentum. 
7. Multiple topographic involvement 
In multiple topographic involvement with large-size hematomas (Figure 8), limb weakness, 
diabetes, and altered consciousness were independent clinical factors selected in the 
multivariate analysis. In relation to limb weakness (found in 97% of the cases), persistent 
hemiplegia is caused by involvement of the pyramidal tract fibers. It is well known that 
severity of hemiplegia is related to survival [4,9]. The state of alertness of the patient is a 
clinical feature that correlates with prognosis in ICH and, in general, in acute stroke 
patients. In the Lausanne Stroke Registry [35], 50% of ICH patients had some reduction in 
the level of consciousness, which is similar to 45.9% of our series. However, in patients with 
hemorrhage of multiple topographies, altered consciousness was found in 76.5% of cases. 
Reduced alertness in ICH is due to either a generalized increase in intracranial pressure, or 
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to compromise of both hemispheres, or to the reticular activating system bilaterally in the 
brainstem tegmentum [4]. 
 
 
(a)                                                   (b) 
Fig. 8. A) and B) Multiple parenchymal hematoma in cerebral amyloid angiopathy 
In patients with ICH, diabetes was more frequently associated with multiple parenchymal 
hematoma (35.3%) [35]. Little is known about the influence of diabetes on the volume of 
damaged brain tissue in ICH patients. Diabetes is known to produce deleterious effects on 
the microvasculature that may result in increased bleeding risk. The ICH of multiple 
topography in patients with diabetes might be related to the specific angiopathy induced by 
diabetes in small vessels. The vasculopathy of perforating cerebral arteries, the walls of 
which are weakened by lipid and hyaline material (lipohyalinosis and fibrinoid necrosis), 
microaneurysms and/or microangiopathy may be a real risk for hematoma of multiple 
topography in diabetic patients [35]. These changes in cerebral vessels would perhaps make 
diabetics more prone to develop hemorrhages of large size than nondiabetics. More 
information, however, is needed on the cerebrovascular pathology whereby diabetes affects 
large and small blood vessels.  
8. Primary intraventricular hemorrhage 
Data regarding the frequency of primary intraventricular hemorrhage in the different 
hospital-based stroke registries are scarce. In our experience, primary intraventricular 
hemorrhage (Figure 9) is a rare subgroup of haemorrhagic stroke that accounted for 0.31% 
of all cases of stroke and 3.3% of intracerebral hemorrhages [5]. The clinical syndrome 
closely mimics subarachnoid hemorrhage, with sudden headache, stiff neck, vomiting  and 
lethargy [36]. In childhood ventricular bleeding usually arises from small subependymal 
arteriovenous malformations. In adults, most intraventricular hemorrhages are due to 
ventricular spread of primary hypertensive bleeds into periventricular structures. Primary 
intraventricular hemorrhage is a severe clinical condition with an in-hospital mortality rate, 
in the present study, of 41.7%, and only one patient (8.3%) was symptom-free at discharge 
[5]. In other series, the mortality rate ranged between 33.3% and 43% [36-38]. 
 
Neuroimaging – Methods 
 
290 
 
Fig. 9. Axial CT showing hemorrhage within the 3rd and both lateral ventricles with small 
layering fluid-fluid levels. 
In conclusion, different topographies of ICH have an influence on the clinical spectrum and 
early outcome of patients with hemorrhagic stroke. Sensory deficit is frequently associated 
with ICH in the thalamus, lacunar syndrome and hypertension with internal capsule/basal 
ganglia ICH, seizures and non-sudden stroke onset with lobar ICH, ataxia with hemorrhage 
in the cerebellum, cranial nerve palsy with brainstem ICH, and limb weakness, diabetes, 
and altered consciousness with multiple topographic involvement. In-hospital mortality 
rates are also different according to the site of bleeding, varying from 16% in patients with 
internal capsule/basal ganglia hematomas, 20% in those with cerebellar hemorrhage and 
25% for lobar and thalamic hematomas. Brainstem, primary intraventricular hemorrhage, 
and multiple topographic involvement are very severe conditions, with in-hospital mortality 
rates ranging between 40% to 65%.The morbidity and mortality associated with ICH remain 
high despite recent advances in our understanding of the clinical course of ICH. Rapid 
recognition and diagnosis of ICH as well as identification of early prognostic indicators are 
essential for planning the level of care and avoiding acute rapid progression during the first 
hours. Aggressive treatment of hypertension is essential in the primary and secondary 
prevention of ICH. 
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1. Introduction 
Late-onset Alzheimer's disease (LOAD) is the most common cause of dementia and the fifth 
leading cause of death in Americans older than 65 years.1 Although other major causes of 
death have decreased, deaths due to LOAD have been rising dramatically over the past two 
decades, between 2000 and 2006 they increased by 46.1%.1 Clinically, LOAD is characterized 
by progressive cognitive decline in particular in the memory domain. Neuropathologically it 
is characterized by the aggregation and deposition of misfolded proteins, in particular 
aggregated β-amyloid (Aβ) peptide in the form of extracellular senile (or neuritic) 
“plaques,” and hyperphosphorlylated tau (τ) protein in the form of intracellular 
neurofibrillary “tangles” (NFTs). These changes are often accompanied by microvascular 
damage, vascular amyloid deposits, inflammation, microgliosis, and loss of neurons and 
synapses. 
Although twin studies suggest that  37% to 78% of the variance in the age-at-onset of LOAD 
can be attributed to additive genetic effects,2 few genes have been identified and validated, 
and these genes likely explain less than 50% of the genetic contribution to LOAD. This is the 
upper bound of explained heritability in other complex diseases for which—unlike LOAD—
significant association has been demonstrated for several common loci of large effect (i.e., 
ORs > 2 to > 3), such as age-related macular degeneration. Thus, a substantial proportion of 
the heritability for LOAD remains unexplained by the currently known susceptibility genes. 
A likely explanation for the difficulty in gene identification is that LOAD is a multifactorial 
complex disorder with both genetic and environmental components, and that multiple 
genes with small effects are likely to contribute. 
Several neuroimaging measures correlate with LOAD risk and progression, in particular the 
volumes of the hippocampus, parahippocampus and entorhinal cortex, and the cerebral 
grey matter. Also these measures appear to have a substantial genetic contribution reflected 
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by heritability estimates ranging from 40% to 80%.3-5 Advances in brain imaging and high 
throughput genotyping enable new approaches to study the influence of genetic variation 
on brain structure and function. As a result, imaging genetics has become an emergent 
transdisciplinary research field, where genetic variation is evaluated using imaging 
measures as quantitative traits (QTs) or continuous phenotypes. Imaging genetics studies 
have advantages over traditional case-control designs. An important consideration is that 
QT association studies have increased statistical power and thus decreased sample size 
requirements. Additionally, imaging phenotypes may be closer to the underlying biological 
etiology of AD, making it easier to identify underlying genes. Together with studies of the 
genetics of brain structure and function among normal individuals which have been 
extended to the entire human lifespan from childhood through extreme old age,6-8 the data 
of such studies provide an invaluable backdrop for understanding the genetic influences on 
neuroanatomy and neurophysiology and are powerful tools for understanding the genetics 
of neurodegenerative diseases associated with changes in these brain structures such as 
LOAD. In this chapter, we summarize the current evidence relating genetic variation with 
LOAD and review the usefulness of imaging endophenotypes in identification of genes 
increasing susceptibility to LOAD. 
2. Imaging endophenotypes in LOAD 
Structural MRI. On structural magnetic resonance imaging (LOAD) is characterized by 
atrophy of the medial temporal lobe, foremostly the hippocampus and the amygdala (Figure 
1),9 which may further involve the posterior cortex,1 occipital lobes, precuneus and posterior 
cingulate.10 Atrophy in the hippocampus and entorhinal cortex is associated with a decline 
in memory function, progression of memory impairment and an increased risk of LOAD.11 
However, these structural changes on MRI are not specific to LOAD and not sufficient to 
establish a definitive diagnosis of LOAD, as similar atrophy is observed in other 
neurodegenerative disorders and normal aging. In addition, while nonspecific white matter 
changes appear frequently in healthy elderly individuals, such changes are also common in 
elderly people with cognitive decline, stroke or MCI. Nevertheless, several studies have 
suggested that certain structural MRI biomarkers possess some degree of discriminative 
diagnostic power. For example, evidence exists that in LOAD, the corpus callosum 
(particularly the anterior area) exhibits atrophy. This change helps to distinguish LOAD 
from frontotemporal dementia, in which the posterior area of the corpus callosum shows 
greater atrophy than the anterior area of this brain structure.12 There is also evidence that 
among patients with amnestic MCI, those who convert to LOAD show greater atrophy in 
the hippocampus and the inferior and middle temporal gyri than those who do not convert 
to LOAD.13 
Functional MRI. Functional MRI (fMRI) can visualize neuronal activity either during rest or 
in association with a task that activates specific brain regions. The most common method is 
blood oxygen level-dependent (BOLD) fMRI, which measures alterations in blood flow on 
the basis of changes in deoxyhemoglobin. As the deoxyhemoglobin concentration depends 
on neuronal activity, BOLD reflects brain activity. This technique is widely used in research 
and in the diagnosis of various brain disorders because of its high sensitivity and easy 
implementation. 
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Fig. 1. LOAD Endophenotypes on MRI 
BOLD signals depend on several anatomical, physiological and imaging parameters, and 
can be interpreted qualitatively or semiquantitatively. As a result, interindividual and 
intraindividual variability limits the use of such signals in the differential diagnosis of 
dementia- causing disorders. Nevertheless, fMRI can facilitate the characterization of 
functional abnormalities in specific diseases. People with LOAD exhibit reduced brain 
activity in parietal and hippocampal regions in comparison with healthy controls when 
undergoing memory encoding tasks.14-16 In addition, some studies have found different 
neuronal activity patterns in healthy controls and patients with MCI. Recent advances in 
fMRI have allowed intrinsic functional networks in the human brain to be defined. The 
study of cognitive–behavioral function in the early stages of neurodegenerative disorders 
may allow the identification of the neuroanatomical networks affected by these diseases, 
and may assist in the differential diagnosis of the various disorders that underlie dementia. 
PET and single-photon emission CT. PET and single-photon emission CT (SPECT) have 
been widely explored as diagnostic tools for dementia, and both techniques have shown 
good diagnostic and prognostic capabilities. PET studies have mostly used the tracer 
2-[18F]-fluoro-2-deoxy-d-glucose (18F-FDG), which provides a measure of cerebral glucose 
metabolism and, hence, indirectly demonstrates synaptic activity. In the early stages of 
LOAD, 18F-FDG-PET reveals a characteristic pattern of symmetric hypometabolism in the 
posterior cingulate and parietotemporal regions that spreads to the prefrontal cortices 
(Figure 2a). These changes are distinct from the changes in cerebral glucose metabolism that 
are seen in healthy controls and cases of other forms of dementia, and the extent of 
hypometabolism inversely correlates with the degree of cognitive impairment.17 18F-FDG-
PET has a high sensitivity (94%) but a low specificity (73–78%) for the diagnosis of 
dementia.18 SPECT, which involves studying regional blood flow with Tc-
hexamethylpropyleneamine oxime, has a similar specificity to 18F-FDG-PET for this 
condition.19 A number of low-molecular-weight tracers have been developed for PET to 
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assess Aβ deposits in vivo. The most frequently used tracer is Pittsburgh compound B (PIB). 
Compared with healthy controls, patients with LOAD show increased 11C-PIB retention in 
cortical regions targeted by Aβ deposits (Figure 2b).20 Deposition of this peptide seems to 
reach a plateau by the early stages of LOAD. In MCI, PIB binding is bimodal, with ≈ 50% of 
patients showing an increase in 11C-PIB binding, resembling the 11C-PIB retention that is 
seen in LOAD, while the other ≈ 50% of patients exhibit low levels of 11C-PIB binding that 
are similar to the levels seen in controls.21 In MRI studies, 11C-PIB binding correlated 
positively with atrophy in the amygdala and hippocampus but not other cortical areas, 
suggesting that various brain areas have different susceptibilities to Aβ deposit-mediated 
toxicity, or that amyloid deposition is nonessential for neurodegeneration.21 New PET 
tracers for amyloid deposits, such as 18F-FDDNP, are being developed. In studies 
comparing 11C-PIB and 18F-FDDNP, these tracers showed differences in regional binding 
and in the cognitive domains with which they seem to be associated, suggesting that these 
tracers measure related but different characteristics of LOAD.22 
 
 
Fig. 2. A) FDG PET patterns characteristic of metabolic activity in cognitively normal 
individuals and patients with LOAD. Red: high FDG uptake, Blue: low FDG uptake. 
Compared to persons aging normally, persons with LOAD show decreased bilateral glucose 
metabolism particularly in the temporal and parietal regions. B) PIB PET images 
characteristic of elderly individuals without cognitive impairment and patients with LOAD.  
Red: high PiB retention, Purple: low PiB retention. The image of the LOAD case shows red 
and yellow areas indicating high concentrations of PiB in the brain thereby suggesting high 
amounts of amyloid deposits. 
3. Genetic influences on brain morphological endophenotypes 
Elucidating the extent to which genetic and environmental factors influence normal brain 
structure is of great importance for understanding age-related normal and pathological 
changes in brain and cognition. Twin studies, which estimate heritability based on data from 
monozygotic (MZ) and dizygotic (DZ) twin pairs, provide the optimal genetic method for 
clarifying this issue because they allow decomposing the variance of any variable into genetic, 
shared environmental influences, and unique individual-specific environmental influences.  
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As MZ twin pairs are genetically identical (with rare exceptions due to somatic mutations) 
while DZ twin pairs share on average 50% of their segregating genes, variation of a certain 
measure is considered heritable if MZ twin pairs resemble each other for this measure more 
closely than DZ twin pairs. An influence of shared environmental factors is suspected when 
correlations in DZ twin pairs are >50% of the MZ twin pair correlation.23 Unique 
environmental factors determine the extent to which MZ twins do not resemble each other. 
Extended twin-studies include additional relatives thereby increasing the statistical power 
to detect the influences of environmental influences shared by members from the same 
family.  
Heritability of Brain Volumes and Structures. To date, more than 30 twin studies on brain 
imaging measures have been performed that aim to define the genetic contribution to brain 
structures (reviewed by Krasuski et al. and Karas et al9, 10). Overall, these studies 
demonstrated substantial heritability of these endophenotypes, particularly for larger 
structures.  
Twin studies using magnetic resonance imaging (MRI), found high heritability estimates of 
global brain measures including intracranial volume (>72%),3, 9, 11, 24-26 total brain volume 
(66–97%),3, 11, 24, 27-30 lobar tissue (in particular the temporal and parietal cortices),25, 30, 31 total 
gray matter volume3, 11, 24 and total white matter volume.3, 11, 24 Brain areas that in contrast 
seem to be under stronger environmental control include the gyral patterning of the 
cortex,27, 32 the volume of the lateral ventricles,12, 24, 26, 29, 33 and the volume of the 
hippocampus.11, 12, 24, 29, 34, 35  It is important to point out that some of these studies did not 
correct for total cranial volume or height when measuring brain volumes. Although it is 
likely that the ratio of brain volume/total cranial volume is comparable among monozygotic 
twins, it remains possible that this lack of correction has led in some studies to spurious 
results.  
More recent studies have predominantly examined possible genetic effects on specific brain 
areas using voxel-based morphometry36 and cortical thickness measures. Overall, these 
studies confirmed in particular the high heritabilities for the frontal, parietal and temporal 
cortices. In a study by Thompson et al., that constructed detailed three-dimensional maps 
based on a genetic continuum of similarity in grey matter in groups of unrelated subjects as 
well as DZ and MZ twins, genetic factors influenced in particular anatomical regions that 
include frontal and language-related cortices (ie., sensorimotor, middle frontal, anterior 
temporal and Wernicke’s cortices; r2(MZ) > 0.8, p < 0.05).5 In a study by Holshoff Pol et al.37 
which examined both gray and white matter density in a large sample of 54 monozygotic 
and 58 dizygotic twin pairs and 34 of their siblings, genetic factors significantly influenced 
white matter density of the superior occipitofrontal fascicle, corpus callosum, optic 
radiation, and corticospinal tract, as well as grey matter density of the medial frontal, 
superior frontal, superior temporal, occipital, postcentral, posterior cingulate, and 
parahippocampal cortices (heritability>0.69).37 In a study by Wright et al., voxel-based 
morphometry revealed moderate heritabilities (42-66%) for temporal/parietal neocortical 
areas and paralimbic structures.29 In a study by Rijsdijk et al.,38 heritability estimates were 
only significant for left posterior cingulate and right dorsal anterior cingulate gray matter 
concentrations (46% and 37%, respectively). In a  recent study that derived both surface-
based and voxel-based representations of brain structure,39 both  heritability estimates for 
thickness and surface area were highest for the temporal and parietal lobes. In addition, this 
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study suggested that grey matter volume is more closely related to surface area than cortical 
thickness suggesting that surface area and cortical thickness measurements should be 
considered separately and preferred over gray matter volumes for imaging genetic studies. 
Only one study has measured the heritability estimates for changes in brain volumes over 
time.  In this study which used structural MRI, the genetic contributions to variability in 
intracranial volume, corpus callosum, and lateral ventricles in healthy elderly were high (88-
92%)26 but did not change after 4 years follow-up.40 
4. Genetic epidemiology of LOAD 
Genetically, AD is categorized into two forms: (1) familial cases with Mendelian inheritance 
of predominantly early-onset (<60 years, early-onset familial AD [EOFAD]), and (2) 
“sporadic” cases with less apparent or no familial aggregation and later age of onset (≥60 
years, late-onset AD [LOAD]). It is important to note that this traditional dichotomization is 
overly simplistic as there are cases of early-onset AD without evidence for Mendelian 
transmission while, conversely, LOAD is frequently observed with a strong familial 
clustering, sometimes resembling a Mendelian pattern.  
In contrast to early-onset Alzheimer’s disease which is caused by autosomal dominant 
mutations in the APP (amyloid precursor protein), PSEN1 (presenilin 1) and PSEN2 
(presenilin 2) genes, the genetics of LOAD is more complex. The genes involved in LOAD 
increase disease risk and are not inherited in a Mendelian fashion. First-degree relatives of 
patients with LOAD have twice the expected lifetime risk of this disease of people who do 
not have a LOAD-affected first-degree relative.41 In addition, LOAD occurs more frequently 
in monozygotic than in dizygotic co-twins,42 suggesting a substantial genetic contribution 
to this disorder. In the largest twin study of dementia, involving 11,884 participants in the 
Swedish registry who were aged >65 years, 395 twin pairs were identified in which either 
one or both twins had LOAD.42 This study demonstrated a heritability of 58–79% for 
LOAD, depending on the model that was used in the data analysis. 
Apolipoprotein E. APOE is the only established susceptibility gene for LOAD and maps to 
chromosome 19 in a cluster with the genes encoding translocase of outer mitochondrial 
membrane 40 (TOMM40), apolipoprotein C1 and apolipoprotein C2. APOE is a lipid-
binding protein that is expressed in humans as one of three common isoforms, which are 
encoded by three different alleles, namely APOE ε2, APOE ε3 and APOE ε4. The presence of 
a single APOE ε4 allele is associated with a 2–3-fold increase in the risk of LOAD, while the 
presence of two copies of this allele is associated with a fivefold increase in the risk of this 
disease. 
Each inherited APOE ε4 allele lowers the age of LOAD onset by 6–7 years. Furthermore, the 
presence of this allele is associated with memory impairment, MCI, and progression from 
MCI to dementia.38 APOE ε4 has been suggested to account for as much as 20–30% of LOAD 
risk. 
Despite the studies linking APOE ε4 with LOAD, the presence of this allele is neither 
necessary nor sufficient for disease: among participants in the Framingham study,39 55% of 
those who were homozygous for APOEε4, 27% of those with one copy of this allele and 9% 
of those without an APOE ε4 allele developed LOAD by 85 years of age. Segregation 
analyses conducted in families of patients with LOAD support the presence of at least four 
to six additional major LOAD risk genes.43 Additional genetic risk variants. After APOE, 
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the best-validated gene LOAD risk is the sortilin-related receptor 1 (SORL1) gene, which is 
located on chromosome 11q23. SorL1 belongs to a group of five type I transmembrane 
receptors (the others being sortilin, SorCS1, SorCS2 and SorCS3) that are highly expressed in 
the CNS and are characterized by a luminal, extracellular vacuolar protein sorting 10 
domain. From family-based and population-based studies that, together, included over 
6,000 individuals from four ethnic groups, Rogaeva et al. identified two haplotypes in the 3’ 
and 5’ regions of SORL1 that are associated with LOAD risk.44 In addition, these researchers 
demonstrated that SorL1 promotes the translocation and retention of APP in subcellular 
compartments that exhibit low secretase activity, thereby reducing the extent of proteolytic 
breakdown into both amyloidogenic and nonamyloidogenic products.44 As a consequence, 
underexpression of SORL1 leads to overexpression of Aβ and an increased risk of LOAD. 
Several subsequent studies replicated these initial genetic association findings, and the 
results were further validated by a collaborative, unbiased metaanalysis of all published 
genetic data sets that included a total of 12,464 LOAD cases and 17,929 controls.45 In the 
past year, several studies demonstrated that, in addition, genetic variation in the SORL1 
homolog SORCS1 influences LOAD risk, cognitive performance, APP processing and Aβ1–
40 and Aβ1–42 levels through an effect on γ-secretase processing of APP,46, 47 further 
emphazising the role of sortilin-related proteins in LOAD etiology. 
Genome-wide association studies48-50 for LOAD using large numbers of cases and controls 
have revealed modest effect sizes for several genes on LOAD risk, with odds ratios in the 
range of 1.1–1.5, although most of these studies have only confirmed the association of 
APOE with this disease. One such study showed that variants of TOMM40—which is 
proximally located to and in linkage disequilibrium with APOE—were associated with 
LOAD risk, but whether these genetic associations are independent of the APOE locus 
remains unclear. 
Together, two genome-wide association studies identified variants in the clusterin gene 
(CLU),16, 51 the phosphatidylinositol- binding clathrin assembly protein gene (PICALM)16 
and complement receptor type 1 gene (CR1)51 as being associated with LOAD and several 
subsequent studies replicated these findings, but functional data confirming the roles in 
LOAD of the proteins encoded by these genes are still lacking. Clusterin is a lipoprotein that 
is expressed in mammalian tissues and is incorporated into amyloid plaques. This protein 
binds to soluble Aβ in CSF, forming complexes that can penetrate the BBB. Clusterin levels 
are positively correlated with the number of APOE ε4 alleles, suggesting a compensatory 
induction of CLU in the brains of LOAD patients with the APOE ε4 allele, who show low 
brain levels of APOE. CR1 encodes a protein that is likely to contribute to Aβ clearance from 
the brain, while PICALM protein is involved in clathrin-mediated endocytosis, allowing 
intracellular trafficking of proteins and lipids such as nutrients, growth factors and 
neurotransmitters. PICALM protein also has a role in the trafficking of vesicle-associated 
membrane protein 2, a soluble N-ethylmaleimide-sensitive factor attachment protein 
receptor that is involved in the fusion of synaptic vesicles to the presynaptic membrane in 
neurotransmitter release. A third large genome-wide association study confirmed the 
associations of PICALM and CLU with LOAD and reported two additional loci as being 
associated with LOAD52: rs744373, which is near the bridging integrator 1 gene (BIN1) on 
chromosome 2q14.3, and rs597668, which is located on chromosome 19q13.3. BIN1 is a 
member of the BAR (BIN–amphiphysin–Rvs) adaptor family, which has been implicated in 
caspase-independent apoptosis and membrane dynamics, including vesicle fusion and 
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trafficking, neuronal membrane organization, and clathrin-mediated synaptic vesicle 
formation. Of note, the latter process is disrupted by Aβ. Changes in BIN1 expression have 
also been shown in aging mice and in transgenic mouse models of LOAD. The locus 
rs597668 is not in linkage disequilibrium with APOE, suggesting that the effect of this locus 
on LOAD risk is independent. Six genes are found in this region, of which at least two 
(genes encoding biogenesis of lysosomal organelles complex 1 subunit 3 and microtubule 
associated protein–microtubule affinity-regulating kinase 4) are implicated in molecular 
pathways linked to LOAD or other brain disorders. 
It is important to note, that the results of the published genome-wide association studies are 
informative, but that the genetic associations need functional validation. Indeed, such 
studies alone cannot prove causality or assess the biological significance of an observed 
genetic association. Genomewide association studies represent a method of screening the 
genome, but are limited in their ability to detect true associations. 
5. Genetic variation and neuroimaging measures in LOAD 
As described above, multiple neuroimaging measures that correlate with LOAD risk and 
progression appear to have genetic underpinnings, with heritability estimates ranging from 
40% to 80%. Recent studies that aimed to determine whether the discovered genetic risk 
factors for LOAD also influence these neuroimaging traits suggest that several of these 
candidate genes also influence specific LOAD imaging endophenotypes. Most studies chose 
hippocampal volume as the quantitative phenotype because of its sensitivity to the changes 
of early LOAD, and by far the best studied gene is APOE. In line with the strong and 
consistent results for APOE when using LOAD as the phenotype, most T-1 weighted MRI 
studies reported an association of APOE e4 with accelerated LOAD-related volume loss in 
the hippocampal region.53-56 This is supported by several studies exploring the effect of the 
APOE e4 allele on glucose metabolism using FDG-PET,57-60 or amyloid deposition using 
([¹¹C] PiB-PET. 61-63 
Few studies have examined the association between other genes and LOAD imaging 
measures, and most of these were GWAS studies. In a GWAS of 381 participants of the 
Alzheimer’s Disease Neuroimaging Initiative (ADNI) cohort, 21 chromosomal areas were 
associated with hippocampal atrophy.64 These candidate regions included the APOE, 
EFNA5, CAND1, MAGI2, ARSB, and PRUNE2 genes, which are involved in the 
regulation of protein degradation, apoptosis, neuronal loss and neurodevelopment. In the 
same study, APOE and TOMM40 were confirmed when LOAD was used as the 
phenotype of interest.64 Additional studies by the same group, that included a larger set 
of imaging phenotypes and used T1-weighted MRI, 65 voxel-based 
morphometry/FreeSurfer methods 66or 3D mapping of temporal lobe volume differences 
using tensor-based morphometry,67 confirmed  SNPs in APOE and TOMM40 as strongly 
associated with multiple brain regions (including hippocampal volume, entorhinal cortex 
volume, amygdala volume, cortical thickness measures, grey-matter density) and 
revealed other SNPs in or close to candidate genes that have been repeatedly associated 
with LOAD as described above (PICALM, SORL1, SORCS1, APP, CR1, BIN1). In addition 
these studies reported novel SNPs in proximity to the EPHA4, TP63, NXPH1, GRIN2B, 
NEDD9, DAPK1, IL1B, MYH13, TNK1, ACE, PRNP, PCK1 and GAPDHS genes.  Several 
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of these genes are biologically plausible. NXPH1 codes for neurexophilin-1, a protein 
implicated in synaptogenesis, that forms a tight complex with alpha neurexins, a group of 
proteins that promote adhesion between dendrites and axons. This adhesion is a key 
factor in synaptic integrity, the loss of which is a hallmark of AD. GRIN2B encodes the N-
methyl-D-aspartate glutamate receptor NR2B subunit, which is a target for memantine 
therapy to decrease excitotoxic damage. ACE has been shown to cleave amyloid beta in 
vitro and is in addition involved in blood pressure regulation. Both high and low blood 
pressure have been associated with LOAD.  
There have been few studies exploring the effects of specific candidate genes (other than 
APOE) on brain imaging phenotypes. Ho et al.68 investigated the relationship between an 
obesity-associated candidate gene (FTO) and regional brain volume differences in 206 ADNI 
control participants. Systematic brain volume deficits were detected in cognitively normal 
obesity-associated risk allele carriers, as well as in subjects with increased body mass index 
indicating that this obesity susceptibility gene is associated with detectable deficits in brain 
structure, which may indirectly influence future risk for neurodegenerative disease. In 129 
hypertensive individuals from a family-based cohort sampled from a Dutch genetically 
isolated population,69 four SNPs located at the 3'-end of SORL1 (rs1699102, rs3824968, 
rs2282649, rs1010159) were associated with frequency of microbleeds  which is potentially 
related to amyloid angiopathy. In the MIRAGE Study70 several SORL1 SNPs that have been 
reported to be associated with LOAD, were associated with hippocampal atrophy, 
cerebrovascular disease, and white matter hyperintensities. In a candidate gene study that 
used (FDG-PET) measurements as a quantitative pre-symptomatic endophenotype  in 158 
cognitively normal late-middle-aged APOEε4 homozygotes, heterozygotes, and non-
carriers,71 the GAB2 protective haplotype was associated with higher regional-to-whole 
brain FDG uptake in APOEε4 carriers. 
6. Discussion 
The work reviewed above indicates that there are various brain imaging measures that are 
useful endophenotypes associated with genetic liability for LOAD. The strongest evidence 
of heritability, linkage and/or association in studies of normal brain aging have been found 
for the medial frontal cortex, Heschl’s gyrus and postcentral gyrus, Broca’s area, anterior 
cingulate, gray matter of the parahippocampal gyrus and white matter of the superior 
occipitofrontal fasciculus. The high heritability for these endophenotypes seems to be 
present throughout life and seems to be functionally relevant. In contrast, the heritability of 
volume of the hippocampus, which is central to the formation of new memories and 
memory consolidation, the process for converting short-term memory into stored or long-
term memory,72  seems to be modest.  Support for an environmental component of 
hippocampus volume comes from a twin study of Ammon’s horn sclerosis73 in which only 
the twin of MZ pairs who had experienced prolonged, childhood febrile seizures developed 
sclerosis. This discordance in hippocampal response to trauma suggests susceptibility of this 
structure to environmental events. Mammalian studies reporting neurogenesis of the 
hippocampal dentate gyrus in adult animals even into senescence74, 75 suggest that the 
relatively stable size of the hippocampus throughout adulthood76, 77 may reflect a lifelong 
relative maintenance of volume 78, 79 through mechanisms such as neurogenesis and 
synaptogenesis with rich environmental stimulation75 even when genetically 
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compromised.80, 81 This speculation must, however, be tempered by the relatively small 
number of new neurons generated in confined regions of the hippocampus82 and the lack of 
evidence that volume necessarily reflects cell number. In any case, if neurogenesis could be 
adequately and functionally amplified, it may carry new promise for conditions affecting 
the hippocampus such as LOAD.  
The GWAS and candidate gene studies, however, which explored the impact of genetic 
variation on imaging endophenotypes of LOAD, do support an impact of genetic factors. In 
particular studies exploring the effect of APOE genotype on morphological changes 
consistently suggest a modulation of volume/structure dependent on level of genetic risk. 
Thus, taken together these studies of the genetics of brain structure and function among 
normal individuals suggest that variation in brain structure and function can be expected 
and that pathological states represent the extremes of this variation. They further indicate 
that the morphological characteristics of several brain structures represent both differential 
vulnerability to environmental influences and phenotypical expressions of different sets of 
genes, which may operate on morphology at different times throughout development and 
aging. As a consequence, these data provide a valuable background for understanding the 
genetics of neurodegenerative diseases associated with changes in brain structures including 
LOAD. They suggest that using these quantitative imaging traits may provide an 
informative phenotype and may increase statistical power.    
Although encouraging, this also raises some additional questions and challenges. First, are 
the genes mediating each endophenotype involved in abnormal brain aging and cognition at 
least partially distinct from each other? This is a key assumption of the endophenotype 
approach, yet empirical proof of this remains to be determined. A substantial degree of 
overlap appears likely for a number of the known genes associated with early- and late-
onset AD, at least including the APP, PSEN1, PSEN2, APOE, SORL1 and SORCS1, given 
that these genes are involved in either the production or processing of the β-amyloid 
peptide. Nevertheless, each gene has a unique role in this cascade and it thus seems likely 
these loci will differ in their magnitudes of influence across the brain systems affected in this 
disorder. How do these genes (along with others that remain to be identified) coalesce in 
influencing liability to overt expression of LOAD? Are their effects additive or interactive? 
The answers to these questions depend on large-scale studies of genetically at-risk samples 
with and without environmental exposures and the use of sophisticated statistical modeling 
algorithms that can powerfully probe the resulting datasets for evidence of gene-gene and 
gene-environment interactions. Finally, are these endophenotypes and associated genes 
unique to cognitive impairment in LOAD, or are they shared by other diseases such as 
Dementia with Lewy Bodies, Parkinson’s disease or depression? Lewy body inclusions and 
Lewy neurites, the key pathological hallmarks of dementia with Lewy Bodies and 
Parkinson’s disease, are a frequent coexistent pathologic change observed in autopsy-
confirmed LOAD.   
The questions posed above raise considerable challenges for investigators attempting to 
unravel the genetic complexity of LOAD. Nevertheless, we have entered a new era in which 
conjoint advances in molecular genetics and dissection of the dementing phenotype are 
enabling rapid progress with multiple gene discoveries. These discoveries validate the 
dissection of this disorder into its more discretely determined subcomponents in order to 
elucidate the mechanisms underlying cognitive impairment in the elderly.  
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Author Subjects Age in years, mean (range) Brain region Heritability  
in % (95% CI) 
Reveley et 
al.33 (1984) 
18 MZ, 18 DZ NA LV 82-85% (NA) 
Bartley et 
al.27 (1997) 
10 MZ, 9 DZ MZ: 31 (19-54), DZ: 33 (18-29) TB 94% (NA) 
Carmelli et 
al.25 (1998) 
74 MZ, 71 DZ 68-79 years IC 91% (NA) 
Pennington 
et al.28 
(2000) 
Reading 
disability: 25 
MZ, 23 DZ; 
Non-Reading 
disability: 9 MZ, 
9 DZ 
Reading disability: MZ: 17.1, 
DZ: 16.8; Non-reading 
disability: MZ: 19.4, DZ: 18.7
TB 
Neocortex 
97% (NA) 
56% (NA) 
Pfefferbau
m et al.26 
(2000) 
45 MZ, 40 DZ MZ: 72.2, DZ: 71.4, range: 68-
78 
Subcortex 
IC 
CC 
LV 
70% (NA) 
81% (72-90) 
79% (69-89) 
79% (55-100) 
Posthuma 
et al.3 (2000) 
See Baaré et al 
(2001) 
See Baaré et al (2001) CB 88% (81-92) 
Sullivan et 
al.34 (2001) 
45 MZ, 40 DZ MZ: 72.2, DZ: 71.4, range: 68-
78 
HIP 40% (NA) 
Thompson 
et al.5 (2001) 
10 MZ, 10 DZ 48.2 ±3.4 Middle frontal 
sensimotor and 
anterior 
temporal 
cortices, Broca`s 
and Wernicke`s 
region (cortical 
thickness) 
90-95% (NA) 
Baaré et 
al.24 (2001) 
54 MZ, 58 DZ, 
34 sibs 
15 MZ, 18 DZ 
MZM: 31.2, MZF: 34.1, DZM: 
30.3, DZF: 30.6, OS: 30.3, sibs: 
29.0; range: 19-69 
75.7 ± years 
IC 
TB 
GM 
WM 
LV 
Size CC 
Microstructure 
CC (DTI) 
88% (82-92) 
90% (85-93) 
82% (73-88) 
87% (80-91) 
C: 59%  
(47-69), E: 41% 
(31-53) 
5:1 (NA) 
3:1 (NA) 
Geschwind 
et al.30 
(2002) 
72 MZ, 67 DZ MZ: 72.3, DZ: 71.8 Cerebral 
hemispheres 
65% (NA) 
Eckert  
et al.32 
(2002) 
27 MZ, 12 DZ MZ: 6.9-16.4, DZ: 6.1-15.0 Planum 
temporale 
asymmetry 
NA (NA) 
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Author Subjects Age in years, mean (range) Brain region Heritability  
in % (95% CI) 
Wright et 
al.29 (2002) 
10 MZ, 10 DZ MZ: 31 (19-54), DZ: 23 (18-29) TB 
LV 
CB 
Ventrolateral 
FR, cingulate, 
anterior/superi
or/transverse 
temp, 
retrosplenium 
66% (17-100) 
C: 48% (0-97), 
E: 50% (32-84) 
63%, E: 22% 
(NA) 
58-73% (NA) 
White et 
al.83 (2002) 
12 MZ, 12 
control pairs 
MZ: 24.5±7.2, controls: 
 24.4 ±7.2 
TB, GM, WM, 
CB 
CAU, PUT, 
THAL, cortical 
depth 
r>0.90 
r>0.75 
Scamvouge
ras et al.84 
(2003) 
14 MZ, 12 DZ MZ: 16-41, DZ: 18-32 CC 94% (NA) 
Pfefferbau
m et al.40 
(2004) 
34 MZ, 37 DZ 4-year longitudinal follow-
up 
T1: 68-80 years, T2: 72-84 
years 
CC (T1) 
CC (T2) 
LV (T1) 
LV (T2) 
89% (NA) 
92% (NA) 
92% (NA) 
88% (NA) 
Wallace et 
al.31 (2006) 
90 MZ, 37 DZ MZ: 11.9, DZ: 10.9, range: 5-
19 
TB 
GM 
WM 
FR, TEMP, 
PAR 
CB 
LV 
89% (67-92) 
82% (50-87) 
85% (56-90) 
77-88% (50-90) 
49% (13-83) 
31% (0-67), C: 
24% (0-58), E: 
45% (33-60) 
Hulshoff 
Pol et al.37 
(2006) 
See Baaré et al 
(2001) 
See Baaré et al (2001) WM (SOF, CC, 
CST) 
GM, MFL, SFL, 
STL, CING, 
PARAHIP, 
AMYG, OCC 
69-82% (NA) 
55-85% (NA) 
AMYG, amygdala; CAU, caudate; CB, cerebellum; CC, corpus callosum; CI, confidence interval; CING, 
cingulate; CST, corticospinal tract; DTI, diffusion tensor imaging; DZ, dizygotic; DZF, dizygotic female; 
DZM, dizygotic male; FR, frontal lobe; GM, gray matter; HIP, hippocampus; IC, intracranial volume; 
LH, left handed; LV, lateral ventricles; MFL, medial frontal lobe; MZ, monozygotic; MZF, monozygotic 
female; MZM, monozygotic male; NA, not available; OCC, occipital lobe; occ-front-temp, occipito-
fronto temporal; PAR, parietal lobe; PARAHIP, parahippocampal gyrus; PUT, putamen; SOF, superior 
orbitofrontal; TB, total brain; TEMP, temporal lobe; THAL, thalamus; SFL, superior frontal lobe; STL, 
superior temporal lobe; WM, white matter. 
Table 1. Studies on heritability of human brain volumes 
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It is important to note that - despite their utility in the context of etiological research on 
LOAD - endophenotypes have not proven to have great utility in the clinical distinction of 
dementing disorders. As described above, the different forms of dementia show substantial 
clinical and pathological overlap, and likely do not reflect completely separate underlying 
pathologies or genetic causes but rather a continuous spectrum of disease. Therefore, 
although they more realistically reflect variation in the underlying causes of illness, the use 
of endophenotypic assessments in diagnostic or treatment contexts is difficult. 
In conclusion, given that the pathways from genotypes to end-stage phenotypes are 
circuitous at best, discernment of endophenotypes more proximal to the effects of genetic 
variation can improve statistical power and thereby be a powerful tool in the identification 
of genes linked to complex disorders. They can help understand how environmental and 
genetic factors interact to influence disease susceptibility and expression, and can help 
identify targets for the development of new treatment and prevention strategies. 
7. Acknowledgements 
This work was supported by grants from the National Institute of Health and the National 
Institute on Aging: R37-AG15473, P01-AG07232, The Blanchett Hooker Rockefeller 
Foundation, The Charles S. Robertson Gift from the Banbury Fund, and The Merrill Lynch 
Foundation. Dr. Reitz was further supported by a Paul B. Beeson Career Development 
Award (K23AG034550).  
8. References 
[1] Teipel SJ, Schapiro MB, Alexander GE, Krasuski JS, Horwitz B, Hoehne C, Moller HJ, 
Rapoport SI, Hampel H. Relation of corpus callosum and hippocampal size to age 
in nondemented adults with down's syndrome. The American journal of psychiatry. 
2003;160:1870-1878 
[2] Meyer JM, Breitner JC. Multiple threshold model for the onset of alzheimer's disease in 
the nas-nrc twin panel. American journal of medical genetics. 1998;81:92-97 
[3] Posthuma D, de Geus EJ, Neale MC, Hulshoff Pol HE, Baare WEC, Kahn RS, Boomsma 
D. Multivariate genetic analysis of brain structure in an extended twin design. 
Behavior genetics. 2000;30:311-319 
[4] Thompson P, Cannon TD, Toga AW. Mapping genetic influences on human brain 
structure. Annals of medicine. 2002;34:523-536 
[5] Thompson PM, Cannon TD, Narr KL, van Erp T, Poutanen VP, Huttunen M, Lonnqvist 
J, Standertskjold-Nordenstam CG, Kaprio J, Khaledy M, Dail R, Zoumalan CI, Toga 
AW. Genetic influences on brain structure. Nature neuroscience. 2001;4:1253-1258 
[6] Gogtay N, Giedd JN, Lusk L, Hayashi KM, Greenstein D, Vaituzis AC, Nugent TF, 3rd, 
Herman DH, Clasen LS, Toga AW, Rapoport JL, Thompson PM. Dynamic mapping 
of human cortical development during childhood through early adulthood. 
Proceedings of the National Academy of Sciences of the United States of America. 
2004;101:8174-8179 
[7] Sowell ER, Peterson BS, Thompson PM, Welcome SE, Henkenius AL, Toga AW. 
Mapping cortical change across the human life span. Nature neuroscience. 
2003;6:309-315 
 
Neuroimaging – Methods 
 
306 
[8] Thompson PM, Hayashi KM, Dutton RA, Chiang MC, Leow AD, Sowell ER, De 
Zubicaray G, Becker JT, Lopez OL, Aizenstein HJ, Toga AW. Tracking alzheimer's 
disease. Ann N Y Acad Sci. 2007;1097:183-214 
[9] Krasuski JS, Alexander GE, Horwitz B, Daly EM, Murphy DG, Rapoport SI, Schapiro 
MB. Volumes of medial temporal lobe structures in patients with alzheimer's 
disease and mild cognitive impairment (and in healthy controls). Biological 
psychiatry. 1998;43:60-68 
[10] Karas G, Scheltens P, Rombouts S, van Schijndel R, Klein M, Jones B, van der Flier W, 
Vrenken H, Barkhof F. Precuneus atrophy in early-onset alzheimer's disease: A 
morphometric structural mri study. Neuroradiology. 2007;49:967-976 
[11] Mungas D, Harvey D, Reed BR, Jagust WJ, DeCarli C, Beckett L, Mack WJ, Kramer JH, 
Weiner MW, Schuff N, Chui HC. Longitudinal volumetric mri change and rate of 
cognitive decline. Neurology. 2005;65:565-571 
[12] Likeman M, Anderson VM, Stevens JM, Waldman AD, Godbolt AK, Frost C, Rossor 
MN, Fox NC. Visual assessment of atrophy on magnetic resonance imaging in the 
diagnosis of pathologically confirmed young-onset dementias. Archives of neurology. 
2005;62:1410-1415 
[13] Chetelat G, Landeau B, Eustache F, Mezenge F, Viader F, de la Sayette V, Desgranges B, 
Baron JC. Using voxel-based morphometry to map the structural changes 
associated with rapid conversion in mci: A longitudinal mri study. NeuroImage. 
2005;27:934-946 
[14] Wolk DA, Dickerson BC. Fractionating verbal episodic memory in alzheimer's disease. 
NeuroImage. 2011;54:1530-1539 
[15] Rombouts SA, Barkhof F, Veltman DJ, Machielsen WC, Witter MP, Bierlaagh MA, 
Lazeron RH, Valk J, Scheltens P. Functional mr imaging in alzheimer's disease 
during memory encoding. AJNR Am J Neuroradiol. 2000;21:1869-1875 
[16] Bokde AL, Karmann M, Born C, Teipel SJ, Omerovic M, Ewers M, Frodl T, Meisenzahl 
E, Reiser M, Moller HJ, Hampel H. Altered brain activation during a verbal 
working memory task in subjects with amnestic mild cognitive impairment. J 
Alzheimers Dis. 2010;21:103-118 
[17] Small GW, Bookheimer SY, Thompson PM, Cole GM, Huang SC, Kepe V, Barrio JR. 
Current and future uses of neuroimaging for cognitively impaired patients. Lancet 
neurology. 2008;7:161-172 
[18] Silverman DH, Small GW, Chang CY, Lu CS, Kung De Aburto MA, Chen W, Czernin J, 
Rapoport SI, Pietrini P, Alexander GE, Schapiro MB, Jagust WJ, Hoffman JM, 
Welsh-Bohmer KA, Alavi A, Clark CM, Salmon E, de Leon MJ, Mielke R, 
Cummings JL, Kowell AP, Gambhir SS, Hoh CK, Phelps ME. Positron emission 
tomography in evaluation of dementia: Regional brain metabolism and long-term 
outcome. JAMA. 2001;286:2120-2127 
[19] O'Brien JT. Role of imaging techniques in the diagnosis of dementia. Br J Radiol. 2007;80 
Spec No 2:S71-77 
[20] Klunk WE, Engler H, Nordberg A, Wang Y, Blomqvist G, Holt DP, Bergstrom M, 
Savitcheva I, Huang GF, Estrada S, Ausen B, Debnath ML, Barletta J, Price JC, 
Sandell J, Lopresti BJ, Wall A, Koivisto P, Antoni G, Mathis CA, Langstrom B. 
Imaging brain amyloid in alzheimer's disease with pittsburgh compound-b. Ann 
Neurol. 2004;55:306-319 
 
Genetic Risk Factors of Imaging Measures Associated with Late-Onset Alzheimer’s Disease 
 
307 
[21] Frisoni GB, Lorenzi M, Caroli A, Kemppainen N, Nagren K, Rinne JO. In vivo mapping 
of amyloid toxicity in alzheimer disease. Neurology. 2009;72:1504-1511 
[22] Tolboom N, van der Flier WM, Yaqub M, Koene T, Boellaard R, Windhorst AD, 
Scheltens P, Lammertsma AA, van Berckel BN. Differential association of [11c]pib 
and [18f]fddnp binding with cognitive impairment. Neurology. 2009;73:2079-2085 
[23] Boomsma D, Busjahn A, Peltonen L. Classical twin studies and beyond. Nature reviews. 
2002;3:872-882 
[24] Baare WF, Hulshoff Pol HE, Boomsma DI, Posthuma D, de Geus EJ, Schnack HG, van 
Haren NE, van Oel CJ, Kahn RS. Quantitative genetic modeling of variation in 
human brain morphology. Cereb Cortex. 2001;11:816-824 
[25] Carmelli D, DeCarli C, Swan GE, Jack LM, Reed T, Wolf PA, Miller BL. Evidence for 
genetic variance in white matter hyperintensity volume in normal elderly male 
twins. Stroke; a journal of cerebral circulation. 1998;29:1177-1181 
[26] Pfefferbaum A, Sullivan EV, Swan GE, Carmelli D. Brain structure in men remains 
highly heritable in the seventh and eighth decades of life. Neurobiology of aging. 
2000;21:63-74 
[27] Bartley AJ, Jones DW, Weinberger DR. Genetic variability of human brain size and 
cortical gyral patterns. Brain. 1997;120 ( Pt 2):257-269 
[28] Pennington BF, Filipek PA, Lefly D, Chhabildas N, Kennedy DN, Simon JH, Filley CM, 
Galaburda A, DeFries JC. A twin mri study of size variations in human brain. 
Journal of cognitive neuroscience. 2000;12:223-232 
[29] Wright IC, Sham P, Murray RM, Weinberger DR, Bullmore ET. Genetic contributions to 
regional variability in human brain structure: Methods and preliminary results. 
NeuroImage. 2002;17:256-271 
[30] Geschwind DH, Miller BL, DeCarli C, Carmelli D. Heritability of lobar brain volumes in 
twins supports genetic models of cerebral laterality and handedness. Proceedings of 
the National Academy of Sciences of the United States of America. 2002;99:3176-3181 
[31] Wallace GL, Eric Schmitt J, Lenroot R, Viding E, Ordaz S, Rosenthal MA, Molloy EA, 
Clasen LS, Kendler KS, Neale MC, Giedd JN. A pediatric twin study of brain 
morphometry. Journal of child psychology and psychiatry, and allied disciplines. 
2006;47:987-993 
[32] Eckert MA, Leonard CM, Molloy EA, Blumenthal J, Zijdenbos A, Giedd JN. The 
epigenesis of planum temporale asymmetry in twins. Cereb Cortex. 2002;12:749-755 
[33] Reveley AM, Reveley MA, Chitkara B, Clifford C. The genetic basis of cerebral 
ventricular volume. Psychiatry research. 1984;13:261-266 
[34] Sullivan EV, Pfefferbaum A, Swan GE, Carmelli D. Heritability of hippocampal size in 
elderly twin men: Equivalent influence from genes and environment. Hippocampus. 
2001;11:754-762 
[35] Chetelat G, Fouquet M, Kalpouzos G, Denghien I, De la Sayette V, Viader F, Mezenge F, 
Landeau B, Baron JC, Eustache F, Desgranges B. Three-dimensional surface 
mapping of hippocampal atrophy progression from mci to ad and over normal 
aging as assessed using voxel-based morphometry. Neuropsychologia. 2008;46:1721-
1731 
[36] Ashburner J, Friston KJ. Why voxel-based morphometry should be used. NeuroImage. 
2001;14:1238-1243 
 
Neuroimaging – Methods 
 
308 
[37] Hulshoff Pol HE, Schnack HG, Posthuma D, Mandl RC, Baare WF, van Oel C, van 
Haren NE, Collins DL, Evans AC, Amunts K, Burgel U, Zilles K, de Geus E, 
Boomsma DI, Kahn RS. Genetic contributions to human brain morphology and 
intelligence. J Neurosci. 2006;26:10235-10242 
[38] Farlow MR, He Y, Tekin S, Xu J, Lane R, Charles HC. Impact of apoe in mild cognitive 
impairment. Neurology. 2004;63:1898-1901 
[39] Myers RH, Schaefer EJ, Wilson PW, D'Agostino R, Ordovas JM, Espino A, Au R, White 
RF, Knoefel JE, Cobb JL, McNulty KA, Beiser A, Wolf PA. Apolipoprotein e 
epsilon4 association with dementia in a population-based study: The framingham 
study. Neurology. 1996;46:673-677 
[40] Pfefferbaum A, Sullivan EV, Carmelli D. Morphological changes in aging brain 
structures are differentially affected by time-linked environmental influences 
despite strong genetic stability. Neurobiology of aging. 2004;25:175-183 
[41] Green RC, Cupples LA, Go R, Benke KS, Edeki T, Griffith PA, Williams M, Hipps Y, 
Graff-Radford N, Bachman D, Farrer LA. Risk of dementia among white and 
african american relatives of patients with alzheimer disease. JAMA. 2002;287:329-
336 
[42] Gatz M, Reynolds CA, Fratiglioni L, Johansson B, Mortimer JA, Berg S, Fiske A, 
Pedersen NL. Role of genes and environments for explaining alzheimer disease. 
Archives of general psychiatry. 2006;63:168-174 
[43] Daw EW, Payami H, Nemens EJ, Nochlin D, Bird TD, Schellenberg GD, Wijsman EM. 
The number of trait loci in late-onset alzheimer disease. American journal of human 
genetics. 2000;66:196-204 
[44] Rogaeva E, Meng Y, Lee JH, Gu Y, Kawarai T, Zou F, Katayama T, Baldwin CT, Cheng 
R, Hasegawa H, Chen F, Shibata N, Lunetta KL, Pardossi-Piquard R, Bohm C, 
Wakutani Y, Cupples LA, Cuenco KT, Green RC, Pinessi L, Rainero I, Sorbi S, Bruni 
A, Duara R, Friedland RP, Inzelberg R, Hampe W, Bujo H, Song YQ, Andersen OM, 
Willnow TE, Graff-Radford N, Petersen RC, Dickson D, Der SD, Fraser PE, Schmitt-
Ulms G, Younkin S, Mayeux R, Farrer LA, St George-Hyslop P. The neuronal 
sortilin-related receptor sorl1 is genetically associated with alzheimer disease. 
Nature genetics. 2007;39:168-177 
[45] Reitz C, Cheng R, Rogaeva E, Lee JH, Tokuhiro S, Zou F, Bettens K, Sleegers K, Tan EK, 
Kimura R, Shibata N, Arai H, Kamboh MI, Prince JA, Maier W, Riemenschneider 
M, Owen M, Harold D, Hollingworth P, Cellini E, Sorbi S, Nacmias B, Takeda M, 
Pericak-Vance MA, Haines JL, Younkin S, Williams J, van Broeckhoven C, Farrer 
LA, St George-Hyslop PH, Mayeux R. Meta-analysis of the association between 
variants in sorl1 and alzheimer disease. Archives of neurology. 2011;68:99-106 
[46] Reitz C, Lee J, Clark L, Rogers R, Rogaeva E, St George-Hyslop P, Mayeux R. Impact of 
genetic variation in sorcs1 on memory retention. Neurobiology of aging. 2011;In press 
[47] Reitz C, Tokuhiro S, Clark L, Conrad C, Vonsattel JP, Hazrati L-N, Palotas A, Lantigua 
R, Medrano M, Jimenez-Velazquez I, Vardarajan B, Simkin I, Haines JL, Pericak-
Vance MA, Farrer L, Lee J, Rogaeva E, St George-Hyslop P, Mayeux R. Sorcs1 alters 
amyloid precursor protein processing and variants may increase alzheimer's 
disease risk. Ann Neurol. 2011;In press 
 
Genetic Risk Factors of Imaging Measures Associated with Late-Onset Alzheimer’s Disease 
 
309 
[48] Beecham GW, Martin ER, Li YJ, Slifer MA, Gilbert JR, Haines JL, Pericak-Vance MA. 
Genome-wide association study implicates a chromosome 12 risk locus for late-
onset alzheimer disease. American journal of human genetics. 2009;84:35-43 
[49] Bertram L, McQueen MB, Mullin K, Blacker D, Tanzi RE. Systematic meta-analyses of 
alzheimer disease genetic association studies: The alzgene database. Nature genetics. 
2007;39:17-23 
[50] Carrasquillo MM, Zou F, Pankratz VS, Wilcox SL, Ma L, Walker LP, Younkin SG, 
Younkin CS, Younkin LH, Bisceglio GD, Ertekin-Taner N, Crook JE, Dickson DW, 
Petersen RC, Graff-Radford NR. Genetic variation in pcdh11x is associated with 
susceptibility to late-onset alzheimer's disease. Nature genetics. 2009;41:192-198 
[51] Lambert JC, Heath S, Even G, Campion D, Sleegers K, Hiltunen M, Combarros O, 
Zelenika D, Bullido MJ, Tavernier B, Letenneur L, Bettens K, Berr C, Pasquier F, 
Fievet N, Barberger-Gateau P, Engelborghs S, De Deyn P, Mateo I, Franck A, 
Helisalmi S, Porcellini E, Hanon O, de Pancorbo MM, Lendon C, Dufouil C, Jaillard 
C, Leveillard T, Alvarez V, Bosco P, Mancuso M, Panza F, Nacmias B, Bossu P, 
Piccardi P, Annoni G, Seripa D, Galimberti D, Hannequin D, Licastro F, Soininen H, 
Ritchie K, Blanche H, Dartigues JF, Tzourio C, Gut I, Van Broeckhoven C, 
Alperovitch A, Lathrop M, Amouyel P. Genome-wide association study identifies 
variants at clu and cr1 associated with alzheimer's disease. Nature genetics. 
2009;41:1094-1099 
[52] Seshadri S, Fitzpatrick AL, Ikram MA, DeStefano AL, Gudnason V, Boada M, Bis JC, 
Smith AV, Carassquillo MM, Lambert JC, Harold D, Schrijvers EM, Ramirez-Lorca 
R, Debette S, Longstreth WT, Jr., Janssens AC, Pankratz VS, Dartigues JF, 
Hollingworth P, Aspelund T, Hernandez I, Beiser A, Kuller LH, Koudstaal PJ, 
Dickson DW, Tzourio C, Abraham R, Antunez C, Du Y, Rotter JI, Aulchenko YS, 
Harris TB, Petersen RC, Berr C, Owen MJ, Lopez-Arrieta J, Varadarajan BN, Becker 
JT, Rivadeneira F, Nalls MA, Graff-Radford NR, Campion D, Auerbach S, Rice K, 
Hofman A, Jonsson PV, Schmidt H, Lathrop M, Mosley TH, Au R, Psaty BM, 
Uitterlinden AG, Farrer LA, Lumley T, Ruiz A, Williams J, Amouyel P, Younkin 
SG, Wolf PA, Launer LJ, Lopez OL, van Duijn CM, Breteler MM. Genome-wide 
analysis of genetic loci associated with alzheimer disease. JAMA. 2010;303:1832-
1840 
[53] Bigler ED, Tate DF, Miller MJ, Rice SA, Hessel CD, Earl HD, Tschanz JT, Plassman B, 
Welsh-Bohmer KA. Dementia, asymmetry of temporal lobe structures, and 
apolipoprotein e genotype: Relationships to cerebral atrophy and neuropsychological 
impairment. J Int Neuropsychol Soc. 2002;8:925-933 
[54] Burggren AC, Zeineh MM, Ekstrom AD, Braskie MN, Thompson PM, Small GW, 
Bookheimer SY. Reduced cortical thickness in hippocampal subregions among 
cognitively normal apolipoprotein e e4 carriers. NeuroImage. 2008;41:1177-1183 
[55] Morra JH, Tu Z, Apostolova LG, Green AE, Avedissian C, Madsen SK, Parikshak N, 
Toga AW, Jack CR, Jr., Schuff N, Weiner MW, Thompson PM. Automated mapping 
of hippocampal atrophy in 1-year repeat mri data from 490 subjects with 
alzheimer's disease, mild cognitive impairment, and elderly controls. NeuroImage. 
2009;45:S3-15 
[56] Chen K, Reiman EM, Alexander GE, Caselli RJ, Gerkin R, Bandy D, Domb A, Osborne 
D, Fox N, Crum WR, Saunders AM, Hardy J. Correlations between apolipoprotein 
 
Neuroimaging – Methods 
 
310 
e epsilon4 gene dose and whole brain atrophy rates. The American journal of 
psychiatry. 2007;164:916-921 
[57] Valla J, Yaari R, Wolf AB, Kusne Y, Beach TG, Roher AE, Corneveaux JJ, Huentelman 
MJ, Caselli RJ, Reiman EM. Reduced posterior cingulate mitochondrial activity in 
expired young adult carriers of the apoe epsilon4 allele, the major late-onset 
alzheimer's susceptibility gene. J Alzheimers Dis. 2010;22:307-313 
[58] Mosconi L, Perani D, Sorbi S, Herholz K, Nacmias B, Holthoff V, Salmon E, Baron JC, 
De Cristofaro MT, Padovani A, Borroni B, Franceschi M, Bracco L, Pupi A. Mci 
conversion to dementia and the apoe genotype: A prediction study with fdg-pet. 
Neurology. 2004;63:2332-2340 
[59] Scarmeas N, Anderson KE, Hilton J, Park A, Habeck C, Flynn J, Tycko B, Stern Y. Apoe-
dependent pet patterns of brain activation in alzheimer disease. Neurology. 
2004;63:913-915 
[60] Mosconi L, Nacmias B, Sorbi S, De Cristofaro MT, Fayazz M, Tedde A, Bracco L, 
Herholz K, Pupi A. Brain metabolic decreases related to the dose of the apoe e4 
allele in alzheimer's disease. J Neurol Neurosurg Psychiatry. 2004;75:370-376 
[61] Grimmer T, Tholen S, Yousefi BH, Alexopoulos P, Forschler A, Forstl H, Henriksen G, 
Klunk WE, Mathis CA, Perneczky R, Sorg C, Kurz A, Drzezga A. Progression of 
cerebral amyloid load is associated with the apolipoprotein e epsilon4 genotype in 
alzheimer's disease. Biological psychiatry. 2010;68:879-884 
[62] Reiman EM, Chen K, Liu X, Bandy D, Yu M, Lee W, Ayutyanont N, Keppler J, Reeder 
SA, Langbaum JB, Alexander GE, Klunk WE, Mathis CA, Price JC, Aizenstein HJ, 
DeKosky ST, Caselli RJ. Fibrillar amyloid-beta burden in cognitively normal people 
at 3 levels of genetic risk for alzheimer's disease. Proceedings of the National Academy 
of Sciences of the United States of America. 2009;106:6820-6825 
[63] Drzezga A, Grimmer T, Henriksen G, Muhlau M, Perneczky R, Miederer I, Praus C, 
Sorg C, Wohlschlager A, Riemenschneider M, Wester HJ, Foerstl H, Schwaiger M, 
Kurz A. Effect of apoe genotype on amyloid plaque load and gray matter volume 
in alzheimer disease. Neurology. 2009;72:1487-1494 
[64] Potkin SG, Guffanti G, Lakatos A, Turner JA, Kruggel F, Fallon JH, Saykin AJ, Orro A, 
Lupoli S, Salvi E, Weiner M, Macciardi F. Hippocampal atrophy as a quantitative 
trait in a genome-wide association study identifying novel susceptibility genes for 
alzheimer's disease. PLoS One. 2009;4:e6501 
[65] Saykin AJ, Shen L, Foroud TM, Potkin SG, Swaminathan S, Kim S, Risacher SL, Nho K, 
Huentelman MJ, Craig DW, Thompson PM, Stein JL, Moore JH, Farrer LA, Green 
RC, Bertram L, Jack CR, Jr., Weiner MW. Alzheimer's disease neuroimaging 
initiative biomarkers as quantitative phenotypes: Genetics core aims, progress, and 
plans. Alzheimers Dement. 2010;6:265-273 
[66] Shen L, Kim S, Risacher SL, Nho K, Swaminathan S, West JD, Foroud T, Pankratz N, 
Moore JH, Sloan CD, Huentelman MJ, Craig DW, Dechairo BM, Potkin SG, Jack CR, 
Jr., Weiner MW, Saykin AJ. Whole genome association study of brain-wide imaging 
phenotypes for identifying quantitative trait loci in mci and ad: A study of the adni 
cohort. NeuroImage. 2010;53:1051-1063 
[67] Stein JL, Hua X, Morra JH, Lee S, Hibar DP, Ho AJ, Leow AD, Toga AW, Sul JH, Kang 
HM, Eskin E, Saykin AJ, Shen L, Foroud T, Pankratz N, Huentelman MJ, Craig DW, 
Gerber JD, Allen AN, Corneveaux JJ, Stephan DA, Webster J, DeChairo BM, Potkin 
 
Genetic Risk Factors of Imaging Measures Associated with Late-Onset Alzheimer’s Disease 
 
311 
SG, Jack CR, Jr., Weiner MW, Thompson PM. Genome-wide analysis reveals novel 
genes influencing temporal lobe structure with relevance to neurodegeneration in 
alzheimer's disease. NeuroImage. 2010;51:542-554 
[68] Ho AJ, Stein JL, Hua X, Lee S, Hibar DP, Leow AD, Dinov ID, Toga AW, Saykin AJ, 
Shen L, Foroud T, Pankratz N, Huentelman MJ, Craig DW, Gerber JD, Allen AN, 
Corneveaux JJ, Stephan DA, DeCarli CS, DeChairo BM, Potkin SG, Jack CR, Jr., 
Weiner MW, Raji CA, Lopez OL, Becker JT, Carmichael OT, Thompson PM. A 
commonly carried allele of the obesity-related fto gene is associated with reduced 
brain volume in the healthy elderly. Proceedings of the National Academy of Sciences of 
the United States of America. 2010;107:8404-8409 
[69] Schuur M, van Swieten JC, Schol-Gelok S, Ikram MA, Vernooij MW, Liu F, Isaacs A, de 
Boer R, de Koning I, Niessen WJ, Vrooman H, Oostra BA, van der Lugt A, Breteler 
MM, van Duijn CM. Genetic risk factors for cerebral small-vessel disease in 
hypertensive patients from a genetically isolated population. J Neurol Neurosurg 
Psychiatry. 2011;82:41-44 
[70] K TC, Lunetta KL, Baldwin CT, McKee AC, Guo J, Cupples LA, Green RC, St George-
Hyslop PH, Chui H, DeCarli C, Farrer LA. Association of distinct variants in sorl1 
with cerebrovascular and neurodegenerative changes related to alzheimer disease. 
Archives of neurology. 2008;65:1640-1648 
[71] Liang WS, Chen K, Lee W, Sidhar K, Corneveaux JJ, Allen AN, Myers A, Villa S, 
Meechoovet B, Pruzin J, Bandy D, Fleisher AS, Langbaum JB, Huentelman MJ, 
Jensen K, Dunckley T, Caselli RJ, Kaib S, Reiman EM. Association between gab2 
haplotype and higher glucose metabolism in alzheimer's disease-affected brain 
regions in cognitively normal apoeepsilon4 carriers. NeuroImage. 2011;54:1896-1902 
[72] Wittenberg GM, Tsien JZ. An emerging molecular and cellular framework for memory 
processing by the hippocampus. Trends in neurosciences. 2002;25:501-505 
[73] Jackson GD, Berkovic SF, Tress BM, Kalnins RM, Fabinyi GC, Bladin PF. Hippocampal 
sclerosis can be reliably detected by magnetic resonance imaging. Neurology. 
1990;40:1869-1875 
[74] Eriksson PS, Perfilieva E, Bjork-Eriksson T, Alborn AM, Nordborg C, Peterson DA, 
Gage FH. Neurogenesis in the adult human hippocampus. Nature medicine. 
1998;4:1313-1317 
[75] Gould E, Beylin A, Tanapat P, Reeves A, Shors TJ. Learning enhances adult 
neurogenesis in the hippocampal formation. Nature neuroscience. 1999;2:260-265 
[76] Gallagher M, Landfield PW, McEwen B, Meaney MJ, Rapp PR, Sapolsky R, West MJ. 
Hippocampal neurodegeneration in aging. Science (New York, N.Y. 1996;274:484-485 
[77] Harding AJ, Halliday GM, Kril JJ. Variation in hippocampal neuron number with age 
and brain volume. Cereb Cortex. 1998;8:710-718 
[78] Cameron HA, McKay RD. Restoring production of hippocampal neurons in old age. 
Nature neuroscience. 1999;2:894-897 
[79] Kempermann G, Kuhn HG, Gage FH. Experience-induced neurogenesis in the 
senescent dentate gyrus. J Neurosci. 1998;18:3206-3212 
[80] Rampon C, Tang YP, Goodhouse J, Shimizu E, Kyin M, Tsien JZ. Enrichment induces 
structural changes and recovery from nonspatial memory deficits in ca1 nmdar1-
knockout mice. Nature neuroscience. 2000;3:238-244 
 
Neuroimaging – Methods 
 
312 
[81] Rampon C, Tsien JZ. Genetic analysis of learning behavior-induced structural plasticity. 
Hippocampus. 2000;10:605-609 
[82] Kornack DR, Rakic P. Continuation of neurogenesis in the hippocampus of the adult 
macaque monkey. Proceedings of the National Academy of Sciences of the United States 
of America. 1999;96:5768-5773 
[83] White T, Andreasen NC, Nopoulos P. Brain volumes and surface morphology in 
monozygotic twins. Cereb Cortex. 2002;12:486-493 
[84] Scamvougeras A, Kigar DL, Jones D, Weinberger DR, Witelson SF. Size of the human 
corpus callosum is genetically determined: An mri study in mono and dizygotic 
twins. Neuroscience letters. 2003;338:91-94 
17 
Neuroimaging Findings  
in Dementia with Lewy Body: A Review  
Francesca Baglio, Maria Giulia Preti and Elisabetta Farina 
Fondazione Don Carlo Gnocchi ONLUS Milano 
Politecnico di Milano 
Italy 
1. Introduction 
1.1 Dementia with Lewy bodies: An overview 
Dementia with Lewy bodies (DLB) is a progressive neurodegenerative disorder 
characterized by the core clinical features of fluctuating consciousness, visual hallucinations 
and parkinsonism.  
The term DLB and the clinical criteria were first introduced and proposed by Mc Keith and 
colleagues in 1996 during the First International Workshop of the Consortium on Dementia 
with Lewy Bodies (McKeith et al., 1996) and were revised in 2005 to improve the sensitivity 
for diagnosis (McKeith et al., 2005). Interestingly, in these revised criteria, imaging with 
Single Photon Emission Computed Tomography (SPECT) or Positron Emission 
Tomography (PET) played an important role for the first time in the clinical diagnostic 
criteria of a dementia and was included as a suggestive feature supporting the diagnosis.  
After Alzheimer's disease (AD), DLB is now considered the second most common type of 
degenerative dementia in elderly people (Aarsland et al., 2008; McKeith et al., 2004) 
observed in 15 to 25% of autopsy series (Heidebrink, 2002; McKeith et al., 1996; Perry et al., 
1990). These percentages are consistent with the few available epidemiological population-
based studies (de Silva et al., 2003; Herrera et al., 2002; Rahkonen et al., 2003; Stevens et al., 
2002; Yamada et al., 2001; Yamada et al., 2002), which have reported the prevalence of DLB 
ranging from 0 to 30.5% of all dementia cases in individuals older than 65 years and from 0 
to 5% in the general population (Zaccai et al., 2005). However, DLB is a regularly 
misdiagnosed clinical condition, with autopsy reports indicating a higher frequency than 
that detected in clinical settings (Farina et al., 2009; Mollenhauer et al., 2010).  
The pathological background of DLB has been a matter of controversy and is a complex 
issue (see Fig. 1). The core neuropathological finding is the presence of α-synuclein 
aggregates which form neuronal inclusions called Lewy bodies (LBs). According to the 
consensus pathological guidelines, based on a semiquantitative scoring of α-synuclein 
pathology (LBs density and distribution) in specific brain regions, DLB is distinguished into 
three different phenotypes (brainstem, transitional/limbic, and diffuse neocortical). 
Moreover, DLB pathological features are often associated to various degrees of AD 
pathology (i.e. limbic and neocortical spread of LB lesions with or without concomitant AD 
amyloid plaque pathology). 
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Fig. 1. Clinicopathological interaction between dementia with Lewy bodies (DLB), 
Parkinson's disease dementia (PDD) and Alzheimer's disease (AD). LBs: Lewy Bodies; 
NFTs: neurofibrillary tangles;  APs: amyloid plaques. 
As previously described, the clinical criteria for the diagnosis of DLB were established in 
1996 (McKeith et al., 1996) and revised in 2005 (McKetih et al., 2005) to include additional 
suggestive clinical features (REM sleep behaviour disorder and  severe neuroleptic 
sensitivity) as well as specific neuroradiological findings (Dopamine SPECT or PET 
imaging). The central feature for the diagnosis, that must be present for either probable or 
possible DLB, is a condition of dementia. This dementia is defined as a progressive cognitive 
decline of sufficient magnitude to interfere with normal social or occupational function and 
with prominent deficits on tests of attention, executive function, and visuospatial ability. 
The cognitive deficits are not necessarily associated with memory impairment at list at the 
early stages of the diseases. Then, “probable” DLB is characterized by the presence of this 
central characteristic with any two of the three core features (fluctuating cognition, recurrent 
visual hallucinations, or parkinsonism) or one core feature and one suggestive feature, 
whereas “possible” DLB is diagnosed in the absence of any core features but in the presence 
of one or more suggestive features. Finally, clinical criteria also includes supportive features 
(commonly present but not proven to have diagnostic specificity) and  findings that do not 
support DLB (see Table 1 for a detailed description of clinical criteria).  
DLB shares many common clinical (motor, cognitive, attentional, and psychiatric 
symptoms), neuropsychological (prominent deficits on tests of attention, executive function, 
and visuospatial ability) and pathological features (LBs α-synuclein aggregates) with 
Parkinson Disease Dementia (PDD). In the last years, in fact, DLB and PDD have been both 
included in the same nosological chapter of synucleinopathies, that is Lewy Body Dementias 
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THE CLINICAL DIAGNOSTIC CRITERIA FOR DEMENTIA WITH LEWY BODIES 
from the Third International report of the DLB consortium  
(McKeith et al, 2005) 
CENTRAL FEATURE 
 Dementia with impairment in 
everyday functioning. 
 Prominent or persistent memory 
impairment may not necessarily 
occur in the early stages but is 
usually evident with progression. 
 Deficits on tests of attention, 
executive function, and 
visuospatial ability may be 
especially prominent. 
CORE FEATURES 
 Fluctuating cognition 
with pronounced 
variations in attention and 
alertness 
 Recurrent visual 
hallucinations 
 Parkinsonism 
SUGGESTIVE features 
 REM sleep behavior 
disorder 
 Severe neuroleptic 
sensitivity 
  Reduced dopaminergic 
activity in basal ganglia 
(SPECT or PET imaging) 
For a diagnosis of "Probable" DLB: 
Central feature  AND two core features  - OR -Central feature  AND one or more core features with 
one or more suggestive features  
For a diagnosis of "Possible" DLB: 
Central feature AND one core feature  - OR - Central feature AND one or more suggestive features 
-- 
Timing cut-off 
"one -year rule" between the onset of dementia and parkinsonism to distinguish DLB and PDD  
SUPPORTIVE FEATURES  
these are often present but do not have diagnostic specificity 
 Repeated falls and syncope 
 Transient, unexplained loss of consciousness 
 Severe autonomic dysfunction, e.g., orthostatic hypotension, urinary incontinence 
 Hallucinations in other modalities 
 Systematized delusions 
 Depression 
 Relative preservation of medial temporal lobe structures on CT/MRI scan 
 Generalized low uptake on SPECT/PET perfusion scan with reduced occipital activity 
 Abnormal (low uptake) MIBG myocardial scintigraphy 
 Prominent slow wave activity on EEG with temporal lobe transient sharp waves 
FINDINGS THAT DO NOT SUPPORT DLB 
 Presence of cerebrovascular lesions on brain imaging (brain CT or MRI) or focal 
neurologic signs  
 Presence of any other physical illness or brain disorder sufficient to explain the clinical 
symptoms 
 Parkinsonism that occurs for the first time when dementia is severe 
Table 1. The clinical diagnostic criteria for dementia with Lewy bodies taken from the third 
international report of the DLB consortium (McKeith et al., 2005). SPECT:  single photon 
emission computed tomography; PET: positron emission tomography; CT: computed 
tomography; MRI: magnetic resonance imaging; MIBG: 31-iodine metaiodobenzylguanidine 
single photon emission computed tomography; EEG: electroencephalography. 
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(Lippa et al., 2007). PDD should be the suspected diagnosis in patients with Parkinson’s 
disease (PD) who develop cognitive deficits and/or behavioural disturbances such as 
hallucinations during the course of their illness (Emre et al., 2007). These two diseases are so 
closely related that they are distinguished by an arbitrary cut-off ("one year rule") in the 
timing of motor compared to cognitive dimensions (PDD can be diagnosed only when 
cognitive deterioration supervenes after one year of the motor symptoms onset). Their 
response to the treatment with acetylcholinesterase inhibitors (AChEI) and the side effects 
associated with administration of conventional neuroleptic drugs are similar. Whether the 
distinction between PDD and DLB is nowadays based on an arbitrary time criterion, the 
distinction between DLB and other types of dementias such as Alzheimer Disease (AD) at 
the onset (Watson et al., 2009) is not always straightforward. Particularly, clinical 
differentiation between DLB and AD is sometimes difficult in the early stage because the 
symptoms overlap and the cognitive decline can also appear without the parkinsonism. In 
case of clinical uncertainty some additional investigation for differential diagnosis can be 
helpful: neuropsychological evaluation with formal tests, neuroimaging tools such as 
magnetic resonance imaging (MRI) or nuclear medical procedures (PET/SPECT), 
electroencephalography (EEG) and cerebrospinal fluid analysis. 
2. Neuroimaging techniques contribution to DLB diagnosis 
In this chapter we propose a systematic literature review concerning the principal 
neuroimaging techniques used for the diagnosis of DLB and their results. In contrast to PET 
and SPECT analysis, MRI represents a non-invasive tool to assess changes in macroscopic 
tissue structure (conventional MRI), microstructure (diffusion tensor imaging, DTI), 
metabolism (MR Spectroscopy, MRS), and cerebral activity (functional MRI, fMRI), and 
could bring invaluable additional information for the diagnosis of the pathology. The 
systematic literature search was performed using the computer database MEDLINE 
accessed via the Web of Knowledge. Two searches were performed including the following 
terms: "radionuclide imaging"[MeSH Terms] AND "lewy body disease"[MeSH Terms] for 
the first and "magnetic resonance imaging"[MeSH Terms] AND "lewy body disease"[MeSH 
Terms] for the second search. We limited the results with these criteria: Humans studies, 
English language, and publication date of last five years (from 2005/01/01 to 2011/03/01). 
The period was limited to the last five years in order to include works published after the 
revision of the clinical criteria for DLB (McKeith et al., 2005). This search produced a total of 
165 papers, which were screened individually by title and abstract, looking for information 
pertaining to PET/SPECT and MR studies in DLB. Moreover, the bibliographies of relevant 
papers were hand searched to find additional references. In this way,  84 original research 
papers were identified. 
2.1 Functional nuclear imaging techniques to diagnose DLB 
The above mentioned techniques PET and SPECT represent well-established, reliable 
imaging methods to assess the functional and metabolic brain changes in DLB (McKeith et 
al., 2005; McKeith et al., 2007). In Box A, technical aspects of these techniques are briefly 
summarized. The role of these techniques is well defined in the context of DLB (McKeith et 
al., 2007), although these procedures are very expensive and not widely used in common 
radiological settings. Moreover, the need of radioactive isotope injection limits the 
application of these exams only to cases of uncertain or difficult diagnosis. 
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2.1.1 Single Photon Emission Computed Tomography (SPECT)  
SPECT studies on DLB have been mainly addressed to the investigation of: 1) efficiency of 
dopamine transporter (DAT) in the the nigrostriatal pathway (usually referred to as DAT 
imaging); 2) the characteristics of perfusion within brain compartments. 
Box A: Functional Nuclear Imaging Techniques: PET and SPECT
Positron Emission Tomography (PET) and  Single Photon Emission Computed 
Tomography (SPECT) are highly specialized nuclear imaging techniques which provide 
a means to quantitatively study the metabolic processes within the body and reliably 
reveal functional abnormalities in the presence of various diseases.  
PET acquisitions require firstly the injection of a short-lived radioactive isotope, which 
combines itself with a specific biologic molecule present in the body. This procedure 
permits to observe the concentration of that molecule in different structures. After a 
determined period of time, the isotope decays with the emission of a positron which 
immediately annihilates with an electron, producing a pair of gamma rays in opposite 
directions. Particular rings of detectors containing special crystals that produce light 
when hit by a gamma ray are included within the PET scanner, and the scanner's 
electronics record these detected gamma rays during the acquisition and map an image 
of the area where the radiopharmaceutical is located. This process allows the 
observation of the metabolic activity of the biologic molecule combined with the 
radiopharmaceutical. For example, glucose combined with a radioisotope will show the 
pathway followed by glucose in the brain, in the heart, or in a growing tumour.   
SPECT procedure of image acquisition is similar to PET, but simpler, as particular 
radiopharmaceuticals are employed, which directly emit gamma rays during their 
decay. Larger detectors of gamma rays rotate around the patient. 
In this way, nuclear medicine techniques of neuroimaging are able to measure the 
physiological functioning of the brain, and can be useful to diagnose a multitude of 
medical conditions, e.g. heart disease, infection, the spread of cancer, thyroid disease, 
but also stroke, head trauma, dementia. The results of the analysis are spatial colour 
maps of the radioactivity distribution within tissues and with these images it could be 
shown that maps of activated brain regions could be produced by detecting the indirect 
effects of neural activity on variables such as Cerebral Blood Flux (Fox et al., 1986), 
Cerebral Blood Volume (Fox and Raichle, 1985) and blood oxygenation (Fox and 
Raichle, 1985; Frostig et al., 1990). Thanks to the double photon emission in PET, the 
acquisition with PET generates results faster and therefore limits radiation exposure to 
the patient. The amount of radiation exposure the patient receives in PET is about the 
same as two chest X-rays.  
In respect to fMRI, PET requires multiple acquisitions and the combination of multiple 
individual brain images in order to obtain a reliable signal. This results in an extension 
of the acquisition time.  
Furthermore, PET and SPECT do not provide structural information about the inspected 
tissues, therefore the acquisition of images using other imaging techniques such as 
structural MRI is needed, to precisely localize the resulting activations. Alternatively, in 
modern PET-CT scans the combined acquisition of a computer tomography (CT) is 
performed. 
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DAT SPECT is useful in DLB for the investigation of dopaminergic neurons in basal ganglia 
(caudatum and putamen), as previous literature proved that a loss of dopaminergic 
neurostriatal neurons is detectable in DLB but not in AD (Piggott et al., 1999; Suzuki et al., 
2002). The first ligand used in dopaminergic SPECT was [123I]-2b-carbomethoxy-3b-(4-
iodophenyl) tropane (b-CIT). More recently, the ligand [123I] N-x-flouropropyl-2b-
carbomethoxy-3b-(4-iodophenyl) nortropane (FP-CIT) was introduced, requiring a shorter 
time interval between injection and scanning (R. W. H. Walker and Z. Walker, 2009). SPECT 
with this ligand (FP-CIT SPECT) has been included in the last revision of the International 
Consensus Criteria for DLB (McKeith et al., 2005). In particular, in a phase III multicentre 
study among a large cohort of subjects,  McKeith and co-workers (McKeith et al., 2007) 
determined the effectiveness of FP-CIT SPECT to distinguish DLB from other dementias 
(principally AD), revealing a sensitivity and specificity of respectively 78% and 90% 
respectively. So far, there have been published many studies that investigated DLB by 
dopaminergic SPECT (Colloby et al., 2005; David et al., 2008; Lim et al., 2009; O’brien et al., 
2009; Roselli et al., 2009;  Walker et al., 2007). All these works consistently show the 
diagnostic value of dopaminergic SPECT as applied to DLB, through the evaluation of the 
striatal dopaminergic innervations reduction,  also in the distinction from other dementias 
(Soret et al., 2006). In particular, Lim and colleagues (Lim et al., 2009) compared b-CIT 
SPECT with FDG-PET in the investigation of patients with DLB and AD, concluding that 
SPECT shows higher accuracy than PET in improving the diagnostic confidence of DLB. 
Moreover, Roselli et al. (Roselli et al., 2009) found significant correlations between decreased 
striatal DAT levels and visual hallucinations in DLB patients. The association of behavioural 
disturbances and SPECT analysis was also investigated (David et al., 2008), in order to 
assess the relationship between apathy and DAT uptake in DLB and AD patients: a 
significant correlation was found between lack of initiative and bilateral putamen DAT 
uptake, demonstrating a relationship between apathy and DAT levels. 
Perfusion SPECT studies, instead, use markers such as 99mTc- hexamethylpropyleneamine 
oxime to identify deficits in the functional pattern of brain activity. The majority of available 
studies highlighted a characteristic pattern of hypoperfusion in DLB patients in parietal and 
occipital brain areas (Brockhuis et al., 2006; Hanyu et al., 2006a; Lobotesis et al., 2001). 
However, other studies also suggested the presence of hypoperfusion in the  frontal, 
parietal, and temporal cortex and in the thalamus (Chang et al., 2008). The differentiation 
between AD and DLB patients was often investigated by means of this second perfusion-
based SPECT approach, in order to identify characteristic features allowing to distinguish 
between the two most common types of dementias (Colloby et al., 2010a; Colloby et al., 
2010b;  Goto et al., 2010; Kasama et al., 2005; Kemp et al., 2005; Mito et al., 2005; Shimizu et 
al., 2005; Shimizu et al., 2008; Tateno et al., 2008a). When compared with AD, DLB patients 
presented a preserved perfusion in the medial temporal lobe structures and a hypoperfusion 
in the occipital lobes, besides an increased perfusion in the striatum and thalamus 
bilaterally. In a recent study by Colloby and colleagues (Colloby et al., 2010a), the utility of 
99mTc-exametazime SPECT in the distinction between AD and DLB was verified through a 
Region Of Interest (ROI) approach and the Principal Component Analysis (PCA). The ROI 
analysis showed decreased regional CBF in AD compared to DLB, in the medial temporal 
lobe, in the striatum bilaterally and in the right thalamus. 
Moreover, a distinction between the two groups was possible through the analysis of the 
principal components (PCs). Two components, in fact, were identified as being differentially 
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affected in AD and DLB. The former revealed concomitant decreased perfusion in the 
medial temporal lobes and increased perfusion in the cerebellum of AD compared to DLB 
patients. Conversely,  the latter represented a concomitant increase of regional CBF in 
thalamus bilaterally ,and in the right striatum of DLB compared to AD patients.  
Interestingly, SPECT imaging was also used in combination with other measures to better 
detect changes in DLB. Several studies (Hanyu et al., 2006b;  Inui et al., 2007; Novellino et 
al., 2010; Tateno et al., 2008b) which combined SPECT and (1,2,3)I-metaiodobenzylguanidine 
myocardial (MIBG) scintigraphy reported that the accuracy power in the diagnostic process 
of DLB resulted increased. Furthermore, Goto and colleagues (Goto et al., 2010) proposed to 
combine the computation of ratios on perfusion SPECT with MRI volumetric data 
(hippocampal, occipital, and striatal structures) to discriminate between DLB and AD. They 
found that the striatal volume and the occipital SPECT ratio in the DLB group was lower 
than that in the AD group and concluded that the combination of SPECT and MRI might 
contribute to a successful differential diagnosis of DLB. Chang et al. (Chang et al., 2008), 
instead, demonstrated the efficacy of perfusion SPECT combined with neuropsychological 
evaluation to differentiate early stage DLB patients at early clinical stage from those 
suffering from PD. SPECT images analysed with a ROI approach resulted in a pattern of 
significant hypoperfusion in DLB compared with healthy controls in frontal, parietal, 
thalamic, and temporal areas; consistent to this imaging finding, neuropsychological tests 
revealed the presence of deficits in DLB patients with respect to controls including the 
following cognitive domains: mental manipulation, short-term memory, abstract thinking, 
drawing and semantic verbal fluencies. Compared with PD, DLB patients showed 
significantly reduced SPECT signals in temporal areas and had lower scores at 
neuropsychological evaluation for mental manipulation, drawing and semantic verbal 
fluency. Conversely, SPECT analyses (FP-CIT and DAT) were unable to discriminate DLB 
and PDD (Rossi et al., 2009), thus supporting the hypothesis that these two forms of 
dementia belong to a continuum spectrum of a unique disease. 
In conclusion, the two different SPECT analyses (DAT and perfusion) have proven to be 
both useful, but DAT scan seems to be more robust and accurate for diagnostic purposes, as 
described in a recent study by Colloby and colleagues (Colloby et al., 2008).  These authors 
directly compared the performances of the two SPECT approaches when applied to the 
differential diagnosis between AD and DLB, and identified dopaminergic SPECT as the 
technique with higher diagnostic accuracy (ROC curve area 0.83, sensitivity 78.6%, 
specificity 87.9% in respect to perfusion SPECT with ROC curve area 0.64, sensitivity 64.3%, 
specificity 63.6%).  
2.1.2 Positron Emission Tomography (PET) 
Together with SPECT, PET allows the functional investigation of brain activity and 
metabolism (see Box A) and therefore represents a powerful instrument for the early 
detection of dementia (Koeppe et al., 2005), since it was proven that brain function deficit in 
dementia occurs long before disease clinical evidences (Tartaglia et al., 2011).   The use of 
different radioisotopes increases PET versatilities. Depending on the specific tracer used, in 
fact, PET imaging allows the representation of specific molecules, and therefore the analysis 
of different functioning systems (e.g. the neural energy metabolism with F-18 2-fluoro-2-
deoxy-D-glucose; the cholinergic way with N-11C-methyl-4-piperidyl acetate; the 
dopaminergic with 18fluorodopa; the brain amyloid burden with  Pittsburgh compound B).   
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The more common tracer used in PET clinical studies is the F-18 2-fluoro-2-deoxy-D-glucose 
(FDG), which provides information about neuronal energy metabolism, in terms of regional 
glucose uptake. In the context of DLB, previous FDG-PET studies revealed a pattern of 
hypometabolism in the medial occipital cortex (Klein et al., 2010; Perneczky et al., 2008a; 
Satoh et al., 2010), in agreement with the previously reported SPECT data of hypoperfusion. 
Furthermore, other literature data found a correlation between cerebral hypometabolism in 
right temporoparietal cortex, prefrontal cortex and the precuneus and patients’ performance 
level of everyday competence (Perneczky et al., 2008b; Perneczky et al., 2009a). Moreover, a 
recent study by Miyazawa and co-workers (Miyazawa et al., 2010) introduced a new pattern 
of hypermetabolism in DLB regarding three different areas: the peri-motor area, the basal 
ganglia and the cerebellum. Interestingly, only patients with hypermetabolism in all these 
three areas experimented recurrent visual hallucinations, therefore authors concluded that 
this pattern may be related to the core features of this behavioural disturbance.   
In recent years, these relationships between brain perfusion and symptoms domain were well 
investigated (Fujishiro et al., 2010; Miyazawa et al., 2010; Nagahama et al., 2008; Nagahama et 
al., 2010; O’Brien et al., 2005; O’Brien et al., 2008; Perneczky et al., 2010). The cognitive 
performances on visual spatial and attentional tasks in DLB were proved to be closely related 
to the frontal-subcortical network dysfunction of these patients (Nagahama et al., 2008; 
Perneczky et al., 2008a; Perneczky et al., 2009b; Perneczky et al., 2010). A recent FDG-PET 
study by Fujishiro and colleagues (Fujishiro et al., 2010) demonstrated the correlation between 
REM sleep behaviour disorder and the development of DLB, observing that the typical pattern 
of occipital hypometabolism  on FDG-PET clearly manifested in patient with DLB also in 
prodromal stages. Furthermore, distinguishable cerebral networks were associated with 
different psychotic symptoms in DLB patients: dysfunctions of the parietal-occipital 
association cortices with visual hallucinations; dysfunctions of limbic and paralimbic 
structures with misidentification and relative hyperperfusion in the frontal cortex with 
delusions (Nagahama et al., 2010; Perneczky et al., 2008a; Perneczky et al., 2009b). 
As to the comparison with PD, instead, a metabolic decrease was found in DLB in the 
inferior and medial frontal lobes and in the right parietal lobe (Yong et al., 2007). Moreover, 
a comparison with PDD revealed similar pattern of metabolism reduction for PDD and DLB, 
except for the anterior cingulated and these findings support the hypothesis that these types 
of dementias are closely related and may be included in a unique spectrum (Yong et al., 
2007). These data are concordant with an innovative multitracer PET study on PDD, PD and 
DLB patients, which aims at highlighting the complex damage pattern at the base of these 
conditions (Klein et al., 2010). For the first time, a multidimensional approach was 
introduced to detect the complex issue of the neuropathological spectrum of Lewy Body 
dementias (see Fig. 1): besides FDG, 18fluorodopa (FDOPA) was used to study the 
dopaminergic system and N-11C-methyl-4-piperidyl acetate (MP4A) for the cholinergic one, 
aiming on identifying the different characteristics of these systems. The results did not 
succeed in the distinction between the two conditions of DLB and PDD, but allowed to 
identify the metabolic features of the observed neuronal systems. A dopaminergic deficit 
was showed in the amygdala, in the anterior cingulated and in the prefrontal cortex of 
patients compared to controls, whereas the analysis with MP4A highlighted a cholinergic 
deficit regarding the occipital cortex. As this cholinergic impairment did not regard PD 
patients without dementias, it seemed to be directly responsible for the development of 
dementia in addition to motor symptoms. In line with previous studies, FDG-PET 
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underlined a pattern of hypometabolism in correspondence of the cholinergic deficit, in the 
parieto-occipital brain regions. Taken together, in agreement with Klein and co-workers, 
these findings strengthen the concept that PDD and DLB represent two sides of the same 
coin in a continuum of Lewy Body Diseases.  
When facing the issue of the comparison between DLB and AD, the FDOPA PET represent 
an interesting way to distinguish between the two pathologies, since differently from DLB,  
AD is not affected by a dopaminergic dysfunction. Moreover, in this context also FDG-PET 
demonstrated effectiveness, revealing a decrease in the occipitotemporal metabolism of 
DLB, in accordance with  the visual processing problems that primarily DLB patients report 
(Gilman et al., 2005).  
The recent development of new PET ligands which can bind amyloid, such as the 
radiolabeled Pittsburgh compound B ([11C]PiB), opened new frontiers on the study of 
amyloid metabolism through PET (Tartaglia et al., 2011).  This aspect appears of importance 
in the study of DLB, since it was proven to be associated with amyloid deposition, as it 
happens in Alzheimer Disease (Brooks et al., 2009).  Previous literature suggested a similar 
pattern of amyloid high cortical deposition in AD and DLB (Backsai et al., 2007; Fodero-
Tavoletti et al., 2007; Maetzler et al., 2009), whereas  conflicting data are reported about the 
comparison between DLB and PDD. In fact, ([11C]PiB)-PET studies reported a significant 
increase in the amyloid load in DLB compared to PDD (Edison et al., 2008; Gomperts et al., 
2008), demonstrating the efficacy of this technique in the distinction between DLB and PDD. 
On the contrary, Foster and colleagues (Foster et al., 2010) showed that amyloid deposition 
did not allow differentation between different subtypes of Lewy Body associated disorders. 
In conclusion, the power of PET as well as SPECT analysis is represented by the modalities 
versatility, allowing the study of the different and complex neuropathological substrates of 
DLB which is not possible with other imaging modalities without tracers (Herholz et al., 
2007; Kemp et al., 2007). Nevertheless, the limits imposed by the use of radioactive isotope 
injection and high costs must be taken in consideration. 
2.2 MRI-based analyses techniques: Adding useful information to clinicians 
The importance of introducing advanced MR imaging techniques in the DLB diagnosis 
beside nuclear imaging methods is due to their capability to non-invasively detect early 
changes which could be potential biomarkers of the pathology. These MRI-based techniques 
can be used in large-scale studies thanks to the wide availability of MR scanners in clinics. 
MRI is a complex field including different approaches which permit the investigation of 
several aspects of brain structure and function. The clinical utility of structural 
neuroimaging with MRI for diagnosis and differential diagnosis of dementias is well-
established (Hentschel et al., 2005), however, conventional MRI in association with 
advanced methods of image processing (e.g. voxel-based morphometry) represent a 
powerful tool in tissue structure analysis. Moreover, the investigation of microstructural 
changes is permitted by DTI through the observation of water molecular displacements 
within tissues. Cerebral activity is also detectable by functional MRI (fMRI) techniques. In 
the following, we summarise the principal literature findings in  the study of DLB obtained 
using the above mentioned MRI approaches.  
2.2.1 Voxel Based Morphometry (VBM) 
The analysis with the technique of voxel based morphometry (VBM) on Magnetic Resonance 
images is one of the most widespread MRI-based approaches aimed at quantifying regional 
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differences across subjects in brain tissue volumes (see Box B for technical details). In the 
context of DLB, the use of VBM appears highly promising to investigate the pattern of gray 
and white matter (GM and WM) atrophy and the severity of the damage.  
Several literature studies used VBM to demonstrate the differences between DLB and PDD, 
and converged to reveal a pattern of more pronounced gray matter atrophy in DLB 
compared to PDD. These results appear in concordance with the ([11C]PiB)-PET findings of 
greater structural cortical changes in DLB related to amyloid burden (Edison et al., 2008; 
Gomperts et al., 2008). However, the distribution of this GM loss appears very 
heterogeneous among the different studies, and regards: the temporal (Beyer et al., 2007; 
Tam et al., 2005), parietal and occipital lobes (Beyer et al., 2007; Lee et al., 2010a), striatal 
areas (Lee et al., 2010a), right premotor areas, right inferior frontal lobe and right superior 
frontal gyrus (Sanchez-Castaneda et al., 2009). In a recent study, Sanchez-Castaneda and 
colleagues (Sanchez-Castaneda et al., 2010) found a different pattern of structural and 
functional correlations between the two dementias, in particular: decreases in volume in 
associative visual areas, left precuneus and inferior frontal lobe which correlates with visual 
hallucinations only in DLB. A possible explanation for these different results is the 
heterogeneity (e.g. disease duration, stage of dementia) amongst patients with PDD 
(patients who developed dementia early or later in the course of their illness) who are 
included in these small size studies. Moreover, the same pattern of atrophy measured in GM 
of DLB in respect to PDD was found also in WM by Lee and co-workers (Lee et al., 2010a). 
In their recent study, they demonstrated a significant decrease of the WM density in DLB, 
specifically in the bilateral occipital and left occipito-parietal areas. Moreover, they found 
that the atrophy level of GM and WM was similar in DLB patients, whereas WM damage 
was observed to a lesser severity in respect to GM loss in PDD. Taken together, these data 
may reflect the different nature of neuropathological aspects or potentially the different 
neuropathological stages regarding PDD and DLB. Further studies including a better clinical 
characterisation of patients (e.g. matching for age, dementia duration, and treatments) are 
needed to clarify the topic and delete this potential bias. 
As to the comparison between DLB and AD, the distinction in terms of cerebral atrophy 
between these two groups was not well defined. A few recent studies attempted to identify 
a pattern of cortical atrophy which could distinguish DLB patients from AD patients (Burton 
et al., 2009; Whitwell et al., 2007).  Whitwell et al. (Whitwell et al., 2007) highlighted a more 
severe cortical atrophy in AD compared to DLB patients regarding the medial temporal 
lobe, inferior temporal regions, the hippocampus and the temporoparietal cortex. Both 
groups revealed a pattern of damage in the midbrain and substantia innominata, although 
DLB patients showed a greater loss regarding the midbrain whereas AD regarding the 
substantia innominata. Thus, the specific pattern of cortical atrophy able to characterize DLB 
from AD was identified by Whitwell as a relatively focused loss in midbrain, substantia 
innominata and hypothalamus, with a sparing in hippocampus and temporal cortex. 
Changes in substantia innominata suggesting cholinergic impairment of DLB were also 
detected by Hanyu and co-workers (Hanyu et al., 2005; Hanyu et al., 2007). Furthermore, 
other studies found that the temporal (Beyer et al., 2007; Burton et al., 2009; Takahashi et al., 
2010) and frontal lobes (Beyer et al., 2007) are potentially interested by a more pronounced 
cortical loss in AD compared to DLB. In particular, Burton and colleagues (Burton et al., 
2009) showed that medial temporal lobe atrophy on MRI had an important role by 
distinguishing AD and DLB in pathologically confirmed cases.  
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Box B: Voxel Based Morphometry
Voxel-based morphometry (VBM) of structural MRI data is a well-established technique 
of group analysis which allows the comparison of regionally specific differences in the 
local concentration of gray matter between two groups of subjects on a voxel by voxel 
basis. Typically T1-weighted MRI scans enter the VBM analysis and the compared 
groups consist in a group of subjects with a disorder and an age-matched control group 
of healthy subjects, in order to highlight the features characterizing pathology, in terms 
of brain volumes. The technique of VBM has become increasingly popular over the last 
few years since it is relatively easy to use. It has also been applied to assess the patterns 
of grey and white matter loss regarding many different pathologies (Whitwell et al., 
2007). The importance of this approach is that it gives a comprehensive assessment of 
anatomical differences throughout the brain, without being biased to one particular 
structure (Ashburner and Friston, 2000), as it does not require any a priori assumptions 
concerning which structures to consider. This gives to the VBM a significant advantage 
over more traditional region of- interest (ROI) approaches, which involve the manual 
delineation of the structures of interest (Withwell et al., 2007), being therefore extremely 
operator-dependent and scarcely reproducible. 
The first step of the VBM analysis involves a spatial normalization of the images of all 
subjects to bring them to the same stereotactic space and perform voxel-wise comparisons. 
This is achieved by registering every image to one previously chosen template image, with 
the minimization of the residual sum of squared differences between them. Then, the gray 
matter is extracted from the normalized images by means of a segmentation of the 
different brain tissues from the images. The next step is the smoothing of gray matter 
images, in order to compensate for normalization errors and also to render the data more 
normally distributed, increasing thus the validity of parametric statistical tests. The 
accuracy of the gray matter segmentation step is essential in order to assure that the 
analysis of the proper structures of interest is performed. 
After that, the voxel-wise statistical analysis is performed with the aim of identifying 
positions in the brain where the gray matter concentration differs significantly between 
groups.  The General Linear Model (GLM) is used for the statistical analysis, allowing 
many different tests to be applied, as group comparisons and identification of regions of 
gray matter concentration that are related to particular covariates (e.g. pathology 
severity, age). The output from the method is a statistical parametric map showing 
regions where gray matter concentration differences between the compared groups 
appear statistically significant. 
Obviously the image pre-processing of the VBM analysis is required to be extremely 
accurate and rigorous to avoid errors of interpretation caused by misclassification of non-
brain voxels or voxels belonging to other  tissues, and to allow precise statistical analyses. 
One shortcoming of the VBM approach is in fact represented by the decrease in the 
sensitivity for the detection of group differences, associated with the variability among 
individuals both due to sample heterogeneity and to inaccuracies introduced with the 
image pre-processing. In addition, the smoothing step involves a trade off to be 
considered: while high levels of smoothing increase the ability of the technique to detect 
group differences by reducing the variance, excess smoothing diminishes the accuracy 
in the localization of changes. 
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In conclusion, the main findings of these studies can be summarised in the following key 
points: 1) the rate of cerebral cortical atrophy of DLB patients appears higher than PDD but 
at the same time lower than AD; 2) the medial temporal lobe structures are more preserved 
in both DLB and PDD in respect to AD (Beyer et al., 2007; Burton et al., 2009; Tam et al., 
2005; Whitwell et al., 2007); 3) DLB and PDD show greater changes in respect to AD in 
subcortical structures and this is due to dopaminergic system dysfunction (Hanyu et al., 
2007; Summerfield et al., 2005; Whitwell et al. 2007).     
2.2.2 Diffusion Tensor Imaging (DTI) 
Diffusion weighted and diffusion tensor imaging (DTI) could play an important role in the 
study of DLB, thanks to the unique capability of these techniques to investigate white matter 
microstructural damages, which could help in the definition of a characteristic 
neurodegenerative pattern and consequently in the differentiation of DLB patients from 
other dementias. White matter diffusion characteristics are primarily assessed by means of 
the computation of Mean Diffusivity (MD) and Fractional Anisotropy (FA) (see Box C for 
further technical details).  
Previous DTI studies on DLB were implemented initially with Regions Of Interest (ROI) based 
methods or voxel-based DTI and found diffusion abnormalities of the corpus callosum, 
pericallosal areas and the frontal, parietal, occipital and, less prominently, temporal white 
matter of patients compared with controls (Bozzali et al., 2005; Firbank et al., 2007a; Firbank et 
al., 2007b; Lee et al., 2010b). These findings in regions with a high prevalence of long 
connecting fibre tracts might suggest the presence of neurodegeneration involving associative 
cortices. Moreover, the selective involvement of parietal, frontal and occipital lobes might 
explain some of the clinical and neuropsychological features of DLB, providing a possible 
distinctive marker for this disease. The modest involvement of the temporal lobe, according to 
previously described VBM studies (Beyer et al., 2007; Burton et al., 2009; Tam et al., 2005; 
Takahashi et al., 2009; Whitwell et al., 2007), is consistent with the relative preservation of 
global neuropsychological measures and memory tasks in the early stage of DLB. More 
recently, Kantarci and colleagues (Kantarci et al., 2010) found increased MD in the amygdala 
and decreased FA in the inferior longitudinal fasciculus in DLB with respect to controls. 
Authors suggested that the former result could reflect the typical microvacuolation associated 
with LBs pathology in this structure, whereas the latter may be due to the presence of core 
symptoms of visual hallucinations. The encountered inferior longitudinal fasciculus damage in 
concordance with a tractography based study by Ota and colleagues (Ota et al., 2009) 
correlates with the pathology, as this bundle is responsible for visuospatial cognition and DLB 
is thought to involve an impairment of the visual association area. 
In the above mentioned study by Ota et al. (Ota et al., 2009) the findings were supported by the 
computation of eigenvalues (λ1, λ2, λ3), providing information about the magnitude of axial (λ1) 
and radial (λ2, λ3) diffusivity.  They found significantly lowered  λ2 and λ3 in the inferior 
longitudinal fasciculus of DLB patients in respect to healthy controls, however no difference was 
found in λ1. Furthermore, a recent study (Kiuchi et al., 2011) introduced the tractographic 
reconstruction of white matter fiber bundles not only for the study of DLB but also for the 
comparison with AD. The analysis was focused on the uncinate fasciculus, inferior fronto-
occipital fasciculus and inferior longitudinal fasciculus. Although no significant differences were 
seen between AD and DLB, some different features in the FA evaluation were found between 
each patient group and controls. In particular, significantly lowered FA values were found in 
bilateral uncinate fasciculus for both AD and DLB, and in bilateral inferior fronto-occipital  
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Box C: Diffusion weighted and Diffusion Tensor Imaging
Diffusion Weighted Imaging (DWI) is an advanced MRI technique providing invaluable 
information concerning tissue structure at a microscopic scale, thanks to the observation of 
the molecular diffusion. The image contrast in DWI depends, in fact, on the entity of water 
molecule diffusive displacements in tissues, and consequently on tissue microstructure. 
The basic principles of DWI, which has been an important area of research in the past 
decade, were introduced in the mid-1980s and combined conventional MR imaging 
principles with the use of sharp bipolar magnetic field gradient pulses in order to encode 
molecular diffusion effects in MR signal. The physical process of molecular diffusion, first 
formally described by Einstein in 1905, refers to the random motion of molecules, also 
called Brownian motion, which results from the thermal energy carried by these molecules 
(Beaulieu, 2002). The erratic motion of molecules in a homogeneous solution is statistically 
described by a displacement distribution, which represents the probability that a particular 
molecule travels a given distance in a given time interval, and is governed by the diffusion 
coefficient D.  In biological tissues, compared to solutions, the movement of molecules is 
hindered by macromolecules and cellular organelles and is also restricted by the 
confinement created by membranes. The macroscopic result is a decreased coefficient of 
diffusion, named apparent diffusion coefficient (ADC). In biological tissues with a highly 
anisotropic structure, such as white matter fibre bundles, diffusion is characterized by a 
specific directionality, since the peculiar structural arrangement of the medium limits 
molecular movement in some directions. To fully describe the diffusion process, it is thus 
necessary to investigate displacements of molecules not only along one direction, but 
along multiple dimensions. This is possible using Diffusion Tensor Imaging (DTI), which 
describes diffusion in the three-dimensional space using a tensor quantity D instead of a 
single coefficient. This provides a  detailed mathematical description of diffusion and 
allows to compute the principal direction of diffusion in every position of the explored 
tissue, as the principal eigenvector of the tensor. Moreover, from the tensor eigenvalues 
(λ1, λ2, λ3) computed in every voxel of the image, two useful scalar measures providing 
information about the diffusion features can be computed: the Mean Diffusivity (1) 
                                                      1 2 3(λ λ λ )MD
3
                                                        (1) 
indicating the diffusion magnitude, and the Fractional Anisotropy (2) 
                                  
2 2 2
1 2 3
2 2 2
1 2 3
(λ MD) (λ MD) (λ MD)3FA
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 
                        (2) 
providing an estimate of the degree of diffusion directionality. These metrics are 
commonly used to quantitatively assess diffusion features in healthy population and 
abnormalities in pathological tissues. Furthermore, DTI is at the base of the advanced 
technique of tractography (or fiber tracking), i.e. the virtual reconstruction of brain 
white matter tracts, starting from the assumption that the direction of major diffusion 
would indicate the overall orientation of the fibres in the brain.  This technique 
represents one of the most important area of current research and, in combination with 
fMRI, opens a window on the important issue of brain  connectivity. 
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Box D: BOLD signal and functional Magnetic Resonance Imaging
The functional Magnetic Resonance Imaging (fMRI) analysis provides invaluable 
information about the localization of neuronal activations related to a task or in a 
condition of rest, and for this reason is one of the most widely used method for brain 
mapping and measuring behaviour-related neural activity in the human brain. The 
development of functional techniques gives to MRI the ability to observe both the 
structures and also which structures participate in specific functions, gaining great 
power in the mapping of functional connectivity. Different fMRI techniques can be 
employed to measure the hemodynamic response, however fMRI based on blood-
oxygen level-dependent (BOLD) contrast has gained great success due to its high 
sensitivity and accessibility (Logothetis, 2002). This contrast was firstly described by 
Ogawa and colleagues in 1990 (Ogawa et al., 1990a; Ogawa et al., 1990b), with the 
introduction of a high resolution gradient-echo-pulse sequence accentuating the 
susceptibility effects of deoxygenated Hemoglobin (dHb) in the venous blood and 
obtaining therefore a signal dependent on the blood oxygen level. In fact, dHb owns a 
paramagnetic nature which induces a local alterations of the magnetic field in 
correspondence of the compartments containing dHb, and a consequent modification 
the T2* weighted MRI signal. The increase in regional CBF caused by a neuronal 
activation does not correspond to an increase in the oxygen consumption rate (Fox & 
Raichle, 1985), thus a decreased oxygen extraction fraction is observable and this results 
in a lower dHb content per volume unit in activated tissues (Logothetis, 2002). For this 
reason, activated areas will be characterized by a higher BOLD signal in the image. 
However, it was demonstrated that BOLD contrast is actually a complex type of 
response controlled by several parameters, depending therefore not only on blood 
oxygenation, but also on cerebral blood flux and volume (Ogawa et al. 1993; Ogawa et 
al., 1998; Van Zijl et al. 1998; Weisskoff et al. 1994). Although the exact relation between 
the blood oxygen-level dependent (BOLD) signal and the underlying neural activity 
appears difficult to explicate, fMRI experiments allow to observe which brain areas 
activate in relation to the performance of a particular task. Patients are required to 
perform a specific task during the MRI acquisition, expecting the activation of specific 
corresponding brain areas during the task. This information is useful both in healthy 
subjects, to map the normal cerebral functions, and in presence of diseases, aiming on 
underlying possible changes of functionality in damaged brains. Moreover, fMRI opens 
a window on the complicated issue of neuronal connectivity, allowing the observation 
of functional connections between different areas in the brain, and of neuronal plasticity, 
i.e. the capability of the brain functions to change and adapt to external inputs, during 
life or in presence of pathologies. Recently, the fMRI analysis in a condition of resting 
(so called resting state condition) is gaining more attention in the current research, 
aiming on exploring the activated areas and their connections during rest. In respect to 
other techniques to map brain functional activity, some aspects characterizing fMRI can 
be listed as advantages of this technique: firstly, the signal does not require injections of 
radioactive isotopes as it happens for positron emission tomography (PET); the in-plane 
resolution of functional images could be less than 1 mm; furthermore, the total 
acquisition time can be very short, depending on the paradigm to perform. 
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fasciculus and left inferior longitudinal fasciculus for DLB with respect to controls, 
suggesting that DLB exhibited modifications in visual-related WM tractcs.  
From all these studies, we can argue that tractographic reconstruction proved to be helpful 
for a better understanding of WM connectivity in DLB patients and in particular for the 
detection of visual related damages in this dementia. 
2.2.3 Functional Magnetic Resonance Imaging (fMRI) 
The most diffuse neuroimaging techniques for the evaluation of brain activity and 
function in DLB are undoubtedly the above mentioned PET and SPECT. Functional 
investigations with fMRI (details in Box D) in DLB are still developing and currently 
appears less widespread than nuclear imaging studies. A unique task-related fMRI study 
(Sauer et al., 2006) was conducted and investigated the pattern of activations in DLB and 
AD during visual colour, face and motor stimuli. A significantly greater activation of DLB 
compared to AD, independent on task performance, age or cognitive score, was found in 
the superior temporal sulcus during the motor task. Instead, performance-dependent 
differences were found in the activation patterns related to the motor and face task, in 
which the activity appeared higher for AD compared to DLB, and in the default mode 
network pattern, in which the effect was greater for AD and DLB with respect to controls. 
Authors concluded thus that fMRI can be reliably used for the detection of functional 
activity distribution patterns in these two conditions. However, the role of fMRI remains 
unclear in the study of those patients, as the significance of the found results are not 
completely understood. Further studies combining anatomical MRI, DTI, and resting state 
fMRI are needed, in order to verify the hypothesis that structural subcortico-cortical 
connections may provide integral routes for communication between cortical resting state 
networks, and that changes in the integrity of these connections have a role in this 
dementia. 
3. Conclusion  
In this chapter, we reviewed the literature concerning the study of DLB through 
imaging techniques. We have shown that the use of neuro-imaging methods could 
noticeably improve the differential diagnosis of DLB when several doubts exist. To 
solve this problem, the nuclear imaging methods (PET/SPECT) play nowadays the 
principal role (O’Brien et al., 2007). However, MRI techniques revealed interesting 
results and although they are now limited to the research field, except for the 
assessment of medial temporal lobe preservation with structural MRI, they seem to be a 
promising measure for detecting early and potentially preclinical DLB changes and for 
the validation of surrogate markers to be applied in longitudinal studies and 
pharmacological trials (von Gunten & Meuli, 2009; Watson et al., 2009). We think that 
the combination of different MRI methods may contribute to a better understanding of 
this often misdiagnosed pathology. 
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1. Introduction 
The fundamental aim of the chapter is to create awareness in the general medical 
community about the benefits of neuroendoscopy imaging for prompt and effective 
diagnosis and treatment of lesions within or adjacent to fluid-filled intracranial cavities. 
Neuroendoscopy is a surgical diagnostic and therapeutic modality that has suffered an 
oscillating course in history, regarding its indications and applications. At present, it enjoys 
another thrust of popularity, which may be evident by the increasing number of 
publications and academic events world-wide related to this discipline. It has been evolving 
continuously, allowing for new indications, applications, and results. 
Neuroendoscopy is not a novel technique. According to a large number of articles and 
books, the application of lenses to observe internal parts of the body without a wide 
exposure, was initiated in the 19th century, and such technology was soon applied to the 
intracranial space. Very primitive equipment was used to explore the ventricular system 
and to excise the choroid plexus. Since the beginning of this new technology, it has suffered 
continuous modifications that have improved optical quality and surgical capability, 
resulting in better surgical outcome (1). 
As a typical example of a minimally invasive neurosurgical technique, neuroendoscopy has 
led to improvement in diagnosis, therapy, and prognosis in many intracranial lesions. 
Practically all intracranial compartments may be reached with an endoscope, whether it is 
rigid or flexible, and indications have increased dramatically. It is now possible to diagnose 
and treat through direct observation intraventricular, as well as subarchnoid and 
parenchymal lesions. 
Hoping to avoid a shunt placement and its complications, third-ventriculostomies were 
initially adopted as promising procedures for most cases of hydrocephalus. Although it has 
not been associated with the postoperative results that were hoped for, it has today very 
clear indications. Hypertensive and obstructive hydrocephalus due to different pathologies 
in the cerebral aqueduct, the posterior part of the third ventricle, or the fourth ventricle, may 
be some of the ideal cases for a third-ventriculostomy. Although some factors may vary 
when performing a third ventriculostomy, such as early age, a final word has not been said 
in this regard, since the controversy continues. Shunt systems, nevertheless, continue to be 
an important part of the instruments needed in the treatment of hydrocephalus. 
Congenital cysts in or adjacent to the ventricular system acting as space occupying lesions 
and hydrocephalus may be another clear indication for endoscopic exploration and cavity 
communication, sometimes requiring a shunt system. Although not as frequent as the 
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previous case, septum cavum pellucidum cysts have been other clear indications for 
endoscopic fenestrations, either with mechanical means (like the endoscope itself) or with 
laser beams. In such cases raised intracranial pressure is normalized and symptomatology 
slowly resides. 
Catheter placements and revisions may represent frequent indications for endoscopic shunt 
revisions, given the large number of shunt operations that take place daily throughout the 
world, so dysfunction of these systems are to be expected. The causes for shunt dysfunction 
are many, but may not be evident with image studies (CT or MRI scans), therefore 
intraventricular endoscopy offers a direct diagnostic method which may yield clear images 
in real time. It also allows the opportunity to apply therapeutic measures during the same 
operation. 
Haematoma drainage, membrane fenestrations, tumour biopsies and resections, and open 
neurosurgical assistance, may be other common procedures that may be assisted with the 
endoscope. Although indications may vary according to the local neuropathological 
illnesses and diagnostic capabilities, it is largely dependent on the neurosurgeons 
experience. 
As published elsewhere (2), there is a need to stress that precise diagnosis is a key factor for 
a correct planning of a successful neuroendoscopic procedures, since conventional image 
studies may be deficient in resolution. This is certainly the case in modest medical facilities, 
where computed tomography (CT) and magnetic resonance imaging (MRI) scanners may 
not be available or updated. This fact may represent a high proportion of primary medical 
care systems world-wide, and it is certainly true for hospitals of our community. To 
demonstrate this fact, the results obtained in our series of endoscopy cases, preoperative 
image studies (CT and MRI) have yielded unparallel results compared with those obtained 
with endoscopy in roughly half of the cases. This is especially true in the beginning of the 
case recollection, because image studies were more primitive than the images obtained from 
more modern machines, and the images were more modest in resolution. 
Neuroendoscopy may yield high quality images which may confirm or discard diagnostic 
possibilities during the surgical procedure, making often times in-situ modifications 
necessary. Derived from the previous statement, and because the original preoperative 
diagnosis was different from the intraoperative endoscopical image, the surgical treatment 
that was finally performed was different from the one originally planned in about a third of 
the cases. In this context, other surgical procedures, including open procedures, were 
avoided, and therefore additional risks and costs to the patient were reduced. 
Neuroendoscopy in our hospitals has been performed by the same neurosurgeon in 102 
procedures. With its limitations, it has demonstrated benefits, as well as drawbacks. Among 
the former, accuracy in diagnosis of lesions that were subject to several differential 
diagnosis, especially when they were based on low definition image studies. Full details of 
our cases can be observed in table 1. 
Endoscopy equipment, in our experience, has changed through different times. Initially, a 
pediatric cystoscope was used and procedures were limited to observations and few cystic 
perforations. Septostomies also were commonly performed. Most of these procedures were 
not recorded in image documents. The same was true for a second generation of 
instruments, which included a semi-rigid, 2mm diameter fibroscope, a new light source, but 
no camera or video-recorder. Our present endoscope is a 4mm rigid Richard Wolf, with 
three working channels, a video system and a high definition screen. 
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Case Age Sex Clinical Diagnosis Image Diagnosis Endoscopic Diagnosis
Ct/Endo 
Correl 
Tx 
Modif 
1 30 M RICP, SD. Global 
Hydrocephalus. No 
visible cause. 
Adherence of the 
catheter to choroid 
plexus. 
NO NO 
2 19 M RICP. Supratentorial 
hydrocephalus. 
Cysticercal 
ependymitis.  
3rd ventricle 
calcifications. 
Ventriculomegaly 
with NO ependymitis 
or calcification. 
NO YES 
3 17 M RICP. Supratentorial 
hydrocephalus. 
Ependymitis. Intra-
ventricular septi 
and/or 3rd ventricle 
cysticerci. 
Ventriculomegaly 
with NO ependymitis, 
cysticerci or septi. 
NO YES 
4 43 M RICP; 
Dementia.
Parenchymal 
calcifications. Global 
hydrocephalus. 
Ventriculomegaly. YES NO 
5 26 F RICP, SD*. Hydrocephalus. 
Thalamic tumour with 
3rd. ventricle 
infiltration and shunt 
involvement. 
Ventricular 
compression with NO 
tumour infiltration. 
Catheter in inter-
ventricular septum*. 
NO/ 
NO 
YES/ 
YES 
6 26 F RICP. Supratentorial 
hydrocephalus. 3rd 
ventricle tumour 
invasion. 
3rd ventricle tumour 
invasion with 
ventriculomegaly. 
NO NO 
7 39 M RICP. Global hydrocephalus. 
Cysticercal basal 
arachnoiditis. 
Multiple ependymal 
calcifications. 
Ventriculomegaly. 
YES NO 
8 30 M RICP. Left ventricular cyst. Septum in ventricle 
without cystic lesion. 
NO YES 
9 42 F CSF 
fistula, SD.
Pneumocephalus with 
hydrocephalus. 
Ventriculomegaly 
with 
pneumocephalus. 
YES NO 
10 34 M RICP. Supratentorial 
hydrocephalus. 
Cerebellar tumour 
with 3rd ventricle 
invasion. 
Ventriculomegaly 
with NO 3rd ventricle 
invasion. 
NO YES 
11 57 M RICP, 
Dementia.
Supratentorial 
hydrocephalus. 
Ventriculomegaly. YES NO 
12 18 F Epilepsy. Mild global cortical 
atrophy. 
Determination of 
callosotomy extent. 
YES NO 
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Case Age Sex Clinical Diagnosis Image Diagnosis Endoscopic Diagnosis
Ct/Endo 
Correl 
Tx 
Modif 
13 28 M RICP, SD. Global hydrocephalus. Ventriculomegaly. 
Multiple 
intraventricular 
adherences*.
NO/ 
NO 
NO/ 
NO 
14 31 F RICP. Global hydrocephalus. 3rd ventricle septum. 
Ventriculomegaly.
NO YES 
15 29 M RICP, 
Dementia.
Supratentorial 
hydrocephalus. 
Porencephalic cyst 
NOT communicated 
with ventricles.
Partial communication 
of cyst to dilated 
ventricles. 
NO YES 
16 32 F Seizures. Right parietal lobe 
cystic tumour with 
septi.
Parietal tumour with 
independent cysts. 
YES NO 
17 17 M RICP, SD. Supratentorial 
hydrocephalus. Two 
ventricular catheters. 
Fibrosis of 3rd ventricle 
floor with one 
catheter. Adherence of 
second catheter to 
choroid plexus.
NO YES 
18 21 M RICP. Hydrocephalus. 
Thalamic tumour. 
Ventriculomegaly. 
Callosotomy 
assistence*.
YES/ 
YES 
NO/ 
NO 
19 54 F RICP; 
Dementia.
Occipital tumour with 
ventricular 
deformation. 
Hydrocephalus. 
Extrinsic 3rd ventricle 
dysplacement. 
Ventriculomegaly. 
YES NO 
20 60 M RICP, 
Hemipare
sis.
Subacute subdural 
hematoma with septi. 
NO septi in 
hematoma. 
NO YES 
21 52 M RICP, SD, 
Infection. 
3rd and left lateral 
ventricle 
hydrocephalus. 
Purulent ependymitis.
Ventriculomegaly and 
abundant adherences* 
No purulent 
ependymitis. 
NO YES 
22 43 M RICP. Global hydrocephalus. 
Septum in right lateral 
ventricle. Pineal 
calcification within the 
3rd ventricle. 
NO septum. Pineal 
calcification not 
visible. 
NO YES 
23 46 M RICP. Hydrocephalus. 
Cortical cyst.
Ventriculomegaly. YES NO 
24 46 M Stroke 
with 
dysartria 
and 
hemiparesis
Hydrocephalus. 3rd 
ventricle displacement 
by arachnoid cyst. 
Discrete 3rd ventricle 
with adherences in the 
lateral ventricle. 
Ventriculomegaly. 
NO NO 
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Case Age Sex Clinical Diagnosis Image Diagnosis Endoscopic Diagnosis
Ct/Endo 
Correl 
Tx 
Modif 
25 77 F Headache, 
seizures. 
Hydrocephalus. 
Multiple parenchymal 
calcifications and cysts.
Ventriculomegaly 
with adhesive 
ependymitis. NO cysts.
 
NO NO 
26 77 M RICP, 
coma. 
Supratentorial 
hydrocephalus. 
Ventriculomegaly 
with a small viable 
cysticercus in choroid 
plexus. 
NO YES 
27 18 F RICP. Compressive septum 
pellucidum cyst. 
Dilated, isolated and 
hypertensive septum 
pellucidum cyst. 
YES NO 
28 29 F Epilepsy. Dilated left temporal 
ventricle. 
Dilated left temporal 
lateral ventricle. 
YES NO 
29 65 M RICP, 
coma. 
Parenchymal 
haemorrhage in frontal 
lobe. 
Parenchymal 
haemorrhage in 
frontal lobe. 
YES NO 
30 19 M RICP, SD, 
infection. 
Supratentorial 
hydrocephalus. 
Severe adhesive  
3rd ventricle 
ependymitis. 
NO NO 
31 32 F Epilepsy. Loss of white-gray 
matter interface in left 
temporal lobe. Normal 
ventricles. 
Narrow left temporal 
ventricle. 
YES NO 
32 37 F RICP. Supratentorial 
hydrocephalus. Right 
supra- infratentorial 
arachnoid cyst. 
Ventriculomegally. 
Right supra- 
infratentorial 
arachnoid cyst. 
YES NO 
33 27 M Dementia. Hydrocephalus. 
Porencephalic cyst. 
Cyst independent 
from dilated 
ventricles. 
YES NO 
34 30 M RICP, SD. 
Left 
hemiparesis
Supratentorial 
hydrocephalus. 4th 
ventricle cyst. 
Ventriculomegaly 
with extensive 
intraventricular 
fibrosis. 
 
NO NO 
35 50 M RICP, 
social 
neglect. 
Supratentorial 
hydrocephalus. 
Ventriculomegaly. YES NO 
36 35 M RICP, 
signs and 
symptoms 
of 
infection. 
Supratentorial 
hydrocephalus with 
ependymitis. 
Ventriculomegaly 
with NO ependymitis. 
Abundant fibrosis  
in 3rd (with small 
compartments) and 
lateral ventricles*. 
NO/ 
NO 
YES/ 
YES 
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Case Age Sex Clinical Diagnosis Image Diagnosis Endoscopic Diagnosis
Ct/Endo 
Correl 
Tx 
Modif 
37 46 M Epilepsy. Left temporal lobe 
atrophy. 
Intraventricular 
electrode placement 
control.  
Ventriculomegaly. 
YES NO 
38 21 M Epilepsy. Left temporal lobe 
epileptogenic focus. 
Narrow ventricle. 
Failed endoscopy. 
-- -- 
39 41 F Arnold 
Chiari and 
RICP. 
Ventriculomegaly. Ventriculomegaly. YES NO 
40 46 M Brain 
injury 
sequels. 
Ventriculomegaly. Turbid CSF poor 
visualization. 
-- -- 
41 19 M RICP. Supratentorial 
hydrocephalus. 
Ventriculomegaly. 
Granular ependymitis.
NO NO 
42 23 M RICP. Universal 
hydrocephalus. 
Fibrous bands and 
ependymitis with 
Monroe obstruction. 
NO YES 
43 45 M Chiasmal 
syndrome.
Hypophyseal 
macroadenoma. 
Bloody tumour bed. -- -- 
44 35 F Acromegaly Supratentorial tumour. Bloody tumour bed. -- -- 
45 42 M Vague 
neurological
symptoms.
Universal 
hydrocephalus. HIV +.
Hypertrophic 
ependymitis with 
fibrous deposits in the 
III ventricle floor. 
Generalized tissue 
paleness. 
NO YES 
46 27 M Postra-
umatic 
hydro-
cephalus. 
Dilated independent 
supratentorial 
ventricles. 
Normal pressure 
ventriculomegaly due 
to Munro foramen 
obstruction. 
NO YES 
47 23 M Postra-
umatic 
hydro-
cephalus. 
Supratentorial 
ventriculomegaly. 
Three ventricle 
dilatation with thin  
3rd ventricle floor. 
YES NO 
48 26 F Amenor-
rhoea, 
galactor-
rhoea, and 
mild 
headache.
Hydrocephalus, 
Lateral 
ventriculomegally 
with sellar 
arachnoidocele. 
Ventriculomegaly, 
Munro foramen 
obstruction due to 
arachnoid membranes.
NO YES 
49 47 M Epilepsy, 
dementia. 
Hydrocephalus, 
Multiple cerebral 
cysticerci. 
Viable cysticerci with 
scolex contained in 
turbid fluid*  
(both endoscopies). 
YES/ 
YES 
NO/ 
NO 
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Case Age Sex Clinical Diagnosis Image Diagnosis Endoscopic Diagnosis
Ct/Endo 
Correl 
Tx 
Modif 
50 56 M RICP. Hypodense images in 
3rd ventricle and basal 
cisterns. 
Viable cysticerci in  
3rd ventricle contained 
in turbid fluid, 
obstructing 
visualization  
of the floor. 
 
YES NO 
51 42 F RICP. Supratentorial 
hydrocephalus with 
widened infundibular 
recess. 
 
Ventriculomegaly 
with widened 
infundibular recess. 
YES NO 
52 54 M RICP, 
mood 
changes, 
episodic 
fever. 
Global hydrocephalus. Ventriculomegaly. YES NO 
53 34 F RICP, 
Right 
frontal 
cystic 
tumour 
Cystic hypodense 
tumour. 
Cerebral surface cyst 
wall 
YES NO 
54 15 M RICP, SD, 
Arnold-
Chiari. 
Three ventricle 
hydrocephalus, corpus 
callosum agenesis, 
cephalic catheter in 
brain tissue. 
Ventriculomegaly, 
ventricular septum 
agenesis, cephalic 
catheter in brain 
tissue. 
 
YES NO 
55 21 M RICP, SD, 
Arnold-
Chiari. 
Three ventricle 
hydrocephalus, corpus 
callosum and septum 
agenesis, cephalic 
catheter in ventricle. 
Ventriculomegaly, 
ventricular septum 
agenesis, granular 
ependymitis, cephalic 
catheter in ventricle. 
 
NO NO 
56 32 M RICP. Left and 3rd ventricle 
hydrocephalus. 
Isolated right ventricle YES NO 
57 25 M RICP, 
dizziness, 
confusion, 
dementia, 
meningeal 
signs.  
HIV + 
3-ventricle 
hypertensive 
hydrocephalus 
Turbid dense liquid, 
pale tissue covering 
ependymal walls, with 
adhesive clots and 
membranes 
NO YES 
 
Neuroimaging – Methods 
 
346 
Case Age Sex Clinical Diagnosis Image Diagnosis Endoscopic Diagnosis
Ct/Endo 
Correl 
Tx 
Modif 
58 57 M RICP. 
Incoherent 
language, 
Dizzyness
Hydrocephalus, 
granular ependymitis.
Ventriculomegaly, 
granular ependymitis 
with café au lait spots 
and verrucae,  
3rd ventricle floor 
stiffness. 
NO NO 
59 39 F RICP, 
diplopia. 
Triventricular 
hydrocephalus. 
Ventriculomegaly 
with severe septum 
lacerations. 
YES NO 
60 33 M RICP. Hydrocephalus Ventriculomegaly, 
severe septum 
lacerations, granular 
ependymitis and 
verrucae. 
NO NO 
61 44 M Headache, 
seizures. 
Viable cysticerci in 
brain parenchyma and 
cisterns. 
Viable parenchymal 
and cisternal 
cysticerci. 
YES NO 
62 44 M RICP, 
cysticercos
is. 
Hydrocephalus, 3rd 
ventricle and cisternal 
cysticerci. 
Ventriculomegaly,  
3rd ventricle and 
cisternal cysticerci. 
YES NO 
63 44 M Shunt 
dysfunctio
n 
Hydrocephalus. Ventriculomegaly, 
cysticercus in  
shunt tip. 
NO NO 
64 58 M RICP, 
ataxia, 
Parinaud, 
diplopia. 
Hydrocephalus, pineal 
tumour with possible 
3rd ventricle 
involvement. 
Ventriculomegaly, 
pineal tumour with  
3rd ventricle 
involvement. 
 
YES NO 
65 44 M RICP. Shunt dysfunction. Cysticercus in shunt 
tip. 
NO NO 
66 28 F RICP, left 
hemi-
paresis. 
 
Right 
frontotemporoparietal 
cyst. 
Cystic breast cancer 
metastasis. 
YES NO 
67 40 F RICP. 
macroceph
alus 
Severe hydrocephalus. Ventriculomegaly, 
fibrous ependymal 
and cisternal bands, 
atrophic choroid 
plexus. 
NO NO 
68 16 F Headache, 
dizziness 
Hydrocephalus, rare 
images in 3rd ventricle 
floor. 
 
Ventriculomegaly. NO NO 
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Case Age Sex Clinical Diagnosis Image Diagnosis Endoscopic Diagnosis
Ct/Endo 
Correl 
Tx 
Modif 
69 33 M Headache, 
dizziness, 
ataxia. 
Hydrocephalus, right 
hemisphere cerebellar 
tumour. 
Ventriculomegaly. YES NO 
70 39 M RICP, 
dizziness. 
Three-ventricle 
hydrocephalus, 
occluded aqueduct. 
Ventriculomegaly, 
prepontine and 
premesencephalic 
adherences. 
NO NO 
71 73 F Sudden 
dysphasia 
and 
headache.
Hydrocephalus and a 
4th ventricle 
hemorrhage 
Ventriculomegaly and 
an active 3rd ventricle 
hemorrhage. 
NO YES 
72 61 F Hakim-
Adams 
triad, 
progressive 
headache
Three-ventricle 
hydrocephalus, 
occluded aqueduct. 
Ventriculomegaly YES NO 
73 40 M RICP, 
headache, 
confusion, 
fever, 
meningeal 
signs, 
ataxia. 
HIV + 
Hydrocephalus, 
thalamic tumour with 
3rd ventricle 
involvement. 
Ventriculomegaly, 
pale granular 
ependyma, no tumour 
in 3rd ventricle. 
NO YES 
74 41 F RICP, 
previous 
posterior 
fossa 
operation 
Three-ventricle 
hydrocephalus. 
Ventriculomegaly, 
adhesive arachnoiditis 
in premesencephalic 
and prepontine 
cistern. 
NO YES 
75 31 M RICP Three-ventricule 
hydrocephalus 
Ventriculomegaly, 
cisternal cysticercosis 
NO NO 
76 67 M Headache, 
tremor, 
confusion, 
incoherent 
language 
Hydrocephalus, 
ventricular cysticerci 
Ventriculomegal, 
aracnoid cyst 
NO YES 
77 65 M Headache, 
aggressive 
behavior, 
somnolence
Cystic lesions in 
Sylvian sulcus 
Epidermoid in Sylvian 
sulcus. 
NO YES 
78 72 M Hakim-
Adams 
triad, 
progressive
headache 
Three-ventricle 
asymmetric 
hydrocephalus, 
occluded aqueduct. 
Ventriculomegaly, 
ependymitis with 
opaque epithelia. 
NO YES 
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Case Age Sex Clinical Diagnosis Image Diagnosis Endoscopic Diagnosis
Ct/Endo 
Correl 
Tx 
Modif 
79 81 M Right 
hemi-
paresis, 
memory 
dysfun-
ction, 
visual and 
auditive 
halluci-
nations. 
Hydrocephalus, 
diencephalic lesion 
affecting 3rd ventricle. 
Ventriculomegaly, 
thinning and 
protruding cyst in  
3rd ventricle wall. 
NO YES 
80 40 F Seizures, 
RICP. 
Three-ventricle 
hydrocephalus, 
increased prepontine 
cistern, brain 
calcifications. 
Ventriculomegaly, 
cysticerci in 
prepontine and 
premesencephalic 
cistern. 
YES NO 
81 27 M RICP, 
ataxia, 
dystonia. 
Brain stem tumour 
with 3rd and 4rd 
ventricle involvement.
Ventriculomegaly, 
tumour invading  
3rd ventricle. 
YES NO 
82 54 M RICP. Three-ventricle 
hydrocephalus, 
cisternal cysticerci. 
Post ETV and 
cysticercal removal. 
Hydrocephalus. 
 
Ventriculomegaly, 
cisternal cysticercosis.
YES NO 
83 54 M RICP Post ETV and 
cysticercal removal. 
Hydrocephalus. 
Ventriculomegaly, 
severe ventriculitis-
arachnoiditis. 
Ventriculomegaly, 
severe ventriculitis-
arachnoiditis 
NO/ 
YES 
NO/ 
NO 
84 39 F RICP Hydrocephalus, 3rd 
ventricle tumour. 
Ventriculomegaly, 
tumour in  
3rd ventricle. 
YES NO 
85 62 F Headache, 
memory 
loss. 
Three-ventricle 
hydrocephalus. 
Ventriculomegaly. YES NO 
86 33 M RICP, 
myalgia. 
Hydrocephalus, 
ependymitis. 
Ventriculomegaly, 
granular ventriculitis 
and arachnoiditis 
 
YES YES 
87 59 M RICP. Three-ventricle 
hydrocephalus. 
Ventriculomegaly, 
cisternal cysticercosis 
YES NO 
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Case Age Sex Clinical Diagnosis Image Diagnosis Endoscopic Diagnosis
Ct/Endo 
Correl 
Tx 
Modif 
88 64 M Dysartria, 
ataxia, 
dementia, 
headache 
Three-ventricle 
hydrocephalus, 
cisternal cysticercosis 
Ventriculomegaly, 
cisternal cysticercosis 
YES NO 
89 69 F Headache, 
seizures, 
aphasia, 
weakness 
Three-ventricle 
hydrocephalus. 
Ventriculomegaly, 
mild arachnoiditis 
NO NO 
90 32 F RICP Hydrocephalus Ventriculomegaly YES NO 
91 37 F RICP, 
ataxia, 
vertigo 
Three-ventricle 
hydrocephalus, cystic 
cerebellar tumour 
Endoscopy-assisted 
resection of 
haemangioblastoma 
YES NO 
92 26 M RICP, 
ophtalmo-
plegia, 
somnolence
Three-ventricle 
hydrocephalus, 
thalamic tumour. 
Ventriculomegaly, 3rd 
ventricle compression, 
sponge-like tumour. 
YES NO 
93 37 M RICP Isolated cyst from 
shunted ventricles. 
Ventriculomegaly, 
intracystic cysticerci, 
isolated from shunt tip 
NO YES 
94 42 F RICP, 
seizures 
Communicating 
hydrocephalus 
Ventriculomegaly, 
cisternal fibrosis  
unable to pass the 
endoscope 
 
NO YES 
95 48 M RICP Three-ventricle 
hydrocephalus 
Ventriculomegaly YES NO 
96 
 
40 F RICP, 
colloid 
cyst in the 
3rd 
ventricle 
Three-ventricle 
hydrocephalus, colloid 
cyst in 3rd ventricle 
roof 
Ventriculomegally, 
colloid cyst. Partial 
resection in second 
endoscopy 
YES/ 
YES 
NO/ 
NO 
97 33 M RICP Hydrocephalus Ventriculomegaly YES NO 
98 37 F RICP Three-ventricle 
hydrocephalus, colloid 
cyst in 3rd ventricle 
Ventriculomegaly, 
colloid cyst. Total 
resection through 
vellum interpositum 
YES NO 
99 16 F Epilepsy Arachnoid cyst in left 
sylvian fissure 
Thick and stiff onion-
skin cystic walls. 
Cystic communication 
to basal cisterns 
YES NO 
100 53 M RICP, 
dementia 
Three-ventricle 
hydrocephalus, third 
ventricle tumour 
Ventriculomegaly, 
third ventricle 
craniopharyngioma 
YES/ 
YES 
NO/ 
YES 
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Case Age Sex Clinical Diagnosis Image Diagnosis Endoscopic Diagnosis
Ct/Endo 
Correl 
Tx 
Modif 
101 70 M RICP, 
dementia 
Communicating 
hydrocephalus 
Ventriculomegaly YES NO 
102 82 M RICP, 
dementia 
Three ventricle 
hydrocephalus 
Ventriculomegally. 
Cysticercal resection 
in basal cistern. 
Widespread 
ependymitis on a 
second operation. 
NO/ 
NO 
YES/
NO 
103 24 F RICP Right lateral ventricle 
hydrocephalus 
Right lateral 
ventriculomegally due 
to Monroe foramen  
blocking by 
ependymal lining 
NO YES 
104 46 F CSF fistula Right frontal floor 
defect with 
encephalocele 
The same YES NO 
105 28 M RICP Universal 
hydrocephalus due to 
intraventricular firm 
tumour 
Soft bloody 
intraventricular 
tumour 
YES YES 
*Diagnosis and findings of second endoscopy. 
RICP: Raised Intracranial Pressure. SD: Shunt dysfunction. CSF: Cerebrospinal Fluid. M: Male. F: 
Female. 
Table 1. Endoscopy Cases Characteristics. 
Among our cases, 72% have been admitted with raised intracranial pressure. Most of these 
consisted of hypertensive hydrocephalus, although some were diagnosed as intracranial 
haematomas, cystic tumours with no hydrocephalus, arachnoid and cysticercal cysts, and 
other diagnosis. All of them but a few were resolved with endoscopic procedures, including 
drainage, resection and fenestration. 
Focal neurological dysfunction was the second syndromic diagnosis which was associated 
with brain infarcts, visual or other cranial nerve impairment. Some of these cases shared 
other syndromes such as raised intracranial pressure, meningismus, etc., since these 
diagnoses were not exclusive. 
Dementia was associated with 14% of the cases explored with endoscopy. Not attributed to 
raised intracranial pressure, necessarily, although shared by this syndrome was a constant 
feature. Many of these patients were diagnosed as Hakim syndromes and had some 
improvement of the dementia component after endoscopic exploration and subsequent 
shunting. 
Seizures as an epileptic entity or an isolated event was present in 13% of the cases studied. 
In some patients epileptic fits were an integral part of the disease, especially in those which 
were operated on for seizure control under endoscopical supervision. Such cases have been 
subject to other publications (2) nevertheless it is worth stressing that endoscope-assisted 
procedures in open neurosurgeries for patients with pharmacological deficient control, have 
made substantial contributions to the success in the treatment of those patients. 
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Central nervous system infection (4%), cerebrospinal-fluid fistula (2%), chiasmal 
compression syndrome (2%), and endocrine syndrome (2%) were other pathological entities 
encountered in the series. 
Neurocysticercosis is a parasitic disease that has been diagnosed not only in some developing 
countries, where it is considered endemic, but also in developed countries, where it is 
experiencing a continuous increase. The cause of this increase is an ever growing migrant 
population towards many countries of Northamerica, Europe, etc. Many series of cases of 
neurocysticercosis highlight the role for endoscopy in order to achieve two main purposes: to 
diagnose with precision in cases of intracranial and intraspinal cysts where no scolex has been 
observed with image studies, and to establish a treatment protocol for different pathological 
entities related to the parasite, such as hidrocephalus, associated with different degrees of 
ventricular/cisternal inflammatory lesions, as well as its appropriate timing. According to our 
observations, individual therapeutic measures may be indicated for different time spans in 
regard to cysticercal disease. The removal of the cyst may be only a limited part of the 
treatment when dealing with a complex case, in which other anti-cystciercal measures have 
failed. In such cases, different treatment modalities may be included simultaneously, given the 
extensive clinico-pathological polymorphism of this disease. 
Cysticercosis cases have presented in our hospitals with many clinical manifestations, such 
as raised intracranial pressure due to mass effect and/or hypertensive hydrocephalus, 
meningitis, stroke, dementia, epilepsy, etc. It is not uncommon to include in the treatment 
protocol several drugs, such as one or more antiepileptics, analgesics, immune depressors, 
gastric protectors, antibiotics, anticysticercals, etc. Moreover, the treatment modalities 
include one or more surgical operations which may commonly include endoscopic 
procedures that the neurosurgeon must be ready to perform. 
 
 
Fig. 1. Vascularised capsule from cyst containing live cysticerci. 
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Fig. 2. Intracapsular view of the viable cysticerci and the characteristics of the highy 
vascularised capsule wall. 
 
 
Fig. 3. Intracapsular communication with the ventricular catheter from the shunt system. 
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Fig. 4. Firmly adhered capsule to pericystic blood vessels in a case of an arachnoid cyst in 
the left Sylvian fissure. 
 
Fig. 5. Colloid cyst capsule involvement of the choroid plexus and foramen of Monroe. Wall 
characteristics resemble closely those of an aracnoid cyst in vascularity, firm consistency and 
piercing resistance. 
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As opposed with some centers in which complicated patients are sent home to meet their 
fate, all the patients in our hospitals receive some kind of treatment, regardless of their 
condition. Cases of so called malignant cysticercosis are treated with all the therapeutic 
resources at hand, with an aggressive treatment that matches the malignancy of the disease. 
Some unusual cases of neurocysticercosis have been described previously (7). Although 
some cases may be considered as coincidences, others may be pathological enigmas. One of 
these latter cases is a patient who was initially diagnosed as having an interhemispheric 
arachnoid cyst. During endoscopic exploration, a cyst with a highly vascularised hard 
capsule was encountered. After several perforations were made, a transparent yellow fluid 
escaped from the interior of the cyst and several viable cysticerci were also found. The 
parasites and several blood clots adhered to de walls of the cyst were then removed and 
finally the cyst was communicated with the ventricluar system where a functional shunt 
system was previously installed (figures 1-3). After a thorough search in the literature, cyst 
formations in the subarachnoid space that surrounded live cysticerci have not been 
previously described. The capsule was similar in resistance, vascularity, and rigidity to 
those found in other cystic lesions, like arachnoid and colloid cysts (figures 4-5). This could 
mean that cystcerci may also colonize arachnoid cysts or, on the other hand, they may form 
a capsule quite similar to that of a congenital condition. 
Although few endoscopically accessible tumours can be resected completely, biopsies of larger 
and more vascularised lesions can be taken with precision from selected areas, considering the 
amount vascular proliferation, its location and associated phenomena. Because of blurring of 
the entire field, which may be time-consuming to clear and sometimes difficult to achieve, a 
bloody fluid-filled space is a major drawback during the tumour resection. Among the tumour 
type that have been reported to complete or almost complete resection, colloid cysts, some 
astrocytomas, subependymomas, third ventricle craniopharingiomas, etc, may be  mentioned. 
Hydrocephalus, if present, can be treated during the same exploratory procedure. 
Our experience with endoscopy in tumour cases has included 19 cases. Biopsies have been 
performed in 11 cases while resections have been accomplished in 8. Some of the tumour 
types include meningiomas and craniopharingiomas within the third ventricle, exophytic 
gliomas, cystic astrocytomas and carcinomas. Although some intracranial lesions don’t have 
a neoplastic nature strictly speaking, colloid, porencephalic, and arachnoid cysts may also 
be included in this section because of its commonly associated mass effect. 
Endoscopic views from the tumour capsule and surface may have a characteristic 
appearance when its fluid is clear or has been washed with physiologic solution. There is 
usually a vascular mesh composed of layers of nets imposed one on top of the other, as 
onion skins. The vascular proliferation as observed with endoscopy vary according to the 
tumour type, and it is most abundant as more malignant the tumour is (figs 6-7). 
Endoscopic assistance in open cranial neurosurgery has been described for several years, 
according to the articles written by Perneczky and coworkers, among others (4). Indications 
of endoscopy related to this modality have also increased, and ongoing publications of new 
indications are constantly appearing in the words neurosurgical literature. It is frequently 
used to reach spaces that are normally difficult to observe with the microscope, making the 
surgical procedure safer. Aneurysm clipping, cranial nerve dissection, are some among 
many the operations that may normally be assisted with endoscopes. 
New indications for endoscopy imaging have been appearing continuously, not only to 
obtain a precise diagnosis, but also to assist in open surgical procedures. It is now possible 
to measure the extent of callosal section with endoscopy assistance, as well as ventricular 
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exploration before electrode implantation during epilepsy surgery (3). Among our cases, an 
endoscopical exploration of the temporal horn of the lateral ventricle was explored previous 
to electrode placement for resective epilepsy surgery in three patients. In another 2 patients, 
the endoscope was used to assess the extent of the callosal section. There were no 
complications derived from these procedures which take only several additional minutes in 
the operating period. Other authors have inserted electrodes within the ventricles for the 
same purpose, and their conclusions are similar to ours (5). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 6. Visceral cyst wall in a case of cystic astrocytoma. Large vessels organized in several 
leyers with different depths, occasionally with varicous formations. 
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HIV-associated hydrocephalus has been explored endoscopically in three patients. 
Clinically, they have been diagnosed following a continuously deteriorating and waisting 
condition that suddenly involved the central nervous system. Other common clinical data, 
like diarrhea, weight loss, cutaneous lesions, etc. were present at the time of hydrocephalus 
diagnosis. CT scans demonstrated obstructive hydrocephalus with a variable degree of 
inflammatory ependymal reaction which was confirmed with endoscopical observations. 
Grayish-white exudates in the ependymal lining, pseudo-membrane formation, 
inflammatory bands, etc. and other lesions that blocked the cerebro-spinal fluid drainage 
systems, like the foramen of Monroe and the cerebral aqueduct, were constant findings. 
Similar to the tuberculous leptomeningitis, the clinical course in these patients was a 
progressive deterioration regardless of the pharmacological and surgical treatments. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 7. Dense proliferation resembling a multi-leyer vascular mesh in a case of cystic 
carcinoma. Opaque yellow fluid has been removed and substituted with saline solution. 
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Postoperative complications after the use of endoscopical equipments are very rare, owing 
to the minimally-invasive nature of the procedure and the relative ease which the 
equipment may be handled. Some of these complications reported in the literature have 
been cases of infections, haemorrhages, or additional cerebral lesions caused by the surgeon; 
raised intracranial pressure during the procedure caused by defective fluid drainage-related 
at the time of endoscopy, which may account for neurological deterioration and death, has 
become a recent concern that was largely ignored in the past. 
Among our cases, the complications that have been observed were accidental punctures to 
the ventricle walls and lacerations to the borders of the foramen of Monroe. These lesions 
have apparently been clinically silent. Unsuccessful endoscopical procedures may 
sometimes be considered as surgical complications, considering the cerebral laceration that 
is necessary to have access to the ventricles.  Taking into account those cases, we would 
have a higher rate of complications, especially in early procedures when the endoscopic 
equipments were more modest. 
Although not described by other authors, and even denied by some (6), the endoscopic 
findings encountered during a second procedure in patients with persistent hydrocephalus 
following cyticercal resection, have consisted of different types of inflammatory lesions. 
Because the release of the cyst content has been the probable cause for such inflammatory 
lesions, these findings that appear in the postoperative period, may be considered by some 
as complications. Four patients diagnosed as persistent cysticercal hydrocephalus, in which 
we have performed a second endoscopical observation, could then have increased our 
complication rate. 
Technological progress has included endoscopy as well as other similar procedures that 
may be yield similar images, like virtual endoscopy. Until now the special lenses-based 
Hopkins system images may be superior compared to those obtained through a pixel-based 
computer reconstruction, although digital technology may be superior to optic technology at 
some point.  
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